P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
3.485e-15 | -33.29 | nucleoside-triphosphatase regulator activity | molecular function | GO:0060589 | 491 | 17 | 18094 | 48 |
DOCK1,DENND1B,RIN3,GIT2,ELMO1,DOCK2,VAV3,ARHGAP27,DOCK10,WAS,DOCK8,RGS14,ARHGAP33,PREX1,GMIP,TBC1D8,AKAP13 |
3.485e-15 | -33.29 | GTPase regulator activity | molecular function | GO:0030695 | 491 | 17 | 18094 | 48 |
GIT2,RIN3,DENND1B,DOCK1,VAV3,ARHGAP27,DOCK2,ELMO1,DOCK10,AKAP13,TBC1D8,GMIP,PREX1,RGS14,ARHGAP33,WAS,DOCK8 |
6.626e-12 | -25.74 | enzyme binding | molecular function | GO:0019899 | 2086 | 25 | 18094 | 48 |
PLCG2,DENND1B,GIT2,SLC4A2,RIN3,SYK,IRF5,CSF1R,CD74,WAS,AKAP13,MICAL1,DOCK1,IL6R,APOE,DOCK2,HIF1A,PRKCD,PTPN6,DOCK10,NEK6,SKAP1,ARHGAP33,RGS14,PREX1 |
2.021e-11 | -24.63 | regulation of immune system process | biological process | GO:0002682 | 1584 | 22 | 18204 | 49 |
DOCK8,RHBDF2,ADCY7,CD74,PRKCD,IL6R,CSF1R,APOE,HIF1A,PIK3CB,RIN3,IRF5,PLCG2,SLC4A2,DENND1B,GSDME,SYK,PTPN6,SKAP1,VAV3,WAS,FYB1 |
2.986e-11 | -24.23 | enzyme regulator activity | molecular function | GO:0030234 | 1305 | 20 | 18094 | 48 |
WAS,ARHGAP33,DOCK8,RGS14,PREX1,TBC1D8,GMIP,AKAP13,PRKCD,DOCK10,ELMO1,PIK3R5,DOCK2,APOE,VAV3,ARHGAP27,DOCK1,DENND1B,RIN3,GIT2 |
3.335e-11 | -24.12 | cell activation | biological process | GO:0001775 | 725 | 16 | 18204 | 49 |
WAS,VAV3,SBNO2,PLCG2,DOCK10,PTPN6,SYK,IL6R,PIK3CB,DOCK8,WDFY4,DOCK2,PRKCD,SEMA4A,CD74,PREX1 |
4.424e-11 | -23.84 | regulation of intracellular signal transduction | biological process | GO:1902531 | 1832 | 23 | 18204 | 49 |
RGS14,APOE,HIF1A,PIK3CB,CSF1R,CD74,PREX1,DOCK2,GMIP,PRKCD,ARHGAP27,AKAP13,DOCK8,PIK3R5,NRK,P2RY6,VAV3,GSDME,GIT2,PTPN6,NEK6,SYK,PLCG2 |
7.960e-11 | -23.25 | PH-like_dom_sf | interpro domains | IPR011993 | 431 | 13 | 18521 | 50 |
TBC1D8,WAS,SKAP1,VAV3,DOCK10,WDFY4,PLCG2,CARMIL3,ARHGAP27,AKAP13,ELMO1,PREX1,IPCEF1 |
1.040e-10 | -22.99 | GTPase activator activity | molecular function | GO:0005096 | 273 | 11 | 18094 | 48 |
GMIP,TBC1D8,PREX1,RGS14,ARHGAP33,GIT2,RIN3,DOCK1,ARHGAP27,VAV3,DOCK2 |
1.342e-10 | -22.73 | signal transduction | biological process | GO:0007165 | 4637 | 34 | 18204 | 49 |
CD74,ADCY7,SEMA4A,GMIP,ARHGAP27,P2RY2,AKAP13,ARHGAP33,DOCK8,HIF1A,IL6R,CSF1R,DOCK1,SYK,PLCG2,DENND1B,PIK3R5,P2RY6,VAV3,FYB1,PREX1,DOCK2,PRKCD,RGS14,APOE,RIN3,PIK3CB,ELMO1,DOCK10,PTPN6,MICAL1,IRF5,SKAP1,WAS |
1.838e-10 | -22.42 | regulation of response to stimulus | biological process | GO:0048583 | 4104 | 32 | 18204 | 49 |
HIF1A,IL6R,CSF1R,GMIP,RHBDF2,ADCY7,CD74,DOCK8,AKAP13,ARHGAP27,P2RY6,PIK3R5,FYB1,VAV3,SBNO2,SYK,NEK6,GIT2,GSDME,DENND1B,PLCG2,PIK3CB,RIN3,APOE,RGS14,PRKCD,DOCK2,PREX1,NRK,WAS,SKAP1,PTPN6 |
2.527e-10 | -22.10 | lymphocyte activation | biological process | GO:0046649 | 476 | 13 | 18204 | 49 |
PREX1,CD74,PRKCD,SEMA4A,DOCK2,WDFY4,DOCK8,IL6R,SYK,PTPN6,DOCK10,PLCG2,WAS |
3.502e-10 | -21.77 | leukocyte activation | biological process | GO:0045321 | 599 | 14 | 18204 | 49 |
IL6R,WDFY4,DOCK8,PREX1,CD74,SEMA4A,PRKCD,DOCK2,SBNO2,WAS,PLCG2,SYK,DOCK10,PTPN6 |
3.565e-10 | -21.75 | guanyl-nucleotide exchange factor activity | molecular function | GO:0005085 | 228 | 10 | 18094 | 48 |
PREX1,ELMO1,DOCK8,AKAP13,VAV3,DOCK2,DENND1B,DOCK1,DOCK10,RIN3 |
4.289e-10 | -21.57 | Fcgamma receptor (FCGR) dependent phagocytosis | REACTOME pathways | R-HSA-2029480 | 86 | 8 | 10285 | 36 |
PRKCD,PIK3CB,PLCG2,ELMO1,SYK,VAV3,DOCK1,WAS |
4.505e-10 | -21.52 | endocytosis | biological process | GO:0006897 | 499 | 13 | 18204 | 49 |
P2RY6,VAV3,SYK,DOCK1,DENND1B,APOE,PIK3CB,RIN3,ELMO1,PRKCD,DOCK2,ARHGAP27,MYO1F |
5.381e-10 | -21.34 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 20 | 18204 | 49 |
DOCK1,DOCK10,PTPN6,SYK,PLCG2,PIK3R5,WAS,VAV3,DOCK2,PRKCD,GMIP,PREX1,ADCY7,DOCK8,ARHGAP33,AKAP13,PIK3CB,APOE,HIF1A,ELMO1 |
9.066e-10 | -20.82 | Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB) | gene3d domains | 2.30.29.30 | 431 | 13 | 14470 | 48 |
DOCK10,SKAP1,ELMO1,WAS,VAV3,CARMIL3,AKAP13,ARHGAP27,IPCEF1,TBC1D8,WDFY4,PLCG2,PREX1 |
9.898e-10 | -20.73 | signaling | biological process | GO:0023052 | 4968 | 34 | 18204 | 49 |
SKAP1,WAS,DOCK10,PTPN6,MICAL1,IRF5,RGS14,APOE,RIN3,PIK3CB,ELMO1,PREX1,DOCK2,PRKCD,PIK3R5,P2RY6,VAV3,FYB1,DOCK1,SYK,PLCG2,DENND1B,HIF1A,IL6R,CSF1R,CD74,ADCY7,SEMA4A,GMIP,ARHGAP27,P2RY2,ARHGAP33,AKAP13,DOCK8 |
1.260e-09 | -20.49 | cell communication | biological process | GO:0007154 | 5010 | 34 | 18204 | 49 |
SYK,DOCK1,DENND1B,PLCG2,P2RY6,PIK3R5,FYB1,VAV3,GMIP,SEMA4A,ADCY7,CD74,DOCK8,AKAP13,ARHGAP33,ARHGAP27,P2RY2,HIF1A,IL6R,CSF1R,PTPN6,DOCK10,IRF5,MICAL1,WAS,SKAP1,PRKCD,DOCK2,PREX1,PIK3CB,RIN3,APOE,RGS14,ELMO1 |
1.691e-09 | -20.20 | immune system process | biological process | GO:0002376 | 1991 | 22 | 18204 | 49 |
SKAP1,WAS,IRF5,PTPN6,DOCK10,PREX1,DOCK2,PRKCD,VAV3,SBNO2,FYB1,PIK3R5,PLCG2,DENND1B,SYK,CSF1R,IL6R,HIF1A,WDFY4,DOCK8,CD74,SEMA4A |
2.261e-09 | -19.91 | plasma membrane | cellular component | GO:0005886 | 5538 | 35 | 19108 | 50 |
DOCK8,ADCY7,DOCK1,IPCEF1,CARMIL3,PTPN6,WAS,RHBDF2,PIK3R5,CD74,DOCK2,P2RY6,CSF1R,MICAL1,GLIPR1,SEMA4A,ELMO1,GMIP,PREX1,FYB1,IL6R,SLC4A2,VAV3,P2RY2,RGS14,APOE,ARHGAP33,PARVG,PLCG2,SYK,GSDME,MYO1F,SKAP1,PIK3CB,PRKCD |
2.422e-09 | -19.84 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 10 | 14470 | 48 |
SKAP1,DOCK1,VAV3,ARHGAP33,ELMO1,FYB1,ARHGAP27,MYO1F,DOCK2,PLCG2 |
2.652e-09 | -19.75 | molecular function regulator activity | molecular function | GO:0098772 | 2079 | 22 | 18094 | 48 |
PRKCD,DOCK10,HIF1A,AKAP13,WAS,DOCK8,RGS14,ARHGAP33,PREX1,TBC1D8,GMIP,RIN3,GIT2,DOCK1,DENND1B,APOE,DOCK2,ARHGAP27,VAV3,SEMA4A,ELMO1,PIK3R5 |
2.791e-09 | -19.70 | intracellular signaling cassette | biological process | GO:0141124 | 837 | 15 | 18204 | 49 |
ELMO1,PIK3CB,APOE,DOCK8,AKAP13,ARHGAP33,DOCK2,WAS,VAV3,PIK3R5,PLCG2,SYK,DOCK1,DOCK10,PTPN6 |
3.352e-09 | -19.51 | enzyme activator activity | molecular function | GO:0008047 | 599 | 13 | 18094 | 48 |
RIN3,GIT2,DOCK1,APOE,DOCK2,ARHGAP27,VAV3,PRKCD,ARHGAP33,RGS14,PREX1,GMIP,TBC1D8 |
4.572e-09 | -19.20 | positive regulation of catalytic activity | biological process | GO:0043085 | 868 | 15 | 18204 | 49 |
P2RY6,TBC1D8,PIK3R5,SYK,DOCK10,APOE,HIF1A,CSF1R,IL6R,GMIP,PRKCD,PREX1,CD74,DOCK8,ARHGAP27 |
4.712e-09 | -19.17 | cell periphery | cellular component | GO:0071944 | 6020 | 36 | 19108 | 50 |
PTPN6,WAS,CD74,PIK3R5,RHBDF2,DOCK2,MICAL1,CSF1R,P2RY6,ADCY7,DOCK8,IPCEF1,DOCK1,CARMIL3,PARVG,APOE,AKAP13,ARHGAP33,P2RY2,RGS14,VAV3,PLCG2,SYK,PRKCD,PIK3CB,SKAP1,MYO1F,GSDME,GLIPR1,FYB1,PREX1,GMIP,ELMO1,SEMA4A,IL6R,SLC4A2 |
4.749e-09 | -19.17 | SH3-like_dom_sf | interpro domains | IPR036028 | 212 | 9 | 18521 | 50 |
ARHGAP33,VAV3,SKAP1,FYB1,MYO1F,ARHGAP27,DOCK2,PLCG2,DOCK1 |
4.970e-09 | -19.12 | LCP2 (lymphocyte cytosolic protein 2) | protein interactions | 3937 | 54 | 6 | 19454 | 50 |
VAV3,WAS,SYK,PLCG2,FYB1,PTPN6 |
5.183e-09 | -19.08 | immune effector process | biological process | GO:0002252 | 389 | 11 | 18204 | 49 |
IL6R,PRKCD,SEMA4A,DOCK2,CD74,SBNO2,VAV3,PLCG2,SYK,DOCK10,PTPN6 |
5.925e-09 | -18.94 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 37 | 18204 | 49 |
IL6R,CSF1R,HIF1A,P2RY2,ARHGAP27,ARHGAP33,AKAP13,DOCK8,CD74,ADCY7,GMIP,SEMA4A,VAV3,SBNO2,FYB1,PIK3R5,P2RY6,PLCG2,IPCEF1,DENND1B,GSDME,DOCK1,SYK,ELMO1,RGS14,APOE,RIN3,PIK3CB,PREX1,DOCK2,PRKCD,SKAP1,WAS,MICAL1,IRF5,PTPN6,DOCK10 |
7.103e-09 | -18.76 | SH3_domain | interpro domains | IPR001452 | 222 | 9 | 18521 | 50 |
VAV3,ARHGAP33,FYB1,SKAP1,MYO1F,ARHGAP27,PLCG2,DOCK2,DOCK1 |
7.159e-09 | -18.75 | regulation of small GTPase mediated signal transduction | biological process | GO:0051056 | 306 | 10 | 18204 | 49 |
PREX1,GIT2,GMIP,DOCK2,AKAP13,ARHGAP27,DOCK8,APOE,PIK3CB,VAV3 |
9.438e-09 | -18.48 | T cell activation | biological process | GO:0042110 | 315 | 10 | 18204 | 49 |
WDFY4,DOCK8,CD74,PREX1,PTPN6,DOCK2,SYK,SEMA4A,IL6R,WAS |
1.295e-08 | -18.16 | leukocyte differentiation | biological process | GO:0002521 | 425 | 11 | 18204 | 49 |
DOCK2,SEMA4A,CD74,PREX1,CSF1R,IL6R,DOCK10,SYK,SLC4A2,PLCG2,SBNO2 |
1.529e-08 | -18.00 | DOCKER_Lobe_C | interpro domains | IPR046773 | 11 | 4 | 18521 | 50 |
DOCK8,DOCK2,DOCK1,DOCK10 |
1.529e-08 | -18.00 | DOCKER_Lobe_B | interpro domains | IPR046770 | 11 | 4 | 18521 | 50 |
DOCK1,DOCK10,DOCK8,DOCK2 |
1.529e-08 | -18.00 | DOCK_C_lobe_C | interpro domains | IPR043162 | 11 | 4 | 18521 | 50 |
DOCK8,DOCK2,DOCK1,DOCK10 |
1.529e-08 | -18.00 | DOCK_C_lobe_A | interpro domains | IPR043161 | 11 | 4 | 18521 | 50 |
DOCK2,DOCK8,DOCK10,DOCK1 |
1.529e-08 | -18.00 | DOCK | interpro domains | IPR026791 | 11 | 4 | 18521 | 50 |
DOCK2,DOCK8,DOCK10,DOCK1 |
1.529e-08 | -18.00 | DOCKER_Lobe_A | interpro domains | IPR046769 | 11 | 4 | 18521 | 50 |
DOCK2,DOCK8,DOCK10,DOCK1 |
1.529e-08 | -18.00 | C2_DOCK-type_domain | interpro domains | IPR027007 | 11 | 4 | 18521 | 50 |
DOCK1,DOCK10,DOCK8,DOCK2 |
1.529e-08 | -18.00 | DOCKER_dom | interpro domains | IPR027357 | 11 | 4 | 18521 | 50 |
DOCK1,DOCK10,DOCK8,DOCK2 |
1.539e-08 | -17.99 | regulation of MAPK cascade | biological process | GO:0043408 | 669 | 13 | 18204 | 49 |
CSF1R,APOE,RGS14,PIK3CB,CD74,PRKCD,PIK3R5,NRK,P2RY6,PLCG2,GSDME,SYK,PTPN6 |
1.793e-08 | -17.84 | DHR-2_Lobe_B | pfam domains | PF20422 | 11 | 4 | 17795 | 50 |
DOCK10,DOCK2,DOCK8,DOCK1 |
1.793e-08 | -17.84 | DHR-2_Lobe_A | pfam domains | PF06920 | 11 | 4 | 17795 | 50 |
DOCK2,DOCK10,DOCK1,DOCK8 |
1.793e-08 | -17.84 | DHR-2_Lobe_C | pfam domains | PF20421 | 11 | 4 | 17795 | 50 |
DOCK1,DOCK8,DOCK2,DOCK10 |
1.793e-08 | -17.84 | DOCK-C2 | pfam domains | PF14429 | 11 | 4 | 17795 | 50 |
DOCK2,DOCK10,DOCK1,DOCK8 |
2.108e-08 | -17.68 | import into cell | biological process | GO:0098657 | 687 | 13 | 18204 | 49 |
DENND1B,DOCK1,SYK,VAV3,P2RY6,MYO1F,ARHGAP27,DOCK2,PRKCD,ELMO1,RIN3,PIK3CB,APOE |
2.144e-08 | -17.66 | hemopoiesis | biological process | GO:0030097 | 688 | 13 | 18204 | 49 |
HIF1A,CSF1R,IL6R,PREX1,CD74,SEMA4A,DOCK2,SBNO2,SYK,DOCK10,PTPN6,PLCG2,SLC4A2 |
2.530e-08 | -17.49 | positive regulation of immune system process | biological process | GO:0002684 | 986 | 15 | 18204 | 49 |
PIK3CB,IL6R,CSF1R,PRKCD,CD74,DOCK8,FYB1,SKAP1,VAV3,PTPN6,SYK,GSDME,DENND1B,IRF5,PLCG2 |
2.717e-08 | -17.42 | GPVI-mediated activation cascade | REACTOME pathways | R-HSA-114604 | 54 | 6 | 10285 | 36 |
PTPN6,PLCG2,PIK3CB,PIK3R5,VAV3,SYK |
3.009e-08 | -17.32 | regulation of body fluid levels | biological process | GO:0050878 | 356 | 10 | 18204 | 49 |
VAV3,WAS,HIF1A,APOE,PIK3CB,P2RY2,PLCG2,PTPN6,SYK,PRKCD |
3.119e-08 | -17.28 | SH3 domain binding | molecular function | GO:0017124 | 122 | 7 | 18094 | 48 |
DOCK1,WAS,ELMO1,SKAP1,MICAL1,ARHGAP27,PTPN6 |
3.402e-08 | -17.20 | PH_domain | interpro domains | IPR001849 | 266 | 9 | 18521 | 50 |
PLCG2,DOCK10,IPCEF1,VAV3,SKAP1,PREX1,ELMO1,AKAP13,ARHGAP27 |
3.457e-08 | -17.18 | - | gene3d domains | 1.20.58.740 | 11 | 4 | 14470 | 48 |
DOCK1,DOCK2,DOCK10,DOCK8 |
3.457e-08 | -17.18 | - | gene3d domains | 1.25.40.410 | 11 | 4 | 14470 | 48 |
DOCK1,DOCK2,DOCK10,DOCK8 |
4.248e-08 | -16.97 | SRC (SRC proto-oncogene, non-receptor tyrosine kinase) | protein interactions | 6714 | 624 | 12 | 19454 | 50 |
PTPN6,FYB1,CSF1R,P2RY2,SKAP1,DOCK1,IL6R,SYK,HIF1A,PRKCD,MICAL1,WAS |
4.411e-08 | -16.94 | positive regulation of molecular function | biological process | GO:0044093 | 1192 | 16 | 18204 | 49 |
DOCK10,SYK,PLCG2,PIK3R5,TBC1D8,P2RY6,CD74,PREX1,PRKCD,GMIP,ARHGAP27,DOCK8,HIF1A,APOE,IL6R,CSF1R |
4.850e-08 | -16.84 | small GTPase binding | molecular function | GO:0031267 | 283 | 9 | 18094 | 48 |
MICAL1,DOCK2,AKAP13,WAS,RIN3,DOCK10,GIT2,DENND1B,DOCK1 |
4.877e-08 | -16.84 | Fc gamma R-mediated phagocytosis | KEGG pathways | hsa04666 | 90 | 7 | 7161 | 29 |
PIK3CB,PLCG2,SYK,PRKCD,VAV3,WAS,DOCK2 |
4.877e-08 | -16.84 | Fc gamma R-mediated phagocytosis | KEGG pathways | ko04666 | 90 | 7 | 7161 | 29 |
PLCG2,SYK,PIK3CB,PRKCD,VAV3,WAS,DOCK2 |
5.254e-08 | -16.76 | DOCKER | prosite domains | PS51651 | 11 | 4 | 12186 | 45 |
DOCK10,DOCK1,DOCK2,DOCK8 |
5.254e-08 | -16.76 | C2_DOCK | prosite domains | PS51650 | 11 | 4 | 12186 | 45 |
DOCK8,DOCK2,DOCK1,DOCK10 |
5.880e-08 | -16.65 | leukocyte activation involved in immune response | biological process | GO:0002366 | 201 | 8 | 18204 | 49 |
CD74,DOCK10,DOCK2,SEMA4A,SYK,PLCG2,SBNO2,IL6R |
6.027e-08 | -16.62 | regulation of catalytic activity | biological process | GO:0050790 | 1395 | 17 | 18204 | 49 |
CSF1R,IL6R,RGS14,HIF1A,APOE,ARHGAP27,DOCK8,CD74,PREX1,PRKCD,GMIP,VAV3,PIK3R5,TBC1D8,P2RY6,DOCK10,SYK |
6.848e-08 | -16.50 | cell activation involved in immune response | biological process | GO:0002263 | 205 | 8 | 18204 | 49 |
SYK,SEMA4A,DOCK10,DOCK2,CD74,PLCG2,IL6R,SBNO2 |
8.546e-08 | -16.28 | antigen receptor-mediated signaling pathway | biological process | GO:0050851 | 139 | 7 | 18204 | 49 |
FYB1,SKAP1,VAV3,DENND1B,PLCG2,SYK,PTPN6 |
9.423e-08 | -16.18 | SH3 | prosite domains | PS50002 | 222 | 9 | 12186 | 45 |
ARHGAP27,MYO1F,PLCG2,VAV3,ARHGAP33,FYB1,DOCK2,SKAP1,DOCK1 |
1.081e-07 | -16.04 | positive regulation of response to stimulus | biological process | GO:0048584 | 2266 | 21 | 18204 | 49 |
PIK3CB,HIF1A,APOE,IL6R,CSF1R,PRKCD,CD74,AKAP13,P2RY6,NRK,PIK3R5,FYB1,WAS,VAV3,SKAP1,NEK6,PTPN6,SYK,GSDME,DENND1B,PLCG2 |
1.138e-07 | -15.99 | regulation of immune response | biological process | GO:0050776 | 944 | 14 | 18204 | 49 |
PLCG2,DENND1B,GSDME,SYK,PTPN6,SKAP1,VAV3,WAS,FYB1,RHBDF2,ADCY7,CD74,PRKCD,APOE |
1.211e-07 | -15.93 | GTPase binding | molecular function | GO:0051020 | 315 | 9 | 18094 | 48 |
GIT2,DOCK10,RIN3,DENND1B,DOCK1,AKAP13,MICAL1,DOCK2,WAS |
1.239e-07 | -15.90 | molecular function activator activity | molecular function | GO:0140677 | 1132 | 15 | 18094 | 48 |
HIF1A,PRKCD,RGS14,ARHGAP33,PREX1,GMIP,TBC1D8,DOCK1,RIN3,GIT2,APOE,DOCK2,ARHGAP27,VAV3,SEMA4A |
1.387e-07 | -15.79 | regulation of cell motility | biological process | GO:2000145 | 1122 | 15 | 18204 | 49 |
APOE,HIF1A,PIK3CB,RIN3,CSF1R,IL6R,PREX1,CD74,SEMA4A,DOCK8,P2RY6,WAS,DOCK10,DOCK1,PLCG2 |
1.552e-07 | -15.68 | immune response-activating cell surface receptor signaling pathway | biological process | GO:0002429 | 228 | 8 | 18204 | 49 |
PRKCD,SYK,PTPN6,DENND1B,PLCG2,FYB1,SKAP1,VAV3 |
1.613e-07 | -15.64 | response to stimulus | biological process | GO:0050896 | 7803 | 39 | 18204 | 49 |
WAS,SKAP1,MICAL1,IRF5,DOCK10,PTPN6,ELMO1,RIN3,PIK3CB,RGS14,APOE,DOCK2,PRKCD,PREX1,FYB1,TBXAS1,VAV3,SBNO2,P2RY6,PIK3R5,DENND1B,IPCEF1,PLCG2,DOCK1,SYK,GSDME,IL6R,CSF1R,HIF1A,DOCK8,P2RY2,ARHGAP27,WDFY4,ARHGAP33,AKAP13,GMIP,SEMA4A,CD74,ADCY7 |
2.012e-07 | -15.42 | protein kinase binding | molecular function | GO:0019901 | 701 | 12 | 18094 | 48 |
PLCG2,SYK,IRF5,HIF1A,PTPN6,PRKCD,NEK6,SKAP1,WAS,ARHGAP33,RGS14,MICAL1 |
2.235e-07 | -15.31 | regulation of locomotion | biological process | GO:0040012 | 1164 | 15 | 18204 | 49 |
PREX1,CD74,SEMA4A,DOCK8,APOE,HIF1A,PIK3CB,RIN3,IL6R,CSF1R,DOCK10,DOCK1,PLCG2,P2RY6,WAS |
2.432e-07 | -15.23 | immune response | biological process | GO:0006955 | 1349 | 16 | 18204 | 49 |
SEMA4A,PRKCD,DOCK2,CD74,IL6R,CSF1R,SYK,DOCK10,PTPN6,PLCG2,IRF5,PIK3R5,WAS,FYB1,SKAP1,SBNO2 |
2.741e-07 | -15.11 | regulation of signal transduction | biological process | GO:0009966 | 3114 | 24 | 18204 | 49 |
PIK3CB,APOE,RGS14,PRKCD,DOCK2,PREX1,NRK,PTPN6,HIF1A,CSF1R,GMIP,RHBDF2,CD74,DOCK8,AKAP13,ARHGAP27,P2RY6,PIK3R5,VAV3,SYK,NEK6,GIT2,GSDME,PLCG2 |
3.616e-07 | -14.83 | C2_domain_sf | interpro domains | IPR035892 | 171 | 7 | 18521 | 50 |
PLCG2,DOCK2,DOCK8,DOCK10,DOCK1,PRKCD,PIK3CB |
3.716e-07 | -14.81 | positive regulation of cell migration | biological process | GO:0030335 | 592 | 11 | 18204 | 49 |
DOCK1,SEMA4A,CD74,PREX1,DOCK8,PLCG2,P2RY6,PIK3CB,HIF1A,CSF1R,IL6R |
3.986e-07 | -14.74 | small GTPase-mediated signal transduction | biological process | GO:0007264 | 258 | 8 | 18204 | 49 |
DOCK10,DOCK2,DOCK1,ARHGAP33,DOCK8,VAV3,ELMO1,WAS |
4.058e-07 | -14.72 | Chemokine signaling pathway | KEGG pathways | ko04062 | 182 | 8 | 7161 | 29 |
ELMO1,PRKCD,VAV3,WAS,DOCK2,PREX1,ADCY7,PIK3CB |
4.058e-07 | -14.72 | Chemokine signaling pathway | KEGG pathways | hsa04062 | 182 | 8 | 7161 | 29 |
ELMO1,WAS,VAV3,PRKCD,DOCK2,PREX1,ADCY7,PIK3CB |
4.083e-07 | -14.71 | positive regulation of intracellular signal transduction | biological process | GO:1902533 | 1048 | 14 | 18204 | 49 |
NEK6,PTPN6,SYK,GSDME,PLCG2,NRK,P2RY6,PIK3R5,VAV3,CD74,AKAP13,PIK3CB,APOE,CSF1R |
4.479e-07 | -14.62 | immune response-regulating cell surface receptor signaling pathway | biological process | GO:0002768 | 262 | 8 | 18204 | 49 |
FYB1,SKAP1,VAV3,PRKCD,SYK,PTPN6,DENND1B,PLCG2 |
4.696e-07 | -14.57 | mononuclear cell differentiation | biological process | GO:1903131 | 364 | 9 | 18204 | 49 |
PLCG2,DOCK2,DOCK10,SEMA4A,SYK,CD74,PREX1,CSF1R,IL6R |
4.740e-07 | -14.56 | regulation of cell migration | biological process | GO:0030334 | 1061 | 14 | 18204 | 49 |
RIN3,PIK3CB,APOE,HIF1A,IL6R,CSF1R,SEMA4A,CD74,PREX1,DOCK8,P2RY6,DOCK10,DOCK1,PLCG2 |
5.781e-07 | -14.36 | positive regulation of cell motility | biological process | GO:2000147 | 619 | 11 | 18204 | 49 |
PLCG2,DOCK1,P2RY6,DOCK8,SEMA4A,PREX1,CD74,IL6R,CSF1R,PIK3CB,HIF1A |
6.301e-07 | -14.28 | kinase binding | molecular function | GO:0019900 | 780 | 12 | 18094 | 48 |
IRF5,HIF1A,NEK6,PTPN6,PRKCD,SKAP1,WAS,ARHGAP33,RGS14,MICAL1,PLCG2,SYK |
7.207e-07 | -14.14 | positive regulation of locomotion | biological process | GO:0040017 | 633 | 11 | 18204 | 49 |
CSF1R,IL6R,PIK3CB,HIF1A,DOCK8,SEMA4A,PREX1,CD74,P2RY6,PLCG2,DOCK1 |
7.517e-07 | -14.10 | C2 domain | gene3d domains | 2.60.40.150 | 156 | 7 | 14470 | 48 |
DOCK10,PIK3CB,DOCK1,DOCK8,PLCG2,DOCK2,PRKCD |
7.787e-07 | -14.07 | vesicle-mediated transport | biological process | GO:0016192 | 1283 | 15 | 18204 | 49 |
GIT2,SYK,DOCK1,DENND1B,P2RY6,VAV3,WAS,PRKCD,DOCK2,ARHGAP27,MYO1F,APOE,PIK3CB,RIN3,ELMO1 |
8.343e-07 | -14.00 | Hemostasis | REACTOME pathways | R-HSA-109582 | 632 | 12 | 10285 | 36 |
CD74,PLCG2,PRKCD,PIK3CB,PTPN6,DOCK10,PIK3R5,DOCK2,SYK,VAV3,DOCK1,DOCK8 |
8.355e-07 | -14.00 | response to external stimulus | biological process | GO:0009605 | 1882 | 18 | 18204 | 49 |
SBNO2,VAV3,WAS,GSDME,PTPN6,SYK,PLCG2,IRF5,HIF1A,PIK3CB,IL6R,CSF1R,CD74,PREX1,DOCK2,SEMA4A,PRKCD,WDFY4 |
8.489e-07 | -13.98 | membrane | cellular component | GO:0016020 | 9220 | 41 | 19108 | 50 |
DOCK8,ADCY7,DOCK1,IPCEF1,EHBP1L1,CARMIL3,PTPN6,WAS,PIK3R5,RHBDF2,CD74,DOCK2,DOCK10,TBC1D8,P2RY6,CSF1R,MICAL1,GLIPR1,SEMA4A,ELMO1,TBXAS1,GMIP,PREX1,FYB1,IL6R,SLC4A2,RGS14,P2RY2,VAV3,AKAP13,APOE,ARHGAP33,PARVG,SYK,PLCG2,GSDME,MYO1F,SKAP1,PIK3CB,PRKCD,ARHGAP27 |
9.639e-07 | -13.85 | lymphocyte differentiation | biological process | GO:0030098 | 290 | 8 | 18204 | 49 |
PREX1,CD74,SEMA4A,SYK,DOCK10,DOCK2,PLCG2,IL6R |
1.029e-06 | -13.79 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 13 | 19454 | 50 |
SLC4A2,PREX1,ARHGAP27,WAS,EHBP1L1,PRKCD,GMIP,ARHGAP33,VAV3,DOCK8,DOCK1,GIT2,DOCK2 |
1.074e-06 | -13.74 | SH3 | smart domains | SM00326 | 202 | 8 | 9717 | 39 |
PLCG2,VAV3,MYO1F,ARHGAP33,DOCK1,SKAP1,FYB1,DOCK2 |
1.075e-06 | -13.74 | CRKL (CRK like proto-oncogene, adaptor protein) | protein interactions | 1399 | 211 | 7 | 19454 | 50 |
WAS,DOCK1,ELMO1,SYK,DOCK2,RIN3,PIK3CB |
1.306e-06 | -13.55 | immune response-activating signaling pathway | biological process | GO:0002757 | 302 | 8 | 18204 | 49 |
PTPN6,SYK,PRKCD,PLCG2,DENND1B,VAV3,SKAP1,FYB1 |
1.400e-06 | -13.48 | positive regulation of chemokine production | biological process | GO:0032722 | 72 | 5 | 18204 | 49 |
HIF1A,CD74,SYK,IL6R,CSF1R |
1.531e-06 | -13.39 | cellular response to chemical stimulus | biological process | GO:0070887 | 2411 | 20 | 18204 | 49 |
IRF5,PLCG2,IPCEF1,SYK,PTPN6,GSDME,WAS,VAV3,SBNO2,P2RY6,DOCK8,P2RY2,PRKCD,PREX1,ADCY7,CD74,CSF1R,IL6R,APOE,HIF1A |
1.789e-06 | -13.23 | Role of phospholipids in phagocytosis | REACTOME pathways | R-HSA-2029485 | 26 | 4 | 10285 | 36 |
PRKCD,PIK3CB,PLCG2,SYK |
1.910e-06 | -13.17 | regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050730 | 220 | 7 | 18204 | 49 |
IL6R,CSF1R,PLCG2,PTPN6,SYK,PRKCD,CD74 |
1.920e-06 | -13.16 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 18 | 18204 | 49 |
IL6R,CSF1R,RGS14,PIK3CB,P2RY2,CD74,SEMA4A,PRKCD,SKAP1,VAV3,FYB1,P2RY6,PLCG2,IRF5,DENND1B,PTPN6,DOCK1,SYK |
2.033e-06 | -13.11 | Regulation of actin dynamics for phagocytic cup formation | REACTOME pathways | R-HSA-2029482 | 61 | 5 | 10285 | 36 |
DOCK1,ELMO1,SYK,VAV3,WAS |
2.110e-06 | -13.07 | regulation of molecular function | biological process | GO:0065009 | 2005 | 18 | 18204 | 49 |
VAV3,TBC1D8,PIK3R5,P2RY6,PLCG2,SYK,DOCK10,CSF1R,IL6R,APOE,HIF1A,RGS14,ARHGAP27,DOCK8,PREX1,CD74,PRKCD,GMIP |
2.126e-06 | -13.06 | response to chemical | biological process | GO:0042221 | 3743 | 25 | 18204 | 49 |
IPCEF1,PLCG2,GSDME,SYK,VAV3,SBNO2,TBXAS1,P2RY6,ARHGAP33,P2RY2,DOCK8,ADCY7,CD74,SEMA4A,IL6R,CSF1R,HIF1A,IRF5,PTPN6,WAS,PREX1,PRKCD,DOCK2,APOE,PIK3CB |
2.136e-06 | -13.06 | positive regulation of cell communication | biological process | GO:0010647 | 1792 | 17 | 18204 | 49 |
CSF1R,PIK3CB,HIF1A,APOE,RGS14,AKAP13,PRKCD,CD74,VAV3,NRK,P2RY6,PIK3R5,PLCG2,SYK,NEK6,PTPN6,GSDME |
2.169e-06 | -13.04 | positive regulation of signaling | biological process | GO:0023056 | 1794 | 17 | 18204 | 49 |
PTPN6,NEK6,SYK,GSDME,PLCG2,P2RY6,NRK,PIK3R5,VAV3,PRKCD,CD74,AKAP13,PIK3CB,RGS14,APOE,HIF1A,CSF1R |
2.257e-06 | -13.00 | positive regulation of signal transduction | biological process | GO:0009967 | 1593 | 16 | 18204 | 49 |
CD74,PRKCD,AKAP13,HIF1A,APOE,PIK3CB,CSF1R,GSDME,NEK6,PTPN6,SYK,PLCG2,PIK3R5,P2RY6,NRK,VAV3 |
2.518e-06 | -12.89 | positive regulation of cytokine production involved in immune response | biological process | GO:0002720 | 81 | 5 | 18204 | 49 |
DENND1B,IRF5,PLCG2,SYK,CD74 |
2.782e-06 | -12.79 | PH_DOMAIN | prosite domains | PS50003 | 246 | 8 | 12186 | 45 |
PREX1,DOCK10,SKAP1,AKAP13,VAV3,ARHGAP27,IPCEF1,PLCG2 |
2.815e-06 | -12.78 | SHC1 (SHC adaptor protein 1) | protein interactions | 6464 | 350 | 8 | 19454 | 50 |
PLCG2,CSF1R,PTPN6,RIN3,PRKCD,HIF1A,SYK,VAV3 |
2.971e-06 | -12.73 | regulation of signaling | biological process | GO:0023051 | 3534 | 24 | 18204 | 49 |
NRK,PTPN6,PIK3CB,RGS14,APOE,DOCK2,PRKCD,PREX1,P2RY6,PIK3R5,VAV3,NEK6,SYK,GSDME,GIT2,PLCG2,HIF1A,CSF1R,GMIP,CD74,RHBDF2,DOCK8,ARHGAP27,AKAP13 |
3.049e-06 | -12.70 | cellular response to cytokine stimulus | biological process | GO:0071345 | 734 | 11 | 18204 | 49 |
HIF1A,CSF1R,IL6R,CD74,DOCK8,WAS,SBNO2,SYK,PTPN6,GSDME,IRF5 |
3.081e-06 | -12.69 | regulation of cell communication | biological process | GO:0010646 | 3541 | 24 | 18204 | 49 |
CSF1R,APOE,HIF1A,RGS14,PIK3CB,AKAP13,ARHGAP27,DOCK8,RHBDF2,PREX1,CD74,GMIP,PRKCD,DOCK2,VAV3,PIK3R5,NRK,P2RY6,PLCG2,GIT2,GSDME,SYK,PTPN6,NEK6 |
3.125e-06 | -12.68 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 11 | 19454 | 50 |
RIN3,PIK3CB,CSF1R,PTPN6,VAV3,WAS,MICAL1,DOCK1,SKAP1,IRF5,SYK |
3.296e-06 | -12.62 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 33 | 18204 | 49 |
PRKCD,DOCK2,PREX1,PIK3CB,APOE,RGS14,IRF5,PTPN6,WAS,SKAP1,NRK,TBC1D8,DOCK8,AKAP13,P2RY2,SEMA4A,CD74,CSF1R,IL6R,HIF1A,DENND1B,PLCG2,SLC4A2,SYK,NEK6,DOCK1,GSDME,TBXAS1,FYB1,VAV3,SBNO2,P2RY6,PIK3R5 |
3.515e-06 | -12.56 | chemotaxis | biological process | GO:0006935 | 345 | 8 | 18204 | 49 |
IL6R,VAV3,PIK3CB,SYK,PRKCD,SEMA4A,DOCK2,PREX1 |
3.574e-06 | -12.54 | myeloid leukocyte activation | biological process | GO:0002274 | 155 | 6 | 18204 | 49 |
PLCG2,SBNO2,PRKCD,SYK,DOCK2,PREX1 |
3.615e-06 | -12.53 | positive regulation of hydrolase activity | biological process | GO:0051345 | 466 | 9 | 18204 | 49 |
PREX1,GMIP,PRKCD,SYK,DOCK10,ARHGAP27,DOCK8,TBC1D8,P2RY6 |
3.669e-06 | -12.52 | taxis | biological process | GO:0042330 | 347 | 8 | 18204 | 49 |
PREX1,DOCK2,PRKCD,SYK,SEMA4A,PIK3CB,VAV3,IL6R |
3.706e-06 | -12.51 | cytosol | cellular component | GO:0005829 | 5475 | 30 | 19108 | 50 |
PLCG2,SYK,ARHGAP33,AKAP13,VAV3,PRKCD,ARHGAP27,PIK3CB,SKAP1,MYO1F,GSDME,FYB1,PREX1,GMIP,TBXAS1,ELMO1,IRF5,RIN3,PIK3R5,PTPN6,WAS,MICAL1,DOCK10,HIF1A,DOCK2,DENND1B,NRK,DOCK8,NEK6,DOCK1 |
4.081e-06 | -12.41 | positive regulation of MAPK cascade | biological process | GO:0043410 | 473 | 9 | 18204 | 49 |
CSF1R,P2RY6,NRK,APOE,PIK3R5,PLCG2,SYK,CD74,GSDME |
4.141e-06 | -12.39 | phagocytosis | biological process | GO:0006909 | 159 | 6 | 18204 | 49 |
DOCK1,PRKCD,SYK,VAV3,ELMO1,P2RY6 |
4.259e-06 | -12.37 | cell migration | biological process | GO:0016477 | 921 | 12 | 18204 | 49 |
IL6R,HIF1A,PIK3CB,DOCK8,PREX1,PRKCD,SEMA4A,DOCK2,VAV3,SYK,DOCK1,CARMIL3 |
4.425e-06 | -12.33 | BLNK (B cell linker) | protein interactions | 29760 | 43 | 4 | 19454 | 50 |
PTPN6,SYK,PLCG2,VAV3 |
4.502e-06 | -12.31 | transport | biological process | GO:0006810 | 3615 | 24 | 18204 | 49 |
MYO1F,ARHGAP33,ARHGAP27,PRKCD,DOCK2,RHBDF2,CD74,ELMO1,PIK3CB,RIN3,HIF1A,APOE,RGS14,DENND1B,PLCG2,IPCEF1,SLC4A2,SYK,DOCK1,GIT2,GSDME,WAS,VAV3,P2RY6 |
4.596e-06 | -12.29 | cell motility | biological process | GO:0048870 | 1101 | 13 | 18204 | 49 |
VAV3,SYK,CARMIL3,DOCK1,IL6R,ELMO1,PIK3CB,HIF1A,DOCK8,PRKCD,SEMA4A,DOCK2,PREX1 |
4.918e-06 | -12.22 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 16 | 18204 | 49 |
CD74,SEMA4A,P2RY2,DOCK8,RGS14,APOE,HIF1A,IL6R,CSF1R,PTPN6,SYK,IRF5,PLCG2,DENND1B,VAV3,TBXAS1 |
4.927e-06 | -12.22 | CBLB (Cbl proto-oncogene B) | protein interactions | 868 | 97 | 5 | 19454 | 50 |
VAV3,WAS,PLCG2,FYB1,SYK |
5.322e-06 | -12.14 | SH3BP2 (SH3 domain binding protein 2) | protein interactions | 6452 | 45 | 4 | 19454 | 50 |
PLCG2,SYK,VAV3,MYO1F |
5.541e-06 | -12.10 | locomotion | biological process | GO:0040011 | 367 | 8 | 18204 | 49 |
PREX1,PRKCD,SYK,SEMA4A,DOCK2,IL6R,VAV3,PIK3CB |
5.653e-06 | -12.08 | immune response-regulating signaling pathway | biological process | GO:0002764 | 368 | 8 | 18204 | 49 |
FYB1,SKAP1,VAV3,PTPN6,SYK,PRKCD,DENND1B,PLCG2 |
5.653e-06 | -12.08 | activation of immune response | biological process | GO:0002253 | 368 | 8 | 18204 | 49 |
PLCG2,DENND1B,SYK,PRKCD,PTPN6,VAV3,SKAP1,FYB1 |
5.700e-06 | -12.08 | MS4A2 (membrane spanning 4-domains A2) | protein interactions | 2206 | 14 | 3 | 19454 | 50 |
PRKCD,PTPN6,SYK |
5.810e-06 | -12.06 | B cell receptor signaling pathway | biological process | GO:0050853 | 44 | 4 | 18204 | 49 |
VAV3,PLCG2,PTPN6,SYK |
5.946e-06 | -12.03 | cellular response to organic substance | biological process | GO:0071310 | 1716 | 16 | 18204 | 49 |
SBNO2,WAS,P2RY6,PLCG2,IRF5,GSDME,SYK,PTPN6,IL6R,CSF1R,HIF1A,P2RY2,DOCK8,ADCY7,CD74,PRKCD |
6.397e-06 | -11.96 | positive regulation of immune response | biological process | GO:0050778 | 640 | 10 | 18204 | 49 |
VAV3,SKAP1,FYB1,PLCG2,DENND1B,CD74,GSDME,SYK,PRKCD,PTPN6 |
6.871e-06 | -11.89 | PH | smart domains | SM00233 | 259 | 8 | 9717 | 39 |
DOCK10,ARHGAP27,IPCEF1,VAV3,PLCG2,PREX1,AKAP13,SKAP1 |
7.429e-06 | -11.81 | blood coagulation | biological process | GO:0007596 | 176 | 6 | 18204 | 49 |
WAS,PLCG2,VAV3,PIK3CB,SYK,PTPN6 |
7.476e-06 | -11.80 | platelet activation | biological process | GO:0030168 | 101 | 5 | 18204 | 49 |
PLCG2,VAV3,PIK3CB,SYK,PTPN6 |
7.544e-06 | -11.79 | regulation of cell adhesion | biological process | GO:0030155 | 807 | 11 | 18204 | 49 |
VAV3,SKAP1,PIK3CB,DOCK8,SLC4A2,DOCK1,PTPN6,SYK,PRKCD,CD74,PREX1 |
7.588e-06 | -11.79 | T cell selection | biological process | GO:0045058 | 47 | 4 | 18204 | 49 |
IL6R,SYK,DOCK2,CD74 |
7.645e-06 | -11.78 | B cell receptor signaling pathway | KEGG pathways | hsa04662 | 70 | 5 | 7161 | 29 |
PIK3CB,VAV3,SYK,PTPN6,PLCG2 |
7.645e-06 | -11.78 | B cell receptor signaling pathway | KEGG pathways | ko04662 | 70 | 5 | 7161 | 29 |
PTPN6,SYK,PLCG2,PIK3CB,VAV3 |
7.673e-06 | -11.78 | regulation of phosphate metabolic process | biological process | GO:0019220 | 1154 | 13 | 18204 | 49 |
HIF1A,APOE,RGS14,CSF1R,IL6R,PRKCD,CD74,P2RY6,PIK3R5,SYK,PTPN6,PLCG2,MICAL1 |
7.746e-06 | -11.77 | regulation of phosphorus metabolic process | biological process | GO:0051174 | 1155 | 13 | 18204 | 49 |
MICAL1,PLCG2,PTPN6,SYK,PIK3R5,P2RY6,CD74,PRKCD,CSF1R,IL6R,RGS14,APOE,HIF1A |
7.811e-06 | -11.76 | Platelet activation | KEGG pathways | hsa04611 | 123 | 6 | 7161 | 29 |
SYK,TBXAS1,PLCG2,PIK3CB,PIK3R5,ADCY7 |
7.845e-06 | -11.76 | alpha-beta T cell activation | biological process | GO:0046631 | 102 | 5 | 18204 | 49 |
WDFY4,IL6R,DOCK2,SYK,SEMA4A |
7.925e-06 | -11.75 | coagulation | biological process | GO:0050817 | 178 | 6 | 18204 | 49 |
WAS,VAV3,PIK3CB,PLCG2,PTPN6,SYK |
8.627e-06 | -11.66 | regulation of chemokine production | biological process | GO:0032642 | 104 | 5 | 18204 | 49 |
SYK,HIF1A,CD74,IL6R,CSF1R |
8.629e-06 | -11.66 | Rho GTPase cycle | REACTOME pathways | R-HSA-194840 | 142 | 6 | 10285 | 36 |
ARHGAP33,AKAP13,PREX1,GMIP,ARHGAP27,VAV3 |
8.916e-06 | -11.63 | regulation of GTPase activity | biological process | GO:0043087 | 278 | 7 | 18204 | 49 |
TBC1D8,VAV3,PREX1,DOCK10,GMIP,ARHGAP27,DOCK8 |
8.984e-06 | -11.62 | regulation of cellular component organization | biological process | GO:0051128 | 2455 | 19 | 18204 | 49 |
RIN3,PIK3CB,HIF1A,APOE,CSF1R,DOCK2,SEMA4A,PRKCD,PREX1,ARHGAP33,AKAP13,TBC1D8,WAS,SKAP1,CARMIL3,NEK6,SYK,SLC4A2,PLCG2 |
9.000e-06 | -11.62 | hemostasis | biological process | GO:0007599 | 182 | 6 | 18204 | 49 |
PIK3CB,SYK,PTPN6,WAS,PLCG2,VAV3 |
9.000e-06 | -11.62 | T cell differentiation | biological process | GO:0030217 | 182 | 6 | 18204 | 49 |
IL6R,CD74,PREX1,DOCK2,SEMA4A,SYK |
9.125e-06 | -11.60 | KIT (KIT proto-oncogene, receptor tyrosine kinase) | protein interactions | 3815 | 110 | 5 | 19454 | 50 |
VAV3,CSF1R,PLCG2,SYK,PTPN6 |
9.217e-06 | -11.59 | T cell receptor complex | cellular component | GO:0042101 | 16 | 3 | 19108 | 50 |
PTPN6,SYK,SKAP1 |
9.652e-06 | -11.55 | FYN (FYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 2534 | 414 | 8 | 19454 | 50 |
FYB1,PLCG2,CSF1R,WAS,SYK,ARHGAP33,PRKCD,SKAP1 |
9.913e-06 | -11.52 | T cell receptor signaling pathway | biological process | GO:0050852 | 107 | 5 | 18204 | 49 |
PTPN6,FYB1,DENND1B,SKAP1,PLCG2 |
1.030e-05 | -11.48 | response to cytokine | biological process | GO:0034097 | 834 | 11 | 18204 | 49 |
SYK,PTPN6,GSDME,IRF5,WAS,SBNO2,CD74,DOCK8,HIF1A,IL6R,CSF1R |
1.105e-05 | -11.41 | SH2 | interpro domains | IPR000980 | 109 | 5 | 18521 | 50 |
PLCG2,RIN3,VAV3,PTPN6,SYK |
1.275e-05 | -11.27 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 31 | 16828 | 46 |
P2RY2,PARVG,P2RY6,RIN3,TBC1D8,RHBDF2,EHBP1L1,AKAP13,IRF5,ARHGAP27,PREX1,IPCEF1,DOCK8,DOCK10,GMIP,SLC4A2,RGS14,PRKCD,HIF1A,DOCK1,CSF1R,ADCY7,PIK3CB,MYO1F,DOCK2,WAS,ELMO1,PLCG2,MICAL1,TBXAS1,VAV3 |
1.311e-05 | -11.24 | regulation of ERK1 and ERK2 cascade | biological process | GO:0070372 | 295 | 7 | 18204 | 49 |
SYK,PTPN6,CD74,P2RY6,APOE,RGS14,CSF1R |
1.316e-05 | -11.24 | SH2_dom_sf | interpro domains | IPR036860 | 113 | 5 | 18521 | 50 |
VAV3,RIN3,PLCG2,SYK,PTPN6 |
1.428e-05 | -11.16 | Fc receptor signaling pathway | biological process | GO:0038093 | 55 | 4 | 18204 | 49 |
VAV3,PLCG2,PRKCD,SYK |
1.661e-05 | -11.01 | establishment of localization | biological process | GO:0051234 | 3887 | 24 | 18204 | 49 |
VAV3,WAS,P2RY6,SLC4A2,PLCG2,IPCEF1,DENND1B,GSDME,GIT2,DOCK1,SYK,ELMO1,RGS14,APOE,HIF1A,RIN3,PIK3CB,ARHGAP27,ARHGAP33,MYO1F,CD74,RHBDF2,DOCK2,PRKCD |
1.686e-05 | -10.99 | localization | biological process | GO:0051179 | 4474 | 26 | 18204 | 49 |
ARHGAP33,ARHGAP27,RHBDF2,CD74,HIF1A,IPCEF1,PLCG2,SLC4A2,DENND1B,GIT2,GSDME,SYK,DOCK1,VAV3,FYB1,P2RY6,MYO1F,PRKCD,DOCK2,ELMO1,APOE,RGS14,PIK3CB,RIN3,SKAP1,WAS |
1.723e-05 | -10.97 | macrophage activation involved in immune response | biological process | GO:0002281 | 19 | 3 | 18204 | 49 |
SBNO2,PLCG2,SYK |
1.731e-05 | -10.96 | regulation of cytokine production involved in immune response | biological process | GO:0002718 | 120 | 5 | 18204 | 49 |
PLCG2,IRF5,DENND1B,CD74,SYK |
1.792e-05 | -10.93 | Signal Transduction | REACTOME pathways | R-HSA-162582 | 2547 | 21 | 10285 | 36 |
ARHGAP27,GMIP,WAS,PREX1,APOE,ELMO1,IL6R,RGS14,ADCY7,P2RY2,DOCK1,SYK,VAV3,PIK3R5,P2RY6,PTPN6,AKAP13,ARHGAP33,HIF1A,PIK3CB,PRKCD |
1.909e-05 | -10.87 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 8 | 19454 | 50 |
WAS,IL6R,SKAP1,PRKCD,SYK,RIN3,PLCG2,PTPN6 |
1.918e-05 | -10.86 | regulation of hydrolase activity | biological process | GO:0051336 | 726 | 10 | 18204 | 49 |
DOCK10,SYK,PRKCD,GMIP,PREX1,DOCK8,ARHGAP27,P2RY6,TBC1D8,VAV3 |
2.023e-05 | -10.81 | Fc-gamma receptor signaling pathway involved in phagocytosis | biological process | GO:0038096 | 20 | 3 | 18204 | 49 |
VAV3,SYK,PRKCD |
2.023e-05 | -10.81 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | biological process | GO:0002433 | 20 | 3 | 18204 | 49 |
VAV3,PRKCD,SYK |
2.064e-05 | -10.79 | G protein-coupled UTP receptor activity | molecular function | GO:0045030 | 3 | 2 | 18094 | 48 |
P2RY2,P2RY6 |
2.084e-05 | -10.78 | positive regulation of GTPase activity | biological process | GO:0043547 | 211 | 6 | 18204 | 49 |
TBC1D8,DOCK10,GMIP,PREX1,DOCK8,ARHGAP27 |
2.088e-05 | -10.78 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 21 | 18204 | 49 |
CSF1R,IL6R,RGS14,HIF1A,APOE,PIK3CB,P2RY2,DOCK8,CD74,ADCY7,SEMA4A,PRKCD,VAV3,TBXAS1,SLC4A2,IRF5,PLCG2,DENND1B,PTPN6,DOCK1,SYK |
2.259e-05 | -10.70 | wound healing | biological process | GO:0042060 | 321 | 7 | 18204 | 49 |
PIK3CB,HIF1A,WAS,VAV3,PTPN6,SYK,PLCG2 |
2.475e-05 | -10.61 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 24 | 16828 | 46 |
GIT2,DOCK2,PIK3CB,MYO1F,CSF1R,DOCK1,PIK3R5,HIF1A,SLC4A2,VAV3,TBXAS1,PLCG2,PTPN6,ELMO1,WAS,IRF5,AKAP13,RHBDF2,EHBP1L1,RIN3,GMIP,DOCK8,IPCEF1,PREX1 |
2.486e-05 | -10.60 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 24 | 16828 | 46 |
RIN3,RHBDF2,EHBP1L1,AKAP13,IRF5,PREX1,IPCEF1,DOCK8,GMIP,SLC4A2,HIF1A,PIK3R5,DOCK1,CSF1R,PIK3CB,MYO1F,GIT2,DOCK2,WAS,ELMO1,PTPN6,PLCG2,TBXAS1,VAV3 |
2.496e-05 | -10.60 | regulation of protein phosphorylation | biological process | GO:0001932 | 917 | 11 | 18204 | 49 |
CD74,PRKCD,IL6R,CSF1R,RGS14,APOE,MICAL1,PLCG2,PTPN6,SYK,PIK3R5 |
2.557e-05 | -10.57 | SH3_2 | pfam domains | PF07653 | 61 | 4 | 17795 | 50 |
DOCK2,VAV3,FYB1,ARHGAP33 |
2.688e-05 | -10.52 | Regulation of RAC1 activity | Pathway Interaction DB | rac1_reg_pathway | 39 | 5 | 2226 | 22 |
DOCK2,ELMO1,DOCK1,VAV3,PREX1 |
2.723e-05 | -10.51 | Fc receptor mediated stimulatory signaling pathway | biological process | GO:0002431 | 22 | 3 | 18204 | 49 |
VAV3,PRKCD,SYK |
2.723e-05 | -10.51 | positive regulation of cell adhesion mediated by integrin | biological process | GO:0033630 | 22 | 3 | 18204 | 49 |
SYK,PTPN6,SKAP1 |
2.827e-05 | -10.47 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 33 | 16828 | 46 |
GIT2,DOCK2,PIK3CB,MYO1F,CSF1R,DOCK1,SLC4A2,PRKCD,RGS14,TBXAS1,VAV3,MICAL1,PLCG2,WAS,PTPN6,ELMO1,AKAP13,EHBP1L1,RHBDF2,IRF5,TBC1D8,NEK6,RIN3,PARVG,P2RY2,SYK,ARHGAP33,DOCK10,GMIP,WDFY4,SBNO2,DENND1B,PREX1 |
2.891e-05 | -10.45 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 24 | 16828 | 46 |
IRF5,EHBP1L1,RHBDF2,AKAP13,RIN3,GMIP,DOCK8,IPCEF1,PREX1,MYO1F,PIK3CB,DOCK2,GIT2,CSF1R,DOCK1,PIK3R5,HIF1A,SLC4A2,VAV3,TBXAS1,PLCG2,PTPN6,ELMO1,WAS |
2.953e-05 | -10.43 | myeloid cell activation involved in immune response | biological process | GO:0002275 | 66 | 4 | 18204 | 49 |
SBNO2,PLCG2,DOCK2,SYK |
2.994e-05 | -10.42 | PE/DAG-bd | interpro domains | IPR002219 | 66 | 4 | 18521 | 50 |
VAV3,PRKCD,GMIP,AKAP13 |
3.056e-05 | -10.40 | positive regulation of production of molecular mediator of immune response | biological process | GO:0002702 | 135 | 5 | 18204 | 49 |
DENND1B,PLCG2,IRF5,SYK,CD74 |
3.194e-05 | -10.35 | SH2 domain | gene3d domains | 3.30.505.10 | 111 | 5 | 14470 | 48 |
PTPN6,RIN3,PLCG2,VAV3,SYK |
3.279e-05 | -10.33 | lymphocyte activation involved in immune response | biological process | GO:0002285 | 137 | 5 | 18204 | 49 |
SEMA4A,DOCK10,CD74,PLCG2,IL6R |
3.387e-05 | -10.29 | regulation of actin cytoskeleton organization | biological process | GO:0032956 | 342 | 7 | 18204 | 49 |
CSF1R,WAS,SLC4A2,AKAP13,PREX1,CARMIL3,PRKCD |
3.611e-05 | -10.23 | biological process involved in interspecies interaction between organisms | biological process | GO:0044419 | 1540 | 14 | 18204 | 49 |
SBNO2,WAS,GSDME,PTPN6,SYK,IRF5,PLCG2,HIF1A,APOE,CSF1R,IL6R,CD74,PRKCD,WDFY4 |
3.774e-05 | -10.18 | Inflammatory mediator regulation of TRP channels | KEGG pathways | hsa04750 | 97 | 5 | 7161 | 29 |
PRKCD,ADCY7,P2RY2,PIK3CB,PLCG2 |
3.774e-05 | -10.18 | Inflammatory mediator regulation of TRP channels | KEGG pathways | ko04750 | 97 | 5 | 7161 | 29 |
P2RY2,PIK3CB,PRKCD,ADCY7,PLCG2 |
4.043e-05 | -10.12 | Fc-epsilon receptor signaling pathway | biological process | GO:0038095 | 25 | 3 | 18204 | 49 |
SYK,VAV3,PLCG2 |
4.077e-05 | -10.11 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 34 | 16828 | 46 |
DOCK8,DENND1B,GMIP,ARHGAP33,DOCK10,IPCEF1,PREX1,ARHGAP27,TBC1D8,IRF5,AKAP13,RHBDF2,EHBP1L1,P2RY6,PARVG,P2RY2,RIN3,MICAL1,VAV3,TBXAS1,PTPN6,ELMO1,WAS,PLCG2,CSF1R,DOCK2,MYO1F,PIK3CB,ADCY7,PRKCD,RGS14,SLC4A2,DOCK1,HIF1A |
4.121e-05 | -10.10 | G protein-coupled pyrimidinergic nucleotide receptor activity | molecular function | GO:0071553 | 4 | 2 | 18094 | 48 |
P2RY2,P2RY6 |
4.197e-05 | -10.08 | positive regulation of cell adhesion | biological process | GO:0045785 | 486 | 8 | 18204 | 49 |
DOCK1,PTPN6,SYK,CD74,PREX1,DOCK8,SKAP1,VAV3 |
4.390e-05 | -10.03 | SH2 | prosite domains | PS50001 | 107 | 5 | 12186 | 45 |
VAV3,PTPN6,SYK,PLCG2,RIN3 |
4.505e-05 | -10.01 | response to other organism | biological process | GO:0051707 | 1363 | 13 | 18204 | 49 |
HIF1A,CSF1R,IL6R,CD74,PRKCD,WDFY4,SBNO2,WAS,GSDME,PTPN6,SYK,PLCG2,IRF5 |
4.560e-05 | -10.00 | protein domain specific binding | molecular function | GO:0019904 | 651 | 9 | 18094 | 48 |
HIF1A,DOCK1,PTPN6,SKAP1,ELMO1,WAS,SYK,ARHGAP27,MICAL1 |
4.562e-05 | -10.00 | Platelet activation, signaling and aggregation | REACTOME pathways | R-HSA-76002 | 282 | 7 | 10285 | 36 |
PRKCD,PIK3CB,PTPN6,PLCG2,PIK3R5,SYK,VAV3 |
4.609e-05 | -9.98 | response to external biotic stimulus | biological process | GO:0043207 | 1366 | 13 | 18204 | 49 |
SBNO2,WAS,IRF5,PLCG2,GSDME,PTPN6,SYK,CSF1R,IL6R,HIF1A,WDFY4,CD74,PRKCD |
4.986e-05 | -9.91 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 8 | 18204 | 49 |
P2RY2,PRKCD,PREX1,TBXAS1,WAS,VAV3,RIN3,APOE |
5.003e-05 | -9.90 | PLCG1 (phospholipase C gamma 1) | protein interactions | 5335 | 258 | 6 | 19454 | 50 |
VAV3,RIN3,WAS,PTPN6,SYK,PLCG2 |
5.129e-05 | -9.88 | positive regulation of cytokine production | biological process | GO:0001819 | 500 | 8 | 18204 | 49 |
HIF1A,CSF1R,IL6R,SYK,CD74,DENND1B,IRF5,PLCG2 |
5.227e-05 | -9.86 | regulation of phosphorylation | biological process | GO:0042325 | 994 | 11 | 18204 | 49 |
MICAL1,PLCG2,PTPN6,PRKCD,SYK,CD74,IL6R,CSF1R,PIK3R5,RGS14,APOE |
5.249e-05 | -9.85 | SH2 | smart domains | SM00252 | 103 | 5 | 9717 | 39 |
VAV3,PLCG2,SYK,PTPN6,RIN3 |
5.439e-05 | -9.82 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 29 | 18204 | 49 |
RGS14,APOE,PIK3CB,PREX1,DOCK2,PRKCD,SKAP1,WAS,TBC1D8,NRK,IRF5,PTPN6,CSF1R,IL6R,HIF1A,AKAP13,DOCK8,CD74,SEMA4A,VAV3,SBNO2,PIK3R5,P2RY6,PLCG2,DENND1B,GSDME,NEK6,DOCK1,SYK |
5.559e-05 | -9.80 | leukocyte proliferation | biological process | GO:0070661 | 153 | 5 | 18204 | 49 |
CSF1R,DOCK8,PTPN6,DOCK2,PRKCD |
5.851e-05 | -9.75 | - | gene3d domains | 3.30.60.20 | 64 | 4 | 14470 | 48 |
AKAP13,PRKCD,VAV3,GMIP |
5.952e-05 | -9.73 | ZF_DAG_PE_1 | prosite domains | PS00479 | 58 | 4 | 12186 | 45 |
VAV3,AKAP13,PRKCD,GMIP |
6.249e-05 | -9.68 | PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) | protein interactions | 5295 | 394 | 7 | 19454 | 50 |
PLCG2,CSF1R,PTPN6,PIK3CB,SYK,WAS,VAV3 |
6.307e-05 | -9.67 | response to biotic stimulus | biological process | GO:0009607 | 1408 | 13 | 18204 | 49 |
CSF1R,IL6R,HIF1A,WDFY4,CD74,PRKCD,SBNO2,WAS,IRF5,PLCG2,GSDME,SYK,PTPN6 |
6.354e-05 | -9.66 | regulation of transport | biological process | GO:0051049 | 1621 | 14 | 18204 | 49 |
MICAL1,PLCG2,PTPN6,SYK,P2RY6,P2RY2,CD74,RHBDF2,DOCK2,PRKCD,HIF1A,APOE,RIN3,PIK3CB |
6.552e-05 | -9.63 | T-Cell antigen Receptor (TCR) Signaling Pathway | WikiPathways | WP69 | 91 | 5 | 5310 | 26 |
FYB1,PRKCD,WAS,VAV3,SKAP1 |
6.709e-05 | -9.61 | CH_dom | interpro domains | IPR001715 | 81 | 4 | 18521 | 50 |
VAV3,EHBP1L1,MICAL1,PARVG |
6.840e-05 | -9.59 | positive regulation of immune effector process | biological process | GO:0002699 | 261 | 6 | 18204 | 49 |
IRF5,PLCG2,DENND1B,CD74,SYK,PTPN6 |
7.039e-05 | -9.56 | CH_dom_sf | interpro domains | IPR036872 | 82 | 4 | 18521 | 50 |
MICAL1,EHBP1L1,PARVG,VAV3 |
7.044e-05 | -9.56 | regulation of actin filament-based process | biological process | GO:0032970 | 384 | 7 | 18204 | 49 |
WAS,CSF1R,PRKCD,CARMIL3,PREX1,AKAP13,SLC4A2 |
7.081e-05 | -9.56 | positive regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050731 | 161 | 5 | 18204 | 49 |
PLCG2,CSF1R,IL6R,CD74,SYK |
7.106e-05 | -9.55 | DOCK_N | interpro domains | IPR032376 | 5 | 2 | 18521 | 50 |
DOCK1,DOCK2 |
7.106e-05 | -9.55 | DOCK_N_sub1 | interpro domains | IPR042455 | 5 | 2 | 18521 | 50 |
DOCK1,DOCK2 |
7.217e-05 | -9.54 | Immune System | REACTOME pathways | R-HSA-168256 | 2101 | 18 | 10285 | 36 |
CSF1R,WAS,ADCY7,CD74,IL6R,PLCG2,IRF5,ELMO1,FYB1,GLIPR1,DOCK2,SYK,VAV3,DOCK1,PRKCD,PIK3CB,HIF1A,PTPN6 |
7.316e-05 | -9.52 | CDC42 (cell division cycle 42) | protein interactions | 998 | 1280 | 12 | 19454 | 50 |
DOCK8,GIT2,PLCG2,NEK6,TBC1D8,GMIP,WAS,EHBP1L1,ARHGAP27,PREX1,SLC4A2,DOCK10 |
7.696e-05 | -9.47 | DOCK_N | pfam domains | PF16172 | 5 | 2 | 17795 | 50 |
DOCK1,DOCK2 |
7.763e-05 | -9.46 | regulation of immune effector process | biological process | GO:0002697 | 390 | 7 | 18204 | 49 |
WAS,DENND1B,IRF5,PLCG2,SYK,PTPN6,CD74 |
7.813e-05 | -9.46 | neutrophil activation | biological process | GO:0042119 | 31 | 3 | 18204 | 49 |
SYK,PRKCD,PREX1 |
8.244e-05 | -9.40 | ZF_DAG_PE_2 | prosite domains | PS50081 | 63 | 4 | 12186 | 45 |
VAV3,AKAP13,GMIP,PRKCD |
8.267e-05 | -9.40 | NME2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 4831 | 174 | 5 | 19454 | 50 |
PREX1,AKAP13,GIT2,DOCK8,PLCG2 |
8.296e-05 | -9.40 | regulation of cytokine production | biological process | GO:0001817 | 863 | 10 | 18204 | 49 |
IL6R,CSF1R,HIF1A,DENND1B,IRF5,PLCG2,SYK,PTPN6,ADCY7,CD74 |
8.372e-05 | -9.39 | regulation of protein modification process | biological process | GO:0031399 | 1242 | 12 | 18204 | 49 |
PIK3R5,SYK,PTPN6,PLCG2,MICAL1,APOE,HIF1A,RGS14,CSF1R,IL6R,CD74,PRKCD |
8.604e-05 | -9.36 | Fc-gamma receptor signaling pathway | biological process | GO:0038094 | 32 | 3 | 18204 | 49 |
SYK,PRKCD,VAV3 |
8.750e-05 | -9.34 | cellular response to virus | biological process | GO:0098586 | 87 | 4 | 18204 | 49 |
WDFY4,IRF5,HIF1A,GSDME |
8.754e-05 | -9.34 | SH2DOMAIN | prints domains | PR00401 | 72 | 4 | 5227 | 18 |
PTPN6,SYK,PLCG2,VAV3 |
9.159e-05 | -9.30 | negative regulation of MAPK cascade | biological process | GO:0043409 | 170 | 5 | 18204 | 49 |
APOE,RGS14,PIK3CB,PRKCD,PTPN6 |
9.560e-05 | -9.26 | regulation of leukocyte apoptotic process | biological process | GO:2000106 | 89 | 4 | 18204 | 49 |
DOCK8,PIK3CB,CD74,HIF1A |
1.034e-04 | -9.18 | positive T cell selection | biological process | GO:0043368 | 34 | 3 | 18204 | 49 |
IL6R,DOCK2,CD74 |
1.050e-04 | -9.16 | regulation of interleukin-6 production | biological process | GO:0032675 | 175 | 5 | 18204 | 49 |
CD74,SYK,PTPN6,IL6R,PLCG2 |
1.063e-04 | -9.15 | regulation of cellular process | biological process | GO:0050794 | 11468 | 43 | 18204 | 49 |
PREX1,DOCK2,PRKCD,ELMO1,RGS14,APOE,RIN3,PIK3CB,MICAL1,IRF5,PTPN6,DOCK10,SKAP1,WAS,TBC1D8,NRK,P2RY2,ARHGAP27,ARHGAP33,AKAP13,DOCK8,CD74,RHBDF2,ADCY7,SEMA4A,GMIP,IL6R,CSF1R,HIF1A,SLC4A2,PLCG2,DENND1B,GSDME,GIT2,CARMIL3,DOCK1,NEK6,SYK,VAV3,SBNO2,FYB1,PIK3R5,P2RY6 |
1.064e-04 | -9.15 | DOCK_C/D_N | interpro domains | IPR021816 | 6 | 2 | 18521 | 50 |
DOCK8,DOCK10 |
1.071e-04 | -9.14 | Dedicator of cytokinesis N-terminal subdomain | gene3d domains | 1.20.1270.350 | 5 | 2 | 14470 | 48 |
DOCK1,DOCK2 |
1.129e-04 | -9.09 | granulocyte activation | biological process | GO:0036230 | 35 | 3 | 18204 | 49 |
PREX1,SYK,PRKCD |
1.129e-04 | -9.09 | positive regulation of myeloid leukocyte cytokine production involved in immune response | biological process | GO:0061081 | 35 | 3 | 18204 | 49 |
PLCG2,SYK,CD74 |
1.152e-04 | -9.07 | DOCK_C-D_N | pfam domains | PF11878 | 6 | 2 | 17795 | 50 |
DOCK8,DOCK10 |
1.207e-04 | -9.02 | bone | COSMIC cancer mutations | bone | 8157 | 35 | 16828 | 46 |
PLCG2,WAS,ELMO1,PTPN6,TBXAS1,VAV3,MICAL1,HIF1A,DOCK1,SLC4A2,PRKCD,RGS14,ADCY7,PIK3CB,MYO1F,DOCK2,CSF1R,ARHGAP27,PREX1,IPCEF1,DOCK10,ARHGAP33,GMIP,WDFY4,DENND1B,DOCK8,RIN3,P2RY2,PARVG,P2RY6,RHBDF2,EHBP1L1,AKAP13,IRF5,TBC1D8 |
1.229e-04 | -9.00 | syncytium formation by plasma membrane fusion | biological process | GO:0000768 | 36 | 3 | 18204 | 49 |
SBNO2,DOCK1,DOCK2 |
1.229e-04 | -9.00 | cell-cell fusion | biological process | GO:0140253 | 36 | 3 | 18204 | 49 |
DOCK2,DOCK1,SBNO2 |
1.258e-04 | -8.98 | C1 | smart domains | SM00109 | 65 | 4 | 9717 | 39 |
AKAP13,GMIP,VAV3,PRKCD |
1.283e-04 | -8.96 | integrin-mediated signaling pathway | biological process | GO:0007229 | 96 | 4 | 18204 | 49 |
VAV3,FYB1,SYK,DOCK1 |
1.327e-04 | -8.93 | mouth | COSMIC cancer mutations | mouth | 9004 | 37 | 16828 | 46 |
DOCK10,ARHGAP33,WDFY4,GMIP,DOCK8,DENND1B,SBNO2,PREX1,RHBDF2,EHBP1L1,AKAP13,IRF5,CD74,TBC1D8,NEK6,APOE,RIN3,P2RY2,PARVG,SYK,TBXAS1,VAV3,MICAL1,PLCG2,WAS,ELMO1,PTPN6,ADCY7,PIK3CB,MYO1F,GIT2,DOCK2,CSF1R,DOCK1,SLC4A2,RGS14,PRKCD |
1.334e-04 | -8.92 | Calponin-like domain | gene3d domains | 1.10.418.10 | 79 | 4 | 14470 | 48 |
MICAL1,PARVG,EHBP1L1,VAV3 |
1.335e-04 | -8.92 | negative regulation of lymphocyte apoptotic process | biological process | GO:0070229 | 37 | 3 | 18204 | 49 |
HIF1A,CD74,DOCK8 |
1.335e-04 | -8.92 | CH | smart domains | SM00033 | 66 | 4 | 9717 | 39 |
EHBP1L1,VAV3,MICAL1,PARVG |
1.340e-04 | -8.92 | regulation of endocytosis | biological process | GO:0030100 | 295 | 6 | 18204 | 49 |
DOCK2,SYK,PLCG2,RIN3,PIK3CB,APOE |
1.363e-04 | -8.90 | DOCK5 (dedicator of cytokinesis 5) | protein interactions | 80005 | 102 | 4 | 19454 | 50 |
GIT2,ELMO1,DOCK1,PIK3CB |
1.384e-04 | -8.89 | regulation of inflammatory response | biological process | GO:0050727 | 428 | 7 | 18204 | 49 |
APOE,SBNO2,PTPN6,PRKCD,SYK,RHBDF2,PLCG2 |
1.394e-04 | -8.88 | Fc epsilon RI signaling pathway | KEGG pathways | hsa04664 | 67 | 4 | 7161 | 29 |
VAV3,PIK3CB,PLCG2,SYK |
1.394e-04 | -8.88 | Fc epsilon RI signaling pathway | KEGG pathways | ko04664 | 67 | 4 | 7161 | 29 |
VAV3,PIK3CB,PLCG2,SYK |
1.445e-04 | -8.84 | response to wounding | biological process | GO:0009611 | 431 | 7 | 18204 | 49 |
SYK,PTPN6,PLCG2,HIF1A,PIK3CB,VAV3,WAS |
1.468e-04 | -8.83 | regulation of epithelial cell migration | biological process | GO:0010632 | 300 | 6 | 18204 | 49 |
PIK3CB,HIF1A,APOE,PLCG2,SEMA4A,DOCK1 |
1.474e-04 | -8.82 | regulation of response to external stimulus | biological process | GO:0032101 | 1116 | 11 | 18204 | 49 |
PRKCD,CD74,RHBDF2,CSF1R,IL6R,RIN3,APOE,PLCG2,PTPN6,SYK,SBNO2 |
1.478e-04 | -8.82 | vascular endothelial growth factor production | biological process | GO:0010573 | 7 | 2 | 18204 | 49 |
HIF1A,IL6R |
1.483e-04 | -8.82 | regulation of biological process | biological process | GO:0050789 | 12079 | 44 | 18204 | 49 |
PREX1,PRKCD,DOCK2,APOE,RGS14,PIK3CB,RIN3,ELMO1,PTPN6,DOCK10,IRF5,MICAL1,TBC1D8,NRK,SKAP1,WAS,RHBDF2,ADCY7,CD74,SEMA4A,GMIP,ARHGAP33,AKAP13,ARHGAP27,P2RY2,DOCK8,HIF1A,CSF1R,IL6R,GIT2,GSDME,SYK,DOCK1,CARMIL3,NEK6,PLCG2,SLC4A2,DENND1B,PIK3R5,P2RY6,VAV3,SBNO2,TBXAS1,FYB1 |
1.499e-04 | -8.81 | FCERI mediated Ca+2 mobilization | REACTOME pathways | R-HSA-2871809 | 30 | 3 | 10285 | 36 |
PLCG2,VAV3,SYK |
1.502e-04 | -8.80 | positive regulation of interleukin-6 production | biological process | GO:0032755 | 100 | 4 | 18204 | 49 |
SYK,CD74,PLCG2,IL6R |
1.506e-04 | -8.80 | regulation of production of molecular mediator of immune response | biological process | GO:0002700 | 189 | 5 | 18204 | 49 |
CD74,SYK,IRF5,PLCG2,DENND1B |
1.527e-04 | -8.79 | SH3DOMAIN | prints domains | PR00452 | 83 | 4 | 5227 | 18 |
VAV3,PLCG2,SKAP1,MYO1F |
1.565e-04 | -8.76 | syncytium formation | biological process | GO:0006949 | 39 | 3 | 18204 | 49 |
SBNO2,DOCK1,DOCK2 |
1.599e-04 | -8.74 | Rap1 signaling pathway | KEGG pathways | ko04015 | 210 | 6 | 7161 | 29 |
PIK3CB,ADCY7,FYB1,CSF1R,SKAP1,RGS14 |
1.599e-04 | -8.74 | Rap1 signaling pathway | KEGG pathways | hsa04015 | 210 | 6 | 7161 | 29 |
SKAP1,CSF1R,RGS14,FYB1,PIK3CB,ADCY7 |
1.622e-04 | -8.73 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 46 | 16828 | 46 |
SLC4A2,RGS14,ADCY7,MYO1F,GIT2,ELMO1,PTPN6,VAV3,PARVG,EHBP1L1,IRF5,WDFY4,DENND1B,DOCK8,HIF1A,DOCK1,PIK3R5,PRKCD,PIK3CB,DOCK2,CSF1R,PLCG2,WAS,TBXAS1,MICAL1,APOE,GLIPR1,RIN3,P2RY2,P2RY6,SYK,RHBDF2,IL6R,AKAP13,CD74,TBC1D8,NEK6,ARHGAP27,PREX1,IPCEF1,DOCK10,SEMA4A,ARHGAP33,SKAP1,GMIP,SBNO2 |
1.622e-04 | -8.73 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 46 | 16828 | 46 |
PTPN6,ELMO1,VAV3,SLC4A2,RGS14,ADCY7,MYO1F,GIT2,DOCK8,DENND1B,WDFY4,PARVG,EHBP1L1,IRF5,WAS,PLCG2,MICAL1,TBXAS1,PRKCD,HIF1A,DOCK1,PIK3R5,CSF1R,PIK3CB,DOCK2,ARHGAP27,PREX1,IPCEF1,SBNO2,SEMA4A,DOCK10,ARHGAP33,SKAP1,GMIP,P2RY2,P2RY6,SYK,APOE,RIN3,GLIPR1,TBC1D8,NEK6,RHBDF2,IL6R,AKAP13,CD74 |
1.642e-04 | -8.71 | Natural killer cell mediated cytotoxicity | KEGG pathways | ko04650 | 132 | 5 | 7161 | 29 |
PIK3CB,VAV3,PTPN6,SYK,PLCG2 |
1.642e-04 | -8.71 | Natural killer cell mediated cytotoxicity | KEGG pathways | hsa04650 | 132 | 5 | 7161 | 29 |
VAV3,PIK3CB,PLCG2,PTPN6,SYK |
1.687e-04 | -8.69 | response to organic substance | biological process | GO:0010033 | 2498 | 17 | 18204 | 49 |
IL6R,CSF1R,HIF1A,P2RY2,DOCK8,CD74,ADCY7,PRKCD,SBNO2,WAS,TBXAS1,P2RY6,PLCG2,IRF5,GSDME,PTPN6,SYK |
1.709e-04 | -8.67 | PRAM1 (PML-RARA regulated adaptor molecule 1) | protein interactions | 84106 | 42 | 3 | 19454 | 50 |
SKAP1,NEK6,APOE |
1.754e-04 | -8.65 | PH | pfam domains | PF00169 | 187 | 5 | 17795 | 50 |
DOCK10,VAV3,IPCEF1,SKAP1,ARHGAP27 |
1.773e-04 | -8.64 | SH2 | pfam domains | PF00017 | 100 | 4 | 17795 | 50 |
PTPN6,VAV3,SYK,PLCG2 |
1.870e-04 | -8.58 | SH2 domain binding | molecular function | GO:0042169 | 42 | 3 | 18094 | 48 |
SKAP1,PTPN6,SYK |
1.910e-04 | -8.56 | phosphorylation-dependent protein binding | molecular function | GO:0140031 | 8 | 2 | 18094 | 48 |
PTPN6,PLCG2 |
1.979e-04 | -8.53 | bMERB_dom | interpro domains | IPR022735 | 8 | 2 | 18521 | 50 |
EHBP1L1,MICAL1 |
2.007e-04 | -8.51 | negative regulation of inflammatory response | biological process | GO:0050728 | 201 | 5 | 18204 | 49 |
RHBDF2,APOE,PRKCD,SYK,PTPN6 |
2.060e-04 | -8.49 | anatomical structure formation involved in morphogenesis | biological process | GO:0048646 | 964 | 10 | 18204 | 49 |
PTPN6,DOCK2,DOCK1,SEMA4A,SYK,SLC4A2,PIK3CB,HIF1A,SBNO2,VAV3 |
2.097e-04 | -8.47 | regulation of bone resorption | biological process | GO:0045124 | 43 | 3 | 18204 | 49 |
SYK,SLC4A2,CSF1R |
2.097e-04 | -8.47 | positive regulation of interleukin-12 production | biological process | GO:0032735 | 43 | 3 | 18204 | 49 |
PLCG2,IRF5,SYK |
2.101e-04 | -8.47 | EPOR (erythropoietin receptor) | protein interactions | 2057 | 45 | 3 | 19454 | 50 |
SYK,PTPN6,PLCG2 |
2.143e-04 | -8.45 | bMERB_dom | pfam domains | PF12130 | 8 | 2 | 17795 | 50 |
EHBP1L1,MICAL1 |
2.179e-04 | -8.43 | functioning | COSMIC cancer mutations | functioning | 1803 | 14 | 16828 | 46 |
DOCK2,ADCY7,CSF1R,DOCK1,RIN3,RGS14,SLC4A2,WDFY4,SKAP1,SBNO2,DOCK8,IPCEF1,PTPN6,ELMO1 |
2.179e-04 | -8.43 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 14 | 16828 | 46 |
DOCK2,ADCY7,CSF1R,DOCK1,RIN3,RGS14,SLC4A2,WDFY4,SKAP1,SBNO2,DOCK8,IPCEF1,PTPN6,ELMO1 |
2.194e-04 | -8.42 | CH | prosite domains | PS50021 | 81 | 4 | 12186 | 45 |
PARVG,MICAL1,VAV3,EHBP1L1 |
2.276e-04 | -8.39 | Bacterial invasion of epithelial cells | KEGG pathways | ko05100 | 76 | 4 | 7161 | 29 |
ELMO1,PIK3CB,DOCK1,WAS |
2.276e-04 | -8.39 | Bacterial invasion of epithelial cells | KEGG pathways | hsa05100 | 76 | 4 | 7161 | 29 |
PIK3CB,DOCK1,WAS,ELMO1 |
2.304e-04 | -8.38 | KLRA1P (killer cell lectin like receptor A1, pseudogene) | protein interactions | 10748 | 9 | 2 | 19454 | 50 |
SYK,PTPN6 |
2.388e-04 | -8.34 | phosphatidylinositol 3-kinase complex, class I | cellular component | GO:0097651 | 9 | 2 | 19108 | 50 |
PIK3R5,PIK3CB |
2.388e-04 | -8.34 | phosphatidylinositol 3-kinase complex, class IA | cellular component | GO:0005943 | 9 | 2 | 19108 | 50 |
PIK3CB,PIK3R5 |
2.405e-04 | -8.33 | regulation of adaptive immune response | biological process | GO:0002819 | 209 | 5 | 18204 | 49 |
SKAP1,DENND1B,WAS,ADCY7,PTPN6 |
2.532e-04 | -8.28 | regulation of cell activation | biological process | GO:0050865 | 630 | 8 | 18204 | 49 |
SLC4A2,DOCK8,CD74,PTPN6,PRKCD,SYK,VAV3,APOE |
2.549e-04 | -8.27 | Phospholipase D signaling pathway | KEGG pathways | hsa04072 | 145 | 5 | 7161 | 29 |
PLCG2,SYK,ADCY7,PIK3R5,PIK3CB |
2.549e-04 | -8.27 | Phospholipase D signaling pathway | KEGG pathways | ko04072 | 145 | 5 | 7161 | 29 |
PIK3R5,ADCY7,PIK3CB,PLCG2,SYK |
2.617e-04 | -8.25 | phosphotyrosine residue binding | molecular function | GO:0001784 | 47 | 3 | 18094 | 48 |
PLCG2,SYK,PTPN6 |
2.683e-04 | -8.22 | negative regulation of cell activation | biological process | GO:0050866 | 214 | 5 | 18204 | 49 |
SLC4A2,APOE,CD74,PRKCD,PTPN6 |
2.693e-04 | -8.22 | CBL (Cbl proto-oncogene) | protein interactions | 867 | 499 | 7 | 19454 | 50 |
PIK3CB,CSF1R,FYB1,PTPN6,WAS,HIF1A,SYK |
2.734e-04 | -8.20 | negative regulation of MAP kinase activity | biological process | GO:0043407 | 47 | 3 | 18204 | 49 |
PRKCD,APOE,RGS14 |
2.751e-04 | -8.20 | PH_12 | pfam domains | PF16457 | 9 | 2 | 17795 | 50 |
ELMO1,PLCG2 |
2.800e-04 | -8.18 | cell chemotaxis | biological process | GO:0060326 | 216 | 5 | 18204 | 49 |
VAV3,IL6R,SYK,PRKCD,PREX1 |
2.838e-04 | -8.17 | regulation of receptor-mediated endocytosis | biological process | GO:0048259 | 118 | 4 | 18204 | 49 |
RIN3,PIK3CB,SYK,PLCG2 |
2.854e-04 | -8.16 | ARM-type_fold | interpro domains | IPR016024 | 338 | 6 | 18521 | 50 |
PIK3CB,WDFY4,DOCK1,ELMO1,DOCK2,DOCK8 |
2.911e-04 | -8.14 | icosanoid biosynthetic process | biological process | GO:0046456 | 48 | 3 | 18204 | 49 |
SYK,CD74,TBXAS1 |
2.986e-04 | -8.12 | lung-carcinoma-undifferentiated_carcinoma | COSMIC cancer mutations | lung-carcinoma-undifferentiated_carcinoma | 1408 | 12 | 16828 | 46 |
CSF1R,PIK3CB,P2RY6,SYK,PRKCD,P2RY2,RIN3,PIK3R5,VAV3,PTPN6,WAS,PLCG2 |
3.095e-04 | -8.08 | regulation of cell adhesion mediated by integrin | biological process | GO:0033628 | 49 | 3 | 18204 | 49 |
SKAP1,SYK,PTPN6 |
3.188e-04 | -8.05 | undifferentiated_carcinoma | COSMIC cancer mutations | undifferentiated_carcinoma | 1418 | 12 | 16828 | 46 |
CSF1R,PIK3CB,PRKCD,P2RY6,SYK,P2RY2,PIK3R5,RIN3,VAV3,PTPN6,WAS,PLCG2 |
3.223e-04 | -8.04 | regulation of leukocyte chemotaxis | biological process | GO:0002688 | 122 | 4 | 18204 | 49 |
IL6R,CSF1R,RIN3,CD74 |
3.258e-04 | -8.03 | GAB2 (GRB2 associated binding protein 2) | protein interactions | 9846 | 128 | 4 | 19454 | 50 |
PIK3CB,PLCG2,PTPN6,SYK |
3.292e-04 | -8.02 | Nef and signal transduction | REACTOME pathways | R-HSA-164944 | 8 | 2 | 10285 | 36 |
ELMO1,DOCK2 |
3.301e-04 | -8.02 | Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | REACTOME pathways | R-HSA-983695 | 39 | 3 | 10285 | 36 |
SYK,PLCG2,PTPN6 |
3.397e-04 | -7.99 | breast-carcinoma-ER-PR-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-ER-PR-positive_carcinoma | 1881 | 14 | 16828 | 46 |
PLCG2,WAS,ELMO1,PTPN6,DOCK10,VAV3,RIN3,PIK3R5,P2RY2,SYK,P2RY6,PRKCD,PIK3CB,CSF1R |
3.397e-04 | -7.99 | ER-PR-positive_carcinoma | COSMIC cancer mutations | ER-PR-positive_carcinoma | 1881 | 14 | 16828 | 46 |
PLCG2,WAS,ELMO1,PTPN6,DOCK10,VAV3,RIN3,PIK3R5,P2RY2,SYK,PRKCD,P2RY6,PIK3CB,CSF1R |
3.419e-04 | -7.98 | ELMO2 (engulfment and cell motility 2) | protein interactions | 63916 | 53 | 3 | 19454 | 50 |
DOCK1,DOCK2,ELMO1 |
3.474e-04 | -7.97 | regulation of cellular component size | biological process | GO:0032535 | 352 | 6 | 18204 | 49 |
PREX1,APOE,RIN3,PRKCD,VAV3,WAS |
3.485e-04 | -7.96 | regulation of bone remodeling | biological process | GO:0046850 | 51 | 3 | 18204 | 49 |
SLC4A2,CSF1R,SYK |
3.577e-04 | -7.94 | regulation of cell-cell adhesion | biological process | GO:0022407 | 500 | 7 | 18204 | 49 |
CD74,PRKCD,SYK,PTPN6,SKAP1,SLC4A2,DOCK8 |
3.668e-04 | -7.91 | NHLRC2 (NHL repeat containing 2) | protein interactions | 374354 | 372 | 6 | 19454 | 50 |
TBXAS1,MYO1F,DOCK10,AKAP13,SYK,PRKCD |
3.681e-04 | -7.91 | BMERB | prosite domains | PS51848 | 8 | 2 | 12186 | 45 |
MICAL1,EHBP1L1 |
3.801e-04 | -7.88 | regulation of biological quality | biological process | GO:0065008 | 2936 | 18 | 18204 | 49 |
SLC4A2,PLCG2,PTPN6,SYK,TBXAS1,WAS,VAV3,P2RY2,ARHGAP33,PRKCD,SEMA4A,PREX1,CSF1R,RIN3,PIK3CB,RGS14,APOE,HIF1A |
3.812e-04 | -7.87 | regulation of leukocyte migration | biological process | GO:0002685 | 231 | 5 | 18204 | 49 |
IL6R,CSF1R,DOCK8,CD74,RIN3 |
3.847e-04 | -7.86 | actin cytoskeleton | cellular component | GO:0015629 | 520 | 7 | 19108 | 50 |
WAS,ARHGAP33,AKAP13,PARVG,MYO1F,MICAL1,FYB1 |
3.868e-04 | -7.86 | regulation of B cell activation | biological process | GO:0050864 | 128 | 4 | 18204 | 49 |
VAV3,SYK,PTPN6,CD74 |
3.906e-04 | -7.85 | regulation of platelet activation | biological process | GO:0010543 | 53 | 3 | 18204 | 49 |
APOE,SYK,PRKCD |
4.092e-04 | -7.80 | adaptive immune response | biological process | GO:0002250 | 363 | 6 | 18204 | 49 |
SYK,SEMA4A,PRKCD,CD74,SKAP1,IL6R |
4.102e-04 | -7.80 | lymphocyte proliferation | biological process | GO:0046651 | 130 | 4 | 18204 | 49 |
DOCK2,PTPN6,PRKCD,DOCK8 |
4.203e-04 | -7.77 | RWDD1 (RWD domain containing 1) | protein interactions | 51389 | 12 | 2 | 19454 | 50 |
CD74,P2RY6 |
4.322e-04 | -7.75 | regulation of vesicle-mediated transport | biological process | GO:0060627 | 516 | 7 | 18204 | 49 |
APOE,RIN3,PIK3CB,DOCK2,SYK,MICAL1,PLCG2 |
4.329e-04 | -7.75 | DUF3585 | smart domains | SM01203 | 8 | 2 | 9717 | 39 |
EHBP1L1,MICAL1 |
4.357e-04 | -7.74 | neutrophil chemotaxis | biological process | GO:0030593 | 55 | 3 | 18204 | 49 |
SYK,PREX1,VAV3 |
4.578e-04 | -7.69 | regulation of cytoskeleton organization | biological process | GO:0051493 | 521 | 7 | 18204 | 49 |
PREX1,CARMIL3,PRKCD,SLC4A2,CSF1R,AKAP13,WAS |
4.595e-04 | -7.69 | negative regulation of leukocyte apoptotic process | biological process | GO:2000107 | 56 | 3 | 18204 | 49 |
HIF1A,CD74,DOCK8 |
4.601e-04 | -7.68 | mononuclear cell proliferation | biological process | GO:0032943 | 134 | 4 | 18204 | 49 |
DOCK8,DOCK2,PTPN6,PRKCD |
4.605e-04 | -7.68 | positive thymic T cell selection | biological process | GO:0045059 | 12 | 2 | 18204 | 49 |
DOCK2,CD74 |
4.605e-04 | -7.68 | negative thymic T cell selection | biological process | GO:0045060 | 12 | 2 | 18204 | 49 |
CD74,DOCK2 |
4.616e-04 | -7.68 | NCK2 (NCK adaptor protein 2) | protein interactions | 8440 | 252 | 5 | 19454 | 50 |
DOCK1,FYB1,GIT2,WAS,MICAL1 |
4.842e-04 | -7.63 | osteoclast differentiation | biological process | GO:0030316 | 57 | 3 | 18204 | 49 |
CSF1R,SLC4A2,SBNO2 |
4.842e-04 | -7.63 | regulation of lymphocyte apoptotic process | biological process | GO:0070228 | 57 | 3 | 18204 | 49 |
CD74,HIF1A,DOCK8 |
4.845e-04 | -7.63 | biological regulation | biological process | GO:0065007 | 12501 | 44 | 18204 | 49 |
RGS14,APOE,PREX1,SKAP1,TBC1D8,NRK,IRF5,PTPN6,CSF1R,IL6R,AKAP13,ARHGAP33,CD74,GMIP,SBNO2,TBXAS1,P2RY6,SLC4A2,GIT2,NEK6,CARMIL3,SYK,ELMO1,RIN3,PIK3CB,DOCK2,PRKCD,WAS,MICAL1,DOCK10,HIF1A,ARHGAP27,P2RY2,DOCK8,ADCY7,RHBDF2,SEMA4A,VAV3,FYB1,PIK3R5,PLCG2,DENND1B,GSDME,DOCK1 |
4.866e-04 | -7.63 | regulation of MAP kinase activity | biological process | GO:0043405 | 136 | 4 | 18204 | 49 |
APOE,PIK3R5,RGS14,PRKCD |
4.959e-04 | -7.61 | FCRL3 (Fc receptor like 3) | protein interactions | 115352 | 13 | 2 | 19454 | 50 |
SYK,PTPN6 |
4.959e-04 | -7.61 | RINL (Ras and Rab interactor like) | protein interactions | 126432 | 13 | 2 | 19454 | 50 |
MICAL1,RIN3 |
4.970e-04 | -7.61 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 21 | 16828 | 46 |
DOCK1,PRKCD,SYK,SLC4A2,PIK3CB,DOCK2,GIT2,AKAP13,CSF1R,TBC1D8,IPCEF1,PLCG2,ELMO1,PTPN6,SKAP1,WDFY4,GMIP,DOCK10,ARHGAP33,DENND1B,SBNO2 |
4.970e-04 | -7.61 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 21 | 16828 | 46 |
DOCK1,SLC4A2,SYK,PRKCD,AKAP13,GIT2,DOCK2,PIK3CB,TBC1D8,CSF1R,PLCG2,IPCEF1,ELMO1,PTPN6,ARHGAP33,DOCK10,WDFY4,GMIP,SKAP1,SBNO2,DENND1B |
4.982e-04 | -7.60 | positive regulation of phosphorus metabolic process | biological process | GO:0010562 | 697 | 8 | 18204 | 49 |
IL6R,CSF1R,P2RY6,PIK3R5,PLCG2,PRKCD,SYK,CD74 |
4.982e-04 | -7.60 | positive regulation of phosphate metabolic process | biological process | GO:0045937 | 697 | 8 | 18204 | 49 |
P2RY6,PIK3R5,CSF1R,IL6R,PRKCD,SYK,CD74,PLCG2 |
4.987e-04 | -7.60 | leukocyte migration | biological process | GO:0050900 | 245 | 5 | 18204 | 49 |
DOCK8,IL6R,VAV3,SYK,PREX1 |
5.002e-04 | -7.60 | myeloid leukocyte migration | biological process | GO:0097529 | 137 | 4 | 18204 | 49 |
SYK,PREX1,VAV3,IL6R |
5.129e-04 | -7.58 | regulation of kinase activity | biological process | GO:0043549 | 531 | 7 | 18204 | 49 |
PRKCD,CD74,PIK3R5,RGS14,APOE,IL6R,CSF1R |
5.175e-04 | -7.57 | regulation of leukocyte mediated immunity | biological process | GO:0002703 | 247 | 5 | 18204 | 49 |
PLCG2,DENND1B,WAS,SYK,PTPN6 |
5.276e-04 | -7.55 | G protein-coupled purinergic nucleotide receptor activity | molecular function | GO:0045028 | 13 | 2 | 18094 | 48 |
P2RY6,P2RY2 |
5.276e-04 | -7.55 | insulin receptor substrate binding | molecular function | GO:0043560 | 13 | 2 | 18094 | 48 |
PIK3CB,PRKCD |
5.284e-04 | -7.55 | positive regulation of transferase activity | biological process | GO:0051347 | 381 | 6 | 18204 | 49 |
CD74,PRKCD,APOE,PIK3R5,CSF1R,IL6R |
5.392e-04 | -7.53 | protein phosphorylated amino acid binding | molecular function | GO:0045309 | 60 | 3 | 18094 | 48 |
PLCG2,PTPN6,SYK |
5.432e-04 | -7.52 | negative T cell selection | biological process | GO:0043383 | 13 | 2 | 18204 | 49 |
DOCK2,CD74 |
5.432e-04 | -7.52 | G protein-coupled purinergic nucleotide receptor signaling pathway | biological process | GO:0035589 | 13 | 2 | 18204 | 49 |
P2RY6,P2RY2 |
5.460e-04 | -7.51 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 29 | 16828 | 46 |
PREX1,GMIP,WDFY4,DOCK10,ARHGAP33,DOCK8,SBNO2,RIN3,APOE,SYK,P2RY2,IRF5,CD74,RHBDF2,AKAP13,NEK6,TBC1D8,PLCG2,PTPN6,ELMO1,TBXAS1,PRKCD,RGS14,SLC4A2,PIK3CB,MYO1F,GIT2,DOCK2,ADCY7 |
5.507e-04 | -7.50 | cytokine-mediated signaling pathway | biological process | GO:0019221 | 384 | 6 | 18204 | 49 |
CSF1R,IL6R,IRF5,PTPN6,SYK,CD74 |
5.507e-04 | -7.50 | regulation of leukocyte cell-cell adhesion | biological process | GO:1903037 | 384 | 6 | 18204 | 49 |
SKAP1,SLC4A2,DOCK8,CD74,PTPN6,SYK |
5.776e-04 | -7.46 | LYSMD2 (LysM domain containing 2) | protein interactions | 256586 | 14 | 2 | 19454 | 50 |
PRKCD,HIF1A |
5.815e-04 | -7.45 | regulation of supramolecular fiber organization | biological process | GO:1902903 | 388 | 6 | 18204 | 49 |
PREX1,APOE,PRKCD,CARMIL3,AKAP13,WAS |
5.854e-04 | -7.44 | Signaling by Rho GTPases | REACTOME pathways | R-HSA-194315 | 426 | 7 | 10285 | 36 |
VAV3,ARHGAP27,WAS,GMIP,PREX1,AKAP13,ARHGAP33 |
5.865e-04 | -7.44 | Regulation of toll-like receptor signaling pathway | WikiPathways | WP1449 | 145 | 5 | 5310 | 26 |
PIK3CB,IRF5,PTPN6,PIK3R5,SYK |
5.967e-04 | -7.42 | C1-like_sf | interpro domains | IPR046349 | 61 | 3 | 18521 | 50 |
AKAP13,GMIP,PRKCD |
5.990e-04 | -7.42 | tube development | biological process | GO:0035295 | 903 | 9 | 18204 | 49 |
PTPN6,SEMA4A,SYK,SLC4A2,PIK3CB,APOE,HIF1A,VAV3,CSF1R |
6.118e-04 | -7.40 | actin cytoskeleton organization | biological process | GO:0030036 | 547 | 7 | 18204 | 49 |
PREX1,DOCK2,MICAL1,MYO1F,PARVG,ELMO1,WAS |
6.199e-04 | -7.39 | macrophage activation | biological process | GO:0042116 | 62 | 3 | 18204 | 49 |
SBNO2,PLCG2,SYK |
6.327e-04 | -7.37 | immunological synapse formation | biological process | GO:0001771 | 14 | 2 | 18204 | 49 |
DOCK2,DOCK8 |
6.497e-04 | -7.34 | regulation of receptor internalization | biological process | GO:0002090 | 63 | 3 | 18204 | 49 |
PLCG2,SYK,RIN3 |
6.521e-04 | -7.34 | leukocyte chemotaxis | biological process | GO:0030595 | 147 | 4 | 18204 | 49 |
VAV3,IL6R,PREX1,SYK |
6.625e-04 | -7.32 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 15 | 16828 | 46 |
SBNO2,DOCK8,MICAL1,WDFY4,SKAP1,ELMO1,PTPN6,IPCEF1,CSF1R,ADCY7,DOCK2,SLC4A2,RGS14,RIN3,DOCK1 |
6.645e-04 | -7.32 | receptor complex | cellular component | GO:0043235 | 409 | 6 | 19108 | 50 |
IL6R,CSF1R,SKAP1,PTPN6,CD74,SYK |
6.689e-04 | -7.31 | regulation of reactive oxygen species metabolic process | biological process | GO:2000377 | 148 | 4 | 18204 | 49 |
PLCG2,HIF1A,PRKCD,SYK |
6.714e-04 | -7.31 | regulation of localization | biological process | GO:0032879 | 2028 | 14 | 18204 | 49 |
P2RY2,PRKCD,DOCK2,RHBDF2,CD74,PIK3CB,RIN3,HIF1A,APOE,PLCG2,MICAL1,SYK,PTPN6,P2RY6 |
6.753e-04 | -7.30 | HIF-1 signaling pathway | KEGG pathways | hsa04066 | 101 | 4 | 7161 | 29 |
HIF1A,PLCG2,IL6R,PIK3CB |
6.803e-04 | -7.29 | actin polymerization or depolymerization | biological process | GO:0008154 | 64 | 3 | 18204 | 49 |
PREX1,MICAL1,WAS |
6.803e-04 | -7.29 | regulation of interleukin-12 production | biological process | GO:0032655 | 64 | 3 | 18204 | 49 |
SYK,PLCG2,IRF5 |
6.860e-04 | -7.28 | positive regulation of leukocyte migration | biological process | GO:0002687 | 149 | 4 | 18204 | 49 |
CD74,DOCK8,CSF1R,IL6R |
7.136e-04 | -7.25 | multicellular organismal process | biological process | GO:0032501 | 6177 | 28 | 18204 | 49 |
TBC1D8,WAS,DOCK10,PTPN6,PIK3CB,APOE,RGS14,PRKCD,DOCK2,PREX1,TBXAS1,VAV3,SBNO2,SYK,GIT2,GSDME,PLCG2,SLC4A2,HIF1A,IL6R,CSF1R,SEMA4A,ADCY7,CD74,DOCK8,AKAP13,WDFY4,P2RY2 |
7.188e-04 | -7.24 | RhoGAP_dom | interpro domains | IPR000198 | 65 | 3 | 18521 | 50 |
ARHGAP27,GMIP,ARHGAP33 |
7.288e-04 | -7.22 | regulation of phospholipid transport | biological process | GO:2001138 | 15 | 2 | 18204 | 49 |
APOE,PRKCD |
7.320e-04 | -7.22 | regulation of programmed cell death | biological process | GO:0043067 | 1569 | 12 | 18204 | 49 |
CSF1R,PIK3CB,HIF1A,DOCK8,PRKCD,CD74,MICAL1,PLCG2,IRF5,PTPN6,SYK,GSDME |
7.444e-04 | -7.20 | peptidyl-tyrosine phosphorylation | biological process | GO:0018108 | 66 | 3 | 18204 | 49 |
CSF1R,PTPN6,SYK |
7.444e-04 | -7.20 | neutrophil migration | biological process | GO:1990266 | 66 | 3 | 18204 | 49 |
VAV3,SYK,PREX1 |
7.484e-04 | -7.20 | regulation of leukocyte proliferation | biological process | GO:0070663 | 268 | 5 | 18204 | 49 |
CD74,PTPN6,SLC4A2,VAV3,CSF1R |
7.488e-04 | -7.20 | TRAF6 (TNF receptor associated factor 6) | protein interactions | 7189 | 426 | 6 | 19454 | 50 |
PRKCD,IRF5,SYK,HIF1A,VAV3,PTPN6 |
7.592e-04 | -7.18 | IL1RL2 (interleukin 1 receptor like 2) | protein interactions | 8808 | 16 | 2 | 19454 | 50 |
MYO1F,MICAL1 |
7.592e-04 | -7.18 | CYP2C8 (cytochrome P450 family 2 subfamily C member 8) | protein interactions | 1558 | 16 | 2 | 19454 | 50 |
APOE,RIN3 |
7.592e-04 | -7.18 | TAMALIN (trafficking regulator and scaffold protein tamalin) | protein interactions | 160622 | 16 | 2 | 19454 | 50 |
DOCK1,SYK |
7.691e-04 | -7.17 | P2Y receptors | REACTOME pathways | R-HSA-417957 | 12 | 2 | 10285 | 36 |
P2RY6,P2RY2 |
7.739e-04 | -7.16 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0051896 | 270 | 5 | 18204 | 49 |
PIK3R5,PIK3CB,PTPN6,CSF1R,VAV3 |
7.747e-04 | -7.16 | INPP5D (inositol polyphosphate-5-phosphatase D) | protein interactions | 3635 | 70 | 3 | 19454 | 50 |
CSF1R,PRKCD,SYK |
7.747e-04 | -7.16 | IL6ST (interleukin 6 cytokine family signal transducer) | protein interactions | 3572 | 70 | 3 | 19454 | 50 |
PRKCD,PTPN6,IL6R |
8.065e-04 | -7.12 | RhoGAP | pfam domains | PF00620 | 65 | 3 | 17795 | 50 |
ARHGAP33,GMIP,ARHGAP27 |
8.122e-04 | -7.12 | peptidyl-tyrosine modification | biological process | GO:0018212 | 68 | 3 | 18204 | 49 |
SYK,PTPN6,CSF1R |
8.129e-04 | -7.11 | positive regulation of protein phosphorylation | biological process | GO:0001934 | 574 | 7 | 18204 | 49 |
PRKCD,SYK,CD74,PLCG2,PIK3R5,CSF1R,IL6R |
8.342e-04 | -7.09 | positive regulation of endocytosis | biological process | GO:0045807 | 157 | 4 | 18204 | 49 |
PLCG2,DOCK2,SYK,APOE |
8.590e-04 | -7.06 | ARL4A (ADP ribosylation factor like GTPase 4A) | protein interactions | 10124 | 17 | 2 | 19454 | 50 |
ELMO1,DOCK1 |
8.686e-04 | -7.05 | regulation of protein-containing complex assembly | biological process | GO:0043254 | 419 | 6 | 18204 | 49 |
PREX1,PRKCD,SYK,PLCG2,APOE,SKAP1 |
8.754e-04 | -7.04 | TLR9 (toll like receptor 9) | protein interactions | 54106 | 73 | 3 | 19454 | 50 |
PRKCD,SYK,MICAL1 |
8.810e-04 | -7.03 | CH | pfam domains | PF00307 | 67 | 3 | 17795 | 50 |
MICAL1,EHBP1L1,PARVG |
8.822e-04 | -7.03 | actin filament organization | biological process | GO:0007015 | 278 | 5 | 18204 | 49 |
PREX1,MICAL1,ELMO1,MYO1F,WAS |
8.838e-04 | -7.03 | positive regulation of reactive oxygen species metabolic process | biological process | GO:2000379 | 70 | 3 | 18204 | 49 |
PRKCD,SYK,PLCG2 |
8.923e-04 | -7.02 | DH-domain | interpro domains | IPR000219 | 70 | 3 | 18521 | 50 |
VAV3,PREX1,AKAP13 |
8.965e-04 | -7.02 | positive regulation of leukocyte cell-cell adhesion | biological process | GO:1903039 | 279 | 5 | 18204 | 49 |
CD74,SYK,PTPN6,SKAP1,DOCK8 |
9.069e-04 | -7.01 | Signal regulatory protein (SIRP) family interactions | REACTOME pathways | R-HSA-391160 | 13 | 2 | 10285 | 36 |
FYB1,PTPN6 |
9.299e-04 | -6.98 | DBL_dom_sf | interpro domains | IPR035899 | 71 | 3 | 18521 | 50 |
AKAP13,VAV3,PREX1 |
9.308e-04 | -6.98 | nef (Nef) | protein interactions | 156110 | 802 | 8 | 19454 | 50 |
CSF1R,PIK3CB,SYK,DOCK2,ELMO1,CD74,PRKCD,ADCY7 |
9.644e-04 | -6.94 | Innate Immune System | REACTOME pathways | R-HSA-168249 | 1285 | 12 | 10285 | 36 |
PRKCD,PIK3CB,PTPN6,GLIPR1,VAV3,SYK,DOCK1,DOCK2,ADCY7,PLCG2,ELMO1,WAS |
9.685e-04 | -6.94 | PLSCR1 (phospholipid scramblase 1) | protein interactions | 5359 | 171 | 4 | 19454 | 50 |
P2RY6,DOCK2,ADCY7,PRKCD |
9.696e-04 | -6.94 | negative regulation of response to external stimulus | biological process | GO:0032102 | 428 | 6 | 18204 | 49 |
APOE,RIN3,RHBDF2,SYK,PRKCD,PTPN6 |
1.001e-03 | -6.91 | RhoGEF | pfam domains | PF00621 | 70 | 3 | 17795 | 50 |
VAV3,AKAP13,PREX1 |
1.002e-03 | -6.91 | G protein-coupled receptor signaling pathway | biological process | GO:0007186 | 1178 | 10 | 18204 | 49 |
PTPN6,ADCY7,PREX1,P2RY2,AKAP13,P2RY6,PIK3CB,RGS14,PIK3R5,APOE |
1.043e-03 | -6.87 | negative regulation of intracellular signal transduction | biological process | GO:1902532 | 599 | 7 | 18204 | 49 |
PIK3CB,APOE,HIF1A,RGS14,PRKCD,PTPN6,CD74 |
1.054e-03 | -6.85 | blood vessel morphogenesis | biological process | GO:0048514 | 435 | 6 | 18204 | 49 |
VAV3,PIK3CB,APOE,HIF1A,SYK,SEMA4A |
1.056e-03 | -6.85 | positive regulation of type 2 immune response | biological process | GO:0002830 | 18 | 2 | 18204 | 49 |
DENND1B,CD74 |
1.056e-03 | -6.85 | positive regulation of superoxide anion generation | biological process | GO:0032930 | 18 | 2 | 18204 | 49 |
SYK,PRKCD |
1.056e-03 | -6.85 | negative regulation of platelet activation | biological process | GO:0010544 | 18 | 2 | 18204 | 49 |
APOE,PRKCD |
1.079e-03 | -6.83 | intracellular monoatomic ion homeostasis | biological process | GO:0006873 | 437 | 6 | 18204 | 49 |
PIK3CB,APOE,HIF1A,TBXAS1,SLC4A2,P2RY2 |
1.080e-03 | -6.83 | positive regulation of type I interferon production | biological process | GO:0032481 | 75 | 3 | 18204 | 49 |
SYK,PLCG2,IRF5 |
1.099e-03 | -6.81 | negative regulation of protein phosphorylation | biological process | GO:0001933 | 292 | 5 | 18204 | 49 |
APOE,RGS14,PRKCD,PTPN6,MICAL1 |
1.105e-03 | -6.81 | regulation of secretion | biological process | GO:0051046 | 605 | 7 | 18204 | 49 |
APOE,HIF1A,MICAL1,P2RY2,SYK,CD74,RHBDF2 |
1.115e-03 | -6.80 | negative regulation of defense response | biological process | GO:0031348 | 293 | 5 | 18204 | 49 |
APOE,RHBDF2,PTPN6,SYK,PRKCD |
1.122e-03 | -6.79 | T cell proliferation | biological process | GO:0042098 | 76 | 3 | 18204 | 49 |
DOCK2,PTPN6,DOCK8 |
1.122e-03 | -6.79 | alpha-beta T cell differentiation | biological process | GO:0046632 | 76 | 3 | 18204 | 49 |
SEMA4A,SYK,IL6R |
1.124e-03 | -6.79 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 4 | 19454 | 50 |
PTPN6,SYK,PLCG2,VAV3 |
1.162e-03 | -6.76 | regulation of organelle organization | biological process | GO:0033043 | 1201 | 10 | 18204 | 49 |
PREX1,NEK6,CARMIL3,PRKCD,SLC4A2,AKAP13,TBC1D8,HIF1A,CSF1R,WAS |
1.175e-03 | -6.75 | NRAGE signals death through JNK | REACTOME pathways | R-HSA-193648 | 60 | 3 | 10285 | 36 |
VAV3,PREX1,AKAP13 |
1.194e-03 | -6.73 | B Cell Receptor Signaling Pathway | WikiPathways | WP23 | 98 | 4 | 5310 | 26 |
PTPN6,SYK,PLCG2,PRKCD |
1.204e-03 | -6.72 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 22 | 16828 | 46 |
ADCY7,DOCK2,MYO1F,SLC4A2,PIK3R5,DOCK1,ELMO1,TBC1D8,AKAP13,EHBP1L1,RHBDF2,IRF5,PARVG,P2RY6,RIN3,SBNO2,DOCK8,DOCK10,GMIP,WDFY4,PREX1,IPCEF1 |
1.204e-03 | -6.72 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 22 | 16828 | 46 |
MYO1F,IRF5,DOCK2,EHBP1L1,ADCY7,RHBDF2,AKAP13,TBC1D8,PIK3R5,RIN3,DOCK1,P2RY6,SLC4A2,PARVG,GMIP,WDFY4,DOCK10,DOCK8,SBNO2,IPCEF1,PREX1,ELMO1 |
1.212e-03 | -6.72 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 44 | 16828 | 46 |
RIN3,GLIPR1,APOE,SYK,P2RY6,P2RY2,CD74,RHBDF2,IL6R,AKAP13,NEK6,TBC1D8,PREX1,SKAP1,GMIP,SEMA4A,DOCK10,ARHGAP33,SBNO2,PIK3R5,DOCK1,HIF1A,PRKCD,PIK3CB,DOCK2,CSF1R,PLCG2,WAS,TBXAS1,MICAL1,PARVG,IRF5,EHBP1L1,WDFY4,DENND1B,DOCK8,RGS14,SLC4A2,MYO1F,GIT2,ADCY7,ELMO1,PTPN6,VAV3 |
1.227e-03 | -6.70 | actin filament-based process | biological process | GO:0030029 | 616 | 7 | 18204 | 49 |
WAS,MYO1F,MICAL1,ELMO1,DOCK2,PARVG,PREX1 |
1.234e-03 | -6.70 | Nucleotide GPCRs | WikiPathways | WP80 | 11 | 2 | 5310 | 26 |
P2RY2,P2RY6 |
1.245e-03 | -6.69 | HCK (HCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3055 | 183 | 4 | 19454 | 50 |
ELMO1,PLCG2,PIK3CB,WAS |
1.255e-03 | -6.68 | env (Envelope surface glycoprotein gp160, precursor) | protein interactions | 155971 | 1501 | 11 | 19454 | 50 |
PLCG2,PIK3CB,HIF1A,APOE,PRKCD,CD74,SKAP1,ADCY7,IL6R,WAS,VAV3 |
1.261e-03 | -6.68 | positive regulation of phosphorylation | biological process | GO:0042327 | 619 | 7 | 18204 | 49 |
IL6R,CSF1R,PIK3R5,PLCG2,SYK,PRKCD,CD74 |
1.270e-03 | -6.67 | nucleotide receptor activity | molecular function | GO:0016502 | 20 | 2 | 18094 | 48 |
P2RY6,P2RY2 |
1.270e-03 | -6.67 | purinergic nucleotide receptor activity | molecular function | GO:0001614 | 20 | 2 | 18094 | 48 |
P2RY6,P2RY2 |
1.274e-03 | -6.67 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | biological process | GO:0002460 | 176 | 4 | 18204 | 49 |
CD74,PRKCD,SEMA4A,IL6R |
1.276e-03 | -6.66 | positive regulation of kinase activity | biological process | GO:0033674 | 302 | 5 | 18204 | 49 |
PIK3R5,CD74,PRKCD,CSF1R,IL6R |
1.290e-03 | -6.65 | defense response to other organism | biological process | GO:0098542 | 1006 | 9 | 18204 | 49 |
WAS,IL6R,CSF1R,IRF5,PLCG2,PTPN6,SYK,PRKCD,CD74 |
1.307e-03 | -6.64 | regulation of antigen processing and presentation | biological process | GO:0002577 | 20 | 2 | 18204 | 49 |
WAS,CD74 |
1.332e-03 | -6.62 | DAP12 signaling | REACTOME pathways | R-HSA-2424491 | 356 | 6 | 10285 | 36 |
PIK3CB,PRKCD,ADCY7,PLCG2,SYK,VAV3 |
1.354e-03 | -6.60 | Rho GTPase activation protein | gene3d domains | 1.10.555.10 | 66 | 3 | 14470 | 48 |
ARHGAP27,GMIP,ARHGAP33 |
1.356e-03 | -6.60 | positive regulation of epithelial cell migration | biological process | GO:0010634 | 179 | 4 | 18204 | 49 |
HIF1A,PIK3CB,DOCK1,PLCG2 |
1.382e-03 | -6.58 | regulation of cellular component biogenesis | biological process | GO:0044087 | 1016 | 9 | 18204 | 49 |
PREX1,SYK,PRKCD,SEMA4A,PLCG2,TBC1D8,APOE,SKAP1,WAS |
1.386e-03 | -6.58 | Nucleotide-like (purinergic) receptors | REACTOME pathways | R-HSA-418038 | 16 | 2 | 10285 | 36 |
P2RY2,P2RY6 |
1.398e-03 | -6.57 | granulocyte chemotaxis | biological process | GO:0071621 | 82 | 3 | 18204 | 49 |
VAV3,PREX1,SYK |
1.398e-03 | -6.57 | T cell activation involved in immune response | biological process | GO:0002286 | 82 | 3 | 18204 | 49 |
CD74,SEMA4A,IL6R |
1.407e-03 | -6.57 | WAS (WASP actin nucleation promoting factor) | protein interactions | 7454 | 86 | 3 | 19454 | 50 |
FYB1,RGS14,WAS |
1.423e-03 | -6.56 | superpathway of inositol phosphate compounds | BIOCYC pathways | HUMAN_PWY-6371 | 66 | 3 | 902 | 4 |
PIK3CB,PLCG2,PIK3R5 |
1.426e-03 | -6.55 | GPCR downstream signaling | REACTOME pathways | R-HSA-388396 | 974 | 10 | 10285 | 36 |
AKAP13,RGS14,ADCY7,PIK3CB,PRKCD,P2RY2,VAV3,PIK3R5,PREX1,P2RY6 |
1.442e-03 | -6.54 | regulation of cytokine-mediated signaling pathway | biological process | GO:0001959 | 182 | 4 | 18204 | 49 |
CD74,HIF1A,PTPN6,SYK |
1.443e-03 | -6.54 | thymic T cell selection | biological process | GO:0045061 | 21 | 2 | 18204 | 49 |
CD74,DOCK2 |
1.443e-03 | -6.54 | prostanoid biosynthetic process | biological process | GO:0046457 | 21 | 2 | 18204 | 49 |
TBXAS1,CD74 |
1.443e-03 | -6.54 | positive regulation by host of viral process | biological process | GO:0044794 | 21 | 2 | 18204 | 49 |
CSF1R,APOE |
1.443e-03 | -6.54 | regulation of superoxide anion generation | biological process | GO:0032928 | 21 | 2 | 18204 | 49 |
PRKCD,SYK |
1.443e-03 | -6.54 | prostaglandin biosynthetic process | biological process | GO:0001516 | 21 | 2 | 18204 | 49 |
CD74,TBXAS1 |
1.448e-03 | -6.54 | positive regulation of B cell activation | biological process | GO:0050871 | 83 | 3 | 18204 | 49 |
VAV3,CD74,SYK |
1.452e-03 | -6.54 | GDS_CDC24_CS | interpro domains | IPR001331 | 21 | 2 | 18521 | 50 |
VAV3,PREX1 |
1.455e-03 | -6.53 | PLCG2 (phospholipase C gamma 2) | protein interactions | 5336 | 87 | 3 | 19454 | 50 |
PTPN6,SYK,PLCG2 |
1.494e-03 | -6.51 | negative regulation of phosphorylation | biological process | GO:0042326 | 313 | 5 | 18204 | 49 |
MICAL1,PTPN6,PRKCD,RGS14,APOE |
1.531e-03 | -6.48 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0051897 | 185 | 4 | 18204 | 49 |
VAV3,CSF1R,PIK3R5,PTPN6 |
1.550e-03 | -6.47 | regulation of protein kinase activity | biological process | GO:0045859 | 469 | 6 | 18204 | 49 |
APOE,RGS14,PIK3R5,CSF1R,IL6R,PRKCD |
1.556e-03 | -6.47 | plasma membrane signaling receptor complex | cellular component | GO:0098802 | 191 | 4 | 19108 | 50 |
SYK,SKAP1,IL6R,PTPN6 |
1.581e-03 | -6.45 | cytoskeleton organization | biological process | GO:0007010 | 1251 | 10 | 18204 | 49 |
WAS,ELMO1,RGS14,PARVG,APOE,MYO1F,MICAL1,NEK6,DOCK2,PREX1 |
1.598e-03 | -6.44 | regulation of transferase activity | biological process | GO:0051338 | 645 | 7 | 18204 | 49 |
PRKCD,CD74,CSF1R,IL6R,APOE,RGS14,PIK3R5 |
1.618e-03 | -6.43 | Signaling by PTK6 | REACTOME pathways | R-HSA-8848021 | 67 | 3 | 10285 | 36 |
ELMO1,DOCK1,HIF1A |
1.632e-03 | -6.42 | PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3) | protein interactions | 8503 | 197 | 4 | 19454 | 50 |
SKAP1,IL6R,PIK3CB,MICAL1 |
1.639e-03 | -6.41 | guanyl-nucleotide exchange factor complex | cellular component | GO:0032045 | 23 | 2 | 19108 | 50 |
ELMO1,DOCK1 |
1.646e-03 | -6.41 | DAP12 interactions | REACTOME pathways | R-HSA-2172127 | 371 | 6 | 10285 | 36 |
PLCG2,PRKCD,PIK3CB,ADCY7,SYK,VAV3 |
1.650e-03 | -6.41 | MTOR (mechanistic target of rapamycin kinase) | protein interactions | 2475 | 335 | 5 | 19454 | 50 |
PREX1,P2RY6,HIF1A,PRKCD,CD74 |
1.655e-03 | -6.40 | SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1) | protein interactions | 6654 | 91 | 3 | 19454 | 50 |
PTPN6,PRKCD,CSF1R |
1.656e-03 | -6.40 | B cell activation | biological process | GO:0042113 | 189 | 4 | 18204 | 49 |
PLCG2,DOCK10,SYK,PRKCD |
1.656e-03 | -6.40 | regulation of intrinsic apoptotic signaling pathway | biological process | GO:2001242 | 189 | 4 | 18204 | 49 |
PIK3CB,CD74,GSDME,HIF1A |
1.656e-03 | -6.40 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 37 | 16828 | 46 |
CSF1R,ADCY7,GIT2,DOCK2,MYO1F,PIK3CB,SLC4A2,PRKCD,RGS14,HIF1A,PIK3R5,DOCK1,VAV3,WAS,ELMO1,PTPN6,PLCG2,TBC1D8,NEK6,AKAP13,IL6R,RHBDF2,IRF5,PARVG,P2RY2,P2RY6,SYK,RIN3,GLIPR1,DOCK8,DENND1B,ARHGAP33,SEMA4A,DOCK10,WDFY4,SKAP1,PREX1 |
1.671e-03 | -6.39 | Dbl homology (DH) domain | gene3d domains | 1.20.900.10 | 71 | 3 | 14470 | 48 |
AKAP13,VAV3,PREX1 |
1.677e-03 | -6.39 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 37 | 16828 | 46 |
GLIPR1,RIN3,SYK,P2RY6,PARVG,P2RY2,IRF5,AKAP13,RHBDF2,IL6R,NEK6,TBC1D8,PREX1,WDFY4,SKAP1,ARHGAP33,DOCK10,SEMA4A,DOCK8,DENND1B,DOCK1,PIK3R5,HIF1A,RGS14,PRKCD,SLC4A2,DOCK2,GIT2,PIK3CB,MYO1F,ADCY7,CSF1R,PLCG2,ELMO1,PTPN6,WAS,VAV3 |
1.683e-03 | -6.39 | phospholipase binding | molecular function | GO:0043274 | 23 | 2 | 18094 | 48 |
WAS,SYK |
1.684e-03 | -6.39 | Osteoclast differentiation | KEGG pathways | ko04380 | 129 | 4 | 7161 | 29 |
SYK,CSF1R,PLCG2,PIK3CB |
1.684e-03 | -6.39 | Osteoclast differentiation | KEGG pathways | hsa04380 | 129 | 4 | 7161 | 29 |
PIK3CB,SYK,CSF1R,PLCG2 |
1.713e-03 | -6.37 | regulation of tissue remodeling | biological process | GO:0034103 | 88 | 3 | 18204 | 49 |
SYK,CSF1R,SLC4A2 |
1.713e-03 | -6.37 | NRAS (NRAS proto-oncogene, GTPase) | protein interactions | 4893 | 683 | 7 | 19454 | 50 |
FYB1,SLC4A2,PREX1,DOCK8,RHBDF2,PRKCD,EHBP1L1 |
1.716e-03 | -6.37 | ERBB3 (erb-b2 receptor tyrosine kinase 3) | protein interactions | 2065 | 338 | 5 | 19454 | 50 |
VAV3,PIK3CB,PLCG2,PTPN6,SYK |
1.720e-03 | -6.37 | positive regulation of transport | biological process | GO:0051050 | 844 | 8 | 18204 | 49 |
HIF1A,APOE,P2RY6,PRKCD,SYK,DOCK2,PLCG2,P2RY2 |
1.723e-03 | -6.36 | FYB1 (FYN binding protein 1) | protein interactions | 2533 | 24 | 2 | 19454 | 50 |
SKAP1,WAS |
1.732e-03 | -6.36 | stimulatory C-type lectin receptor signaling pathway | biological process | GO:0002223 | 23 | 2 | 18204 | 49 |
SYK,PLCG2 |
1.732e-03 | -6.36 | response to lectin | biological process | GO:1990840 | 23 | 2 | 18204 | 49 |
PLCG2,SYK |
1.732e-03 | -6.36 | phosphatidylinositol-mediated signaling | biological process | GO:0048015 | 23 | 2 | 18204 | 49 |
PLCG2,PIK3CB |
1.732e-03 | -6.36 | cellular response to lectin | biological process | GO:1990858 | 23 | 2 | 18204 | 49 |
SYK,PLCG2 |
1.752e-03 | -6.35 | RHOGAP | prosite domains | PS50238 | 65 | 3 | 12186 | 45 |
GMIP,ARHGAP27,ARHGAP33 |
1.758e-03 | -6.34 | cell development | biological process | GO:0048468 | 2236 | 14 | 18204 | 49 |
SBNO2,PTPN6,DOCK10,SYK,SLC4A2,PLCG2,APOE,HIF1A,IL6R,CSF1R,DOCK2,SEMA4A,CD74,PREX1 |
1.759e-03 | -6.34 | testis-germ_cell_tumour-seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-seminoma | 648 | 7 | 16828 | 46 |
RIN3,SYK,PRKCD,RHBDF2,ADCY7,NEK6,CSF1R |
1.759e-03 | -6.34 | Regulation of signaling by CBL | REACTOME pathways | R-HSA-912631 | 18 | 2 | 10285 | 36 |
SYK,PIK3CB |
1.769e-03 | -6.34 | positive regulation of lipid biosynthetic process | biological process | GO:0046889 | 89 | 3 | 18204 | 49 |
CD74,APOE,PRKCD |
1.822e-03 | -6.31 | regulation of response to cytokine stimulus | biological process | GO:0060759 | 194 | 4 | 18204 | 49 |
CD74,HIF1A,PTPN6,SYK |
1.835e-03 | -6.30 | positive regulation of cell-cell adhesion | biological process | GO:0022409 | 328 | 5 | 18204 | 49 |
CD74,SYK,PTPN6,SKAP1,DOCK8 |
1.835e-03 | -6.30 | positive regulation of lymphocyte activation | biological process | GO:0051251 | 328 | 5 | 18204 | 49 |
CD74,SYK,PTPN6,VAV3,DOCK8 |
1.844e-03 | -6.30 | Rho_GTPase_activation_prot | interpro domains | IPR008936 | 90 | 3 | 18521 | 50 |
ARHGAP33,GMIP,ARHGAP27 |
1.854e-03 | -6.29 | VAV1 (vav guanine nucleotide exchange factor 1) | protein interactions | 7409 | 204 | 4 | 19454 | 50 |
DOCK2,PTPN6,SYK,PLCG2 |
1.870e-03 | -6.28 | PIK3AP1 (phosphoinositide-3-kinase adaptor protein 1) | protein interactions | 118788 | 25 | 2 | 19454 | 50 |
PLCG2,SYK |
1.886e-03 | -6.27 | negative regulation of T cell apoptotic process | biological process | GO:0070233 | 24 | 2 | 18204 | 49 |
DOCK8,HIF1A |
1.886e-03 | -6.27 | positive regulation of macrophage cytokine production | biological process | GO:0060907 | 24 | 2 | 18204 | 49 |
PLCG2,CD74 |
1.913e-03 | -6.26 | human chr7p14.2-p14.1 | chromosome location | human chr7p14.2-p14.1 | 1 | 1 | 26134 | 50 |
ELMO1 |
1.923e-03 | -6.25 | phosphoprotein binding | molecular function | GO:0051219 | 93 | 3 | 18094 | 48 |
PLCG2,SYK,PTPN6 |
1.945e-03 | -6.24 | positive regulation of leukocyte chemotaxis | biological process | GO:0002690 | 92 | 3 | 18204 | 49 |
CSF1R,IL6R,CD74 |
1.999e-03 | -6.22 | positive regulation of ERK1 and ERK2 cascade | biological process | GO:0070374 | 199 | 4 | 18204 | 49 |
CSF1R,P2RY6,APOE,CD74 |
2.047e-03 | -6.19 | PTK2B (protein tyrosine kinase 2 beta) | protein interactions | 2185 | 98 | 3 | 19454 | 50 |
PRKCD,PTPN6,SYK |
2.056e-03 | -6.19 | Factors involved in megakaryocyte development and platelet production | REACTOME pathways | R-HSA-983231 | 156 | 4 | 10285 | 36 |
DOCK1,DOCK10,DOCK8,DOCK2 |
2.069e-03 | -6.18 | negative regulation of protein serine/threonine kinase activity | biological process | GO:0071901 | 94 | 3 | 18204 | 49 |
RGS14,APOE,PRKCD |
2.103e-03 | -6.16 | RhoGAP | smart domains | SM00324 | 64 | 3 | 9717 | 39 |
ARHGAP27,ARHGAP33,GMIP |
2.108e-03 | -6.16 | Shigellosis | KEGG pathways | hsa05131 | 64 | 3 | 7161 | 29 |
DOCK1,WAS,ELMO1 |
2.133e-03 | -6.15 | endocytic vesicle | cellular component | GO:0030139 | 349 | 5 | 19108 | 50 |
CD74,SYK,APOE,RIN3,WAS |
2.149e-03 | -6.14 | negative regulation of cell-cell adhesion | biological process | GO:0022408 | 203 | 4 | 18204 | 49 |
SLC4A2,PTPN6,PRKCD,CD74 |
2.167e-03 | -6.13 | DH_2 | prosite domains | PS50010 | 70 | 3 | 12186 | 45 |
VAV3,AKAP13,PREX1 |
2.181e-03 | -6.13 | CD72 (CD72 molecule) | protein interactions | 971 | 27 | 2 | 19454 | 50 |
PTPN6,SYK |
2.181e-03 | -6.13 | CD19 (CD19 molecule) | protein interactions | 930 | 27 | 2 | 19454 | 50 |
PLCG2,SYK |
2.185e-03 | -6.13 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 7 | 19454 | 50 |
PRKCD,SKAP1,SYK,CSF1R,PLCG2,PTPN6,TBC1D8 |
2.197e-03 | -6.12 | granulocyte migration | biological process | GO:0097530 | 96 | 3 | 18204 | 49 |
PREX1,SYK,VAV3 |
2.197e-03 | -6.12 | negative regulation of response to wounding | biological process | GO:1903035 | 96 | 3 | 18204 | 49 |
PTPN6,PRKCD,APOE |
2.201e-03 | -6.12 | angiogenesis | biological process | GO:0001525 | 342 | 5 | 18204 | 49 |
VAV3,PIK3CB,SYK,SEMA4A,HIF1A |
2.202e-03 | -6.12 | anchoring junction | cellular component | GO:0070161 | 902 | 8 | 19108 | 50 |
GIT2,FYB1,WAS,PTPN6,PARVG,SLC4A2,SKAP1,PRKCD |
2.217e-03 | -6.11 | ATG16L1 (autophagy related 16 like 1) | protein interactions | 55054 | 1138 | 9 | 19454 | 50 |
PLCG2,GIT2,DOCK2,SYK,GMIP,AKAP13,ELMO1,WAS,MICAL1 |
2.249e-03 | -6.10 | tube morphogenesis | biological process | GO:0035239 | 685 | 7 | 18204 | 49 |
SYK,SEMA4A,PIK3CB,APOE,HIF1A,CSF1R,VAV3 |
2.250e-03 | -6.10 | regulation of lymphocyte activation | biological process | GO:0051249 | 505 | 6 | 18204 | 49 |
SYK,PTPN6,CD74,DOCK8,SLC4A2,VAV3 |
2.286e-03 | -6.08 | CRK (CRK proto-oncogene, adaptor protein) | protein interactions | 1398 | 361 | 5 | 19454 | 50 |
DOCK1,ELMO1,RIN3,PIK3CB,MICAL1 |
2.294e-03 | -6.08 | GRAP2 (GRB2 related adaptor protein 2) | protein interactions | 9402 | 102 | 3 | 19454 | 50 |
CSF1R,SYK,RIN3 |
2.314e-03 | -6.07 | PSMD3 (proteasome 26S subunit, non-ATPase 3) | protein interactions | 5709 | 362 | 5 | 19454 | 50 |
RIN3,PTPN6,P2RY6,CD74,PLCG2 |
2.324e-03 | -6.06 | Cell death signalling via NRAGE, NRIF and NADE | REACTOME pathways | R-HSA-204998 | 76 | 3 | 10285 | 36 |
VAV3,PREX1,AKAP13 |
2.344e-03 | -6.06 | breast-carcinoma-HER-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-HER-positive_carcinoma | 2025 | 13 | 16828 | 46 |
PLCG2,PTPN6,WAS,VAV3,DOCK8,RIN3,PIK3R5,SYK,P2RY6,PRKCD,P2RY2,PIK3CB,CSF1R |
2.344e-03 | -6.06 | HER-positive_carcinoma | COSMIC cancer mutations | HER-positive_carcinoma | 2025 | 13 | 16828 | 46 |
CSF1R,PIK3CB,SYK,P2RY6,PRKCD,P2RY2,PIK3R5,RIN3,DOCK8,VAV3,PTPN6,WAS,PLCG2 |
2.387e-03 | -6.04 | positive regulation of receptor internalization | biological process | GO:0002092 | 27 | 2 | 18204 | 49 |
PLCG2,SYK |
2.387e-03 | -6.04 | mature B cell differentiation involved in immune response | biological process | GO:0002313 | 27 | 2 | 18204 | 49 |
PLCG2,DOCK10 |
2.387e-03 | -6.04 | cytokine production | biological process | GO:0001816 | 27 | 2 | 18204 | 49 |
HIF1A,IL6R |
2.388e-03 | -6.04 | regulation of chemotaxis | biological process | GO:0050920 | 209 | 4 | 18204 | 49 |
RIN3,CD74,IL6R,CSF1R |
2.424e-03 | -6.02 | GRK2 (G protein-coupled receptor kinase 2) | protein interactions | 156 | 104 | 3 | 19454 | 50 |
PIK3CB,PRKCD,GIT2 |
2.482e-03 | -6.00 | monoatomic ion homeostasis | biological process | GO:0050801 | 515 | 6 | 18204 | 49 |
HIF1A,APOE,PIK3CB,TBXAS1,SLC4A2,P2RY2 |
2.502e-03 | -5.99 | RhoGEF | smart domains | SM00325 | 68 | 3 | 9717 | 39 |
VAV3,AKAP13,PREX1 |
2.514e-03 | -5.99 | CNTF (ciliary neurotrophic factor) | protein interactions | 1270 | 29 | 2 | 19454 | 50 |
IL6R,APOE |
2.520e-03 | -5.98 | PDGFRB (platelet derived growth factor receptor beta) | protein interactions | 5159 | 222 | 4 | 19454 | 50 |
CSF1R,PTPN6,HIF1A,VAV3 |
2.566e-03 | -5.97 | purinergic nucleotide receptor signaling pathway | biological process | GO:0035590 | 28 | 2 | 18204 | 49 |
P2RY6,P2RY2 |
2.570e-03 | -5.96 | Prkch (protein kinase C, eta) | protein interactions | 81749 | 1 | 1 | 19454 | 50 |
AKAP13 |
2.570e-03 | -5.96 | Pstpip1 (proline-serine-threonine phosphatase-interacting protein 1) | protein interactions | 19200 | 1 | 1 | 19454 | 50 |
WAS |
2.570e-03 | -5.96 | ARP3 (actin-related protein 3) | protein interactions | 853528 | 1 | 1 | 19454 | 50 |
WAS |
2.570e-03 | -5.96 | Bmal1 (basic helix-loop-helix ARNT like 1) | protein interactions | 11865 | 1 | 1 | 19454 | 50 |
HIF1A |
2.570e-03 | -5.96 | ARC40 (Arc40p) | protein interactions | 852536 | 1 | 1 | 19454 | 50 |
WAS |
2.570e-03 | -5.96 | EUC1 (Euc1p) | protein interactions | 855138 | 1 | 1 | 19454 | 50 |
DOCK8 |
2.570e-03 | -5.96 | NTA1 (amidase) | protein interactions | 853525 | 1 | 1 | 19454 | 50 |
DOCK8 |
2.570e-03 | -5.96 | FDPSP4 (farnesyl diphosphate synthase pseudogene 4) | protein interactions | 2228 | 1 | 1 | 19454 | 50 |
RIN3 |
2.570e-03 | -5.96 | RPL26P32 (ribosomal protein L26 pseudogene 32) | protein interactions | 400055 | 1 | 1 | 19454 | 50 |
RIN3 |
2.604e-03 | -5.95 | phosphatidylinositol 3-kinase complex | cellular component | GO:0005942 | 29 | 2 | 19108 | 50 |
PIK3R5,PIK3CB |
2.610e-03 | -5.95 | regulation of phagocytosis | biological process | GO:0050764 | 102 | 3 | 18204 | 49 |
PLCG2,DOCK2,SYK |
2.617e-03 | -5.95 | NOS2-CD74 complex | cellular component | GO:0035693 | 1 | 1 | 19108 | 50 |
CD74 |
2.628e-03 | -5.94 | RPL39 (ribosomal protein L39) | protein interactions | 6170 | 107 | 3 | 19454 | 50 |
SYK,PTPN6,P2RY6 |
2.628e-03 | -5.94 | TPP2 (tripeptidyl peptidase 2) | protein interactions | 7174 | 107 | 3 | 19454 | 50 |
P2RY6,CD74,RIN3 |
2.645e-03 | -5.93 | JPH1 (junctophilin 1) | protein interactions | 56704 | 225 | 4 | 19454 | 50 |
CSF1R,SKAP1,RHBDF2,TBC1D8 |
2.653e-03 | -5.93 | MHC class II protein binding, via antigen binding groove | molecular function | GO:0042658 | 1 | 1 | 18094 | 48 |
CD74 |
2.653e-03 | -5.93 | ciliary neurotrophic factor binding | molecular function | GO:0070119 | 1 | 1 | 18094 | 48 |
IL6R |
2.653e-03 | -5.93 | interleukin-15 receptor binding | molecular function | GO:0016170 | 1 | 1 | 18094 | 48 |
SYK |
2.653e-03 | -5.93 | metal chelating activity | molecular function | GO:0046911 | 1 | 1 | 18094 | 48 |
APOE |
2.675e-03 | -5.92 | kidney-carcinoma | COSMIC cancer mutations | kidney-carcinoma | 3720 | 19 | 16828 | 46 |
VAV3,SEMA4A,ARHGAP33,PTPN6,PREX1,PLCG2,NEK6,CSF1R,IRF5,PIK3CB,GIT2,IL6R,AKAP13,SYK,PRKCD,RGS14,DOCK1,PIK3R5,HIF1A |
2.678e-03 | -5.92 | DH_1 | prosite domains | PS00741 | 21 | 2 | 12186 | 45 |
PREX1,VAV3 |
2.688e-03 | -5.92 | PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2) | protein interactions | 5296 | 226 | 4 | 19454 | 50 |
PIK3CB,SYK,SKAP1,CSF1R |
2.690e-03 | -5.92 | CSF3R (colony stimulating factor 3 receptor) | protein interactions | 1441 | 30 | 2 | 19454 | 50 |
SYK,PRKCD |
2.690e-03 | -5.92 | regulation of lymphocyte differentiation | biological process | GO:0045619 | 216 | 4 | 18204 | 49 |
PTPN6,SYK,CD74,SLC4A2 |
2.692e-03 | -5.92 | memory T cell proliferation | biological process | GO:0061485 | 1 | 1 | 18204 | 49 |
DOCK8 |
2.692e-03 | -5.92 | positive regulation of transport across blood-brain barrier | biological process | GO:0150201 | 1 | 1 | 18204 | 49 |
APOE |
2.692e-03 | -5.92 | regulation of T cell antigen processing and presentation | biological process | GO:0002625 | 1 | 1 | 18204 | 49 |
WAS |
2.692e-03 | -5.92 | positive regulation of lipid transport across blood-brain barrier | biological process | GO:1903002 | 1 | 1 | 18204 | 49 |
APOE |
2.692e-03 | -5.92 | cellular response to pyrimidine ribonucleotide | biological process | GO:1905835 | 1 | 1 | 18204 | 49 |
P2RY6 |
2.692e-03 | -5.92 | positive regulation of heparan sulfate proteoglycan binding | biological process | GO:1905860 | 1 | 1 | 18204 | 49 |
APOE |
2.692e-03 | -5.92 | positive regulation of phospholipid scramblase activity | biological process | GO:1900163 | 1 | 1 | 18204 | 49 |
PRKCD |
2.692e-03 | -5.92 | negative regulation of mast cell chemotaxis | biological process | GO:0060755 | 1 | 1 | 18204 | 49 |
RIN3 |
2.692e-03 | -5.92 | regulation of phospholipid scramblase activity | biological process | GO:1900161 | 1 | 1 | 18204 | 49 |
PRKCD |
2.692e-03 | -5.92 | response to pyrimidine ribonucleotide | biological process | GO:1905834 | 1 | 1 | 18204 | 49 |
P2RY6 |
2.692e-03 | -5.92 | intermediate-density lipoprotein particle clearance | biological process | GO:0071831 | 1 | 1 | 18204 | 49 |
APOE |
2.692e-03 | -5.92 | positive regulation of glucosylceramide catabolic process | biological process | GO:2000753 | 1 | 1 | 18204 | 49 |
PRKCD |
2.692e-03 | -5.92 | cellular response to interleukin-11 | biological process | GO:0071348 | 1 | 1 | 18204 | 49 |
SBNO2 |
2.692e-03 | -5.92 | positive regulation of interleukin-3 production | biological process | GO:0032752 | 1 | 1 | 18204 | 49 |
SYK |
2.692e-03 | -5.92 | zygote asymmetric cell division | biological process | GO:0010070 | 1 | 1 | 18204 | 49 |
RGS14 |
2.692e-03 | -5.92 | macrophage migration inhibitory factor signaling pathway | biological process | GO:0035691 | 1 | 1 | 18204 | 49 |
CD74 |
2.692e-03 | -5.92 | regulation of cellular response to very-low-density lipoprotein particle stimulus | biological process | GO:1905890 | 1 | 1 | 18204 | 49 |
APOE |
2.692e-03 | -5.92 | regulation of lipid transport across blood-brain barrier | biological process | GO:1903000 | 1 | 1 | 18204 | 49 |
APOE |
2.692e-03 | -5.92 | regulation of transport across blood-brain barrier | biological process | GO:0150200 | 1 | 1 | 18204 | 49 |
APOE |
2.692e-03 | -5.92 | regulation of heparan sulfate proteoglycan binding | biological process | GO:1905858 | 1 | 1 | 18204 | 49 |
APOE |
2.700e-03 | -5.91 | TBC1D8_PH-GRAM2 | interpro domains | IPR036016 | 1 | 1 | 18521 | 50 |
TBC1D8 |
2.700e-03 | -5.91 | CSF-1_receptor | interpro domains | IPR030658 | 1 | 1 | 18521 | 50 |
CSF1R |
2.700e-03 | -5.91 | MHCII_invariant_trimer_sf | interpro domains | IPR036613 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | PKC_delta | interpro domains | IPR027436 | 1 | 1 | 18521 | 50 |
PRKCD |
2.700e-03 | -5.91 | RBD2_RGS14 | interpro domains | IPR046993 | 1 | 1 | 18521 | 50 |
RGS14 |
2.700e-03 | -5.91 | DHR2_DOCK2 | interpro domains | IPR026799 | 1 | 1 | 18521 | 50 |
DOCK2 |
2.700e-03 | -5.91 | FYB_hSH3 | interpro domains | IPR035540 | 1 | 1 | 18521 | 50 |
FYB1 |
2.700e-03 | -5.91 | MHC_II-assoc_invar/CLIP_MHC-bd | interpro domains | IPR015386 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | nPKC_delta | interpro domains | IPR034667 | 1 | 1 | 18521 | 50 |
PRKCD |
2.700e-03 | -5.91 | PLCgamma2_SH3 | interpro domains | IPR035723 | 1 | 1 | 18521 | 50 |
PLCG2 |
2.700e-03 | -5.91 | RIN3_SH2 | interpro domains | IPR035869 | 1 | 1 | 18521 | 50 |
RIN3 |
2.700e-03 | -5.91 | DOCK1_C2 | interpro domains | IPR047026 | 1 | 1 | 18521 | 50 |
DOCK1 |
2.700e-03 | -5.91 | VAV3_SH3_2 | interpro domains | IPR035734 | 1 | 1 | 18521 | 50 |
VAV3 |
2.700e-03 | -5.91 | CD74_antigen | interpro domains | IPR043530 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | MHC_II-assoc_invariant_trimer | interpro domains | IPR011988 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | P2Y6_rcpt | interpro domains | IPR001973 | 1 | 1 | 18521 | 50 |
P2RY6 |
2.700e-03 | -5.91 | MHC_II-assoc_invar_chain | interpro domains | IPR022339 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | P2Y2_rcpt | interpro domains | IPR000356 | 1 | 1 | 18521 | 50 |
P2RY2 |
2.700e-03 | -5.91 | RBD1_RGS14 | interpro domains | IPR046992 | 1 | 1 | 18521 | 50 |
RGS14 |
2.700e-03 | -5.91 | SKAP1_SH3 | interpro domains | IPR035765 | 1 | 1 | 18521 | 50 |
SKAP1 |
2.700e-03 | -5.91 | VAV3_SH3_1 | interpro domains | IPR047015 | 1 | 1 | 18521 | 50 |
VAV3 |
2.700e-03 | -5.91 | PI3Kbeta_dom | interpro domains | IPR037702 | 1 | 1 | 18521 | 50 |
PIK3CB |
2.700e-03 | -5.91 | TBC1D8_PH-GRAM1 | interpro domains | IPR036009 | 1 | 1 | 18521 | 50 |
TBC1D8 |
2.700e-03 | -5.91 | VAV3_SH2 | interpro domains | IPR035881 | 1 | 1 | 18521 | 50 |
VAV3 |
2.700e-03 | -5.91 | Anion_exchange_2 | interpro domains | IPR002978 | 1 | 1 | 18521 | 50 |
SLC4A2 |
2.700e-03 | -5.91 | HIF-1_alpha | interpro domains | IPR001321 | 1 | 1 | 18521 | 50 |
HIF1A |
2.700e-03 | -5.91 | RGS14_RGS | interpro domains | IPR037881 | 1 | 1 | 18521 | 50 |
RGS14 |
2.721e-03 | -5.91 | seminoma | COSMIC cancer mutations | seminoma | 700 | 7 | 16828 | 46 |
RHBDF2,ADCY7,NEK6,CSF1R,RIN3,SYK,PRKCD |
2.730e-03 | -5.90 | Kinase-like_dom_sf | interpro domains | IPR011009 | 523 | 6 | 18521 | 50 |
PIK3CB,PRKCD,CSF1R,SYK,NEK6,NRK |
2.731e-03 | -5.90 | PRKCD (protein kinase C delta) | protein interactions | 5580 | 227 | 4 | 19454 | 50 |
PTPN6,ADCY7,PRKCD,PIK3CB |
2.735e-03 | -5.90 | positive regulation of cellular catabolic process | biological process | GO:0031331 | 217 | 4 | 18204 | 49 |
PRKCD,PIK3CB,HIF1A,APOE |
2.751e-03 | -5.90 | cellular response to interleukin-6 | biological process | GO:0071354 | 29 | 2 | 18204 | 49 |
IL6R,SBNO2 |
2.751e-03 | -5.90 | regulation of platelet aggregation | biological process | GO:0090330 | 29 | 2 | 18204 | 49 |
SYK,PRKCD |
2.751e-03 | -5.90 | myoblast fusion | biological process | GO:0007520 | 29 | 2 | 18204 | 49 |
DOCK1,DOCK2 |
2.810e-03 | -5.87 | MHCassoc_trimer | pfam domains | PF08831 | 1 | 1 | 17795 | 50 |
CD74 |
2.810e-03 | -5.87 | MHC2-interact | pfam domains | PF09307 | 1 | 1 | 17795 | 50 |
CD74 |
2.814e-03 | -5.87 | positive regulation of leukocyte activation | biological process | GO:0002696 | 362 | 5 | 18204 | 49 |
SYK,PTPN6,CD74,DOCK8,VAV3 |
2.819e-03 | -5.87 | PCMT1 (protein-L-isoaspartate (D-aspartate) O-methyltransferase) | protein interactions | 5110 | 229 | 4 | 19454 | 50 |
RIN3,AKAP13,APOE,DOCK8 |
2.836e-03 | -5.87 | negative regulation of immune system process | biological process | GO:0002683 | 529 | 6 | 18204 | 49 |
SLC4A2,CD74,RHBDF2,PTPN6,RIN3,SYK |
2.844e-03 | -5.86 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 31 | 16828 | 46 |
ELMO1,VAV3,PIK3R5,DOCK1,HIF1A,PRKCD,SLC4A2,GIT2,DOCK2,MYO1F,PIK3CB,ADCY7,CSF1R,IPCEF1,PREX1,ARHGAP27,WDFY4,GMIP,SKAP1,ARHGAP33,DOCK10,SBNO2,DOCK8,DENND1B,RIN3,APOE,SYK,PARVG,AKAP13,NEK6,TBC1D8 |
2.862e-03 | -5.86 | blood vessel development | biological process | GO:0001568 | 530 | 6 | 18204 | 49 |
VAV3,PIK3CB,HIF1A,APOE,SEMA4A,SYK |
2.870e-03 | -5.85 | CSF2RB (colony stimulating factor 2 receptor subunit beta) | protein interactions | 1439 | 31 | 2 | 19454 | 50 |
SYK,PTPN6 |
2.916e-03 | -5.84 | response to oxidative stress | biological process | GO:0006979 | 365 | 5 | 18204 | 49 |
APOE,HIF1A,RGS14,PRKCD,IPCEF1 |
2.921e-03 | -5.84 | regulation of cell-substrate adhesion | biological process | GO:0010810 | 221 | 4 | 18204 | 49 |
PIK3CB,DOCK1,PREX1,SKAP1 |
2.921e-03 | -5.84 | leukocyte mediated immunity | biological process | GO:0002443 | 221 | 4 | 18204 | 49 |
PRKCD,SYK,PTPN6,CD74 |
2.942e-03 | -5.83 | regulation of superoxide metabolic process | biological process | GO:0090322 | 30 | 2 | 18204 | 49 |
PRKCD,SYK |
2.956e-03 | -5.82 | P2YPURNOCPTR | prints domains | PR01157 | 24 | 2 | 5227 | 18 |
P2RY6,P2RY2 |
3.057e-03 | -5.79 | AAMDC (adipogenesis associated Mth938 domain containing) | protein interactions | 28971 | 32 | 2 | 19454 | 50 |
VAV3,GMIP |
3.067e-03 | -5.79 | LAT (linker for activation of T cells) | protein interactions | 27040 | 113 | 3 | 19454 | 50 |
SYK,PTPN6,PLCG2 |
3.113e-03 | -5.77 | cell population proliferation | biological process | GO:0008283 | 726 | 7 | 18204 | 49 |
DOCK8,DOCK2,PTPN6,PRKCD,CSF1R,HIF1A,PIK3CB |
3.140e-03 | -5.76 | B cell homeostasis | biological process | GO:0001782 | 31 | 2 | 18204 | 49 |
DOCK10,HIF1A |
3.185e-03 | -5.75 | phosphorylation | biological process | GO:0016310 | 729 | 7 | 18204 | 49 |
CSF1R,PIK3CB,NRK,SYK,PRKCD,NEK6,PTPN6 |
3.186e-03 | -5.75 | positive regulation of cellular biosynthetic process | biological process | GO:0031328 | 2652 | 15 | 18204 | 49 |
WAS,SKAP1,SBNO2,P2RY6,DENND1B,IRF5,PLCG2,SYK,IL6R,CSF1R,PIK3CB,APOE,HIF1A,PRKCD,CD74 |
3.191e-03 | -5.75 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 15 | 16828 | 46 |
IPCEF1,PTPN6,ELMO1,WDFY4,SKAP1,SBNO2,MICAL1,DOCK8,RIN3,DOCK1,SLC4A2,RGS14,ADCY7,DOCK2,CSF1R |
3.249e-03 | -5.73 | ELMO3 (engulfment and cell motility 3) | protein interactions | 79767 | 33 | 2 | 19454 | 50 |
ELMO1,DOCK1 |
3.286e-03 | -5.72 | SH3_1 | pfam domains | PF00018 | 106 | 3 | 17795 | 50 |
PLCG2,DOCK1,MYO1F |
3.317e-03 | -5.71 | MHC class II-associated invariant chain, trimerisation domain | gene3d domains | 1.10.870.10 | 1 | 1 | 14470 | 48 |
CD74 |
3.335e-03 | -5.70 | SLC1A5 (solute carrier family 1 member 5) | protein interactions | 6510 | 240 | 4 | 19454 | 50 |
RIN3,RHBDF2,P2RY6,NEK6 |
3.349e-03 | -5.70 | negative regulation of phosphate metabolic process | biological process | GO:0045936 | 377 | 5 | 18204 | 49 |
MICAL1,PRKCD,PTPN6,APOE,RGS14 |
3.367e-03 | -5.69 | PRKCA (protein kinase C alpha) | protein interactions | 5578 | 395 | 5 | 19454 | 50 |
AKAP13,SYK,PTPN6,PLCG2,PRKCD |
3.387e-03 | -5.69 | negative regulation of phosphorus metabolic process | biological process | GO:0010563 | 378 | 5 | 18204 | 49 |
PTPN6,PRKCD,RGS14,APOE,MICAL1 |
3.401e-03 | -5.68 | Protein_kinase_ATP_BS | interpro domains | IPR017441 | 377 | 5 | 18521 | 50 |
PRKCD,SYK,NEK6,NRK,CSF1R |
3.406e-03 | -5.68 | localization within membrane | biological process | GO:0051668 | 549 | 6 | 18204 | 49 |
DENND1B,RHBDF2,DOCK2,SKAP1,FYB1,APOE |
3.436e-03 | -5.67 | vasculature development | biological process | GO:0001944 | 550 | 6 | 18204 | 49 |
SEMA4A,SYK,VAV3,PIK3CB,APOE,HIF1A |
3.444e-03 | -5.67 | ANIONEXHNGR2 | prints domains | PR01188 | 1 | 1 | 5227 | 18 |
SLC4A2 |
3.444e-03 | -5.67 | P2Y2PRNOCPTR | prints domains | PR00594 | 1 | 1 | 5227 | 18 |
P2RY2 |
3.444e-03 | -5.67 | CD74ANTIGEN | prints domains | PR01990 | 1 | 1 | 5227 | 18 |
CD74 |
3.444e-03 | -5.67 | P2Y6PRNOCPTR | prints domains | PR01068 | 1 | 1 | 5227 | 18 |
P2RY6 |
3.444e-03 | -5.67 | HYPOXIAIF1A | prints domains | PR01080 | 1 | 1 | 5227 | 18 |
HIF1A |
3.446e-03 | -5.67 | ELMO1 (engulfment and cell motility 1) | protein interactions | 9844 | 34 | 2 | 19454 | 50 |
DOCK2,DOCK1 |
3.486e-03 | -5.66 | innate immune response | biological process | GO:0045087 | 741 | 7 | 18204 | 49 |
CSF1R,WAS,CD74,PTPN6,SYK,PLCG2,IRF5 |
3.486e-03 | -5.66 | negative regulation of intrinsic apoptotic signaling pathway | biological process | GO:2001243 | 113 | 3 | 18204 | 49 |
PIK3CB,CD74,HIF1A |
3.492e-03 | -5.66 | negative regulation of programmed cell death | biological process | GO:0043069 | 946 | 8 | 18204 | 49 |
MICAL1,PLCG2,DOCK8,CD74,PRKCD,CSF1R,HIF1A,PIK3CB |
3.504e-03 | -5.65 | positive regulation of cell activation | biological process | GO:0050867 | 381 | 5 | 18204 | 49 |
VAV3,DOCK8,CD74,PTPN6,SYK |
3.516e-03 | -5.65 | testis | COSMIC cancer mutations | testis | 733 | 7 | 16828 | 46 |
RHBDF2,ADCY7,CSF1R,NEK6,RIN3,PRKCD,SYK |
3.524e-03 | -5.65 | G alpha (12/13) signalling events | REACTOME pathways | R-HSA-416482 | 88 | 3 | 10285 | 36 |
VAV3,AKAP13,PREX1 |
3.553e-03 | -5.64 | mature B cell differentiation | biological process | GO:0002335 | 33 | 2 | 18204 | 49 |
PLCG2,DOCK10 |
3.553e-03 | -5.64 | negative regulation of inflammatory response to antigenic stimulus | biological process | GO:0002862 | 33 | 2 | 18204 | 49 |
RHBDF2,SYK |
3.574e-03 | -5.63 | icosanoid metabolic process | biological process | GO:0006690 | 114 | 3 | 18204 | 49 |
TBXAS1,CD74,SYK |
3.623e-03 | -5.62 | regulation of T cell activation | biological process | GO:0050863 | 384 | 5 | 18204 | 49 |
DOCK8,SLC4A2,PTPN6,SYK,CD74 |
3.649e-03 | -5.61 | IL2RB (interleukin 2 receptor subunit beta) | protein interactions | 3560 | 35 | 2 | 19454 | 50 |
PTPN6,SYK |
3.677e-03 | -5.61 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia | 739 | 7 | 16828 | 46 |
MICAL1,CSF1R,PIK3CB,DOCK2,PTPN6,PLCG2,DOCK1 |
3.677e-03 | -5.61 | acute_lymphoblastic_T_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_T_cell_leukaemia | 739 | 7 | 16828 | 46 |
PIK3CB,DOCK1,DOCK2,PLCG2,MICAL1,PTPN6,CSF1R |
3.694e-03 | -5.60 | regulation of endothelial cell migration | biological process | GO:0010594 | 236 | 4 | 18204 | 49 |
APOE,HIF1A,PIK3CB,SEMA4A |
3.751e-03 | -5.59 | regulation of lymphocyte proliferation | biological process | GO:0050670 | 237 | 4 | 18204 | 49 |
CD74,PTPN6,VAV3,SLC4A2 |
3.756e-03 | -5.58 | positive regulation of biosynthetic process | biological process | GO:0009891 | 2697 | 15 | 18204 | 49 |
SBNO2,SKAP1,WAS,P2RY6,PLCG2,IRF5,DENND1B,SYK,CSF1R,IL6R,APOE,HIF1A,PIK3CB,CD74,PRKCD |
3.769e-03 | -5.58 | response to interleukin-6 | biological process | GO:0070741 | 34 | 2 | 18204 | 49 |
SBNO2,IL6R |
3.769e-03 | -5.58 | regulation of B cell differentiation | biological process | GO:0045577 | 34 | 2 | 18204 | 49 |
PTPN6,SYK |
3.769e-03 | -5.58 | regulation of type 2 immune response | biological process | GO:0002828 | 34 | 2 | 18204 | 49 |
DENND1B,CD74 |
3.841e-03 | -5.56 | EGFR tyrosine kinase inhibitor resistance | KEGG pathways | hsa01521 | 79 | 3 | 7161 | 29 |
PIK3CB,IL6R,PLCG2 |
3.841e-03 | -5.56 | EGFR tyrosine kinase inhibitor resistance | KEGG pathways | ko01521 | 79 | 3 | 7161 | 29 |
PIK3CB,IL6R,PLCG2 |
3.887e-03 | -5.55 | cell junction | cellular component | GO:0030054 | 2224 | 13 | 19108 | 50 |
RGS14,WAS,PTPN6,APOE,ARHGAP33,PARVG,DOCK10,MICAL1,SKAP1,PRKCD,GIT2,FYB1,SLC4A2 |
3.917e-03 | -5.54 | Cytokine Signaling in Immune system | REACTOME pathways | R-HSA-1280215 | 756 | 8 | 10285 | 36 |
SYK,CSF1R,IRF5,IL6R,PTPN6,PRKCD,HIF1A,PIK3CB |
3.957e-03 | -5.53 | PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | REACTOME pathways | R-HSA-8849471 | 27 | 2 | 10285 | 36 |
ELMO1,DOCK1 |
4.031e-03 | -5.51 | protein kinase activity | molecular function | GO:0004672 | 577 | 6 | 18094 | 48 |
NEK6,PRKCD,PIK3CB,CSF1R,NRK,SYK |
4.036e-03 | -5.51 | membrane organization | biological process | GO:0061024 | 761 | 7 | 18204 | 49 |
ELMO1,VAV3,APOE,PRKCD,DOCK1,NEK6,DOCK2 |
4.040e-03 | -5.51 | regulation of mononuclear cell proliferation | biological process | GO:0032944 | 242 | 4 | 18204 | 49 |
CD74,PTPN6,SLC4A2,VAV3 |
4.065e-03 | -5.51 | positive regulation of protein modification process | biological process | GO:0031401 | 762 | 7 | 18204 | 49 |
PLCG2,PRKCD,SYK,CD74,CSF1R,IL6R,PIK3R5 |
4.071e-03 | -5.50 | CD22 (CD22 molecule) | protein interactions | 933 | 37 | 2 | 19454 | 50 |
SYK,PTPN6 |
4.071e-03 | -5.50 | CARD11 (caspase recruitment domain family member 11) | protein interactions | 84433 | 37 | 2 | 19454 | 50 |
FYB1,PRKCD |
4.128e-03 | -5.49 | regulation of apoptotic signaling pathway | biological process | GO:2001233 | 396 | 5 | 18204 | 49 |
HIF1A,CD74,GSDME,PRKCD,PIK3CB |
4.163e-03 | -5.48 | regulation of leukocyte activation | biological process | GO:0002694 | 572 | 6 | 18204 | 49 |
PTPN6,SYK,CD74,DOCK8,VAV3,SLC4A2 |
4.165e-03 | -5.48 | UQCRH (ubiquinol-cytochrome c reductase hinge protein) | protein interactions | 7388 | 126 | 3 | 19454 | 50 |
GSDME,P2RY6,APOE |
4.218e-03 | -5.47 | regulation of homotypic cell-cell adhesion | biological process | GO:0034110 | 36 | 2 | 18204 | 49 |
PRKCD,SYK |
4.218e-03 | -5.47 | phagocytosis, engulfment | biological process | GO:0006911 | 36 | 2 | 18204 | 49 |
ELMO1,DOCK1 |
4.229e-03 | -5.47 | regulation of response to stress | biological process | GO:0080134 | 1431 | 10 | 18204 | 49 |
PLCG2,RHBDF2,CD74,SYK,PRKCD,PTPN6,SBNO2,WAS,APOE,PIK3CB |
4.229e-03 | -5.47 | defense response | biological process | GO:0006952 | 1431 | 10 | 18204 | 49 |
WAS,CSF1R,IL6R,HIF1A,IRF5,PLCG2,PRKCD,SYK,PTPN6,CD74 |
4.244e-03 | -5.46 | Interferon gamma signaling | REACTOME pathways | R-HSA-877300 | 94 | 3 | 10285 | 36 |
PRKCD,PTPN6,IRF5 |
4.252e-03 | -5.46 | Calmodulin induced events | REACTOME pathways | R-HSA-111933 | 28 | 2 | 10285 | 36 |
PRKCD,ADCY7 |
4.252e-03 | -5.46 | Dectin-2 family | REACTOME pathways | R-HSA-5621480 | 28 | 2 | 10285 | 36 |
SYK,PLCG2 |
4.252e-03 | -5.46 | CaM pathway | REACTOME pathways | R-HSA-111997 | 28 | 2 | 10285 | 36 |
ADCY7,PRKCD |
4.280e-03 | -5.45 | 3-phosphoinositide biosynthesis | BIOCYC pathways | META_PWY-6352 | 25 | 2 | 902 | 4 |
PIK3CB,PIK3R5 |
4.324e-03 | -5.44 | intracellular vesicle | cellular component | GO:0097708 | 2527 | 14 | 19108 | 50 |
APOE,WAS,PTPN6,CD74,PLCG2,SYK,DOCK2,PRKCD,MICAL1,WDFY4,GLIPR1,DENND1B,EHBP1L1,RIN3 |
4.352e-03 | -5.44 | BTK (Bruton tyrosine kinase) | protein interactions | 695 | 128 | 3 | 19454 | 50 |
WAS,PLCG2,SYK |
4.382e-03 | -5.43 | lobular_carcinoma | COSMIC cancer mutations | lobular_carcinoma | 763 | 7 | 16828 | 46 |
CSF1R,NEK6,GMIP,WDFY4,PIK3CB,SYK,PRKCD |
4.382e-03 | -5.43 | breast-carcinoma-lobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-lobular_carcinoma | 763 | 7 | 16828 | 46 |
PRKCD,SYK,CSF1R,NEK6,GMIP,WDFY4,PIK3CB |
4.433e-03 | -5.42 | PTPN6 (protein tyrosine phosphatase non-receptor type 6) | protein interactions | 5777 | 260 | 4 | 19454 | 50 |
SYK,PTPN6,PLCG2,PRKCD |
4.451e-03 | -5.41 | regulation of macrophage cytokine production | biological process | GO:0010935 | 37 | 2 | 18204 | 49 |
CD74,PLCG2 |
4.452e-03 | -5.41 | pleura-mesothelioma | COSMIC cancer mutations | pleura-mesothelioma | 4189 | 20 | 16828 | 46 |
VAV3,SEMA4A,ARHGAP33,PREX1,PLCG2,PTPN6,WAS,PIK3CB,IRF5,GIT2,IL6R,AKAP13,NEK6,CSF1R,DOCK1,PIK3R5,HIF1A,PRKCD,SYK,RGS14 |
4.491e-03 | -5.41 | intracellular chemical homeostasis | biological process | GO:0055082 | 581 | 6 | 18204 | 49 |
TBXAS1,SLC4A2,P2RY2,PIK3CB,APOE,HIF1A |
4.523e-03 | -5.40 | positive regulation of lipid metabolic process | biological process | GO:0045834 | 124 | 3 | 18204 | 49 |
CD74,APOE,PRKCD |
4.523e-03 | -5.40 | positive regulation of cell-substrate adhesion | biological process | GO:0010811 | 124 | 3 | 18204 | 49 |
DOCK1,PREX1,SKAP1 |
4.557e-03 | -5.39 | The role of Nef in HIV-1 replication and disease pathogenesis | REACTOME pathways | R-HSA-164952 | 29 | 2 | 10285 | 36 |
DOCK2,ELMO1 |
4.564e-03 | -5.39 | positive regulation of gene expression | biological process | GO:0010628 | 1212 | 9 | 18204 | 49 |
SYK,CD74,DENND1B,PLCG2,IRF5,PIK3CB,HIF1A,IL6R,CSF1R |
4.634e-03 | -5.37 | p75 NTR receptor-mediated signalling | REACTOME pathways | R-HSA-193704 | 97 | 3 | 10285 | 36 |
PREX1,AKAP13,VAV3 |
4.655e-03 | -5.37 | positive regulation of cell population proliferation | biological process | GO:0008284 | 992 | 8 | 18204 | 49 |
VAV3,CSF1R,IL6R,HIF1A,TBC1D8,P2RY6,CD74,PTPN6 |
4.691e-03 | -5.36 | actin filament polymerization | biological process | GO:0030041 | 38 | 2 | 18204 | 49 |
WAS,PREX1 |
4.691e-03 | -5.36 | unsaturated fatty acid biosynthetic process | biological process | GO:0006636 | 38 | 2 | 18204 | 49 |
CD74,TBXAS1 |
4.730e-03 | -5.35 | regulation of type I interferon production | biological process | GO:0032479 | 126 | 3 | 18204 | 49 |
IRF5,PLCG2,SYK |
4.744e-03 | -5.35 | FLRT1 (fibronectin leucine rich transmembrane protein 1) | protein interactions | 23769 | 40 | 2 | 19454 | 50 |
PIK3CB,RHBDF2 |
4.777e-03 | -5.34 | ACTG1 (actin gamma 1) | protein interactions | 71 | 429 | 5 | 19454 | 50 |
APOE,GIT2,ARHGAP27,GSDME,RIN3 |
4.843e-03 | -5.33 | PLD2 (phospholipase D2) | protein interactions | 5338 | 133 | 3 | 19454 | 50 |
SKAP1,PRKCD,HIF1A |
4.852e-03 | -5.33 | cellular process | biological process | GO:0009987 | 14996 | 47 | 18204 | 49 |
RGS14,APOE,MYO1F,PREX1,SKAP1,NRK,IRF5,PTPN6,CSF1R,IL6R,ARHGAP33,AKAP13,CD74,GMIP,SBNO2,TBXAS1,P2RY6,SLC4A2,IPCEF1,GIT2,NEK6,CARMIL3,SYK,ELMO1,PARVG,RIN3,PIK3CB,DOCK2,PRKCD,WAS,MICAL1,DOCK10,HIF1A,P2RY2,ARHGAP27,WDFY4,DOCK8,ADCY7,RHBDF2,SEMA4A,VAV3,FYB1,PIK3R5,PLCG2,DENND1B,GSDME,DOCK1 |
4.861e-03 | -5.33 | positive regulation of T cell activation | biological process | GO:0050870 | 255 | 4 | 18204 | 49 |
PTPN6,SYK,CD74,DOCK8 |
4.872e-03 | -5.32 | Ca-dependent events | REACTOME pathways | R-HSA-111996 | 30 | 2 | 10285 | 36 |
ADCY7,PRKCD |
4.897e-03 | -5.32 | kidney-carcinoma-renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-renal_cell_carcinoma | 4535 | 21 | 16828 | 46 |
PIK3R5,DOCK1,HIF1A,SYK,RGS14,PRKCD,GIT2,DOCK2,PIK3CB,IRF5,AKAP13,IL6R,CSF1R,NEK6,PREX1,PLCG2,PTPN6,WAS,VAV3,ARHGAP33,SEMA4A |
4.897e-03 | -5.32 | renal_cell_carcinoma | COSMIC cancer mutations | renal_cell_carcinoma | 4535 | 21 | 16828 | 46 |
SYK,RGS14,PRKCD,PIK3R5,DOCK1,HIF1A,NEK6,CSF1R,IRF5,PIK3CB,GIT2,DOCK2,IL6R,AKAP13,PTPN6,WAS,PREX1,PLCG2,VAV3,SEMA4A,ARHGAP33 |
4.911e-03 | -5.32 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 13 | 18204 | 49 |
CSF1R,PIK3CB,APOE,HIF1A,SEMA4A,DOCK2,SBNO2,VAV3,SLC4A2,SYK,DOCK10,PTPN6,DOCK1 |
4.929e-03 | -5.31 | positive regulation of protein kinase activity | biological process | GO:0045860 | 256 | 4 | 18204 | 49 |
IL6R,CSF1R,PIK3R5,PRKCD |
4.936e-03 | -5.31 | long-term memory | biological process | GO:0007616 | 39 | 2 | 18204 | 49 |
APOE,RGS14 |
4.936e-03 | -5.31 | regulation of T cell apoptotic process | biological process | GO:0070232 | 39 | 2 | 18204 | 49 |
HIF1A,DOCK8 |
4.936e-03 | -5.31 | positive regulation of nitric oxide biosynthetic process | biological process | GO:0045429 | 39 | 2 | 18204 | 49 |
PIK3CB,APOE |
4.980e-03 | -5.30 | HCLS1 (hematopoietic cell-specific Lyn substrate 1) | protein interactions | 3059 | 41 | 2 | 19454 | 50 |
WAS,SYK |
4.993e-03 | -5.30 | 3-phosphoinositide biosynthesis | BIOCYC pathways | HUMAN_PWY-6352 | 27 | 2 | 902 | 4 |
PIK3CB,PIK3R5 |
5.015e-03 | -5.30 | Type II diabetes mellitus | WikiPathways | WP1584 | 22 | 2 | 5310 | 26 |
PIK3R5,PRKCD |
5.134e-03 | -5.27 | Rab5b (RAB5B, member RAS oncogene family) | protein interactions | 288779 | 2 | 1 | 19454 | 50 |
PIK3CB |
5.134e-03 | -5.27 | ARPC3 (actin related protein 2/3 complex subunit 3) | protein interactions | 506596 | 2 | 1 | 19454 | 50 |
WAS |
5.134e-03 | -5.27 | ARPC2 (actin related protein 2/3 complex subunit 2) | protein interactions | 540838 | 2 | 1 | 19454 | 50 |
WAS |
5.134e-03 | -5.27 | ACTR3 (actin related protein 3) | protein interactions | 281597 | 2 | 1 | 19454 | 50 |
WAS |
5.134e-03 | -5.27 | ACTR2 (actin related protein 2) | protein interactions | 538486 | 2 | 1 | 19454 | 50 |
WAS |
5.134e-03 | -5.27 | KIR2DL5A (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A) | protein interactions | 57292 | 2 | 1 | 19454 | 50 |
PTPN6 |
5.134e-03 | -5.27 | Per1 (period circadian clock 1) | protein interactions | 18626 | 2 | 1 | 19454 | 50 |
HIF1A |
5.134e-03 | -5.27 | Arnt (aryl hydrocarbon receptor nuclear translocator) | protein interactions | 11863 | 2 | 1 | 19454 | 50 |
HIF1A |
5.134e-03 | -5.27 | MPIG6B (megakaryocyte and platelet inhibitory receptor G6b) | protein interactions | 80739 | 2 | 1 | 19454 | 50 |
PTPN6 |
5.134e-03 | -5.27 | Siglece (sialic acid binding Ig-like lectin E) | protein interactions | 83382 | 2 | 1 | 19454 | 50 |
PTPN6 |
5.134e-03 | -5.27 | CUZD1 (CUB and zona pellucida like domains 1) | protein interactions | 50624 | 2 | 1 | 19454 | 50 |
PTPN6 |
5.134e-03 | -5.27 | HIF1A-AS2 (HIF1A antisense RNA 2) | protein interactions | 100750247 | 2 | 1 | 19454 | 50 |
HIF1A |
5.134e-03 | -5.27 | ALDOA (aldolase, fructose-bisphosphate A) | protein interactions | 100009055 | 2 | 1 | 19454 | 50 |
WAS |
5.153e-03 | -5.27 | IRS1 (insulin receptor substrate 1) | protein interactions | 3667 | 136 | 3 | 19454 | 50 |
PIK3CB,PLCG2,PRKCD |
5.153e-03 | -5.27 | NEFL (neurofilament light chain) | protein interactions | 4747 | 136 | 3 | 19454 | 50 |
SKAP1,NEK6,GMIP |
5.160e-03 | -5.27 | B cell differentiation | biological process | GO:0030183 | 130 | 3 | 18204 | 49 |
PLCG2,DOCK10,SYK |
5.160e-03 | -5.27 | negative regulation of T cell activation | biological process | GO:0050868 | 130 | 3 | 18204 | 49 |
CD74,PTPN6,SLC4A2 |
5.187e-03 | -5.26 | positive regulation of nitric oxide metabolic process | biological process | GO:1904407 | 40 | 2 | 18204 | 49 |
PIK3CB,APOE |
5.187e-03 | -5.26 | prostaglandin metabolic process | biological process | GO:0006693 | 40 | 2 | 18204 | 49 |
TBXAS1,CD74 |
5.188e-03 | -5.26 | CLEC7A (Dectin-1) signaling | REACTOME pathways | R-HSA-5607764 | 101 | 3 | 10285 | 36 |
PRKCD,PLCG2,SYK |
5.215e-03 | -5.26 | negative regulation of multicellular organismal process | biological process | GO:0051241 | 1237 | 9 | 18204 | 49 |
SLC4A2,SEMA4A,PRKCD,PTPN6,ADCY7,CD74,PIK3CB,APOE,HIF1A |
5.227e-03 | -5.25 | CSF1-CSF1R complex | cellular component | GO:1990682 | 2 | 1 | 19108 | 50 |
CSF1R |
5.227e-03 | -5.25 | chylomicron remnant | cellular component | GO:0034360 | 2 | 1 | 19108 | 50 |
APOE |
5.227e-03 | -5.25 | discoidal high-density lipoprotein particle | cellular component | GO:0034365 | 2 | 1 | 19108 | 50 |
APOE |
5.227e-03 | -5.25 | hippocampal mossy fiber expansion | cellular component | GO:1990026 | 2 | 1 | 19108 | 50 |
MICAL1 |
5.227e-03 | -5.25 | macrophage migration inhibitory factor receptor complex | cellular component | GO:0035692 | 2 | 1 | 19108 | 50 |
CD74 |
5.237e-03 | -5.25 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 11 | 16828 | 46 |
CSF1R,DOCK10,AKAP13,PIK3CB,DOCK2,CD74,SYK,ELMO1,HIF1A,PLCG2,DOCK1 |
5.253e-03 | -5.25 | RHOJ (ras homolog family member J) | protein interactions | 57381 | 628 | 6 | 19454 | 50 |
SLC4A2,WAS,DOCK10,DOCK8,TBC1D8,GIT2 |
5.299e-03 | -5.24 | thromboxane-A synthase activity | molecular function | GO:0004796 | 2 | 1 | 18094 | 48 |
TBXAS1 |
5.299e-03 | -5.24 | interleukin-6 binding | molecular function | GO:0019981 | 2 | 1 | 18094 | 48 |
IL6R |
5.299e-03 | -5.24 | macrophage migration inhibitory factor binding | molecular function | GO:0035718 | 2 | 1 | 18094 | 48 |
CD74 |
5.299e-03 | -5.24 | interleukin-6 receptor activity | molecular function | GO:0004915 | 2 | 1 | 18094 | 48 |
IL6R |
5.299e-03 | -5.24 | macrophage colony-stimulating factor receptor activity | molecular function | GO:0005011 | 2 | 1 | 18094 | 48 |
CSF1R |
5.299e-03 | -5.24 | G protein-coupled UDP receptor activity | molecular function | GO:0045029 | 2 | 1 | 18094 | 48 |
P2RY6 |
5.341e-03 | -5.23 | negative regulation of protein modification process | biological process | GO:0031400 | 421 | 5 | 18204 | 49 |
MICAL1,PRKCD,PTPN6,APOE,RGS14 |
5.376e-03 | -5.23 | inositol trisphosphate biosynthetic process | biological process | GO:0032959 | 2 | 1 | 18204 | 49 |
PLCG2 |
5.376e-03 | -5.23 | positive regulation of lipid transporter activity | biological process | GO:0110113 | 2 | 1 | 18204 | 49 |
PRKCD |
5.376e-03 | -5.23 | serotonin secretion by platelet | biological process | GO:0002554 | 2 | 1 | 18204 | 49 |
SYK |
5.376e-03 | -5.23 | sulfur oxidation | biological process | GO:0019417 | 2 | 1 | 18204 | 49 |
MICAL1 |
5.376e-03 | -5.23 | regulation of sphingomyelin catabolic process | biological process | GO:2000754 | 2 | 1 | 18204 | 49 |
PRKCD |
5.376e-03 | -5.23 | positive regulation of inhibitory synapse assembly | biological process | GO:1905704 | 2 | 1 | 18204 | 49 |
SEMA4A |
5.376e-03 | -5.23 | hepatic immune response | biological process | GO:0002384 | 2 | 1 | 18204 | 49 |
IL6R |
5.376e-03 | -5.23 | regulation of interleukin-3 production | biological process | GO:0032672 | 2 | 1 | 18204 | 49 |
SYK |
5.376e-03 | -5.23 | positive regulation of macrophage migration inhibitory factor signaling pathway | biological process | GO:2000448 | 2 | 1 | 18204 | 49 |
CD74 |
5.376e-03 | -5.23 | response to interleukin-11 | biological process | GO:0071105 | 2 | 1 | 18204 | 49 |
SBNO2 |
5.376e-03 | -5.23 | positive regulation of sphingomyelin catabolic process | biological process | GO:2000755 | 2 | 1 | 18204 | 49 |
PRKCD |
5.376e-03 | -5.23 | lipid transport involved in lipid storage | biological process | GO:0010877 | 2 | 1 | 18204 | 49 |
APOE |
5.376e-03 | -5.23 | negative regulation of CD8-positive, alpha-beta T cell proliferation | biological process | GO:2000565 | 2 | 1 | 18204 | 49 |
SLC4A2 |
5.382e-03 | -5.22 | lung-carcinoma | COSMIC cancer mutations | lung-carcinoma | 4255 | 20 | 16828 | 46 |
VAV3,SEMA4A,ARHGAP33,PLCG2,PREX1,PTPN6,WAS,IRF5,PIK3CB,GIT2,IL6R,AKAP13,NEK6,CSF1R,DOCK1,PIK3R5,HIF1A,PRKCD,SYK,RGS14 |
5.383e-03 | -5.22 | dendrite | cellular component | GO:0030425 | 620 | 6 | 19108 | 50 |
RIN3,DOCK10,APOE,ARHGAP33,RGS14,PREX1 |
5.392e-03 | -5.22 | HIF-1_CTAD | interpro domains | IPR014887 | 2 | 1 | 18521 | 50 |
HIF1A |
5.392e-03 | -5.22 | iRhom1_2_N | interpro domains | IPR022241 | 2 | 1 | 18521 | 50 |
RHBDF2 |
5.392e-03 | -5.22 | GIT1/2_CC | interpro domains | IPR032352 | 2 | 1 | 18521 | 50 |
GIT2 |
5.392e-03 | -5.22 | GIT_SHD | interpro domains | IPR013724 | 2 | 1 | 18521 | 50 |
GIT2 |
5.392e-03 | -5.22 | SYK/ZAP-70_N_SH2 | interpro domains | IPR035838 | 2 | 1 | 18521 | 50 |
SYK |
5.392e-03 | -5.22 | PLC-gamma_N-SH2 | interpro domains | IPR035024 | 2 | 1 | 18521 | 50 |
PLCG2 |
5.392e-03 | -5.22 | SKAP_fam | interpro domains | IPR037781 | 2 | 1 | 18521 | 50 |
SKAP1 |
5.392e-03 | -5.22 | WAS_C | interpro domains | IPR011026 | 2 | 1 | 18521 | 50 |
WAS |
5.392e-03 | -5.22 | WASPfam_EVH1 | interpro domains | IPR033927 | 2 | 1 | 18521 | 50 |
WAS |
5.392e-03 | -5.22 | GSDME | interpro domains | IPR042377 | 2 | 1 | 18521 | 50 |
GSDME |
5.392e-03 | -5.22 | GIT-like | interpro domains | IPR047161 | 2 | 1 | 18521 | 50 |
GIT2 |
5.392e-03 | -5.22 | GIT1_C | interpro domains | IPR022018 | 2 | 1 | 18521 | 50 |
GIT2 |
5.392e-03 | -5.22 | SNO | interpro domains | IPR026741 | 2 | 1 | 18521 | 50 |
SBNO2 |
5.392e-03 | -5.22 | Tyr_Pase_non-rcpt_typ-6/11 | interpro domains | IPR012152 | 2 | 1 | 18521 | 50 |
PTPN6 |
5.392e-03 | -5.22 | Ie/If_SH3 | interpro domains | IPR035507 | 2 | 1 | 18521 | 50 |
MYO1F |
5.392e-03 | -5.22 | PLC-gamma | interpro domains | IPR016279 | 2 | 1 | 18521 | 50 |
PLCG2 |
5.392e-03 | -5.22 | PLC-gamma_C-SH2 | interpro domains | IPR035023 | 2 | 1 | 18521 | 50 |
PLCG2 |
5.392e-03 | -5.22 | Kinase_SYK/ZAP-70_inter-SH2_sf | interpro domains | IPR023420 | 2 | 1 | 18521 | 50 |
SYK |
5.392e-03 | -5.22 | DOCK1_5_SH3 | interpro domains | IPR047025 | 2 | 1 | 18521 | 50 |
DOCK1 |
5.392e-03 | -5.22 | SBNO_Helicase_C_dom | interpro domains | IPR026937 | 2 | 1 | 18521 | 50 |
SBNO2 |
5.392e-03 | -5.22 | Tyr_kinase_non-rcpt_SYK/ZAP70 | interpro domains | IPR012234 | 2 | 1 | 18521 | 50 |
SYK |
5.392e-03 | -5.22 | PIK3R5/6 | interpro domains | IPR019522 | 2 | 1 | 18521 | 50 |
PIK3R5 |
5.392e-03 | -5.22 | SNO_AAA | interpro domains | IPR039187 | 2 | 1 | 18521 | 50 |
SBNO2 |
5.443e-03 | -5.21 | prostanoid metabolic process | biological process | GO:0006692 | 41 | 2 | 18204 | 49 |
CD74,TBXAS1 |
5.467e-03 | -5.21 | dendritic tree | cellular component | GO:0097447 | 622 | 6 | 19108 | 50 |
DOCK10,RIN3,RGS14,APOE,ARHGAP33,PREX1 |
5.491e-03 | -5.20 | VEGFA-VEGFR2 Pathway | REACTOME pathways | R-HSA-4420097 | 330 | 5 | 10285 | 36 |
VAV3,ELMO1,DOCK1,PRKCD,PIK3CB |
5.497e-03 | -5.20 | regulation of sequestering of calcium ion | biological process | GO:0051282 | 133 | 3 | 18204 | 49 |
PLCG2,P2RY6,PTPN6 |
5.502e-03 | -5.20 | Regulation of Actin Cytoskeleton | WikiPathways | WP51 | 149 | 4 | 5310 | 26 |
PIK3CB,DOCK1,PIK3R5,WAS |
5.547e-03 | -5.19 | Ser-Thr/Tyr_kinase_cat_dom | interpro domains | IPR001245 | 133 | 3 | 18521 | 50 |
NEK6,CSF1R,SYK |
5.556e-03 | -5.19 | regulation of hemopoiesis | biological process | GO:1903706 | 425 | 5 | 18204 | 49 |
SLC4A2,PTPN6,SYK,CD74,HIF1A |
5.612e-03 | -5.18 | HIF-1a_CTAD | pfam domains | PF08778 | 2 | 1 | 17795 | 50 |
HIF1A |
5.612e-03 | -5.18 | PKC_C2 | pfam domains | PF21494 | 2 | 1 | 17795 | 50 |
PRKCD |
5.612e-03 | -5.18 | iRhom1-2_N | pfam domains | PF12595 | 2 | 1 | 17795 | 50 |
RHBDF2 |
5.612e-03 | -5.18 | GIT_SHD | pfam domains | PF08518 | 2 | 1 | 17795 | 50 |
GIT2 |
5.612e-03 | -5.18 | GIT_CC | pfam domains | PF16559 | 2 | 1 | 17795 | 50 |
GIT2 |
5.612e-03 | -5.18 | GIT1_C | pfam domains | PF12205 | 2 | 1 | 17795 | 50 |
GIT2 |
5.612e-03 | -5.18 | PI3K_1B_p101 | pfam domains | PF10486 | 2 | 1 | 17795 | 50 |
PIK3R5 |
5.612e-03 | -5.18 | Helicase_C_4 | pfam domains | PF13871 | 2 | 1 | 17795 | 50 |
SBNO2 |
5.612e-03 | -5.18 | AAA_34 | pfam domains | PF13872 | 2 | 1 | 17795 | 50 |
SBNO2 |
5.612e-03 | -5.18 | growth factor binding | molecular function | GO:0019838 | 136 | 3 | 18094 | 48 |
RHBDF2,IL6R,CSF1R |
5.669e-03 | -5.17 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 37 | 16828 | 46 |
SKAP1,WDFY4,GMIP,DOCK10,ARHGAP33,DOCK8,IPCEF1,PREX1,IRF5,CD74,EHBP1L1,RHBDF2,AKAP13,NEK6,TBC1D8,RIN3,P2RY6,SYK,P2RY2,PARVG,VAV3,TBXAS1,MICAL1,PLCG2,PTPN6,ELMO1,PIK3CB,MYO1F,GIT2,DOCK2,ADCY7,CSF1R,PIK3R5,DOCK1,HIF1A,PRKCD,SLC4A2 |
5.669e-03 | -5.17 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 37 | 16828 | 46 |
HIF1A,DOCK1,PIK3R5,SLC4A2,PRKCD,ADCY7,GIT2,DOCK2,PIK3CB,MYO1F,CSF1R,PLCG2,ELMO1,PTPN6,TBXAS1,VAV3,MICAL1,RIN3,PARVG,P2RY2,P2RY6,SYK,AKAP13,RHBDF2,EHBP1L1,CD74,IRF5,TBC1D8,NEK6,PREX1,IPCEF1,ARHGAP33,DOCK10,WDFY4,GMIP,SKAP1,DOCK8 |
5.696e-03 | -5.17 | NCAPD3 (non-SMC condensin II complex subunit D3) | protein interactions | 23310 | 141 | 3 | 19454 | 50 |
P2RY6,SKAP1,CD74 |
5.706e-03 | -5.17 | positive regulation of interleukin-10 production | biological process | GO:0032733 | 42 | 2 | 18204 | 49 |
PLCG2,SYK |
5.713e-03 | -5.16 | regulation of protein serine/threonine kinase activity | biological process | GO:0071900 | 267 | 4 | 18204 | 49 |
PRKCD,APOE,RGS14,PIK3R5 |
5.738e-03 | -5.16 | Signalling by NGF | REACTOME pathways | R-HSA-166520 | 477 | 6 | 10285 | 36 |
VAV3,PREX1,ADCY7,PIK3CB,PRKCD,AKAP13 |
5.864e-03 | -5.14 | regulation of actin filament organization | biological process | GO:0110053 | 269 | 4 | 18204 | 49 |
PREX1,PRKCD,CARMIL3,WAS |
5.875e-03 | -5.14 | Generation of second messenger molecules | REACTOME pathways | R-HSA-202433 | 33 | 2 | 10285 | 36 |
WAS,FYB1 |
5.973e-03 | -5.12 | SKAP2 (src kinase associated phosphoprotein 2) | protein interactions | 8935 | 45 | 2 | 19454 | 50 |
FYB1,SKAP1 |
5.974e-03 | -5.12 | T-helper cell differentiation | biological process | GO:0042093 | 43 | 2 | 18204 | 49 |
SEMA4A,IL6R |
5.974e-03 | -5.12 | CD4-positive, alpha-beta T cell differentiation involved in immune response | biological process | GO:0002294 | 43 | 2 | 18204 | 49 |
IL6R,SEMA4A |
5.974e-03 | -5.12 | positive regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900026 | 43 | 2 | 18204 | 49 |
PREX1,DOCK1 |
6.037e-03 | -5.11 | PTPN12 (protein tyrosine phosphatase non-receptor type 12) | protein interactions | 5782 | 144 | 3 | 19454 | 50 |
WAS,EHBP1L1,PTPN6 |
6.037e-03 | -5.11 | COPG2 (COPI coat complex subunit gamma 2) | protein interactions | 26958 | 144 | 3 | 19454 | 50 |
P2RY6,RHBDF2,CD74 |
6.071e-03 | -5.10 | Signaling by VEGF | REACTOME pathways | R-HSA-194138 | 338 | 5 | 10285 | 36 |
VAV3,DOCK1,ELMO1,PIK3CB,PRKCD |
6.104e-03 | -5.10 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 41 | 16828 | 46 |
DENND1B,DOCK8,SBNO2,DOCK10,ARHGAP33,SKAP1,GMIP,WDFY4,PREX1,IPCEF1,TBC1D8,NEK6,RHBDF2,EHBP1L1,AKAP13,IRF5,CD74,P2RY2,PARVG,SYK,GLIPR1,RIN3,MICAL1,TBXAS1,VAV3,WAS,ELMO1,PTPN6,PLCG2,CSF1R,ADCY7,PIK3CB,MYO1F,DOCK2,GIT2,SLC4A2,RGS14,PRKCD,HIF1A,DOCK1,PIK3R5 |
6.154e-03 | -5.09 | KDR (kinase insert domain receptor) | protein interactions | 3791 | 145 | 3 | 19454 | 50 |
P2RY2,PTPN6,PLCG2 |
6.183e-03 | -5.09 | immunological synapse | cellular component | GO:0001772 | 45 | 2 | 19108 | 50 |
VAV3,SKAP1 |
6.229e-03 | -5.08 | DAG and IP3 signaling | REACTOME pathways | R-HSA-1489509 | 34 | 2 | 10285 | 36 |
ADCY7,PRKCD |
6.247e-03 | -5.08 | alpha-beta T cell activation involved in immune response | biological process | GO:0002287 | 44 | 2 | 18204 | 49 |
IL6R,SEMA4A |
6.247e-03 | -5.08 | alpha-beta T cell differentiation involved in immune response | biological process | GO:0002293 | 44 | 2 | 18204 | 49 |
IL6R,SEMA4A |
6.324e-03 | -5.06 | protein tyrosine kinase activity | molecular function | GO:0004713 | 142 | 3 | 18094 | 48 |
SYK,CSF1R,PRKCD |
6.344e-03 | -5.06 | non-membrane spanning protein tyrosine kinase activity | molecular function | GO:0004715 | 45 | 2 | 18094 | 48 |
SYK,PRKCD |
6.404e-03 | -5.05 | regulation of apoptotic process | biological process | GO:0042981 | 1518 | 10 | 18204 | 49 |
HIF1A,PIK3CB,CSF1R,GSDME,CD74,PTPN6,PRKCD,MICAL1,IRF5,DOCK8 |
6.461e-03 | -5.04 | positive regulation of chemotaxis | biological process | GO:0050921 | 141 | 3 | 18204 | 49 |
IL6R,CSF1R,CD74 |
6.527e-03 | -5.03 | positive regulation of B cell proliferation | biological process | GO:0030890 | 45 | 2 | 18204 | 49 |
VAV3,CD74 |
6.527e-03 | -5.03 | plasma membrane invagination | biological process | GO:0099024 | 45 | 2 | 18204 | 49 |
ELMO1,DOCK1 |
6.527e-03 | -5.03 | negative regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050732 | 45 | 2 | 18204 | 49 |
PRKCD,PTPN6 |
6.527e-03 | -5.03 | negative regulation of blood coagulation | biological process | GO:0030195 | 45 | 2 | 18204 | 49 |
PRKCD,APOE |
6.588e-03 | -5.02 | positive regulation of small molecule metabolic process | biological process | GO:0062013 | 142 | 3 | 18204 | 49 |
APOE,CD74,P2RY6 |
6.622e-03 | -5.02 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 34 | 16828 | 46 |
MICAL1,VAV3,WAS,PTPN6,PLCG2,CSF1R,ADCY7,DOCK2,GIT2,PIK3CB,MYO1F,RGS14,PRKCD,HIF1A,PIK3R5,DOCK1,SBNO2,DOCK8,ARHGAP33,DOCK10,SEMA4A,WDFY4,SKAP1,PREX1,NEK6,AKAP13,IL6R,EHBP1L1,IRF5,PARVG,SYK,APOE,RIN3,GLIPR1 |
6.624e-03 | -5.02 | - | gene3d domains | 6.10.250.220 | 2 | 1 | 14470 | 48 |
SKAP1 |
6.719e-03 | -5.00 | stomach-carcinoma | COSMIC cancer mutations | stomach-carcinoma | 439 | 5 | 16828 | 46 |
CSF1R,SYK,PRKCD,NEK6,PIK3CB |
6.767e-03 | -5.00 | Myometrial Relaxation and Contraction Pathways | WikiPathways | WP289 | 158 | 4 | 5310 | 26 |
PRKCD,ADCY7,RGS14,PLCG2 |
6.772e-03 | -4.99 | CYTH2 (cytohesin 2) | protein interactions | 9266 | 48 | 2 | 19454 | 50 |
DOCK1,IPCEF1 |
6.812e-03 | -4.99 | negative regulation of hemostasis | biological process | GO:1900047 | 46 | 2 | 18204 | 49 |
PRKCD,APOE |
6.827e-03 | -4.99 | cytokine binding | molecular function | GO:0019955 | 146 | 3 | 18094 | 48 |
CD74,CSF1R,IL6R |
6.903e-03 | -4.98 | positive regulation of cellular metabolic process | biological process | GO:0031325 | 3164 | 16 | 18204 | 49 |
DENND1B,PLCG2,IRF5,SYK,WAS,SKAP1,SBNO2,P2RY6,PIK3R5,PRKCD,CD74,IL6R,CSF1R,PIK3CB,APOE,HIF1A |
6.964e-03 | -4.97 | PLC-gamma1 signalling | REACTOME pathways | R-HSA-167021 | 36 | 2 | 10285 | 36 |
ADCY7,PRKCD |
6.964e-03 | -4.97 | EGFR interacts with phospholipase C-gamma | REACTOME pathways | R-HSA-212718 | 36 | 2 | 10285 | 36 |
PRKCD,ADCY7 |
6.982e-03 | -4.96 | PTK2 (protein tyrosine kinase 2) | protein interactions | 5747 | 296 | 4 | 19454 | 50 |
DOCK1,SYK,PTPN6,MICAL1 |
6.998e-03 | -4.96 | regulation of cell population proliferation | biological process | GO:0042127 | 1790 | 11 | 18204 | 49 |
IL6R,CSF1R,VAV3,P2RY6,APOE,TBC1D8,HIF1A,SLC4A2,PTPN6,CD74,GSDME |
7.006e-03 | -4.96 | Class I PI3K signaling events | Pathway Interaction DB | pi3kcipathway | 41 | 3 | 2226 | 22 |
PREX1,PIK3CB,PLCG2 |
7.009e-03 | -4.96 | regulation of defense response | biological process | GO:0031347 | 843 | 7 | 18204 | 49 |
PLCG2,RHBDF2,PRKCD,SYK,PTPN6,SBNO2,APOE |
7.017e-03 | -4.96 | Estrogen signaling pathway | KEGG pathways | hsa04915 | 98 | 3 | 7161 | 29 |
PRKCD,ADCY7,PIK3CB |
7.017e-03 | -4.96 | Estrogen signaling pathway | KEGG pathways | ko04915 | 98 | 3 | 7161 | 29 |
PRKCD,ADCY7,PIK3CB |
7.049e-03 | -4.95 | CYTH1 (cytohesin 1) | protein interactions | 9267 | 49 | 2 | 19454 | 50 |
PRKCD,IPCEF1 |
7.094e-03 | -4.95 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 10 | 16828 | 46 |
ELMO1,PREX1,DOCK1,IPCEF1,DOCK10,AKAP13,VAV3,SKAP1,WDFY4,DOCK2 |
7.094e-03 | -4.95 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 10 | 16828 | 46 |
DOCK1,IPCEF1,PREX1,ELMO1,WDFY4,DOCK2,SKAP1,VAV3,AKAP13,DOCK10 |
7.217e-03 | -4.93 | AGE-RAGE signaling pathway in diabetic complications | KEGG pathways | hsa04933 | 99 | 3 | 7161 | 29 |
PIK3CB,PRKCD,PLCG2 |
7.217e-03 | -4.93 | Choline metabolism in cancer | KEGG pathways | hsa05231 | 99 | 3 | 7161 | 29 |
WAS,PIK3CB,HIF1A |
7.217e-03 | -4.93 | AGE-RAGE signaling pathway in diabetic complications | KEGG pathways | ko04933 | 99 | 3 | 7161 | 29 |
PRKCD,PIK3CB,PLCG2 |
7.217e-03 | -4.93 | Choline metabolism in cancer | KEGG pathways | ko05231 | 99 | 3 | 7161 | 29 |
PIK3CB,WAS,HIF1A |
7.266e-03 | -4.92 | response to oxygen-containing compound | biological process | GO:1901700 | 1546 | 10 | 18204 | 49 |
TBXAS1,SBNO2,P2RY6,HIF1A,APOE,P2RY2,PLCG2,IRF5,PRKCD,ADCY7 |
7.330e-03 | -4.92 | TRIM15 (tripartite motif containing 15) | protein interactions | 89870 | 50 | 2 | 19454 | 50 |
SYK,IRF5 |
7.346e-03 | -4.91 | regulation of canonical NF-kappaB signal transduction | biological process | GO:0043122 | 287 | 4 | 18204 | 49 |
NEK6,CD74,AKAP13,PLCG2 |
7.388e-03 | -4.91 | Signaling Pathways in Glioblastoma | WikiPathways | WP2261 | 83 | 3 | 5310 | 26 |
PRKCD,PLCG2,PIK3CB |
7.399e-03 | -4.91 | T cell differentiation involved in immune response | biological process | GO:0002292 | 48 | 2 | 18204 | 49 |
SEMA4A,IL6R |
7.399e-03 | -4.91 | regulation of inflammatory response to antigenic stimulus | biological process | GO:0002861 | 48 | 2 | 18204 | 49 |
SYK,RHBDF2 |
7.517e-03 | -4.89 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 46 | 16828 | 46 |
VAV3,PTPN6,ELMO1,GIT2,MYO1F,ADCY7,RGS14,SLC4A2,WDFY4,DOCK8,DENND1B,IRF5,EHBP1L1,PARVG,TBXAS1,MICAL1,PLCG2,WAS,DOCK2,PIK3CB,CSF1R,PIK3R5,DOCK1,HIF1A,PRKCD,GMIP,SKAP1,ARHGAP33,DOCK10,SEMA4A,SBNO2,IPCEF1,PREX1,ARHGAP27,CD74,AKAP13,IL6R,RHBDF2,NEK6,TBC1D8,RIN3,GLIPR1,APOE,P2RY6,SYK,P2RY2 |
7.518e-03 | -4.89 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 15 | 16828 | 46 |
TBC1D8,PIK3CB,DOCK2,PRKCD,SYK,APOE,HIF1A,DOCK8,SKAP1,WDFY4,DOCK10,WAS,IPCEF1,PLCG2,PREX1 |
7.519e-03 | -4.89 | negative regulation of leukocyte cell-cell adhesion | biological process | GO:1903038 | 149 | 3 | 18204 | 49 |
SLC4A2,PTPN6,CD74 |
7.569e-03 | -4.88 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 26 | 16828 | 46 |
PLCG2,ELMO1,ADCY7,DOCK2,MYO1F,PIK3CB,CSF1R,DOCK1,SLC4A2,PRKCD,RGS14,ARHGAP33,DOCK10,WDFY4,SKAP1,DOCK8,PREX1,IPCEF1,AKAP13,IRF5,TBC1D8,NEK6,PARVG,P2RY2,SYK,P2RY6 |
7.569e-03 | -4.88 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 26 | 16828 | 46 |
DOCK1,P2RY2,SLC4A2,PARVG,PRKCD,SYK,P2RY6,RGS14,ADCY7,AKAP13,PIK3CB,IRF5,MYO1F,DOCK2,TBC1D8,NEK6,CSF1R,PREX1,PLCG2,IPCEF1,ELMO1,DOCK10,ARHGAP33,SKAP1,WDFY4,DOCK8 |
7.617e-03 | -4.88 | CD247 (CD247 molecule) | protein interactions | 919 | 51 | 2 | 19454 | 50 |
PTPN6,DOCK2 |
7.617e-03 | -4.88 | IL4R (interleukin 4 receptor) | protein interactions | 3566 | 51 | 2 | 19454 | 50 |
RHBDF2,PTPN6 |
7.631e-03 | -4.88 | human chr2q36.2 | chromosome location | human chr2q36.2 | 4 | 1 | 26134 | 50 |
DOCK10 |
7.658e-03 | -4.87 | PPP6R1 (protein phosphatase 6 regulatory subunit 1) | protein interactions | 22870 | 157 | 3 | 19454 | 50 |
IRF5,P2RY6,CD74 |
7.691e-03 | -4.87 | RAB6D (RAB6D, member RAS oncogene family) | protein interactions | 150786 | 3 | 1 | 19454 | 50 |
RIN3 |
7.691e-03 | -4.87 | CX3CR1 (C-X3-C motif chemokine receptor 1) | protein interactions | 1524 | 3 | 1 | 19454 | 50 |
HIF1A |
7.691e-03 | -4.87 | SIGLEC11 (sialic acid binding Ig like lectin 11) | protein interactions | 114132 | 3 | 1 | 19454 | 50 |
PTPN6 |
7.691e-03 | -4.87 | FAM220A (family with sequence similarity 220 member A) | protein interactions | 84792 | 3 | 1 | 19454 | 50 |
NEK6 |
7.691e-03 | -4.87 | ARP2 (actin-related protein 2) | protein interactions | 851532 | 3 | 1 | 19454 | 50 |
WAS |
7.691e-03 | -4.87 | MPEG1 (macrophage expressed 1) | protein interactions | 219972 | 3 | 1 | 19454 | 50 |
RIN3 |
7.691e-03 | -4.87 | Ahr (aryl-hydrocarbon receptor) | protein interactions | 11622 | 3 | 1 | 19454 | 50 |
HIF1A |
7.691e-03 | -4.87 | Cops5 (COP9 signalosome subunit 5) | protein interactions | 26754 | 3 | 1 | 19454 | 50 |
HIF1A |
7.691e-03 | -4.87 | SSX4B (SSX family member 4B) | protein interactions | 548313 | 3 | 1 | 19454 | 50 |
HIF1A |
7.691e-03 | -4.87 | Cbl (Casitas B-lineage lymphoma) | protein interactions | 12402 | 3 | 1 | 19454 | 50 |
SYK |
7.691e-03 | -4.87 | EPYC (epiphycan) | protein interactions | 1833 | 3 | 1 | 19454 | 50 |
PLCG2 |
7.691e-03 | -4.87 | ORF34 (ORF34;ORF36) | protein interactions | 4961504 | 3 | 1 | 19454 | 50 |
HIF1A |
7.700e-03 | -4.87 | negative regulation of coagulation | biological process | GO:0050819 | 49 | 2 | 18204 | 49 |
PRKCD,APOE |
7.700e-03 | -4.87 | platelet aggregation | biological process | GO:0070527 | 49 | 2 | 18204 | 49 |
PTPN6,PIK3CB |
7.700e-03 | -4.87 | negative regulation of T cell differentiation | biological process | GO:0045581 | 49 | 2 | 18204 | 49 |
CD74,SLC4A2 |
7.700e-03 | -4.87 | visual learning | biological process | GO:0008542 | 49 | 2 | 18204 | 49 |
HIF1A,RGS14 |
7.830e-03 | -4.85 | ciliary neurotrophic factor receptor complex | cellular component | GO:0070110 | 3 | 1 | 19108 | 50 |
IL6R |
7.830e-03 | -4.85 | interleukin-6 receptor complex | cellular component | GO:0005896 | 3 | 1 | 19108 | 50 |
IL6R |
7.834e-03 | -4.85 | Focal adhesion | KEGG pathways | ko04510 | 198 | 4 | 7161 | 29 |
DOCK1,VAV3,PARVG,PIK3CB |
7.834e-03 | -4.85 | Focal adhesion | KEGG pathways | hsa04510 | 198 | 4 | 7161 | 29 |
VAV3,DOCK1,PIK3CB,PARVG |
7.836e-03 | -4.85 | T cell receptor signaling pathway | KEGG pathways | hsa04660 | 102 | 3 | 7161 | 29 |
PIK3CB,VAV3,PTPN6 |
7.836e-03 | -4.85 | T cell receptor signaling pathway | KEGG pathways | ko04660 | 102 | 3 | 7161 | 29 |
VAV3,PIK3CB,PTPN6 |
7.928e-03 | -4.84 | COG6 (component of oligomeric golgi complex 6) | protein interactions | 57511 | 159 | 3 | 19454 | 50 |
NEK6,P2RY6,DOCK8 |
7.938e-03 | -4.84 | interleukin-11 receptor activity | molecular function | GO:0004921 | 3 | 1 | 18094 | 48 |
IL6R |
7.938e-03 | -4.84 | interleukin-11 binding | molecular function | GO:0019970 | 3 | 1 | 18094 | 48 |
IL6R |
7.938e-03 | -4.84 | A1 adenosine receptor binding | molecular function | GO:0031686 | 3 | 1 | 18094 | 48 |
P2RY2 |
7.938e-03 | -4.84 | 12-hydroxyheptadecatrienoic acid synthase activity | molecular function | GO:0036134 | 3 | 1 | 18094 | 48 |
TBXAS1 |
7.938e-03 | -4.84 | diacylglycerol-dependent, calcium-independent serine/threonine kinase activity | molecular function | GO:0004699 | 3 | 1 | 18094 | 48 |
PRKCD |
7.938e-03 | -4.84 | G protein-coupled ADP receptor activity | molecular function | GO:0001621 | 3 | 1 | 18094 | 48 |
P2RY6 |
7.941e-03 | -4.84 | regulation of lipid transport | biological process | GO:0032368 | 152 | 3 | 18204 | 49 |
PRKCD,SYK,APOE |
7.941e-03 | -4.84 | regulation of tube diameter | biological process | GO:0035296 | 152 | 3 | 18204 | 49 |
TBXAS1,P2RY2,APOE |
7.941e-03 | -4.84 | regulation of actin polymerization or depolymerization | biological process | GO:0008064 | 152 | 3 | 18204 | 49 |
PRKCD,PREX1,WAS |
7.941e-03 | -4.84 | blood vessel diameter maintenance | biological process | GO:0097746 | 152 | 3 | 18204 | 49 |
TBXAS1,P2RY2,APOE |
7.989e-03 | -4.83 | programmed cell death | biological process | GO:0012501 | 1087 | 8 | 18204 | 49 |
HIF1A,ELMO1,IL6R,PRKCD,NEK6,DOCK1,GSDME,PLCG2 |
8.007e-03 | -4.83 | modulation by host of viral process | biological process | GO:0044788 | 50 | 2 | 18204 | 49 |
APOE,CSF1R |
8.011e-03 | -4.83 | GIT | smart domains | SM00555 | 2 | 1 | 9717 | 39 |
GIT2 |
8.054e-03 | -4.82 | positive regulation of low-density lipoprotein particle receptor catabolic process | biological process | GO:0032805 | 3 | 1 | 18204 | 49 |
APOE |
8.054e-03 | -4.82 | negative regulation of synaptic plasticity | biological process | GO:0031914 | 3 | 1 | 18204 | 49 |
RGS14 |
8.054e-03 | -4.82 | beta selection | biological process | GO:0043366 | 3 | 1 | 18204 | 49 |
SYK |
8.054e-03 | -4.82 | serotonin production involved in inflammatory response | biological process | GO:0002351 | 3 | 1 | 18204 | 49 |
SYK |
8.054e-03 | -4.82 | negative regulation of CD8-positive, alpha-beta T cell differentiation | biological process | GO:0043377 | 3 | 1 | 18204 | 49 |
SLC4A2 |
8.054e-03 | -4.82 | positive regulation of excitatory synapse assembly | biological process | GO:1904891 | 3 | 1 | 18204 | 49 |
SEMA4A |
8.054e-03 | -4.82 | adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process | biological process | GO:0086023 | 3 | 1 | 18204 | 49 |
AKAP13 |
8.054e-03 | -4.82 | follicular B cell differentiation | biological process | GO:0002316 | 3 | 1 | 18204 | 49 |
PLCG2 |
8.054e-03 | -4.82 | serotonin secretion involved in inflammatory response | biological process | GO:0002442 | 3 | 1 | 18204 | 49 |
SYK |
8.054e-03 | -4.82 | termination of signal transduction | biological process | GO:0023021 | 3 | 1 | 18204 | 49 |
PRKCD |
8.054e-03 | -4.82 | serotonin secretion | biological process | GO:0001820 | 3 | 1 | 18204 | 49 |
SYK |
8.054e-03 | -4.82 | positive regulation of chemokine-mediated signaling pathway | biological process | GO:0070101 | 3 | 1 | 18204 | 49 |
HIF1A |
8.054e-03 | -4.82 | membrane raft polarization | biological process | GO:0001766 | 3 | 1 | 18204 | 49 |
DOCK2 |
8.054e-03 | -4.82 | regulation of macrophage migration inhibitory factor signaling pathway | biological process | GO:2000446 | 3 | 1 | 18204 | 49 |
CD74 |
8.054e-03 | -4.82 | myeloid dendritic cell activation involved in immune response | biological process | GO:0002277 | 3 | 1 | 18204 | 49 |
DOCK2 |
8.054e-03 | -4.82 | positive regulation of phospholipid catabolic process | biological process | GO:0060697 | 3 | 1 | 18204 | 49 |
PRKCD |
8.054e-03 | -4.82 | very-low-density lipoprotein particle clearance | biological process | GO:0034447 | 3 | 1 | 18204 | 49 |
APOE |
8.054e-03 | -4.82 | neural fold elevation formation | biological process | GO:0021502 | 3 | 1 | 18204 | 49 |
HIF1A |
8.066e-03 | -4.82 | Signaling by the B Cell Receptor (BCR) | REACTOME pathways | R-HSA-983705 | 229 | 4 | 10285 | 36 |
PIK3CB,PTPN6,PLCG2,SYK |
8.077e-03 | -4.82 | myeloid cell differentiation | biological process | GO:0030099 | 295 | 4 | 18204 | 49 |
CSF1R,SBNO2,SLC4A2,PTPN6 |
8.078e-03 | -4.82 | C2_Dock-D | interpro domains | IPR037809 | 3 | 1 | 18521 | 50 |
DOCK10 |
8.078e-03 | -4.82 | CARMIL_PH | interpro domains | IPR041245 | 3 | 1 | 18521 | 50 |
CARMIL3 |
8.078e-03 | -4.82 | ELMO_ARM | interpro domains | IPR024574 | 3 | 1 | 18521 | 50 |
ELMO1 |
8.078e-03 | -4.82 | DENND1A/B/C | interpro domains | IPR040032 | 3 | 1 | 18521 | 50 |
DENND1B |
8.078e-03 | -4.82 | V5_allergen-like | interpro domains | IPR002413 | 3 | 1 | 18521 | 50 |
GLIPR1 |
8.078e-03 | -4.82 | RII-bd_1 | interpro domains | IPR018459 | 3 | 1 | 18521 | 50 |
AKAP13 |
8.078e-03 | -4.82 | hSH3 | interpro domains | IPR029294 | 3 | 1 | 18521 | 50 |
FYB1 |
8.078e-03 | -4.82 | SCP_GLIPR-1-like | interpro domains | IPR034121 | 3 | 1 | 18521 | 50 |
GLIPR1 |
8.078e-03 | -4.82 | Parvin | interpro domains | IPR028433 | 3 | 1 | 18521 | 50 |
PARVG |
8.078e-03 | -4.82 | Anion_exchange | interpro domains | IPR001717 | 3 | 1 | 18521 | 50 |
SLC4A2 |
8.078e-03 | -4.82 | FYB1/2-like | interpro domains | IPR043443 | 3 | 1 | 18521 | 50 |
FYB1 |
8.078e-03 | -4.82 | HIF_alpha-like | interpro domains | IPR021537 | 3 | 1 | 18521 | 50 |
HIF1A |
8.078e-03 | -4.82 | RGS10/12/14-like | interpro domains | IPR046995 | 3 | 1 | 18521 | 50 |
RGS14 |
8.078e-03 | -4.82 | Anion_exchange_CS | interpro domains | IPR018241 | 3 | 1 | 18521 | 50 |
SLC4A2 |
8.078e-03 | -4.82 | C2_Dock-C | interpro domains | IPR037808 | 3 | 1 | 18521 | 50 |
DOCK8 |
8.078e-03 | -4.82 | CARMIL_C | interpro domains | IPR031943 | 3 | 1 | 18521 | 50 |
CARMIL3 |
8.078e-03 | -4.82 | PH_Vav | interpro domains | IPR037832 | 3 | 1 | 18521 | 50 |
VAV3 |
8.085e-03 | -4.82 | regulation of tube size | biological process | GO:0035150 | 153 | 3 | 18204 | 49 |
APOE,TBXAS1,P2RY2 |
8.085e-03 | -4.82 | myeloid leukocyte differentiation | biological process | GO:0002573 | 153 | 3 | 18204 | 49 |
CSF1R,SLC4A2,SBNO2 |
8.161e-03 | -4.81 | cell death | biological process | GO:0008219 | 1091 | 8 | 18204 | 49 |
PLCG2,DOCK1,NEK6,PRKCD,GSDME,IL6R,ELMO1,HIF1A |
8.166e-03 | -4.81 | TCR signaling | REACTOME pathways | R-HSA-202403 | 119 | 3 | 10285 | 36 |
PIK3CB,FYB1,WAS |
8.206e-03 | -4.80 | KLHDC10 (kelch domain containing 10) | protein interactions | 23008 | 53 | 2 | 19454 | 50 |
PIK3CB,RIN3 |
8.206e-03 | -4.80 | GNA12 (G protein subunit alpha 12) | protein interactions | 2768 | 53 | 2 | 19454 | 50 |
PRKCD,AKAP13 |
8.206e-03 | -4.80 | CLEC7A (C-type lectin domain containing 7A) | protein interactions | 64581 | 53 | 2 | 19454 | 50 |
CD74,SYK |
8.207e-03 | -4.80 | cytoplasm | cellular component | GO:0005737 | 12081 | 40 | 19108 | 50 |
MICAL1,DOCK10,HIF1A,DOCK2,CD74,RHBDF2,PIK3R5,WAS,PTPN6,CARMIL3,NEK6,EHBP1L1,IPCEF1,DOCK1,DENND1B,NRK,WDFY4,DOCK8,PRKCD,ARHGAP27,PIK3CB,SKAP1,GSDME,MYO1F,SYK,PLCG2,PARVG,APOE,AKAP13,ARHGAP33,VAV3,RGS14,RIN3,FYB1,PREX1,GMIP,TBXAS1,IRF5,ELMO1,GLIPR1 |
8.320e-03 | -4.79 | regulation of granulocyte chemotaxis | biological process | GO:0071622 | 51 | 2 | 18204 | 49 |
CD74,CSF1R |
8.357e-03 | -4.78 | HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha) | protein interactions | 3030 | 491 | 5 | 19454 | 50 |
SYK,P2RY6,APOE,CD74,RIN3 |
8.377e-03 | -4.78 | regulation of G protein-coupled receptor signaling pathway | biological process | GO:0008277 | 155 | 3 | 18204 | 49 |
RGS14,HIF1A,GIT2 |
8.377e-03 | -4.78 | regulation of actin filament length | biological process | GO:0030832 | 155 | 3 | 18204 | 49 |
WAS,PREX1,PRKCD |
8.406e-03 | -4.78 | CARMIL_C | pfam domains | PF16000 | 3 | 1 | 17795 | 50 |
CARMIL3 |
8.406e-03 | -4.78 | Carm_PH | pfam domains | PF17888 | 3 | 1 | 17795 | 50 |
CARMIL3 |
8.406e-03 | -4.78 | HIF-1 | pfam domains | PF11413 | 3 | 1 | 17795 | 50 |
HIF1A |
8.406e-03 | -4.78 | hSH3 | pfam domains | PF14603 | 3 | 1 | 17795 | 50 |
FYB1 |
8.406e-03 | -4.78 | PI3K_p85B | pfam domains | PF02192 | 3 | 1 | 17795 | 50 |
PIK3CB |
8.406e-03 | -4.78 | RII_binding_1 | pfam domains | PF10522 | 3 | 1 | 17795 | 50 |
AKAP13 |
8.406e-03 | -4.78 | ELMO_ARM | pfam domains | PF11841 | 3 | 1 | 17795 | 50 |
ELMO1 |
8.440e-03 | -4.77 | Fc Epsilon Receptor I Signaling in Mast Cells | SMPDB pathways | SMP0000358 | 34 | 2 | 1369 | 6 |
SYK,VAV3 |
8.542e-03 | -4.76 | Proteoglycans in cancer | KEGG pathways | hsa05205 | 203 | 4 | 7161 | 29 |
PIK3CB,HIF1A,PLCG2,PTPN6 |
8.542e-03 | -4.76 | Proteoglycans in cancer | KEGG pathways | ko05205 | 203 | 4 | 7161 | 29 |
PIK3CB,PLCG2,HIF1A,PTPN6 |
8.559e-03 | -4.76 | ATP5PO (ATP synthase peripheral stalk subunit OSCP) | protein interactions | 539 | 314 | 4 | 19454 | 50 |
DOCK8,P2RY6,APOE,PREX1 |
8.607e-03 | -4.76 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 6 | 18204 | 49 |
WAS,ARHGAP33,PRKCD,PREX1,TBC1D8,APOE |
8.638e-03 | -4.75 | membrane invagination | biological process | GO:0010324 | 52 | 2 | 18204 | 49 |
ELMO1,DOCK1 |
8.675e-03 | -4.75 | phosphatidylinositol metabolic process | biological process | GO:0046488 | 157 | 3 | 18204 | 49 |
PLCG2,PIK3CB,PIK3R5 |
8.688e-03 | -4.75 | germ_cell_tumour | COSMIC cancer mutations | germ_cell_tumour | 867 | 7 | 16828 | 46 |
PRKCD,SYK,RIN3,CSF1R,NEK6,RHBDF2,ADCY7 |
8.814e-03 | -4.73 | DOCK1 (dedicator of cytokinesis 1) | protein interactions | 1793 | 55 | 2 | 19454 | 50 |
ELMO1,IPCEF1 |
8.962e-03 | -4.71 | positive regulation of calcium-mediated signaling | biological process | GO:0050850 | 53 | 2 | 18204 | 49 |
PLCG2,SYK |
9.058e-03 | -4.70 | Signaling by Interleukins | REACTOME pathways | R-HSA-449147 | 525 | 6 | 10285 | 36 |
HIF1A,PIK3CB,IL6R,PTPN6,CSF1R,SYK |
9.125e-03 | -4.70 | EML3 (EMAP like 3) | protein interactions | 256364 | 56 | 2 | 19454 | 50 |
SKAP1,NEK6 |
9.125e-03 | -4.70 | PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma) | protein interactions | 5294 | 56 | 2 | 19454 | 50 |
SYK,PIK3R5 |
9.201e-03 | -4.69 | phosphotransferase activity, alcohol group as acceptor | molecular function | GO:0016773 | 686 | 6 | 18094 | 48 |
SYK,NRK,CSF1R,PIK3CB,PRKCD,NEK6 |
9.212e-03 | -4.69 | KLK10 (kallikrein related peptidase 10) | protein interactions | 5655 | 168 | 3 | 19454 | 50 |
MYO1F,APOE,PTPN6 |
9.212e-03 | -4.69 | GAB1 (GRB2 associated binding protein 1) | protein interactions | 2549 | 168 | 3 | 19454 | 50 |
PLCG2,SYK,VAV3 |
9.290e-03 | -4.68 | negative regulation of supramolecular fiber organization | biological process | GO:1902904 | 161 | 3 | 18204 | 49 |
APOE,PRKCD,WAS |
9.290e-03 | -4.68 | positive regulation of receptor-mediated endocytosis | biological process | GO:0048260 | 54 | 2 | 18204 | 49 |
SYK,PLCG2 |
9.290e-03 | -4.68 | regulation of alcohol biosynthetic process | biological process | GO:1902930 | 54 | 2 | 18204 | 49 |
APOE,P2RY6 |
9.300e-03 | -4.68 | phospholipid binding | molecular function | GO:0005543 | 489 | 5 | 18094 | 48 |
GSDME,PREX1,DENND1B,ARHGAP33,APOE |
9.303e-03 | -4.68 | Prot_kinase_dom | interpro domains | IPR000719 | 480 | 5 | 18521 | 50 |
NRK,CSF1R,NEK6,SYK,PRKCD |
9.391e-03 | -4.67 | upper_leg | COSMIC cancer mutations | upper_leg | 880 | 7 | 16828 | 46 |
DOCK2,VAV3,SEMA4A,CSF1R,NEK6,DOCK8,ELMO1 |
9.442e-03 | -4.66 | PTPRC (protein tyrosine phosphatase receptor type C) | protein interactions | 5788 | 57 | 2 | 19454 | 50 |
PTPN6,SKAP1 |
9.442e-03 | -4.66 | PRKCQ (protein kinase C theta) | protein interactions | 5588 | 57 | 2 | 19454 | 50 |
PRKCD,FYB1 |
9.442e-03 | -4.66 | ITK (IL2 inducible T cell kinase) | protein interactions | 3702 | 57 | 2 | 19454 | 50 |
PLCG2,WAS |
9.442e-03 | -4.66 | DOCK9 (dedicator of cytokinesis 9) | protein interactions | 23348 | 57 | 2 | 19454 | 50 |
DOCK1,DOCK10 |
9.444e-03 | -4.66 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 14 | 16828 | 46 |
PLCG2,ELMO1,PTPN6,DOCK10,VAV3,WDFY4,DOCK8,APOE,RIN3,DOCK1,SLC4A2,PARVG,EHBP1L1,AKAP13 |
9.444e-03 | -4.66 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 14 | 16828 | 46 |
DOCK8,VAV3,WDFY4,DOCK10,ELMO1,PTPN6,PLCG2,EHBP1L1,AKAP13,SLC4A2,PARVG,DOCK1,RIN3,APOE |
9.503e-03 | -4.66 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 19 | 16828 | 46 |
SBNO2,MICAL1,DOCK8,WDFY4,VAV3,DOCK10,ELMO1,PTPN6,PLCG2,CSF1R,TBC1D8,AKAP13,EHBP1L1,PARVG,SLC4A2,RIN3,DOCK1,GLIPR1,APOE |
9.521e-03 | -4.65 | RHOU (ras homolog family member U) | protein interactions | 58480 | 507 | 5 | 19454 | 50 |
SYK,GIT2,TBC1D8,SLC4A2,EHBP1L1 |
9.544e-03 | -4.65 | defense response to symbiont | biological process | GO:0140546 | 894 | 7 | 18204 | 49 |
CD74,SYK,PTPN6,PLCG2,IRF5,CSF1R,WAS |
9.548e-03 | -4.65 | response to bacterium | biological process | GO:0009617 | 681 | 6 | 18204 | 49 |
IL6R,SBNO2,SYK,PRKCD,PLCG2,IRF5 |
9.575e-03 | -4.65 | negative regulation of cell adhesion | biological process | GO:0007162 | 310 | 4 | 18204 | 49 |
SLC4A2,CD74,PTPN6,PRKCD |
9.579e-03 | -4.65 | human chr11q13.4 | chromosome location | human chr11q13.4 | 77 | 2 | 26134 | 50 |
P2RY2,P2RY6 |
9.606e-03 | -4.65 | receptor-mediated endocytosis | biological process | GO:0006898 | 163 | 3 | 18204 | 49 |
APOE,SYK,ARHGAP27 |
9.625e-03 | -4.64 | neural crest cell migration | biological process | GO:0001755 | 55 | 2 | 18204 | 49 |
SEMA4A,HIF1A |
9.625e-03 | -4.64 | CD4-positive, alpha-beta T cell differentiation | biological process | GO:0043367 | 55 | 2 | 18204 | 49 |
IL6R,SEMA4A |
9.665e-03 | -4.64 | PACSIN2 (protein kinase C and casein kinase substrate in neurons 2) | protein interactions | 11252 | 171 | 3 | 19454 | 50 |
IRF5,RIN3,WAS |
9.679e-03 | -4.64 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 6 | 18204 | 49 |
PREX1,PRKCD,ARHGAP33,TBC1D8,APOE,WAS |
9.761e-03 | -4.63 | Regulation of actin cytoskeleton | KEGG pathways | ko04810 | 211 | 4 | 7161 | 29 |
DOCK1,WAS,VAV3,PIK3CB |
9.761e-03 | -4.63 | Regulation of actin cytoskeleton | KEGG pathways | hsa04810 | 211 | 4 | 7161 | 29 |
PIK3CB,DOCK1,WAS,VAV3 |
9.767e-03 | -4.63 | negative regulation of lymphocyte activation | biological process | GO:0051250 | 164 | 3 | 18204 | 49 |
SLC4A2,PTPN6,CD74 |
9.767e-03 | -4.63 | positive regulation of leukocyte proliferation | biological process | GO:0070665 | 164 | 3 | 18204 | 49 |
CD74,VAV3,CSF1R |
9.809e-03 | -4.62 | mesothelioma | COSMIC cancer mutations | mesothelioma | 4477 | 20 | 16828 | 46 |
HIF1A,DOCK1,PIK3R5,RGS14,SYK,PRKCD,IL6R,AKAP13,PIK3CB,IRF5,GIT2,NEK6,CSF1R,PREX1,PLCG2,WAS,PTPN6,SEMA4A,ARHGAP33,VAV3 |
9.919e-03 | -4.61 | - | gene3d domains | 6.10.140.1000 | 3 | 1 | 14470 | 48 |
DENND1B |
9.919e-03 | -4.61 | - | gene3d domains | 3.10.20.770 | 3 | 1 | 14470 | 48 |
PIK3CB |
9.919e-03 | -4.61 | - | gene3d domains | 6.10.250.810 | 3 | 1 | 14470 | 48 |
ELMO1 |
9.964e-03 | -4.61 | B cell activation involved in immune response | biological process | GO:0002312 | 56 | 2 | 18204 | 49 |
DOCK10,PLCG2 |
9.975e-03 | -4.61 | THOC2 (THO complex subunit 2) | protein interactions | 57187 | 173 | 3 | 19454 | 50 |
SLC4A2,TBC1D8,P2RY6 |
1.008e-02 | -4.60 | cellular homeostasis | biological process | GO:0019725 | 689 | 6 | 18204 | 49 |
PIK3CB,APOE,HIF1A,TBXAS1,P2RY2,SLC4A2 |
1.009e-02 | -4.60 | C1_1 | pfam domains | PF00130 | 54 | 2 | 17795 | 50 |
PRKCD,VAV3 |
1.009e-02 | -4.60 | lymphocyte mediated immunity | biological process | GO:0002449 | 166 | 3 | 18204 | 49 |
CD74,PTPN6,PRKCD |
1.012e-02 | -4.59 | Cholinergic synapse | KEGG pathways | hsa04725 | 112 | 3 | 7161 | 29 |
PIK3CB,PIK3R5,ADCY7 |
1.013e-02 | -4.59 | GYPA (glycophorin A (MNS blood group)) | protein interactions | 2993 | 174 | 3 | 19454 | 50 |
GSDME,DOCK1,NEK6 |
1.013e-02 | -4.59 | SURF4 (surfeit 4) | protein interactions | 6836 | 174 | 3 | 19454 | 50 |
DOCK1,P2RY6,P2RY2 |
1.024e-02 | -4.58 | OR52I1 (olfactory receptor family 52 subfamily I member 1) | protein interactions | 390037 | 4 | 1 | 19454 | 50 |
SLC4A2 |
1.024e-02 | -4.58 | CYP46A1 (cytochrome P450 family 46 subfamily A member 1) | protein interactions | 10858 | 4 | 1 | 19454 | 50 |
RIN3 |
1.024e-02 | -4.58 | H1-10-AS1 (H1-10 antisense RNA 1) | protein interactions | 339942 | 4 | 1 | 19454 | 50 |
PTPN6 |
1.024e-02 | -4.58 | Mapk1 (mitogen activated protein kinase 1) | protein interactions | 116590 | 4 | 1 | 19454 | 50 |
HIF1A |
1.024e-02 | -4.58 | PLEKHD1 (pleckstrin homology and coiled-coil domain containing D1) | protein interactions | 400224 | 4 | 1 | 19454 | 50 |
SYK |
1.024e-02 | -4.58 | CD34 (CD34 molecule) | protein interactions | 947 | 4 | 1 | 19454 | 50 |
PRKCD |
1.024e-02 | -4.58 | ANKRD42 (ankyrin repeat domain 42) | protein interactions | 338699 | 4 | 1 | 19454 | 50 |
RIN3 |
1.024e-02 | -4.58 | Ocln (occludin) | protein interactions | 18260 | 4 | 1 | 19454 | 50 |
PRKCD |
1.030e-02 | -4.58 | ANIONEXCHNGR | prints domains | PR00165 | 3 | 1 | 5227 | 18 |
SLC4A2 |
1.030e-02 | -4.58 | V5ALLERGEN | prints domains | PR00838 | 3 | 1 | 5227 | 18 |
GLIPR1 |
1.031e-02 | -4.58 | dendritic spine | cellular component | GO:0043197 | 172 | 3 | 19108 | 50 |
ARHGAP33,RGS14,DOCK10 |
1.031e-02 | -4.57 | visual behavior | biological process | GO:0007632 | 57 | 2 | 18204 | 49 |
HIF1A,RGS14 |
1.031e-02 | -4.57 | mesenchymal cell migration | biological process | GO:0090497 | 57 | 2 | 18204 | 49 |
SEMA4A,HIF1A |
1.042e-02 | -4.56 | CA2 (carbonic anhydrase 2) | protein interactions | 760 | 60 | 2 | 19454 | 50 |
SLC4A2,VAV3 |
1.043e-02 | -4.56 | phosphatidylinositol 3-kinase complex, class IB | cellular component | GO:0005944 | 4 | 1 | 19108 | 50 |
PIK3R5 |
1.043e-02 | -4.56 | intermediate-density lipoprotein particle | cellular component | GO:0034363 | 4 | 1 | 19108 | 50 |
APOE |
1.047e-02 | -4.56 | Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha | REACTOME pathways | R-HSA-1234162 | 3 | 1 | 10285 | 36 |
HIF1A |
1.056e-02 | -4.55 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 15 | 16828 | 46 |
PIK3R5,RIN3,HIF1A,SYK,P2RY6,PRKCD,P2RY2,PIK3CB,CSF1R,PLCG2,PTPN6,ELMO1,WAS,VAV3,TBXAS1 |
1.056e-02 | -4.55 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 15 | 16828 | 46 |
VAV3,TBXAS1,PLCG2,ELMO1,PTPN6,WAS,PIK3CB,CSF1R,RIN3,PIK3R5,HIF1A,SYK,P2RY6,PRKCD,P2RY2 |
1.057e-02 | -4.55 | MCM3 (minichromosome maintenance complex component 3) | protein interactions | 4172 | 334 | 4 | 19454 | 50 |
HIF1A,P2RY6,DOCK8,RIN3 |
1.057e-02 | -4.55 | very-low-density lipoprotein particle receptor binding | molecular function | GO:0070326 | 4 | 1 | 18094 | 48 |
APOE |
1.057e-02 | -4.55 | ciliary neurotrophic factor receptor activity | molecular function | GO:0004897 | 4 | 1 | 18094 | 48 |
IL6R |
1.062e-02 | -4.54 | Leukocyte transendothelial migration | KEGG pathways | ko04670 | 114 | 3 | 7161 | 29 |
PIK3CB,VAV3,PLCG2 |
1.062e-02 | -4.54 | Leukocyte transendothelial migration | KEGG pathways | hsa04670 | 114 | 3 | 7161 | 29 |
PIK3CB,VAV3,PLCG2 |
1.063e-02 | -4.54 | neuron spine | cellular component | GO:0044309 | 174 | 3 | 19108 | 50 |
ARHGAP33,DOCK10,RGS14 |
1.066e-02 | -4.54 | negative regulation of lymphocyte differentiation | biological process | GO:0045620 | 58 | 2 | 18204 | 49 |
CD74,SLC4A2 |
1.066e-02 | -4.54 | mammary gland epithelium development | biological process | GO:0061180 | 58 | 2 | 18204 | 49 |
CSF1R,HIF1A |
1.070e-02 | -4.54 | negative regulation of apoptotic process | biological process | GO:0043066 | 914 | 7 | 18204 | 49 |
CSF1R,MICAL1,DOCK8,HIF1A,CD74,PIK3CB,PRKCD |
1.071e-02 | -4.54 | G Protein Signaling Pathways | WikiPathways | WP35 | 95 | 3 | 5310 | 26 |
PRKCD,AKAP13,ADCY7 |
1.072e-02 | -4.54 | positive regulation of establishment of T cell polarity | biological process | GO:1903905 | 4 | 1 | 18204 | 49 |
DOCK8 |
1.072e-02 | -4.54 | regulation of phospholipid efflux | biological process | GO:1902994 | 4 | 1 | 18204 | 49 |
APOE |
1.072e-02 | -4.54 | negative regulation of mature B cell apoptotic process | biological process | GO:0002906 | 4 | 1 | 18204 | 49 |
CD74 |
1.072e-02 | -4.54 | cellular response to molecule of fungal origin | biological process | GO:0071226 | 4 | 1 | 18204 | 49 |
SYK |
1.072e-02 | -4.54 | positive regulation of neutrophil apoptotic process | biological process | GO:0033031 | 4 | 1 | 18204 | 49 |
PIK3CB |
1.072e-02 | -4.54 | B-1 B cell homeostasis | biological process | GO:0001922 | 4 | 1 | 18204 | 49 |
HIF1A |
1.072e-02 | -4.54 | regulation of inositol trisphosphate biosynthetic process | biological process | GO:0032960 | 4 | 1 | 18204 | 49 |
P2RY6 |
1.072e-02 | -4.54 | response to caloric restriction | biological process | GO:0061771 | 4 | 1 | 18204 | 49 |
APOE |
1.072e-02 | -4.54 | NMDA glutamate receptor clustering | biological process | GO:0097114 | 4 | 1 | 18204 | 49 |
APOE |
1.072e-02 | -4.54 | negative regulation of mast cell activation involved in immune response | biological process | GO:0033007 | 4 | 1 | 18204 | 49 |
PTPN6 |
1.072e-02 | -4.54 | regulation of inhibitory synapse assembly | biological process | GO:1905702 | 4 | 1 | 18204 | 49 |
SEMA4A |
1.072e-02 | -4.54 | epithelial cell differentiation involved in mammary gland alveolus development | biological process | GO:0061030 | 4 | 1 | 18204 | 49 |
HIF1A |
1.072e-02 | -4.54 | regulation of mature B cell apoptotic process | biological process | GO:0002905 | 4 | 1 | 18204 | 49 |
CD74 |
1.072e-02 | -4.54 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | biological process | GO:0031587 | 4 | 1 | 18204 | 49 |
P2RY6 |
1.072e-02 | -4.54 | positive regulation of inositol trisphosphate biosynthetic process | biological process | GO:0032962 | 4 | 1 | 18204 | 49 |
P2RY6 |
1.072e-02 | -4.54 | macrophage colony-stimulating factor signaling pathway | biological process | GO:0038145 | 4 | 1 | 18204 | 49 |
CSF1R |
1.072e-02 | -4.54 | positive regulation of phospholipid efflux | biological process | GO:1902995 | 4 | 1 | 18204 | 49 |
APOE |
1.072e-02 | -4.54 | positive regulation of endodeoxyribonuclease activity | biological process | GO:0032079 | 4 | 1 | 18204 | 49 |
PRKCD |
1.072e-02 | -4.54 | positive regulation of mast cell cytokine production | biological process | GO:0032765 | 4 | 1 | 18204 | 49 |
SYK |
1.076e-02 | -4.53 | ApoA_E | interpro domains | IPR000074 | 4 | 1 | 18521 | 50 |
APOE |
1.076e-02 | -4.53 | PI3K_ABD | interpro domains | IPR003113 | 4 | 1 | 18521 | 50 |
PIK3CB |
1.076e-02 | -4.53 | NT-C2 | interpro domains | IPR019448 | 4 | 1 | 18521 | 50 |
EHBP1L1 |
1.076e-02 | -4.53 | Prot_kin_PKC_delta | interpro domains | IPR014376 | 4 | 1 | 18521 | 50 |
PRKCD |
1.076e-02 | -4.53 | FBXL12 (F-box and leucine rich repeat protein 12) | protein interactions | 54850 | 61 | 2 | 19454 | 50 |
APOE,DOCK8 |
1.076e-02 | -4.53 | negative regulation of protein kinase activity | biological process | GO:0006469 | 170 | 3 | 18204 | 49 |
RGS14,APOE,PRKCD |
1.077e-02 | -4.53 | IPO8 (importin 8) | protein interactions | 10526 | 178 | 3 | 19454 | 50 |
P2RY6,P2RY2,RIN3 |
1.079e-02 | -4.53 | skin-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-carcinoma-squamous_cell_carcinoma | 493 | 5 | 16828 | 46 |
SYK,CSF1R,WAS,HIF1A,ARHGAP33 |
1.099e-02 | -4.51 | PI3K-Akt signaling pathway | KEGG pathways | hsa04151 | 341 | 5 | 7161 | 29 |
SYK,CSF1R,PIK3CB,IL6R,PIK3R5 |
1.099e-02 | -4.51 | PI3K-Akt signaling pathway | KEGG pathways | ko04151 | 341 | 5 | 7161 | 29 |
IL6R,PIK3R5,PIK3CB,SYK,CSF1R |
1.104e-02 | -4.51 | ANION_EXCHANGER_1 | prosite domains | PS00219 | 3 | 1 | 12186 | 45 |
SLC4A2 |
1.104e-02 | -4.51 | ANION_EXCHANGER_2 | prosite domains | PS00220 | 3 | 1 | 12186 | 45 |
SLC4A2 |
1.106e-02 | -4.50 | Cell-Cell communication | REACTOME pathways | R-HSA-1500931 | 133 | 3 | 10285 | 36 |
FYB1,PTPN6,PIK3CB |
1.108e-02 | -4.50 | protein phosphorylation | biological process | GO:0006468 | 503 | 5 | 18204 | 49 |
NEK6,PTPN6,PRKCD,SYK,CSF1R |
1.111e-02 | -4.50 | negative regulation of secretion | biological process | GO:0051048 | 172 | 3 | 18204 | 49 |
APOE,RHBDF2,CD74 |
1.112e-02 | -4.50 | cytoplasmic vesicle | cellular component | GO:0031410 | 2521 | 13 | 19108 | 50 |
EHBP1L1,RIN3,DOCK2,PRKCD,MICAL1,APOE,WDFY4,GLIPR1,PTPN6,WAS,DENND1B,CD74,SYK |
1.114e-02 | -4.50 | Thyroid hormone signaling pathway | KEGG pathways | hsa04919 | 116 | 3 | 7161 | 29 |
PIK3CB,HIF1A,PLCG2 |
1.119e-02 | -4.49 | NT-C2 | pfam domains | PF10358 | 4 | 1 | 17795 | 50 |
EHBP1L1 |
1.119e-02 | -4.49 | Apolipoprotein | pfam domains | PF01442 | 4 | 1 | 17795 | 50 |
APOE |
1.127e-02 | -4.49 | PRKD1 (protein kinase D1) | protein interactions | 5587 | 181 | 3 | 19454 | 50 |
PLCG2,SYK,AKAP13 |
1.128e-02 | -4.48 | regulation of smooth muscle cell proliferation | biological process | GO:0048660 | 173 | 3 | 18204 | 49 |
P2RY6,APOE,IL6R |
1.137e-02 | -4.48 | positive regulation of cytokine-mediated signaling pathway | biological process | GO:0001961 | 60 | 2 | 18204 | 49 |
CD74,HIF1A |
1.144e-02 | -4.47 | PAG1 (phosphoprotein membrane anchor with glycosphingolipid microdomains 1) | protein interactions | 55824 | 63 | 2 | 19454 | 50 |
PTPN6,SYK |
1.145e-02 | -4.47 | TOP3B (DNA topoisomerase III beta) | protein interactions | 8940 | 1465 | 9 | 19454 | 50 |
SBNO2,RIN3,PREX1,ARHGAP33,AKAP13,IRF5,ADCY7,RHBDF2,EHBP1L1 |
1.148e-02 | -4.47 | Signaling by GPCR | REACTOME pathways | R-HSA-372790 | 1299 | 10 | 10285 | 36 |
PIK3CB,ADCY7,PRKCD,P2RY2,AKAP13,RGS14,P2RY6,PREX1,PIK3R5,VAV3 |
1.148e-02 | -4.47 | regulation of lipid metabolic process | biological process | GO:0019216 | 327 | 4 | 18204 | 49 |
PLCG2,PRKCD,CD74,APOE |
1.148e-02 | -4.47 | specific granule lumen | cellular component | GO:0035580 | 62 | 2 | 19108 | 50 |
PTPN6,DOCK2 |
1.153e-02 | -4.46 | circulatory system process | biological process | GO:0003013 | 508 | 5 | 18204 | 49 |
APOE,TBC1D8,TBXAS1,P2RY2,AKAP13 |
1.160e-02 | -4.46 | lung-carcinoid-endocrine_tumour | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour | 502 | 5 | 16828 | 46 |
TBC1D8,CSF1R,NEK6,SYK,PRKCD |
1.161e-02 | -4.46 | SORBS3 (sorbin and SH3 domain containing 3) | protein interactions | 10174 | 183 | 3 | 19454 | 50 |
NEK6,RIN3,MICAL1 |
1.166e-02 | -4.45 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 19 | 16828 | 46 |
PTPN6,ELMO1,PLCG2,DOCK8,MICAL1,SBNO2,DOCK10,VAV3,WDFY4,SLC4A2,PARVG,APOE,RIN3,GLIPR1,DOCK1,TBC1D8,CSF1R,EHBP1L1,AKAP13 |
1.167e-02 | -4.45 | PLC beta mediated events | REACTOME pathways | R-HSA-112043 | 47 | 2 | 10285 | 36 |
ADCY7,PRKCD |
1.169e-02 | -4.45 | cell differentiation | biological process | GO:0030154 | 3645 | 17 | 18204 | 49 |
APOE,HIF1A,IL6R,CSF1R,DOCK2,SEMA4A,CD74,PREX1,AKAP13,SBNO2,DOCK10,PTPN6,DOCK1,SYK,GSDME,SLC4A2,PLCG2 |
1.172e-02 | -4.45 | regulation of leukocyte differentiation | biological process | GO:1902105 | 329 | 4 | 18204 | 49 |
SLC4A2,PTPN6,SYK,CD74 |
1.174e-02 | -4.44 | bone mineralization | biological process | GO:0030282 | 61 | 2 | 18204 | 49 |
HIF1A,SBNO2 |
1.174e-02 | -4.44 | Cell surface interactions at the vascular wall | REACTOME pathways | R-HSA-202733 | 136 | 3 | 10285 | 36 |
PIK3CB,PTPN6,CD74 |
1.175e-02 | -4.44 | non_small_cell_carcinoma | COSMIC cancer mutations | non_small_cell_carcinoma | 5198 | 22 | 16828 | 46 |
PREX1,DOCK10,SEMA4A,ARHGAP33,WDFY4,SYK,IL6R,AKAP13,IRF5,NEK6,PLCG2,WAS,PTPN6,VAV3,HIF1A,PIK3R5,DOCK1,RGS14,PRKCD,PIK3CB,GIT2,CSF1R |
1.175e-02 | -4.44 | lung-carcinoma-non_small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-non_small_cell_carcinoma | 5198 | 22 | 16828 | 46 |
WDFY4,ARHGAP33,DOCK10,SEMA4A,PREX1,IRF5,AKAP13,IL6R,NEK6,SYK,VAV3,PLCG2,PTPN6,WAS,GIT2,PIK3CB,CSF1R,PIK3R5,DOCK1,HIF1A,RGS14,PRKCD |
1.178e-02 | -4.44 | SDHB (succinate dehydrogenase complex iron sulfur subunit B) | protein interactions | 6390 | 184 | 3 | 19454 | 50 |
RIN3,P2RY6,PIK3R5 |
1.179e-02 | -4.44 | cellular developmental process | biological process | GO:0048869 | 3648 | 17 | 18204 | 49 |
SBNO2,DOCK10,PTPN6,DOCK1,SYK,GSDME,SLC4A2,PLCG2,HIF1A,APOE,IL6R,CSF1R,DOCK2,SEMA4A,CD74,PREX1,AKAP13 |
1.179e-02 | -4.44 | DGKE (diacylglycerol kinase epsilon) | protein interactions | 8526 | 64 | 2 | 19454 | 50 |
P2RY6,CD74 |
1.179e-02 | -4.44 | LRCH2 (leucine rich repeats and calponin homology domain containing 2) | protein interactions | 57631 | 64 | 2 | 19454 | 50 |
DOCK8,DOCK2 |
1.190e-02 | -4.43 | circulatory system development | biological process | GO:0072359 | 933 | 7 | 18204 | 49 |
APOE,HIF1A,PIK3CB,VAV3,SEMA4A,SYK,AKAP13 |
1.194e-02 | -4.43 | Neurotrophin signaling pathway | KEGG pathways | ko04722 | 119 | 3 | 7161 | 29 |
PLCG2,PIK3CB,PRKCD |
1.194e-02 | -4.43 | Neurotrophin signaling pathway | KEGG pathways | hsa04722 | 119 | 3 | 7161 | 29 |
PLCG2,PRKCD,PIK3CB |
1.195e-02 | -4.43 | APBB1 (amyloid beta precursor protein binding family B member 1) | protein interactions | 322 | 185 | 3 | 19454 | 50 |
WAS,RHBDF2,ELMO1 |
1.196e-02 | -4.43 | regulation of small molecule metabolic process | biological process | GO:0062012 | 331 | 4 | 18204 | 49 |
HIF1A,APOE,CD74,P2RY6 |
1.199e-02 | -4.42 | PI3K_p85B | smart domains | SM00143 | 3 | 1 | 9717 | 39 |
PIK3CB |
1.211e-02 | -4.41 | regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900024 | 62 | 2 | 18204 | 49 |
PREX1,DOCK1 |
1.215e-02 | -4.41 | ESRRA (estrogen related receptor alpha) | protein interactions | 2101 | 65 | 2 | 19454 | 50 |
HIF1A,PRKCD |
1.215e-02 | -4.41 | G-protein mediated events | REACTOME pathways | R-HSA-112040 | 48 | 2 | 10285 | 36 |
PRKCD,ADCY7 |
1.215e-02 | -4.41 | G beta:gamma signalling through PI3Kgamma | REACTOME pathways | R-HSA-392451 | 48 | 2 | 10285 | 36 |
PIK3CB,PIK3R5 |
1.215e-02 | -4.41 | G alpha (z) signalling events | REACTOME pathways | R-HSA-418597 | 48 | 2 | 10285 | 36 |
PRKCD,ADCY7 |
1.221e-02 | -4.41 | PROTEIN_KINASE_ATP | prosite domains | PS00107 | 377 | 5 | 12186 | 45 |
SYK,CSF1R,NRK,NEK6,PRKCD |
1.237e-02 | -4.39 | regulation of response to wounding | biological process | GO:1903034 | 179 | 3 | 18204 | 49 |
APOE,PTPN6,PRKCD |
1.246e-02 | -4.39 | peptidyl-amino acid modification | biological process | GO:0018193 | 518 | 5 | 18204 | 49 |
CSF1R,SYK,PRKCD,PTPN6,NEK6 |
1.249e-02 | -4.38 | regulation of nitric oxide biosynthetic process | biological process | GO:0045428 | 63 | 2 | 18204 | 49 |
APOE,PIK3CB |
1.249e-02 | -4.38 | response to fungus | biological process | GO:0009620 | 63 | 2 | 18204 | 49 |
PLCG2,SYK |
1.249e-02 | -4.38 | positive regulation of interleukin-8 production | biological process | GO:0032757 | 63 | 2 | 18204 | 49 |
CD74,SYK |
1.266e-02 | -4.37 | APPBP2 (amyloid beta precursor protein binding protein 2) | protein interactions | 10513 | 189 | 3 | 19454 | 50 |
SKAP1,DOCK8,WAS |
1.274e-02 | -4.36 | DDX54 (DEAD-box helicase 54) | protein interactions | 79039 | 353 | 4 | 19454 | 50 |
PTPN6,SEMA4A,SYK,MYO1F |
1.274e-02 | -4.36 | negative regulation of kinase activity | biological process | GO:0033673 | 181 | 3 | 18204 | 49 |
PRKCD,APOE,RGS14 |
1.274e-02 | -4.36 | response to reactive oxygen species | biological process | GO:0000302 | 181 | 3 | 18204 | 49 |
APOE,HIF1A,PRKCD |
1.277e-02 | -4.36 | phosphate-containing compound metabolic process | biological process | GO:0006796 | 1681 | 10 | 18204 | 49 |
PLCG2,ADCY7,PTPN6,NEK6,SYK,PRKCD,CSF1R,PIK3R5,PIK3CB,NRK |
1.279e-02 | -4.36 | VHLL (VHL like) | protein interactions | 391104 | 5 | 1 | 19454 | 50 |
HIF1A |
1.279e-02 | -4.36 | LINC01139 (long intergenic non-protein coding RNA 1139) | protein interactions | 339535 | 5 | 1 | 19454 | 50 |
HIF1A |
1.279e-02 | -4.36 | Vhl (von Hippel-Lindau tumor suppressor) | protein interactions | 24874 | 5 | 1 | 19454 | 50 |
HIF1A |
1.279e-02 | -4.36 | NBR2 (neighbor of BRCA1 lncRNA 2) | protein interactions | 10230 | 5 | 1 | 19454 | 50 |
GMIP |
1.279e-02 | -4.36 | ANGPTL2 (angiopoietin like 2) | protein interactions | 23452 | 5 | 1 | 19454 | 50 |
RIN3 |
1.279e-02 | -4.36 | SNHG11 (small nucleolar RNA host gene 11) | protein interactions | 128439 | 5 | 1 | 19454 | 50 |
HIF1A |
1.279e-02 | -4.36 | PSPN (persephin) | protein interactions | 5623 | 5 | 1 | 19454 | 50 |
MICAL1 |
1.279e-02 | -4.36 | CKLF (chemokine like factor) | protein interactions | 51192 | 5 | 1 | 19454 | 50 |
GLIPR1 |
1.279e-02 | -4.36 | GIMAP6 (GTPase, IMAP family member 6) | protein interactions | 474344 | 5 | 1 | 19454 | 50 |
MICAL1 |
1.279e-02 | -4.36 | NBPF6 (NBPF member 6) | protein interactions | 653149 | 5 | 1 | 19454 | 50 |
PARVG |
1.279e-02 | -4.36 | regulation of protein metabolic process | biological process | GO:0051246 | 2218 | 12 | 18204 | 49 |
SYK,PTPN6,PLCG2,MICAL1,PIK3R5,CD74,PRKCD,HIF1A,APOE,RGS14,CSF1R,IL6R |
1.281e-02 | -4.36 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 36 | 16828 | 46 |
ELMO1,PTPN6,PLCG2,MICAL1,TBXAS1,VAV3,SLC4A2,RGS14,PRKCD,DOCK1,PIK3R5,CSF1R,ADCY7,DOCK2,GIT2,MYO1F,PREX1,ARHGAP27,IPCEF1,SBNO2,DOCK8,DENND1B,ARHGAP33,DOCK10,GMIP,SKAP1,PARVG,P2RY2,SYK,P2RY6,APOE,RIN3,TBC1D8,AKAP13,RHBDF2,IRF5 |
1.281e-02 | -4.36 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 36 | 16828 | 46 |
DOCK10,ARHGAP33,SKAP1,GMIP,DENND1B,DOCK8,SBNO2,ARHGAP27,PREX1,IPCEF1,RHBDF2,AKAP13,IRF5,TBC1D8,APOE,RIN3,P2RY2,PARVG,SYK,P2RY6,TBXAS1,VAV3,MICAL1,PLCG2,PTPN6,ELMO1,ADCY7,MYO1F,GIT2,DOCK2,CSF1R,PIK3R5,DOCK1,SLC4A2,PRKCD,RGS14 |
1.287e-02 | -4.35 | regulation of B cell proliferation | biological process | GO:0030888 | 64 | 2 | 18204 | 49 |
CD74,VAV3 |
1.296e-02 | -4.35 | kinase activity | molecular function | GO:0016301 | 739 | 6 | 18094 | 48 |
NRK,CSF1R,SYK,PRKCD,PIK3CB,NEK6 |
1.302e-02 | -4.34 | B cell receptor complex | cellular component | GO:0019815 | 5 | 1 | 19108 | 50 |
SYK |
1.302e-02 | -4.34 | alpha-beta T cell receptor complex | cellular component | GO:0042105 | 5 | 1 | 19108 | 50 |
PTPN6 |
1.307e-02 | -4.34 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 12 | 19108 | 50 |
PREX1,DOCK8,CARMIL3,RIN3,PLCG2,APOE,ARHGAP33,RGS14,MYO1F,MICAL1,HIF1A,DOCK10 |
1.312e-02 | -4.33 | regulation of lipid localization | biological process | GO:1905952 | 183 | 3 | 18204 | 49 |
SYK,PRKCD,APOE |
1.313e-02 | -4.33 | Synthesis of PIPs at the plasma membrane | REACTOME pathways | R-HSA-1660499 | 50 | 2 | 10285 | 36 |
PIK3CB,PIK3R5 |
1.320e-02 | -4.33 | NADPH oxidase H202-forming activity | molecular function | GO:0106294 | 5 | 1 | 18094 | 48 |
MICAL1 |
1.320e-02 | -4.33 | UBE3C (ubiquitin protein ligase E3C) | protein interactions | 9690 | 192 | 3 | 19454 | 50 |
CD74,P2RY6,HIF1A |
1.324e-02 | -4.32 | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | COSMIC cancer mutations | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | 181 | 3 | 16828 | 46 |
ELMO1,WDFY4,VAV3 |
1.325e-02 | -4.32 | regulation of nitric oxide metabolic process | biological process | GO:0080164 | 65 | 2 | 18204 | 49 |
APOE,PIK3CB |
1.325e-02 | -4.32 | regulation of interleukin-10 production | biological process | GO:0032653 | 65 | 2 | 18204 | 49 |
SYK,PLCG2 |
1.325e-02 | -4.32 | T cell differentiation in thymus | biological process | GO:0033077 | 65 | 2 | 18204 | 49 |
DOCK2,CD74 |
1.331e-02 | -4.32 | multivesicular body | cellular component | GO:0005771 | 67 | 2 | 19108 | 50 |
CD74,APOE |
1.333e-02 | -4.32 | Integrin-mediated Cell Adhesion | WikiPathways | WP185 | 103 | 3 | 5310 | 26 |
GIT2,VAV3,DOCK1 |
1.333e-02 | -4.32 | Toll-like Receptor Signaling Pathway | WikiPathways | WP75 | 103 | 3 | 5310 | 26 |
PIK3CB,IRF5,PIK3R5 |
1.337e-02 | -4.31 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 9 | 16828 | 46 |
ELMO1,DOCK1,RIN3,CD74,WDFY4,DOCK2,SKAP1,VAV3,DOCK10 |
1.339e-02 | -4.31 | positive regulation of amyloid fibril formation | biological process | GO:1905908 | 5 | 1 | 18204 | 49 |
APOE |
1.339e-02 | -4.31 | hypoxia-inducible factor-1alpha signaling pathway | biological process | GO:0097411 | 5 | 1 | 18204 | 49 |
HIF1A |
1.339e-02 | -4.31 | positive regulation of dendritic spine maintenance | biological process | GO:1902952 | 5 | 1 | 18204 | 49 |
APOE |
1.339e-02 | -4.31 | glutamate receptor clustering | biological process | GO:0097688 | 5 | 1 | 18204 | 49 |
APOE |
1.339e-02 | -4.31 | connective tissue replacement involved in inflammatory response wound healing | biological process | GO:0002248 | 5 | 1 | 18204 | 49 |
HIF1A |
1.339e-02 | -4.31 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | biological process | GO:0031585 | 5 | 1 | 18204 | 49 |
P2RY6 |
1.339e-02 | -4.31 | negative regulation of filopodium assembly | biological process | GO:0051490 | 5 | 1 | 18204 | 49 |
PRKCD |
1.339e-02 | -4.31 | regulation of glucosylceramide catabolic process | biological process | GO:2000752 | 5 | 1 | 18204 | 49 |
PRKCD |
1.339e-02 | -4.31 | AMPA glutamate receptor clustering | biological process | GO:0097113 | 5 | 1 | 18204 | 49 |
APOE |
1.339e-02 | -4.31 | regulation of mast cell activation involved in immune response | biological process | GO:0033006 | 5 | 1 | 18204 | 49 |
PTPN6 |
1.339e-02 | -4.31 | positive regulation of deoxyribonuclease activity | biological process | GO:0032077 | 5 | 1 | 18204 | 49 |
PRKCD |
1.339e-02 | -4.31 | chylomicron remnant clearance | biological process | GO:0034382 | 5 | 1 | 18204 | 49 |
APOE |
1.339e-02 | -4.31 | ciliary neurotrophic factor-mediated signaling pathway | biological process | GO:0070120 | 5 | 1 | 18204 | 49 |
IL6R |
1.339e-02 | -4.31 | response to molecule of fungal origin | biological process | GO:0002238 | 5 | 1 | 18204 | 49 |
SYK |
1.339e-02 | -4.31 | epididymis development | biological process | GO:1905867 | 5 | 1 | 18204 | 49 |
PTPN6 |
1.339e-02 | -4.31 | positive regulation of enamel mineralization | biological process | GO:0070175 | 5 | 1 | 18204 | 49 |
SLC4A2 |
1.343e-02 | -4.31 | FAD-bd | interpro domains | IPR002938 | 5 | 1 | 18521 | 50 |
MICAL1 |
1.343e-02 | -4.31 | Gasdermin_PUB | interpro domains | IPR041263 | 5 | 1 | 18521 | 50 |
GSDME |
1.343e-02 | -4.31 | Hematopoietin_rcpt_L_F3_CS | interpro domains | IPR003530 | 5 | 1 | 18521 | 50 |
IL6R |
1.344e-02 | -4.31 | WNT_subtype | COSMIC cancer mutations | WNT_subtype | 182 | 3 | 16828 | 46 |
WDFY4,VAV3,ELMO1 |
1.351e-02 | -4.30 | regulation of T cell differentiation | biological process | GO:0045580 | 185 | 3 | 18204 | 49 |
SLC4A2,CD74,SYK |
1.355e-02 | -4.30 | SH3_9 | pfam domains | PF14604 | 63 | 2 | 17795 | 50 |
SKAP1,ARHGAP33 |
1.355e-02 | -4.30 | phosphatase binding | molecular function | GO:0019902 | 188 | 3 | 18094 | 48 |
SYK,CSF1R,SKAP1 |
1.361e-02 | -4.30 | EVL (Enah/Vasp-like) | protein interactions | 51466 | 69 | 2 | 19454 | 50 |
WAS,FYB1 |
1.364e-02 | -4.29 | G-protein beta:gamma signalling | REACTOME pathways | R-HSA-397795 | 51 | 2 | 10285 | 36 |
PIK3R5,PIK3CB |
1.364e-02 | -4.29 | homotypic cell-cell adhesion | biological process | GO:0034109 | 66 | 2 | 18204 | 49 |
PIK3CB,PTPN6 |
1.364e-02 | -4.29 | response to ischemia | biological process | GO:0002931 | 66 | 2 | 18204 | 49 |
PIK3CB,CSF1R |
1.364e-02 | -4.29 | positive regulation of tyrosine phosphorylation of STAT protein | biological process | GO:0042531 | 66 | 2 | 18204 | 49 |
IL6R,CSF1R |
1.369e-02 | -4.29 | C-type lectin receptors (CLRs) | REACTOME pathways | R-HSA-5621481 | 144 | 3 | 10285 | 36 |
PRKCD,PLCG2,SYK |
1.390e-02 | -4.28 | regulation of lymphocyte mediated immunity | biological process | GO:0002706 | 187 | 3 | 18204 | 49 |
WAS,DENND1B,PTPN6 |
1.397e-02 | -4.27 | FAD_binding_3 | pfam domains | PF01494 | 5 | 1 | 17795 | 50 |
MICAL1 |
1.397e-02 | -4.27 | Gasdermin_C | pfam domains | PF17708 | 5 | 1 | 17795 | 50 |
GSDME |
1.399e-02 | -4.27 | ITGB3 (integrin subunit beta 3) | protein interactions | 3690 | 70 | 2 | 19454 | 50 |
P2RY2,SYK |
1.404e-02 | -4.27 | innate immune response activating cell surface receptor signaling pathway | biological process | GO:0002220 | 67 | 2 | 18204 | 49 |
PLCG2,SYK |
1.404e-02 | -4.27 | positive regulation of response to cytokine stimulus | biological process | GO:0060760 | 67 | 2 | 18204 | 49 |
CD74,HIF1A |
1.406e-02 | -4.26 | regulation of response to biotic stimulus | biological process | GO:0002831 | 534 | 5 | 18204 | 49 |
SYK,PTPN6,APOE,GSDME,PLCG2 |
1.413e-02 | -4.26 | phosphorus metabolic process | biological process | GO:0006793 | 1707 | 10 | 18204 | 49 |
PTPN6,NEK6,SYK,PRKCD,ADCY7,PLCG2,PIK3CB,NRK,PIK3R5,CSF1R |
1.422e-02 | -4.25 | Autophagy - animal | KEGG pathways | ko04140 | 127 | 3 | 7161 | 29 |
PIK3CB,PRKCD,HIF1A |
1.422e-02 | -4.25 | Autophagy - animal | KEGG pathways | hsa04140 | 127 | 3 | 7161 | 29 |
HIF1A,PRKCD,PIK3CB |
1.430e-02 | -4.25 | regulation of lipid biosynthetic process | biological process | GO:0046890 | 189 | 3 | 18204 | 49 |
PRKCD,CD74,APOE |
1.430e-02 | -4.25 | regulation of tumor necrosis factor production | biological process | GO:0032680 | 189 | 3 | 18204 | 49 |
SYK,PTPN6,PLCG2 |
1.433e-02 | -4.25 | JMJD6 (jumonji domain containing 6, arginine demethylase and lysine hydroxylase) | protein interactions | 23210 | 198 | 3 | 19454 | 50 |
WAS,DOCK1,ELMO1 |
1.444e-02 | -4.24 | CD4-positive, alpha-beta T cell activation | biological process | GO:0035710 | 68 | 2 | 18204 | 49 |
SEMA4A,IL6R |
1.444e-02 | -4.24 | cell-cell recognition | biological process | GO:0009988 | 68 | 2 | 18204 | 49 |
DOCK2,DOCK8 |
1.444e-02 | -4.24 | parathyroid-adenoma | COSMIC cancer mutations | parathyroid-adenoma | 187 | 3 | 16828 | 46 |
PLCG2,PRKCD,TBC1D8 |
1.463e-02 | -4.22 | regulation of developmental process | biological process | GO:0050793 | 2540 | 13 | 18204 | 49 |
SLC4A2,PTPN6,SYK,ARHGAP33,SEMA4A,CD74,PREX1,IL6R,CSF1R,PIK3CB,RGS14,HIF1A,APOE |
1.468e-02 | -4.22 | Type II diabetes mellitus | KEGG pathways | ko04930 | 46 | 2 | 7161 | 29 |
PIK3CB,PRKCD |
1.468e-02 | -4.22 | Type II diabetes mellitus | KEGG pathways | hsa04930 | 46 | 2 | 7161 | 29 |
PIK3CB,PRKCD |
1.469e-02 | -4.22 | C2_NT | prosite domains | PS51840 | 4 | 1 | 12186 | 45 |
EHBP1L1 |
1.469e-02 | -4.22 | PI3K_ABD | prosite domains | PS51544 | 4 | 1 | 12186 | 45 |
PIK3CB |
1.471e-02 | -4.22 | negative regulation of leukocyte activation | biological process | GO:0002695 | 191 | 3 | 18204 | 49 |
SLC4A2,PTPN6,CD74 |
1.472e-02 | -4.22 | FANCI (FA complementation group I) | protein interactions | 55215 | 200 | 3 | 19454 | 50 |
HIF1A,P2RY6,NEK6 |
1.476e-02 | -4.22 | FANCL (FA complementation group L) | protein interactions | 55120 | 72 | 2 | 19454 | 50 |
DOCK8,IL6R |
1.476e-02 | -4.22 | ITGB2 (integrin subunit beta 2) | protein interactions | 3689 | 72 | 2 | 19454 | 50 |
SYK,PRKCD |
1.480e-02 | -4.21 | cytoskeletal protein binding | molecular function | GO:0008092 | 989 | 7 | 18094 | 48 |
MICAL1,APOE,WAS,RGS14,MYO1F,NEK6,PARVG |
1.484e-02 | -4.21 | scaffold protein binding | molecular function | GO:0097110 | 70 | 2 | 18094 | 48 |
SYK,PLCG2 |
1.485e-02 | -4.21 | regulation of blood coagulation | biological process | GO:0030193 | 69 | 2 | 18204 | 49 |
APOE,PRKCD |
1.497e-02 | -4.20 | head_neck | COSMIC cancer mutations | head_neck | 15361 | 46 | 16828 | 46 |
SLC4A2,RGS14,ADCY7,GIT2,MYO1F,PTPN6,ELMO1,VAV3,PARVG,EHBP1L1,IRF5,DOCK8,DENND1B,WDFY4,PRKCD,HIF1A,DOCK1,PIK3R5,CSF1R,DOCK2,PIK3CB,WAS,PLCG2,MICAL1,TBXAS1,P2RY2,P2RY6,SYK,APOE,RIN3,GLIPR1,TBC1D8,NEK6,AKAP13,RHBDF2,IL6R,CD74,PREX1,ARHGAP27,IPCEF1,SBNO2,ARHGAP33,SEMA4A,DOCK10,GMIP,SKAP1 |
1.500e-02 | -4.20 | Signaling events mediated by focal adhesion kinase | Pathway Interaction DB | fak_pathway | 54 | 3 | 2226 | 22 |
ELMO1,GIT2,DOCK1 |
1.508e-02 | -4.19 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 15 | 16828 | 46 |
DOCK1,SLC4A2,AKAP13,DOCK2,GIT2,PIK3CB,CSF1R,PREX1,ARHGAP27,ELMO1,PTPN6,DOCK10,WDFY4,SKAP1,VAV3 |
1.515e-02 | -4.19 | PANK4 (pantothenate kinase 4 (inactive)) | protein interactions | 55229 | 73 | 2 | 19454 | 50 |
GMIP,PTPN6 |
1.532e-02 | -4.18 | NBPF22P (NBPF member 22, pseudogene) | protein interactions | 285622 | 6 | 1 | 19454 | 50 |
PARVG |
1.532e-02 | -4.18 | ARMS2 (age-related maculopathy susceptibility 2) | protein interactions | 387715 | 6 | 1 | 19454 | 50 |
MICAL1 |
1.532e-02 | -4.18 | FXYD7 (FXYD domain containing ion transport regulator 7) | protein interactions | 53822 | 6 | 1 | 19454 | 50 |
APOE |
1.532e-02 | -4.18 | LCAT (lecithin-cholesterol acyltransferase) | protein interactions | 3931 | 6 | 1 | 19454 | 50 |
APOE |
1.532e-02 | -4.18 | SETD9 (SET domain containing 9) | protein interactions | 133383 | 6 | 1 | 19454 | 50 |
PLCG2 |
1.532e-02 | -4.18 | echA1 (enoyl-CoA hydratase EchA1) | protein interactions | 886723 | 6 | 1 | 19454 | 50 |
PTPN6 |
1.532e-02 | -4.18 | CD300LF (CD300 molecule like family member f) | protein interactions | 146722 | 6 | 1 | 19454 | 50 |
PTPN6 |
1.533e-02 | -4.18 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | biological process | GO:0002822 | 194 | 3 | 18204 | 49 |
PTPN6,WAS,DENND1B |
1.535e-02 | -4.18 | Immunoglobulin | interpro domains | IPR013151 | 70 | 2 | 18521 | 50 |
CSF1R,IL6R |
1.535e-02 | -4.18 | protein serine kinase activity | molecular function | GO:0106310 | 362 | 4 | 18094 | 48 |
NRK,NEK6,PIK3CB,PRKCD |
1.538e-02 | -4.17 | signaling receptor binding | molecular function | GO:0005102 | 1493 | 9 | 18094 | 48 |
FYB1,IL6R,VAV3,SYK,APOE,DOCK2,SEMA4A,P2RY2,CD74 |
1.541e-02 | -4.17 | glycerolipid metabolic process | biological process | GO:0046486 | 357 | 4 | 18204 | 49 |
PLCG2,PIK3CB,APOE,PIK3R5 |
1.554e-02 | -4.16 | regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903555 | 195 | 3 | 18204 | 49 |
PLCG2,SYK,PTPN6 |
1.554e-02 | -4.16 | TEC (tec protein tyrosine kinase) | protein interactions | 7006 | 74 | 2 | 19454 | 50 |
PLCG2,WAS |
1.560e-02 | -4.16 | hippocampal mossy fiber | cellular component | GO:0097457 | 6 | 1 | 19108 | 50 |
MICAL1 |
1.560e-02 | -4.16 | multivesicular body, internal vesicle | cellular component | GO:0097487 | 6 | 1 | 19108 | 50 |
APOE |
1.567e-02 | -4.16 | regulation of hemostasis | biological process | GO:1900046 | 71 | 2 | 18204 | 49 |
PRKCD,APOE |
1.567e-02 | -4.16 | lymphocyte homeostasis | biological process | GO:0002260 | 71 | 2 | 18204 | 49 |
HIF1A,DOCK10 |
1.572e-02 | -4.15 | TNFRSF1A (TNF receptor superfamily member 1A) | protein interactions | 7132 | 205 | 3 | 19454 | 50 |
PTPN6,SYK,PRKCD |
1.572e-02 | -4.15 | POLRMT (RNA polymerase mitochondrial) | protein interactions | 5442 | 205 | 3 | 19454 | 50 |
HIF1A,SYK,SKAP1 |
1.581e-02 | -4.15 | phosphatidylcholine-sterol O-acyltransferase activator activity | molecular function | GO:0060228 | 6 | 1 | 18094 | 48 |
APOE |
1.585e-02 | -4.14 | kidney | COSMIC cancer mutations | kidney | 15380 | 46 | 16828 | 46 |
SBNO2,SKAP1,GMIP,DOCK10,SEMA4A,ARHGAP33,IPCEF1,ARHGAP27,PREX1,NEK6,TBC1D8,CD74,RHBDF2,IL6R,AKAP13,P2RY6,SYK,P2RY2,RIN3,GLIPR1,APOE,MICAL1,TBXAS1,WAS,PLCG2,CSF1R,PIK3CB,DOCK2,PRKCD,DOCK1,PIK3R5,HIF1A,DENND1B,DOCK8,WDFY4,IRF5,EHBP1L1,PARVG,VAV3,ELMO1,PTPN6,MYO1F,GIT2,ADCY7,RGS14,SLC4A2 |
1.591e-02 | -4.14 | regulation of secretion by cell | biological process | GO:1903530 | 551 | 5 | 18204 | 49 |
HIF1A,RHBDF2,APOE,SYK,MICAL1 |
1.594e-02 | -4.14 | SPTLC2 (serine palmitoyltransferase long chain base subunit 2) | protein interactions | 9517 | 75 | 2 | 19454 | 50 |
RIN3,P2RY6 |
1.597e-02 | -4.14 | negative regulation of immune response | biological process | GO:0050777 | 197 | 3 | 18204 | 49 |
SYK,PTPN6,RHBDF2 |
1.597e-02 | -4.14 | protein localization to plasma membrane | biological process | GO:0072659 | 197 | 3 | 18204 | 49 |
RHBDF2,FYB1,SKAP1 |
1.604e-02 | -4.13 | G13 Signaling Pathway | WikiPathways | WP524 | 40 | 2 | 5310 | 26 |
WAS,PIK3CB |
1.604e-02 | -4.13 | positive regulation of nuclease activity | biological process | GO:0032075 | 6 | 1 | 18204 | 49 |
PRKCD |
1.604e-02 | -4.13 | regulation of phospholipid translocation | biological process | GO:0061091 | 6 | 1 | 18204 | 49 |
PRKCD |
1.604e-02 | -4.13 | regulation of low-density lipoprotein particle receptor catabolic process | biological process | GO:0032803 | 6 | 1 | 18204 | 49 |
APOE |
1.604e-02 | -4.13 | positive regulation of prostaglandin biosynthetic process | biological process | GO:0031394 | 6 | 1 | 18204 | 49 |
CD74 |
1.604e-02 | -4.13 | regulation of establishment of T cell polarity | biological process | GO:1903903 | 6 | 1 | 18204 | 49 |
DOCK8 |
1.604e-02 | -4.13 | membrane raft distribution | biological process | GO:0031580 | 6 | 1 | 18204 | 49 |
DOCK2 |
1.604e-02 | -4.13 | hemoglobin biosynthetic process | biological process | GO:0042541 | 6 | 1 | 18204 | 49 |
HIF1A |
1.604e-02 | -4.13 | negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway | biological process | GO:1903298 | 6 | 1 | 18204 | 49 |
PIK3CB |
1.604e-02 | -4.13 | intestinal epithelial cell maturation | biological process | GO:0060574 | 6 | 1 | 18204 | 49 |
HIF1A |
1.604e-02 | -4.13 | triglyceride-rich lipoprotein particle clearance | biological process | GO:0071830 | 6 | 1 | 18204 | 49 |
APOE |
1.604e-02 | -4.13 | interleukin-11-mediated signaling pathway | biological process | GO:0038154 | 6 | 1 | 18204 | 49 |
IL6R |
1.604e-02 | -4.13 | inositol trisphosphate metabolic process | biological process | GO:0032957 | 6 | 1 | 18204 | 49 |
PLCG2 |
1.604e-02 | -4.13 | osteoclast fusion | biological process | GO:0072675 | 6 | 1 | 18204 | 49 |
SBNO2 |
1.604e-02 | -4.13 | positive regulation of cell-cell adhesion mediated by integrin | biological process | GO:0033634 | 6 | 1 | 18204 | 49 |
SKAP1 |
1.604e-02 | -4.13 | elastin metabolic process | biological process | GO:0051541 | 6 | 1 | 18204 | 49 |
HIF1A |
1.604e-02 | -4.13 | positive regulation of mucus secretion | biological process | GO:0070257 | 6 | 1 | 18204 | 49 |
P2RY2 |
1.604e-02 | -4.13 | regulation of lipid transporter activity | biological process | GO:0110112 | 6 | 1 | 18204 | 49 |
PRKCD |
1.604e-02 | -4.13 | positive regulation of I-kappaB phosphorylation | biological process | GO:1903721 | 6 | 1 | 18204 | 49 |
PLCG2 |
1.604e-02 | -4.13 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway | biological process | GO:1903297 | 6 | 1 | 18204 | 49 |
PIK3CB |
1.604e-02 | -4.13 | regulation of neutrophil apoptotic process | biological process | GO:0033029 | 6 | 1 | 18204 | 49 |
PIK3CB |
1.604e-02 | -4.13 | positive regulation of macrophage proliferation | biological process | GO:0120041 | 6 | 1 | 18204 | 49 |
CSF1R |
1.604e-02 | -4.13 | regulation of mast cell cytokine production | biological process | GO:0032763 | 6 | 1 | 18204 | 49 |
SYK |
1.607e-02 | -4.13 | kidney-Wilms_tumour | COSMIC cancer mutations | kidney-Wilms_tumour | 545 | 5 | 16828 | 46 |
SLC4A2,CSF1R,NEK6,PRKCD,SYK |
1.609e-02 | -4.13 | CAMSAP-like_CH_dom | interpro domains | IPR022613 | 6 | 1 | 18521 | 50 |
VAV3 |
1.609e-02 | -4.13 | ELMO_dom | interpro domains | IPR006816 | 6 | 1 | 18521 | 50 |
ELMO1 |
1.609e-02 | -4.13 | Adcy_conserved_dom | interpro domains | IPR009398 | 6 | 1 | 18521 | 50 |
ADCY7 |
1.609e-02 | -4.13 | Gasdermin_pore | interpro domains | IPR040460 | 6 | 1 | 18521 | 50 |
GSDME |
1.613e-02 | -4.13 | OPALIN (oligodendrocytic myelin paranodal and inner loop protein) | protein interactions | 93377 | 207 | 3 | 19454 | 50 |
SLC4A2,RHBDF2,PRKCD |
1.619e-02 | -4.12 | Wilms_tumour | COSMIC cancer mutations | Wilms_tumour | 546 | 5 | 16828 | 46 |
NEK6,SYK,PRKCD,CSF1R,SLC4A2 |
1.635e-02 | -4.11 | RUNX2 (RUNX family transcription factor 2) | protein interactions | 860 | 76 | 2 | 19454 | 50 |
PRKCD,HIF1A |
1.640e-02 | -4.11 | positive regulation of protein-containing complex assembly | biological process | GO:0031334 | 199 | 3 | 18204 | 49 |
PLCG2,SKAP1,SYK |
1.648e-02 | -4.11 | Apolipoprotein | gene3d domains | 1.20.120.20 | 5 | 1 | 14470 | 48 |
APOE |
1.649e-02 | -4.11 | clathrin-coated endocytic vesicle membrane | cellular component | GO:0030669 | 75 | 2 | 19108 | 50 |
CD74,APOE |
1.652e-02 | -4.10 | positive regulation of phagocytosis | biological process | GO:0050766 | 73 | 2 | 18204 | 49 |
PLCG2,DOCK2 |
1.652e-02 | -4.10 | negative regulation of wound healing | biological process | GO:0061045 | 73 | 2 | 18204 | 49 |
PRKCD,APOE |
1.655e-02 | -4.10 | ig | pfam domains | PF00047 | 70 | 2 | 17795 | 50 |
IL6R,CSF1R |
1.660e-02 | -4.10 | ERBB2 (erb-b2 receptor tyrosine kinase 2) | protein interactions | 2064 | 583 | 5 | 19454 | 50 |
PLCG2,SYK,PTPN6,VAV3,PIK3CB |
1.674e-02 | -4.09 | CAMSAP_CH | pfam domains | PF11971 | 6 | 1 | 17795 | 50 |
VAV3 |
1.674e-02 | -4.09 | RBD | pfam domains | PF02196 | 6 | 1 | 17795 | 50 |
RGS14 |
1.674e-02 | -4.09 | ELMO_CED12 | pfam domains | PF04727 | 6 | 1 | 17795 | 50 |
ELMO1 |
1.674e-02 | -4.09 | Adcy_cons_dom | pfam domains | PF06327 | 6 | 1 | 17795 | 50 |
ADCY7 |
1.674e-02 | -4.09 | Gasdermin | pfam domains | PF04598 | 6 | 1 | 17795 | 50 |
GSDME |
1.676e-02 | -4.09 | DYM (dymeclin) | protein interactions | 54808 | 77 | 2 | 19454 | 50 |
P2RY2,P2RY6 |
1.683e-02 | -4.08 | inflammatory response | biological process | GO:0006954 | 559 | 5 | 18204 | 49 |
HIF1A,SYK,CSF1R,IL6R,IRF5 |
1.695e-02 | -4.08 | regulation of coagulation | biological process | GO:0050818 | 74 | 2 | 18204 | 49 |
APOE,PRKCD |
1.695e-02 | -4.08 | negative regulation of T cell proliferation | biological process | GO:0042130 | 74 | 2 | 18204 | 49 |
SLC4A2,PTPN6 |
1.696e-02 | -4.08 | HEATR1 (HEAT repeat containing 1) | protein interactions | 55127 | 211 | 3 | 19454 | 50 |
P2RY2,P2RY6,HIF1A |
1.714e-02 | -4.07 | positive regulation of macromolecule biosynthetic process | biological process | GO:0010557 | 2592 | 13 | 18204 | 49 |
CD74,HIF1A,APOE,PIK3CB,CSF1R,IL6R,SYK,IRF5,PLCG2,DENND1B,SKAP1,SBNO2,WAS |
1.722e-02 | -4.06 | negative regulation of response to stimulus | biological process | GO:0048585 | 1760 | 10 | 18204 | 49 |
PTPN6,SYK,PRKCD,CD74,RHBDF2,RIN3,PIK3CB,RGS14,HIF1A,APOE |
1.734e-02 | -4.05 | positive regulation of protein metabolic process | biological process | GO:0051247 | 1247 | 8 | 18204 | 49 |
PIK3R5,APOE,IL6R,CSF1R,CD74,SYK,PRKCD,PLCG2 |
1.738e-02 | -4.05 | PTK6 Expression | REACTOME pathways | R-HSA-8849473 | 5 | 1 | 10285 | 36 |
HIF1A |
1.738e-02 | -4.05 | negative regulation of protein secretion | biological process | GO:0050709 | 75 | 2 | 18204 | 49 |
RHBDF2,APOE |
1.738e-02 | -4.05 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0043491 | 75 | 2 | 18204 | 49 |
PIK3R5,PIK3CB |
1.738e-02 | -4.05 | regulation of alpha-beta T cell differentiation | biological process | GO:0046637 | 75 | 2 | 18204 | 49 |
SYK,SLC4A2 |
1.742e-02 | -4.05 | positive regulation of response to external stimulus | biological process | GO:0032103 | 564 | 5 | 18204 | 49 |
SYK,CD74,CSF1R,IL6R,PLCG2 |
1.761e-02 | -4.04 | NCK1 (NCK adaptor protein 1) | protein interactions | 4690 | 214 | 3 | 19454 | 50 |
WAS,SYK,GIT2 |
1.762e-02 | -4.04 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 6 | 16828 | 46 |
ELMO1,DOCK10,DOCK2,WDFY4,SKAP1,PIK3CB |
1.782e-02 | -4.03 | myotube differentiation | biological process | GO:0014902 | 76 | 2 | 18204 | 49 |
DOCK1,DOCK2 |
1.782e-02 | -4.03 | regulation of tyrosine phosphorylation of STAT protein | biological process | GO:0042509 | 76 | 2 | 18204 | 49 |
IL6R,CSF1R |
1.782e-02 | -4.03 | XPO5 (exportin 5) | protein interactions | 57510 | 215 | 3 | 19454 | 50 |
NEK6,HIF1A,P2RY6 |
1.786e-02 | -4.03 | NSUN7 (NOP2/Sun RNA methyltransferase family member 7) | protein interactions | 79730 | 7 | 1 | 19454 | 50 |
PTPN6 |
1.786e-02 | -4.03 | SERHL2 (serine hydrolase like 2) | protein interactions | 253190 | 7 | 1 | 19454 | 50 |
MICAL1 |
1.786e-02 | -4.03 | HGD (homogentisate 1,2-dioxygenase) | protein interactions | 3081 | 7 | 1 | 19454 | 50 |
GIT2 |
1.786e-02 | -4.03 | Phospho1 (phosphatase, orphan 1) | protein interactions | 237928 | 7 | 1 | 19454 | 50 |
SLC4A2 |
1.786e-02 | -4.03 | GUCY2F (guanylate cyclase 2F, retinal) | protein interactions | 2986 | 7 | 1 | 19454 | 50 |
MICAL1 |
1.786e-02 | -4.03 | DNAI1 (dynein axonemal intermediate chain 1) | protein interactions | 27019 | 7 | 1 | 19454 | 50 |
HIF1A |
1.786e-02 | -4.03 | ERCC6L2 (ERCC excision repair 6 like 2) | protein interactions | 375748 | 7 | 1 | 19454 | 50 |
NEK6 |
1.786e-02 | -4.03 | CDHR3 (cadherin related family member 3) | protein interactions | 222256 | 7 | 1 | 19454 | 50 |
PARVG |
1.786e-02 | -4.03 | LAIR1 (leukocyte associated immunoglobulin like receptor 1) | protein interactions | 3903 | 7 | 1 | 19454 | 50 |
PTPN6 |
1.786e-02 | -4.03 | KCNJ1 (potassium inwardly rectifying channel subfamily J member 1) | protein interactions | 3758 | 7 | 1 | 19454 | 50 |
PRKCD |
1.786e-02 | -4.03 | SIGLEC9 (sialic acid binding Ig like lectin 9) | protein interactions | 27180 | 7 | 1 | 19454 | 50 |
PTPN6 |
1.804e-02 | -4.01 | HACD3 (3-hydroxyacyl-CoA dehydratase 3) | protein interactions | 51495 | 216 | 3 | 19454 | 50 |
P2RY6,NEK6,RIN3 |
1.825e-02 | -4.00 | ovary | COSMIC cancer mutations | ovary | 14770 | 45 | 16828 | 46 |
PARVG,EHBP1L1,IRF5,WDFY4,DOCK8,SLC4A2,RGS14,ADCY7,MYO1F,GIT2,ELMO1,PTPN6,VAV3,APOE,GLIPR1,RIN3,P2RY2,P2RY6,SYK,RHBDF2,IL6R,AKAP13,CD74,TBC1D8,NEK6,ARHGAP27,PREX1,IPCEF1,SEMA4A,DOCK10,ARHGAP33,SKAP1,GMIP,SBNO2,HIF1A,DOCK1,PIK3R5,PRKCD,PIK3CB,DOCK2,CSF1R,PLCG2,WAS,TBXAS1,MICAL1 |
1.827e-02 | -4.00 | positive regulation of small GTPase mediated signal transduction | biological process | GO:0051057 | 77 | 2 | 18204 | 49 |
AKAP13,PIK3CB |
1.833e-02 | -4.00 | HEMATOPO_REC_L_F3 | prosite domains | PS01354 | 5 | 1 | 12186 | 45 |
IL6R |
1.841e-02 | -3.99 | IL-6 signaling pathway | WikiPathways | WP364 | 43 | 2 | 5310 | 26 |
PRKCD,IL6R |
1.843e-02 | -3.99 | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | molecular function | GO:0046934 | 7 | 1 | 18094 | 48 |
PIK3CB |
1.843e-02 | -3.99 | hydroperoxy icosatetraenoate dehydratase activity | molecular function | GO:0106256 | 7 | 1 | 18094 | 48 |
TBXAS1 |
1.843e-02 | -3.99 | MHC class II protein binding | molecular function | GO:0042289 | 7 | 1 | 18094 | 48 |
CD74 |
1.843e-02 | -3.99 | interleukin-6 receptor binding | molecular function | GO:0005138 | 7 | 1 | 18094 | 48 |
IL6R |
1.843e-02 | -3.99 | 1-phosphatidylinositol-4-phosphate 3-kinase activity | molecular function | GO:0035005 | 7 | 1 | 18094 | 48 |
PIK3CB |
1.843e-02 | -3.99 | MRS2 (magnesium transporter MRS2) | protein interactions | 57380 | 81 | 2 | 19454 | 50 |
P2RY2,GSDME |
1.843e-02 | -3.99 | TENT5A (terminal nucleotidyltransferase 5A) | protein interactions | 55603 | 81 | 2 | 19454 | 50 |
RIN3,SYK |
1.843e-02 | -3.99 | KRTAP3-3 (keratin associated protein 3-3) | protein interactions | 85293 | 81 | 2 | 19454 | 50 |
DOCK2,P2RY6 |
1.849e-02 | -3.99 | TRAF3 (TNF receptor associated factor 3) | protein interactions | 7187 | 218 | 3 | 19454 | 50 |
PTPN6,SYK,VAV3 |
1.853e-02 | -3.99 | positive regulation of programmed cell death | biological process | GO:0043068 | 573 | 5 | 18204 | 49 |
GSDME,PIK3CB,PRKCD,SYK,IRF5 |
1.866e-02 | -3.98 | MAPK3 (mitogen-activated protein kinase 3) | protein interactions | 5595 | 396 | 4 | 19454 | 50 |
HIF1A,SYK,PRKCD,RIN3 |
1.866e-02 | -3.98 | IPO5 (importin 5) | protein interactions | 3843 | 396 | 4 | 19454 | 50 |
RIN3,P2RY6,HIF1A,DOCK8 |
1.866e-02 | -3.98 | positive regulation of canonical NF-kappaB signal transduction | biological process | GO:0043123 | 209 | 3 | 18204 | 49 |
NEK6,CD74,AKAP13 |
1.866e-02 | -3.98 | cell projection | cellular component | GO:0042995 | 2398 | 12 | 19108 | 50 |
CARMIL3,RIN3,PREX1,DOCK8,MICAL1,MYO1F,DOCK10,HIF1A,PLCG2,RGS14,APOE,ARHGAP33 |
1.869e-02 | -3.98 | positive regulation of gamma-delta T cell differentiation | biological process | GO:0045588 | 7 | 1 | 18204 | 49 |
SYK |
1.869e-02 | -3.98 | regulation of arachidonic acid secretion | biological process | GO:0090237 | 7 | 1 | 18204 | 49 |
SYK |
1.869e-02 | -3.98 | regulation of phospholipid catabolic process | biological process | GO:0060696 | 7 | 1 | 18204 | 49 |
PRKCD |
1.869e-02 | -3.98 | regulation of macrophage proliferation | biological process | GO:0120040 | 7 | 1 | 18204 | 49 |
CSF1R |
1.869e-02 | -3.98 | positive regulation of ceramide biosynthetic process | biological process | GO:2000304 | 7 | 1 | 18204 | 49 |
PRKCD |
1.869e-02 | -3.98 | very-low-density lipoprotein particle remodeling | biological process | GO:0034372 | 7 | 1 | 18204 | 49 |
APOE |
1.869e-02 | -3.98 | neural fold formation | biological process | GO:0001842 | 7 | 1 | 18204 | 49 |
HIF1A |
1.869e-02 | -3.98 | positive regulation of glomerular mesangial cell proliferation | biological process | GO:0072126 | 7 | 1 | 18204 | 49 |
IL6R |
1.869e-02 | -3.98 | macropinocytosis | biological process | GO:0044351 | 7 | 1 | 18204 | 49 |
DOCK2 |
1.869e-02 | -3.98 | wound healing involved in inflammatory response | biological process | GO:0002246 | 7 | 1 | 18204 | 49 |
HIF1A |
1.869e-02 | -3.98 | positive regulation of activation of Janus kinase activity | biological process | GO:0010536 | 7 | 1 | 18204 | 49 |
IL6R |
1.869e-02 | -3.98 | connective tissue replacement | biological process | GO:0097709 | 7 | 1 | 18204 | 49 |
HIF1A |
1.869e-02 | -3.98 | positive regulation of receptor catabolic process | biological process | GO:2000646 | 7 | 1 | 18204 | 49 |
APOE |
1.869e-02 | -3.98 | positive regulation of interleukin-23 production | biological process | GO:0032747 | 7 | 1 | 18204 | 49 |
PLCG2 |
1.869e-02 | -3.98 | membrane raft localization | biological process | GO:0051665 | 7 | 1 | 18204 | 49 |
DOCK2 |
1.869e-02 | -3.98 | positive regulation of dendritic cell antigen processing and presentation | biological process | GO:0002606 | 7 | 1 | 18204 | 49 |
CD74 |
1.869e-02 | -3.98 | high-density lipoprotein particle clearance | biological process | GO:0034384 | 7 | 1 | 18204 | 49 |
APOE |
1.869e-02 | -3.98 | interleukin-3-mediated signaling pathway | biological process | GO:0038156 | 7 | 1 | 18204 | 49 |
SYK |
1.869e-02 | -3.98 | positive regulation of sphingolipid biosynthetic process | biological process | GO:0090154 | 7 | 1 | 18204 | 49 |
PRKCD |
1.869e-02 | -3.98 | response to yeast | biological process | GO:0001878 | 7 | 1 | 18204 | 49 |
PLCG2 |
1.869e-02 | -3.98 | platelet degranulation | biological process | GO:0002576 | 7 | 1 | 18204 | 49 |
SYK |
1.872e-02 | -3.98 | neural crest cell development | biological process | GO:0014032 | 78 | 2 | 18204 | 49 |
HIF1A,SEMA4A |
1.875e-02 | -3.98 | Vps9-like | interpro domains | IPR045046 | 7 | 1 | 18521 | 50 |
RIN3 |
1.875e-02 | -3.98 | PH_16 | interpro domains | IPR041020 | 7 | 1 | 18521 | 50 |
AKAP13 |
1.875e-02 | -3.98 | RBD_dom | interpro domains | IPR003116 | 7 | 1 | 18521 | 50 |
RGS14 |
1.875e-02 | -3.98 | GoLoco_motif | interpro domains | IPR003109 | 7 | 1 | 18521 | 50 |
RGS14 |
1.875e-02 | -3.98 | Interferon_reg_factor-3 | interpro domains | IPR019471 | 7 | 1 | 18521 | 50 |
IRF5 |
1.875e-02 | -3.98 | PI3K_Ras-bd_dom | interpro domains | IPR000341 | 7 | 1 | 18521 | 50 |
PIK3CB |
1.875e-02 | -3.98 | MYSc_Myo1 | interpro domains | IPR036072 | 7 | 1 | 18521 | 50 |
MYO1F |
1.912e-02 | -3.96 | KRTAP10-8 (keratin associated protein 10-8) | protein interactions | 386681 | 399 | 4 | 19454 | 50 |
ARHGAP33,NEK6,DOCK2,P2RY6 |
1.916e-02 | -3.95 | GTF3C1 (general transcription factor IIIC subunit 1) | protein interactions | 2975 | 221 | 3 | 19454 | 50 |
SYK,SKAP1,CD74 |
1.942e-02 | -3.94 | response to virus | biological process | GO:0009615 | 383 | 4 | 18204 | 49 |
HIF1A,GSDME,WDFY4,IRF5 |
1.951e-02 | -3.94 | GoLoco | pfam domains | PF02188 | 7 | 1 | 17795 | 50 |
RGS14 |
1.951e-02 | -3.94 | PI3K_rbd | pfam domains | PF00794 | 7 | 1 | 17795 | 50 |
PIK3CB |
1.951e-02 | -3.94 | PH_16 | pfam domains | PF17838 | 7 | 1 | 17795 | 50 |
AKAP13 |
1.951e-02 | -3.94 | IRF-3 | pfam domains | PF10401 | 7 | 1 | 17795 | 50 |
IRF5 |
1.961e-02 | -3.93 | negative regulation of transferase activity | biological process | GO:0051348 | 213 | 3 | 18204 | 49 |
APOE,RGS14,PRKCD |
1.963e-02 | -3.93 | regulation of cytokine production involved in inflammatory response | biological process | GO:1900015 | 80 | 2 | 18204 | 49 |
HIF1A,ADCY7 |
1.974e-02 | -3.93 | PER1 (period circadian regulator 1) | protein interactions | 5187 | 84 | 2 | 19454 | 50 |
SKAP1,HIF1A |
1.974e-02 | -3.93 | PPARA (peroxisome proliferator activated receptor alpha) | protein interactions | 5465 | 84 | 2 | 19454 | 50 |
PRKCD,AKAP13 |
1.974e-02 | -3.93 | PHLDB3 (pleckstrin homology like domain family B member 3) | protein interactions | 653583 | 84 | 2 | 19454 | 50 |
SKAP1,GIT2 |
1.974e-02 | -3.93 | Tyr_kinase_cat_dom | interpro domains | IPR020635 | 80 | 2 | 18521 | 50 |
SYK,CSF1R |
1.975e-02 | -3.92 | Pathways in cancer | KEGG pathways | hsa05200 | 395 | 5 | 7161 | 29 |
CSF1R,HIF1A,PLCG2,PIK3CB,ADCY7 |
1.983e-02 | -3.92 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 18 | 16828 | 46 |
AKAP13,ADCY7,EHBP1L1,DOCK2,CD74,PIK3CB,IRF5,HIF1A,PIK3R5,P2RY2,SLC4A2,DOCK10,GMIP,VAV3,DOCK8,MICAL1,PREX1,ELMO1 |
1.984e-02 | -3.92 | clathrin-coated vesicle | cellular component | GO:0030136 | 220 | 3 | 19108 | 50 |
DENND1B,CD74,APOE |
1.989e-02 | -3.92 | plasma membrane protein complex | cellular component | GO:0098797 | 600 | 5 | 19108 | 50 |
IL6R,PTPN6,CD74,SYK,SKAP1 |
1.990e-02 | -3.92 | Regulation of lipolysis in adipocytes | KEGG pathways | hsa04923 | 54 | 2 | 7161 | 29 |
PIK3CB,ADCY7 |
1.991e-02 | -3.92 | TCR signaling in naive CD4+ T cells | Pathway Interaction DB | tcr_pathway | 60 | 3 | 2226 | 22 |
FYB1,PTPN6,WAS |
1.998e-02 | -3.91 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 16 | 16828 | 46 |
ADCY7,AKAP13,MYO1F,GIT2,DOCK2,CSF1R,HIF1A,RIN3,SLC4A2,P2RY6,PRKCD,DOCK10,ARHGAP33,WDFY4,MICAL1,PLCG2 |
2.008e-02 | -3.91 | RINT1 (RAD50 interactor 1) | protein interactions | 60561 | 225 | 3 | 19454 | 50 |
VAV3,P2RY2,P2RY6 |
2.009e-02 | -3.91 | regulation of amide metabolic process | biological process | GO:0034248 | 81 | 2 | 18204 | 49 |
APOE,PRKCD |
2.018e-02 | -3.90 | MYD88 (MYD88 innate immune signal transduction adaptor) | protein interactions | 4615 | 85 | 2 | 19454 | 50 |
SYK,IRF5 |
2.032e-02 | -3.90 | endosome | cellular component | GO:0005768 | 1067 | 7 | 19108 | 50 |
CD74,APOE,WDFY4,PRKCD,MICAL1,EHBP1L1,RIN3 |
2.038e-02 | -3.89 | Adaptive Immune System | REACTOME pathways | R-HSA-1280218 | 810 | 7 | 10285 | 36 |
CD74,PTPN6,PLCG2,FYB1,PIK3CB,WAS,SYK |
2.038e-02 | -3.89 | SRARP (steroid receptor associated and regulated protein) | protein interactions | 149563 | 8 | 1 | 19454 | 50 |
SLC4A2 |
2.038e-02 | -3.89 | Marcks (myristoylated alanine rich protein kinase C substrate) | protein interactions | 17118 | 8 | 1 | 19454 | 50 |
PRKCD |
2.038e-02 | -3.89 | HIF3A (hypoxia inducible factor 3 subunit alpha) | protein interactions | 64344 | 8 | 1 | 19454 | 50 |
HIF1A |
2.038e-02 | -3.89 | SSX4 (SSX family member 4) | protein interactions | 6759 | 8 | 1 | 19454 | 50 |
HIF1A |
2.038e-02 | -3.89 | vIRF-3 (vIRF-3) | protein interactions | 4961493 | 8 | 1 | 19454 | 50 |
HIF1A |
2.038e-02 | -3.89 | LILRB1 (leukocyte immunoglobulin like receptor B1) | protein interactions | 10859 | 8 | 1 | 19454 | 50 |
PTPN6 |
2.038e-02 | -3.89 | RNPEPL1 (arginyl aminopeptidase like 1) | protein interactions | 57140 | 8 | 1 | 19454 | 50 |
RIN3 |
2.038e-02 | -3.89 | DZANK1 (double zinc ribbon and ankyrin repeat domains 1) | protein interactions | 55184 | 8 | 1 | 19454 | 50 |
GLIPR1 |
2.038e-02 | -3.89 | Prkca (protein kinase C, alpha) | protein interactions | 24680 | 8 | 1 | 19454 | 50 |
AKAP13 |
2.038e-02 | -3.89 | CD1D (CD1d molecule) | protein interactions | 912 | 8 | 1 | 19454 | 50 |
CD74 |
2.038e-02 | -3.89 | OR5H1 (olfactory receptor family 5 subfamily H member 1) | protein interactions | 26341 | 8 | 1 | 19454 | 50 |
SLC4A2 |
2.038e-02 | -3.89 | TREML1 (triggering receptor expressed on myeloid cells like 1) | protein interactions | 340205 | 8 | 1 | 19454 | 50 |
PTPN6 |
2.082e-02 | -3.87 | PTK6 promotes HIF1A stabilization | REACTOME pathways | R-HSA-8857538 | 6 | 1 | 10285 | 36 |
HIF1A |
2.082e-02 | -3.87 | CD22 mediated BCR regulation | REACTOME pathways | R-HSA-5690714 | 6 | 1 | 10285 | 36 |
PTPN6 |
2.092e-02 | -3.87 | cellular localization | biological process | GO:0051641 | 2660 | 13 | 18204 | 49 |
HIF1A,APOE,RGS14,RHBDF2,CD74,DOCK2,ARHGAP33,SKAP1,WAS,FYB1,GIT2,SYK,DENND1B |
2.103e-02 | -3.86 | CD4 receptor binding | molecular function | GO:0042609 | 8 | 1 | 18094 | 48 |
CD74 |
2.103e-02 | -3.86 | transcription regulator activator activity | molecular function | GO:0140537 | 8 | 1 | 18094 | 48 |
HIF1A |
2.103e-02 | -3.86 | adenosine receptor binding | molecular function | GO:0031685 | 8 | 1 | 18094 | 48 |
P2RY2 |
2.108e-02 | -3.86 | CMTM6 (CKLF like MARVEL transmembrane domain containing 6) | protein interactions | 54918 | 87 | 2 | 19454 | 50 |
GLIPR1,P2RY2 |
2.108e-02 | -3.86 | FGR (FGR proto-oncogene, Src family tyrosine kinase) | protein interactions | 2268 | 87 | 2 | 19454 | 50 |
WAS,SYK |
2.115e-02 | -3.86 | supramolecular fiber organization | biological process | GO:0097435 | 593 | 5 | 18204 | 49 |
PREX1,MICAL1,ELMO1,WAS,MYO1F |
2.119e-02 | -3.85 | cellular response to oxygen-containing compound | biological process | GO:1901701 | 1047 | 7 | 18204 | 49 |
SBNO2,HIF1A,P2RY6,PLCG2,P2RY2,ADCY7,PRKCD |
2.128e-02 | -3.85 | neuron projection | cellular component | GO:0043005 | 1331 | 8 | 19108 | 50 |
RGS14,APOE,ARHGAP33,PREX1,HIF1A,DOCK10,RIN3,MICAL1 |
2.134e-02 | -3.85 | positive regulation of tooth mineralization | biological process | GO:0070172 | 8 | 1 | 18204 | 49 |
SLC4A2 |
2.134e-02 | -3.85 | regulation of CD8-positive, alpha-beta T cell proliferation | biological process | GO:2000564 | 8 | 1 | 18204 | 49 |
SLC4A2 |
2.134e-02 | -3.85 | regulation of Cdc42 protein signal transduction | biological process | GO:0032489 | 8 | 1 | 18204 | 49 |
APOE |
2.134e-02 | -3.85 | cellular response to macrophage colony-stimulating factor stimulus | biological process | GO:0036006 | 8 | 1 | 18204 | 49 |
CSF1R |
2.134e-02 | -3.85 | regulation of mast cell chemotaxis | biological process | GO:0060753 | 8 | 1 | 18204 | 49 |
RIN3 |
2.134e-02 | -3.85 | regulation of I-kappaB phosphorylation | biological process | GO:1903719 | 8 | 1 | 18204 | 49 |
PLCG2 |
2.134e-02 | -3.85 | regulation of CD8-positive, alpha-beta T cell differentiation | biological process | GO:0043376 | 8 | 1 | 18204 | 49 |
SLC4A2 |
2.134e-02 | -3.85 | regulation of transforming growth factor beta2 production | biological process | GO:0032909 | 8 | 1 | 18204 | 49 |
HIF1A |
2.134e-02 | -3.85 | regulation of neutrophil degranulation | biological process | GO:0043313 | 8 | 1 | 18204 | 49 |
SYK |
2.134e-02 | -3.85 | positive regulation of killing of cells of another organism | biological process | GO:0051712 | 8 | 1 | 18204 | 49 |
SYK |
2.134e-02 | -3.85 | positive regulation of amyloid-beta clearance | biological process | GO:1900223 | 8 | 1 | 18204 | 49 |
APOE |
2.134e-02 | -3.85 | positive regulation of unsaturated fatty acid biosynthetic process | biological process | GO:2001280 | 8 | 1 | 18204 | 49 |
CD74 |
2.134e-02 | -3.85 | multinuclear osteoclast differentiation | biological process | GO:0072674 | 8 | 1 | 18204 | 49 |
SBNO2 |
2.134e-02 | -3.85 | embryonic cleavage | biological process | GO:0040016 | 8 | 1 | 18204 | 49 |
PIK3CB |
2.134e-02 | -3.85 | protein import | biological process | GO:0017038 | 8 | 1 | 18204 | 49 |
APOE |
2.134e-02 | -3.85 | triglyceride-rich lipoprotein particle remodeling | biological process | GO:0034370 | 8 | 1 | 18204 | 49 |
APOE |
2.134e-02 | -3.85 | negative regulation of CD8-positive, alpha-beta T cell activation | biological process | GO:2001186 | 8 | 1 | 18204 | 49 |
SLC4A2 |
2.134e-02 | -3.85 | positive regulation of CoA-transferase activity | biological process | GO:1905920 | 8 | 1 | 18204 | 49 |
APOE |
2.134e-02 | -3.85 | intracellular oxygen homeostasis | biological process | GO:0032364 | 8 | 1 | 18204 | 49 |
HIF1A |
2.134e-02 | -3.85 | mitotic nuclear membrane disassembly | biological process | GO:0007077 | 8 | 1 | 18204 | 49 |
NEK6 |
2.134e-02 | -3.85 | G protein-coupled receptor signaling pathway involved in heart process | biological process | GO:0086103 | 8 | 1 | 18204 | 49 |
AKAP13 |
2.134e-02 | -3.85 | regulation of enamel mineralization | biological process | GO:0070173 | 8 | 1 | 18204 | 49 |
SLC4A2 |
2.134e-02 | -3.85 | regulation of activation of Janus kinase activity | biological process | GO:0010533 | 8 | 1 | 18204 | 49 |
IL6R |
2.134e-02 | -3.85 | regulation of endodeoxyribonuclease activity | biological process | GO:0032071 | 8 | 1 | 18204 | 49 |
PRKCD |
2.139e-02 | -3.84 | antioxidant activity | molecular function | GO:0016209 | 85 | 2 | 18094 | 48 |
IPCEF1,APOE |
2.140e-02 | -3.84 | TypeI_recpt_CBD | interpro domains | IPR015321 | 8 | 1 | 18521 | 50 |
IL6R |
2.140e-02 | -3.84 | Adcy | interpro domains | IPR030672 | 8 | 1 | 18521 | 50 |
ADCY7 |
2.140e-02 | -3.84 | PH-BEACH_dom | interpro domains | IPR023362 | 8 | 1 | 18521 | 50 |
WDFY4 |
2.140e-02 | -3.84 | Tyr_kinase_rcpt_3_CS | interpro domains | IPR001824 | 8 | 1 | 18521 | 50 |
CSF1R |
2.140e-02 | -3.84 | PI3K-type_C2_dom | interpro domains | IPR002420 | 8 | 1 | 18521 | 50 |
PIK3CB |
2.140e-02 | -3.84 | Myosin_TH1 | interpro domains | IPR010926 | 8 | 1 | 18521 | 50 |
MYO1F |
2.140e-02 | -3.84 | AC_N | interpro domains | IPR032628 | 8 | 1 | 18521 | 50 |
ADCY7 |
2.151e-02 | -3.84 | stem cell development | biological process | GO:0048864 | 84 | 2 | 18204 | 49 |
HIF1A,SEMA4A |
2.151e-02 | -3.84 | regulation of release of sequestered calcium ion into cytosol | biological process | GO:0051279 | 84 | 2 | 18204 | 49 |
P2RY6,PTPN6 |
2.165e-02 | -3.83 | negative regulation of cell motility | biological process | GO:2000146 | 396 | 4 | 18204 | 49 |
WAS,RIN3,CD74,APOE |
2.166e-02 | -3.83 | haematopoietic_and_lymphoid_tissue-other-normal | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-other-normal | 8 | 1 | 16828 | 46 |
CSF1R |
2.170e-02 | -3.83 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 27 | 16828 | 46 |
DOCK8,SBNO2,SKAP1,WDFY4,DOCK10,IPCEF1,ARHGAP27,PREX1,EHBP1L1,AKAP13,PARVG,RIN3,GLIPR1,MICAL1,VAV3,TBXAS1,ELMO1,WAS,PIK3CB,MYO1F,DOCK2,GIT2,RGS14,SLC4A2,PIK3R5,DOCK1,HIF1A |
2.175e-02 | -3.83 | Ion Channel and Phorbal Esters Signaling Pathway | SMPDB pathways | SMP0090032 | 5 | 1 | 1369 | 6 |
P2RY2 |
2.195e-02 | -3.82 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 6 | 19108 | 50 |
PREX1,RGS14,ARHGAP33,APOE,DOCK10,RIN3 |
2.196e-02 | -3.82 | ELMO | prosite domains | PS51335 | 6 | 1 | 12186 | 45 |
ELMO1 |
2.199e-02 | -3.82 | INSRR (insulin receptor related receptor) | protein interactions | 3645 | 89 | 2 | 19454 | 50 |
RHBDF2,PRKCD |
2.199e-02 | -3.82 | FCER1G (Fc epsilon receptor Ig) | protein interactions | 2207 | 89 | 2 | 19454 | 50 |
SYK,PLCG2 |
2.215e-02 | -3.81 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 9 | 16828 | 46 |
RIN3,DOCK1,ELMO1,VAV3,SKAP1,WDFY4,CD74,DOCK2,DOCK10 |
2.224e-02 | -3.81 | JAK1 (Janus kinase 1) | protein interactions | 3716 | 234 | 3 | 19454 | 50 |
SYK,PTPN6,PLCG2 |
2.226e-02 | -3.80 | PI3K_C2 | pfam domains | PF00792 | 8 | 1 | 17795 | 50 |
PIK3CB |
2.226e-02 | -3.80 | AC_N | pfam domains | PF16214 | 8 | 1 | 17795 | 50 |
ADCY7 |
2.226e-02 | -3.80 | Myosin_TH1 | pfam domains | PF06017 | 8 | 1 | 17795 | 50 |
MYO1F |
2.226e-02 | -3.80 | IL6Ra-bind | pfam domains | PF09240 | 8 | 1 | 17795 | 50 |
IL6R |
2.241e-02 | -3.80 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 8 | 16828 | 46 |
PTPN6,GLIPR1,DOCK1,ARHGAP27,PLCG2,PREX1,DOCK2,ADCY7 |
2.246e-02 | -3.80 | IPO13 (importin 13) | protein interactions | 9670 | 90 | 2 | 19454 | 50 |
CD74,P2RY6 |
2.247e-02 | -3.80 | positive regulation of lipid transport | biological process | GO:0032370 | 86 | 2 | 18204 | 49 |
APOE,PRKCD |
2.258e-02 | -3.79 | Transferase(Phosphotransferase) domain 1 | gene3d domains | 1.10.510.10 | 490 | 5 | 14470 | 48 |
CSF1R,NRK,NEK6,PRKCD,SYK |
2.262e-02 | -3.79 | striated muscle cell differentiation | biological process | GO:0051146 | 225 | 3 | 18204 | 49 |
AKAP13,DOCK1,DOCK2 |
2.265e-02 | -3.79 | Differentiation Pathway | WikiPathways | WP2848 | 48 | 2 | 5310 | 26 |
CSF1R,IL6R |
2.272e-02 | -3.78 | human chr6q25.2 | chromosome location | human chr6q25.2 | 12 | 1 | 26134 | 50 |
IPCEF1 |
2.276e-02 | -3.78 | Non-small cell lung cancer | KEGG pathways | ko05223 | 58 | 2 | 7161 | 29 |
PLCG2,PIK3CB |
2.276e-02 | -3.78 | Non-small cell lung cancer | KEGG pathways | hsa05223 | 58 | 2 | 7161 | 29 |
PLCG2,PIK3CB |
2.286e-02 | -3.78 | nuclear speck | cellular component | GO:0016607 | 414 | 4 | 19108 | 50 |
NEK6,DENND1B,HIF1A,DOCK1 |
2.288e-02 | -3.78 | anatomical structure development | biological process | GO:0048856 | 5207 | 21 | 18204 | 49 |
SYK,PTPN6,DOCK1,DOCK10,GIT2,GSDME,PLCG2,SLC4A2,WAS,VAV3,SBNO2,SEMA4A,DOCK2,PREX1,CD74,AKAP13,PIK3CB,APOE,HIF1A,IL6R,CSF1R |
2.290e-02 | -3.78 | CASS4 (Cas scaffold protein family member 4) | protein interactions | 57091 | 9 | 1 | 19454 | 50 |
MICAL1 |
2.290e-02 | -3.78 | ADCY7 (adenylate cyclase 7) | protein interactions | 113 | 9 | 1 | 19454 | 50 |
PRKCD |
2.290e-02 | -3.78 | LINC02582 (long intergenic non-protein coding RNA 2582) | protein interactions | 100505817 | 9 | 1 | 19454 | 50 |
APOE |
2.290e-02 | -3.78 | RWDD3 (RWD domain containing 3) | protein interactions | 25950 | 9 | 1 | 19454 | 50 |
HIF1A |
2.290e-02 | -3.78 | DUX3 (double homeobox 3) | protein interactions | 26582 | 9 | 1 | 19454 | 50 |
PRKCD |
2.290e-02 | -3.78 | ARHGAP33 (Rho GTPase activating protein 33) | protein interactions | 115703 | 9 | 1 | 19454 | 50 |
NEK6 |
2.290e-02 | -3.78 | HLA-DMA (major histocompatibility complex, class II, DM alpha) | protein interactions | 3108 | 9 | 1 | 19454 | 50 |
CD74 |
2.290e-02 | -3.78 | LILRB2 (leukocyte immunoglobulin like receptor B2) | protein interactions | 10288 | 9 | 1 | 19454 | 50 |
PTPN6 |
2.290e-02 | -3.78 | PEAR1 (platelet endothelial aggregation receptor 1) | protein interactions | 375033 | 9 | 1 | 19454 | 50 |
SYK |
2.290e-02 | -3.78 | CACNA2D3 (calcium voltage-gated channel auxiliary subunit alpha2delta 3) | protein interactions | 55799 | 9 | 1 | 19454 | 50 |
APOE |
2.292e-02 | -3.78 | KDELR1 (KDEL endoplasmic reticulum protein retention receptor 1) | protein interactions | 10945 | 91 | 2 | 19454 | 50 |
P2RY2,NEK6 |
2.296e-02 | -3.77 | modulation by host of symbiont process | biological process | GO:0051851 | 87 | 2 | 18204 | 49 |
APOE,CSF1R |
2.296e-02 | -3.77 | associative learning | biological process | GO:0008306 | 87 | 2 | 18204 | 49 |
HIF1A,RGS14 |
2.299e-02 | -3.77 | PPP6R3 (protein phosphatase 6 regulatory subunit 3) | protein interactions | 55291 | 237 | 3 | 19454 | 50 |
CD74,P2RY6,IRF5 |
2.305e-02 | -3.77 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 37 | 16828 | 46 |
P2RY2,PARVG,P2RY6,SYK,RIN3,TBC1D8,NEK6,RHBDF2,EHBP1L1,AKAP13,IRF5,CD74,PREX1,IPCEF1,DOCK8,DOCK10,ARHGAP33,SKAP1,GMIP,WDFY4,SLC4A2,PRKCD,HIF1A,DOCK1,PIK3R5,CSF1R,ADCY7,PIK3CB,MYO1F,DOCK2,GIT2,ELMO1,PTPN6,PLCG2,MICAL1,TBXAS1,VAV3 |
2.331e-02 | -3.76 | amyloid-beta binding | molecular function | GO:0001540 | 89 | 2 | 18094 | 48 |
APOE,CD74 |
2.331e-02 | -3.76 | unconventional myosin complex | cellular component | GO:0016461 | 9 | 1 | 19108 | 50 |
MYO1F |
2.339e-02 | -3.76 | MLEC (malectin) | protein interactions | 9761 | 92 | 2 | 19454 | 50 |
RIN3,P2RY6 |
2.339e-02 | -3.76 | ARHGEF16 (Rho guanine nucleotide exchange factor 16) | protein interactions | 27237 | 92 | 2 | 19454 | 50 |
ELMO1,PRKCD |
2.346e-02 | -3.75 | astrocytoma_Grade_II | COSMIC cancer mutations | astrocytoma_Grade_II | 601 | 5 | 16828 | 46 |
PREX1,PIK3CB,WDFY4,RGS14,SBNO2 |
2.350e-02 | -3.75 | VEGF signaling pathway | KEGG pathways | hsa04370 | 59 | 2 | 7161 | 29 |
PIK3CB,PLCG2 |
2.350e-02 | -3.75 | VEGF signaling pathway | KEGG pathways | ko04370 | 59 | 2 | 7161 | 29 |
PLCG2,PIK3CB |
2.355e-02 | -3.75 | IL-3 Signaling Pathway | WikiPathways | WP286 | 49 | 2 | 5310 | 26 |
PTPN6,SYK |
2.363e-02 | -3.75 | NAD(P)H oxidase H2O2-forming activity | molecular function | GO:0016174 | 9 | 1 | 18094 | 48 |
MICAL1 |
2.368e-02 | -3.74 | regulation of plasma membrane bounded cell projection assembly | biological process | GO:0120032 | 229 | 3 | 18204 | 49 |
WAS,TBC1D8,PRKCD |
2.384e-02 | -3.74 | STAT3 (signal transducer and activator of transcription 3) | protein interactions | 6774 | 427 | 4 | 19454 | 50 |
PRKCD,HIF1A,SYK,IL6R |
2.385e-02 | -3.74 | PI3K_rbd | smart domains | SM00144 | 6 | 1 | 9717 | 39 |
PIK3CB |
2.387e-02 | -3.74 | USP25 (ubiquitin specific peptidase 25) | protein interactions | 29761 | 93 | 2 | 19454 | 50 |
HIF1A,SYK |
2.395e-02 | -3.73 | negative regulation of lymphocyte proliferation | biological process | GO:0050672 | 89 | 2 | 18204 | 49 |
SLC4A2,PTPN6 |
2.397e-02 | -3.73 | microglial cell proliferation | biological process | GO:0061518 | 9 | 1 | 18204 | 49 |
CSF1R |
2.397e-02 | -3.73 | positive regulation of myeloid cell apoptotic process | biological process | GO:0033034 | 9 | 1 | 18204 | 49 |
PIK3CB |
2.397e-02 | -3.73 | iris morphogenesis | biological process | GO:0061072 | 9 | 1 | 18204 | 49 |
HIF1A |
2.397e-02 | -3.73 | positive regulation of T-helper 2 cell cytokine production | biological process | GO:2000553 | 9 | 1 | 18204 | 49 |
DENND1B |
2.397e-02 | -3.73 | regulation of gamma-delta T cell differentiation | biological process | GO:0045586 | 9 | 1 | 18204 | 49 |
SYK |
2.397e-02 | -3.73 | negative regulation of inflammatory response to wounding | biological process | GO:0106015 | 9 | 1 | 18204 | 49 |
PTPN6 |
2.397e-02 | -3.73 | sterol catabolic process | biological process | GO:0016127 | 9 | 1 | 18204 | 49 |
APOE |
2.397e-02 | -3.73 | negative regulation of thymocyte apoptotic process | biological process | GO:0070244 | 9 | 1 | 18204 | 49 |
HIF1A |
2.397e-02 | -3.73 | regulation of killing of cells of another organism | biological process | GO:0051709 | 9 | 1 | 18204 | 49 |
SYK |
2.397e-02 | -3.73 | positive regulation of antigen processing and presentation | biological process | GO:0002579 | 9 | 1 | 18204 | 49 |
CD74 |
2.397e-02 | -3.73 | transepithelial chloride transport | biological process | GO:0030321 | 9 | 1 | 18204 | 49 |
P2RY6 |
2.397e-02 | -3.73 | macrophage proliferation | biological process | GO:0061517 | 9 | 1 | 18204 | 49 |
CSF1R |
2.397e-02 | -3.73 | establishment of T cell polarity | biological process | GO:0001768 | 9 | 1 | 18204 | 49 |
DOCK2 |
2.397e-02 | -3.73 | positive regulation of gamma-delta T cell activation | biological process | GO:0046645 | 9 | 1 | 18204 | 49 |
SYK |
2.397e-02 | -3.73 | positive regulation of cell proliferation involved in kidney development | biological process | GO:1901724 | 9 | 1 | 18204 | 49 |
IL6R |
2.397e-02 | -3.73 | cellular response to hydroperoxide | biological process | GO:0071447 | 9 | 1 | 18204 | 49 |
PRKCD |
2.397e-02 | -3.73 | positive regulation of hormone biosynthetic process | biological process | GO:0046886 | 9 | 1 | 18204 | 49 |
HIF1A |
2.397e-02 | -3.73 | cyclooxygenase pathway | biological process | GO:0019371 | 9 | 1 | 18204 | 49 |
TBXAS1 |
2.397e-02 | -3.73 | T-helper 17 cell lineage commitment | biological process | GO:0072540 | 9 | 1 | 18204 | 49 |
IL6R |
2.397e-02 | -3.73 | regulation of mucus secretion | biological process | GO:0070255 | 9 | 1 | 18204 | 49 |
P2RY2 |
2.397e-02 | -3.73 | gamma-delta T cell differentiation | biological process | GO:0042492 | 9 | 1 | 18204 | 49 |
SYK |
2.397e-02 | -3.73 | Cdc42 protein signal transduction | biological process | GO:0032488 | 9 | 1 | 18204 | 49 |
WAS |
2.397e-02 | -3.73 | glandular epithelial cell maturation | biological process | GO:0002071 | 9 | 1 | 18204 | 49 |
HIF1A |
2.397e-02 | -3.73 | marginal zone B cell differentiation | biological process | GO:0002315 | 9 | 1 | 18204 | 49 |
DOCK10 |
2.397e-02 | -3.73 | regulation of sarcomere organization | biological process | GO:0060297 | 9 | 1 | 18204 | 49 |
AKAP13 |
2.397e-02 | -3.73 | cholesterol catabolic process | biological process | GO:0006707 | 9 | 1 | 18204 | 49 |
APOE |
2.402e-02 | -3.73 | HADHB (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta) | protein interactions | 3032 | 428 | 4 | 19454 | 50 |
SYK,P2RY6,APOE,CD74 |
2.404e-02 | -3.73 | Interferon_reg_fac_CS | interpro domains | IPR019817 | 9 | 1 | 18521 | 50 |
IRF5 |
2.404e-02 | -3.73 | BEACH_dom_sf | interpro domains | IPR036372 | 9 | 1 | 18521 | 50 |
WDFY4 |
2.404e-02 | -3.73 | Peptidase_S54_rhomboid_dom | interpro domains | IPR022764 | 9 | 1 | 18521 | 50 |
RHBDF2 |
2.404e-02 | -3.73 | Band3_cytoplasmic_dom | interpro domains | IPR013769 | 9 | 1 | 18521 | 50 |
SLC4A2 |
2.404e-02 | -3.73 | Interferon_reg_fact_DNA-bd_dom | interpro domains | IPR001346 | 9 | 1 | 18521 | 50 |
IRF5 |
2.404e-02 | -3.73 | PI3K_accessory_sf | interpro domains | IPR042236 | 9 | 1 | 18521 | 50 |
PIK3CB |
2.404e-02 | -3.73 | BEACH_dom | interpro domains | IPR000409 | 9 | 1 | 18521 | 50 |
WDFY4 |
2.413e-02 | -3.72 | Interferon alpha/beta signaling | REACTOME pathways | R-HSA-909733 | 69 | 2 | 10285 | 36 |
IRF5,PTPN6 |
2.422e-02 | -3.72 | regulation of cell projection assembly | biological process | GO:0060491 | 231 | 3 | 18204 | 49 |
TBC1D8,PRKCD,WAS |
2.425e-02 | -3.72 | Activation of NIMA Kinases NEK9, NEK6, NEK7 | REACTOME pathways | R-HSA-2980767 | 7 | 1 | 10285 | 36 |
NEK6 |
2.430e-02 | -3.72 | protein binding | molecular function | GO:0005515 | 13983 | 43 | 18094 | 48 |
APOE,DOCK2,ARHGAP27,DOCK1,TBC1D8,GSDME,DOCK8,RGS14,MYO1F,HIF1A,PRKCD,DOCK10,SEMA4A,PLCG2,P2RY6,GIT2,SLC4A2,GMIP,CD74,WAS,IRF5,PIK3CB,FYB1,CSF1R,RHBDF2,GLIPR1,PARVG,IL6R,SKAP1,ARHGAP33,PREX1,PTPN6,NEK6,ELMO1,SYK,VAV3,DENND1B,RIN3,SBNO2,P2RY2,AKAP13,MICAL1,IPCEF1 |
2.435e-02 | -3.72 | NUAK1 (NUAK family kinase 1) | protein interactions | 9891 | 94 | 2 | 19454 | 50 |
ELMO1,DOCK1 |
2.435e-02 | -3.72 | GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) | protein interactions | 2902 | 94 | 2 | 19454 | 50 |
ELMO1,DOCK1 |
2.435e-02 | -3.72 | ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) | protein interactions | 6098 | 94 | 2 | 19454 | 50 |
VAV3,PTPN6 |
2.436e-02 | -3.71 | regulation of cell development | biological process | GO:0060284 | 839 | 6 | 18204 | 49 |
HIF1A,RGS14,SYK,PTPN6,CD74,SLC4A2 |
2.439e-02 | -3.71 | EGF receptor (ErbB1) signaling pathway | Pathway Interaction DB | erbb1_receptor_proximal_pathway | 25 | 2 | 2226 | 22 |
PTPN6,PIK3CB |
2.446e-02 | -3.71 | regulation of Rho protein signal transduction | biological process | GO:0035023 | 90 | 2 | 18204 | 49 |
AKAP13,APOE |
2.448e-02 | -3.71 | Jak-STAT signaling pathway | KEGG pathways | hsa04630 | 156 | 3 | 7161 | 29 |
PTPN6,IL6R,PIK3CB |
2.448e-02 | -3.71 | Jak-STAT signaling pathway | KEGG pathways | ko04630 | 156 | 3 | 7161 | 29 |
PTPN6,IL6R,PIK3CB |
2.462e-02 | -3.70 | LPA receptor mediated events | Pathway Interaction DB | lysophospholipid_pathway | 65 | 3 | 2226 | 22 |
PIK3CB,ADCY7,PRKCD |
2.468e-02 | -3.70 | clathrin-coated endocytic vesicle | cellular component | GO:0045334 | 93 | 2 | 19108 | 50 |
CD74,APOE |
2.480e-02 | -3.70 | negative regulation of locomotion | biological process | GO:0040013 | 413 | 4 | 18204 | 49 |
CD74,APOE,RIN3,WAS |
2.496e-02 | -3.69 | negative regulation of mononuclear cell proliferation | biological process | GO:0032945 | 91 | 2 | 18204 | 49 |
SLC4A2,PTPN6 |
2.496e-02 | -3.69 | neural crest cell differentiation | biological process | GO:0014033 | 91 | 2 | 18204 | 49 |
HIF1A,SEMA4A |
2.496e-02 | -3.69 | cellular oxidant detoxification | biological process | GO:0098869 | 91 | 2 | 18204 | 49 |
IPCEF1,APOE |
2.501e-02 | -3.69 | Beach | pfam domains | PF02138 | 9 | 1 | 17795 | 50 |
WDFY4 |
2.501e-02 | -3.69 | PI3Ka | pfam domains | PF00613 | 9 | 1 | 17795 | 50 |
PIK3CB |
2.501e-02 | -3.69 | Rhomboid | pfam domains | PF01694 | 9 | 1 | 17795 | 50 |
RHBDF2 |
2.501e-02 | -3.69 | Band_3_cyto | pfam domains | PF07565 | 9 | 1 | 17795 | 50 |
SLC4A2 |
2.501e-02 | -3.69 | IRF | pfam domains | PF00605 | 9 | 1 | 17795 | 50 |
IRF5 |
2.530e-02 | -3.68 | protein transport | biological process | GO:0015031 | 1086 | 7 | 18204 | 49 |
HIF1A,APOE,RHBDF2,CD74,SYK,ARHGAP33,DENND1B |
2.532e-02 | -3.68 | KCTD5 (potassium channel tetramerization domain containing 5) | protein interactions | 54442 | 96 | 2 | 19454 | 50 |
NEK6,GIT2 |
2.532e-02 | -3.68 | LMAN2 (lectin, mannose binding 2) | protein interactions | 10960 | 96 | 2 | 19454 | 50 |
P2RY6,SLC4A2 |
2.538e-02 | -3.67 | Hepatitis C and Hepatocellular Carcinoma | WikiPathways | WP3646 | 51 | 2 | 5310 | 26 |
IL6R,HIF1A |
2.541e-02 | -3.67 | SIGLEC10 (sialic acid binding Ig like lectin 10) | protein interactions | 89790 | 10 | 1 | 19454 | 50 |
PTPN6 |
2.541e-02 | -3.67 | IPCEF1 (interaction protein for cytohesin exchange factors 1) | protein interactions | 26034 | 10 | 1 | 19454 | 50 |
DOCK1 |
2.541e-02 | -3.67 | IL11 (interleukin 11) | protein interactions | 3589 | 10 | 1 | 19454 | 50 |
HIF1A |
2.541e-02 | -3.67 | RAB37 (RAB37, member RAS oncogene family) | protein interactions | 326624 | 10 | 1 | 19454 | 50 |
MICAL1 |
2.541e-02 | -3.67 | PGA4 (pepsinogen A4) | protein interactions | 643847 | 10 | 1 | 19454 | 50 |
CD74 |
2.541e-02 | -3.67 | GPLD1 (glycosylphosphatidylinositol specific phospholipase D1) | protein interactions | 2822 | 10 | 1 | 19454 | 50 |
HIF1A |
2.541e-02 | -3.67 | SIGLEC7 (sialic acid binding Ig like lectin 7) | protein interactions | 27036 | 10 | 1 | 19454 | 50 |
PTPN6 |
2.548e-02 | -3.67 | positive regulation of transporter activity | biological process | GO:0032411 | 92 | 2 | 18204 | 49 |
P2RY6,PRKCD |
2.548e-02 | -3.67 | positive regulation of mononuclear cell migration | biological process | GO:0071677 | 92 | 2 | 18204 | 49 |
CSF1R,DOCK8 |
2.551e-02 | -3.67 | lipid binding | molecular function | GO:0008289 | 861 | 6 | 18094 | 48 |
FYB1,DENND1B,APOE,PREX1,ARHGAP33,GSDME |
2.557e-02 | -3.67 | CRISP_1 | prosite domains | PS01009 | 7 | 1 | 12186 | 45 |
GLIPR1 |
2.557e-02 | -3.67 | PI3K_RBD | prosite domains | PS51546 | 7 | 1 | 12186 | 45 |
PIK3CB |
2.557e-02 | -3.67 | GOLOCO | prosite domains | PS50877 | 7 | 1 | 12186 | 45 |
RGS14 |
2.557e-02 | -3.67 | RBD | prosite domains | PS50898 | 7 | 1 | 12186 | 45 |
RGS14 |
2.563e-02 | -3.66 | BCR signaling pathway | Pathway Interaction DB | bcr_5pathway | 66 | 3 | 2226 | 22 |
PLCG2,PTPN6,SYK |
2.577e-02 | -3.66 | Longevity regulating pathway - multiple species | KEGG pathways | hsa04213 | 62 | 2 | 7161 | 29 |
PIK3CB,ADCY7 |
2.577e-02 | -3.66 | Longevity regulating pathway - multiple species | KEGG pathways | ko04213 | 62 | 2 | 7161 | 29 |
PIK3CB,ADCY7 |
2.578e-02 | -3.66 | blood circulation | biological process | GO:0008015 | 418 | 4 | 18204 | 49 |
TBC1D8,APOE,TBXAS1,P2RY2 |
2.581e-02 | -3.66 | alveolar | COSMIC cancer mutations | alveolar | 2414 | 12 | 16828 | 46 |
SLC4A2,DOCK1,GLIPR1,APOE,PLCG2,MICAL1,CSF1R,SBNO2,TBC1D8,VAV3,WDFY4,AKAP13 |
2.581e-02 | -3.66 | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | 2414 | 12 | 16828 | 46 |
APOE,GLIPR1,DOCK1,SLC4A2,AKAP13,TBC1D8,CSF1R,PLCG2,WDFY4,VAV3,SBNO2,MICAL1 |
2.585e-02 | -3.66 | SYK (spleen associated tyrosine kinase) | protein interactions | 6850 | 248 | 3 | 19454 | 50 |
SYK,PTPN6,PLCG2 |
2.585e-02 | -3.66 | MET (MET proto-oncogene, receptor tyrosine kinase) | protein interactions | 4233 | 248 | 3 | 19454 | 50 |
SYK,PLCG2,VAV3 |
2.587e-02 | -3.65 | immunoglobulin complex | cellular component | GO:0019814 | 10 | 1 | 19108 | 50 |
SYK |
2.606e-02 | -3.65 | Succinate Signalling | SMPDB pathways | SMP0083294 | 6 | 1 | 1369 | 6 |
HIF1A |
2.612e-02 | -3.65 | NUP93 (nucleoporin 93) | protein interactions | 9688 | 249 | 3 | 19454 | 50 |
NEK6,HIF1A,RIN3 |
2.616e-02 | -3.64 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 3 | 18204 | 49 |
RHBDF2,FYB1,SKAP1 |
2.622e-02 | -3.64 | 1-phosphatidylinositol-3-kinase activity | molecular function | GO:0016303 | 10 | 1 | 18094 | 48 |
PIK3CB |
2.631e-02 | -3.64 | NUDT16L1 (nudix hydrolase 16 like 1) | protein interactions | 84309 | 98 | 2 | 19454 | 50 |
RIN3,NEK6 |
2.631e-02 | -3.64 | GNAO1 (G protein subunit alpha o1) | protein interactions | 2775 | 98 | 2 | 19454 | 50 |
RGS14,MICAL1 |
2.644e-02 | -3.63 | RHOQ (ras homolog family member Q) | protein interactions | 23433 | 441 | 4 | 19454 | 50 |
GIT2,DOCK8,SLC4A2,WAS |
2.646e-02 | -3.63 | human chr9q22.2 | chromosome location | human chr9q22.2 | 14 | 1 | 26134 | 50 |
SYK |
2.651e-02 | -3.63 | protein serine/threonine kinase activity | molecular function | GO:0004674 | 428 | 4 | 18094 | 48 |
NRK,PRKCD,NEK6,SYK |
2.651e-02 | -3.63 | regulation of calcium-mediated signaling | biological process | GO:0050848 | 94 | 2 | 18204 | 49 |
SYK,PLCG2 |
2.660e-02 | -3.63 | establishment of lymphocyte polarity | biological process | GO:0001767 | 10 | 1 | 18204 | 49 |
DOCK2 |
2.660e-02 | -3.63 | regulation of deoxyribonuclease activity | biological process | GO:0032070 | 10 | 1 | 18204 | 49 |
PRKCD |
2.660e-02 | -3.63 | negative regulation of mast cell activation | biological process | GO:0033004 | 10 | 1 | 18204 | 49 |
PTPN6 |
2.660e-02 | -3.63 | negative regulation of cellular response to hypoxia | biological process | GO:1900038 | 10 | 1 | 18204 | 49 |
PIK3CB |
2.660e-02 | -3.63 | cAMP biosynthetic process | biological process | GO:0006171 | 10 | 1 | 18204 | 49 |
ADCY7 |
2.660e-02 | -3.63 | hemoglobin metabolic process | biological process | GO:0020027 | 10 | 1 | 18204 | 49 |
HIF1A |
2.660e-02 | -3.63 | nitric oxide-cGMP-mediated signaling | biological process | GO:0038060 | 10 | 1 | 18204 | 49 |
APOE |
2.660e-02 | -3.63 | high-density lipoprotein particle assembly | biological process | GO:0034380 | 10 | 1 | 18204 | 49 |
APOE |
2.660e-02 | -3.63 | intracellular chloride ion homeostasis | biological process | GO:0030644 | 10 | 1 | 18204 | 49 |
TBXAS1 |
2.660e-02 | -3.63 | negative regulation of glial cell apoptotic process | biological process | GO:0034351 | 10 | 1 | 18204 | 49 |
PRKCD |
2.660e-02 | -3.63 | regulation of interleukin-23 production | biological process | GO:0032667 | 10 | 1 | 18204 | 49 |
PLCG2 |
2.660e-02 | -3.63 | negative regulation of cholesterol biosynthetic process | biological process | GO:0045541 | 10 | 1 | 18204 | 49 |
APOE |
2.660e-02 | -3.63 | positive regulation of monocyte differentiation | biological process | GO:0045657 | 10 | 1 | 18204 | 49 |
CD74 |
2.660e-02 | -3.63 | regulation of CoA-transferase activity | biological process | GO:1905918 | 10 | 1 | 18204 | 49 |
APOE |
2.660e-02 | -3.63 | negative regulation of sterol biosynthetic process | biological process | GO:0106119 | 10 | 1 | 18204 | 49 |
APOE |
2.660e-02 | -3.63 | regulation of behavioral fear response | biological process | GO:2000822 | 10 | 1 | 18204 | 49 |
APOE |
2.660e-02 | -3.63 | intracellular monoatomic anion homeostasis | biological process | GO:0030002 | 10 | 1 | 18204 | 49 |
TBXAS1 |
2.660e-02 | -3.63 | positive regulation of Rac protein signal transduction | biological process | GO:0035022 | 10 | 1 | 18204 | 49 |
PIK3CB |
2.668e-02 | -3.62 | VPS9_dom_sf | interpro domains | IPR037191 | 10 | 1 | 18521 | 50 |
RIN3 |
2.668e-02 | -3.62 | PI3K_accessory_dom | interpro domains | IPR001263 | 10 | 1 | 18521 | 50 |
PIK3CB |
2.668e-02 | -3.62 | PAS_fold_3 | interpro domains | IPR013655 | 10 | 1 | 18521 | 50 |
HIF1A |
2.668e-02 | -3.62 | PI_Kinase | interpro domains | IPR015433 | 10 | 1 | 18521 | 50 |
PIK3CB |
2.668e-02 | -3.62 | PTrfase/Anion_transptr | interpro domains | IPR016152 | 10 | 1 | 18521 | 50 |
SLC4A2 |
2.668e-02 | -3.62 | VPS9 | interpro domains | IPR003123 | 10 | 1 | 18521 | 50 |
RIN3 |
2.668e-02 | -3.62 | Allrgn_V5/Tpx1_CS | interpro domains | IPR018244 | 10 | 1 | 18521 | 50 |
GLIPR1 |
2.668e-02 | -3.62 | HCO3_transpt_euk | interpro domains | IPR003020 | 10 | 1 | 18521 | 50 |
SLC4A2 |
2.668e-02 | -3.62 | CRIB_dom_sf | interpro domains | IPR036936 | 10 | 1 | 18521 | 50 |
WAS |
2.668e-02 | -3.62 | HCO3_transpt-like_TM_dom | interpro domains | IPR011531 | 10 | 1 | 18521 | 50 |
SLC4A2 |
2.680e-02 | -3.62 | XPO4 (exportin 4) | protein interactions | 64328 | 99 | 2 | 19454 | 50 |
P2RY6,P2RY2 |
2.693e-02 | -3.61 | CXCR4 (C-X-C motif chemokine receptor 4) | protein interactions | 7852 | 252 | 3 | 19454 | 50 |
PTPN6,HIF1A,PIK3CB |
2.693e-02 | -3.61 | PSMD7 (proteasome 26S subunit, non-ATPase 7) | protein interactions | 5713 | 252 | 3 | 19454 | 50 |
PREX1,P2RY6,PTPN6 |
2.693e-02 | -3.61 | CSDE1 (cold shock domain containing E1) | protein interactions | 7812 | 252 | 3 | 19454 | 50 |
RIN3,RHBDF2,P2RY6 |
2.719e-02 | -3.60 | Tyr_kinase_AS | interpro domains | IPR008266 | 95 | 2 | 18521 | 50 |
CSF1R,SYK |
2.730e-02 | -3.60 | skin-upper_leg-malignant_melanoma | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma | 850 | 6 | 16828 | 46 |
DOCK2,VAV3,SEMA4A,ELMO1,NEK6,DOCK8 |
2.731e-02 | -3.60 | MUL1 (mitochondrial E3 ubiquitin protein ligase 1) | protein interactions | 79594 | 100 | 2 | 19454 | 50 |
GSDME,TBC1D8 |
2.731e-02 | -3.60 | SKAP1 (src kinase associated phosphoprotein 1) | protein interactions | 8631 | 100 | 2 | 19454 | 50 |
FYB1,SKAP1 |
2.734e-02 | -3.60 | Glioma | KEGG pathways | hsa05214 | 64 | 2 | 7161 | 29 |
PIK3CB,PLCG2 |
2.734e-02 | -3.60 | Renal cell carcinoma | KEGG pathways | hsa05211 | 64 | 2 | 7161 | 29 |
HIF1A,PIK3CB |
2.734e-02 | -3.60 | Renal cell carcinoma | KEGG pathways | ko05211 | 64 | 2 | 7161 | 29 |
PIK3CB,HIF1A |
2.734e-02 | -3.60 | Glioma | KEGG pathways | ko05214 | 64 | 2 | 7161 | 29 |
PLCG2,PIK3CB |
2.735e-02 | -3.60 | cytokine receptor activity | molecular function | GO:0004896 | 97 | 2 | 18094 | 48 |
CD74,IL6R |
2.736e-02 | -3.60 | pleura | COSMIC cancer mutations | pleura | 4914 | 20 | 16828 | 46 |
IRF5,PIK3CB,GIT2,IL6R,AKAP13,NEK6,CSF1R,PIK3R5,DOCK1,HIF1A,SYK,PRKCD,RGS14,VAV3,SEMA4A,ARHGAP33,PREX1,PLCG2,PTPN6,WAS |
2.738e-02 | -3.60 | central_nervous_system-brain-glioma-astrocytoma_Grade_II | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_II | 420 | 4 | 16828 | 46 |
WDFY4,PREX1,RGS14,SBNO2 |
2.756e-02 | -3.59 | immunoglobulin mediated immune response | biological process | GO:0016064 | 96 | 2 | 18204 | 49 |
CD74,PRKCD |
2.765e-02 | -3.59 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 18 | 16828 | 46 |
PREX1,ELMO1,ARHGAP33,DOCK10,WDFY4,GMIP,VAV3,DOCK8,PIK3R5,DOCK1,RIN3,P2RY2,AKAP13,RHBDF2,DOCK2,MYO1F,TBC1D8,CSF1R |
2.767e-02 | -3.59 | HuR (ELAVL1) binds and stabilizes mRNA | REACTOME pathways | R-HSA-450520 | 8 | 1 | 10285 | 36 |
PRKCD |
2.771e-02 | -3.59 | actin binding | molecular function | GO:0003779 | 434 | 4 | 18094 | 48 |
MICAL1,WAS,PARVG,MYO1F |
2.775e-02 | -3.58 | VPS9 | pfam domains | PF02204 | 10 | 1 | 17795 | 50 |
RIN3 |
2.775e-02 | -3.58 | HCO3_cotransp | pfam domains | PF00955 | 10 | 1 | 17795 | 50 |
SLC4A2 |
2.775e-02 | -3.58 | PAS_3 | pfam domains | PF08447 | 10 | 1 | 17795 | 50 |
HIF1A |
2.776e-02 | -3.58 | MSH6 (mutS homolog 6) | protein interactions | 2956 | 255 | 3 | 19454 | 50 |
P2RY6,HIF1A,RIN3 |
2.777e-02 | -3.58 | GoLoco | smart domains | SM00390 | 7 | 1 | 9717 | 39 |
RGS14 |
2.777e-02 | -3.58 | IRF-3 | smart domains | SM01243 | 7 | 1 | 9717 | 39 |
IRF5 |
2.777e-02 | -3.58 | RBD | smart domains | SM00455 | 7 | 1 | 9717 | 39 |
RGS14 |
2.780e-02 | -3.58 | intracellular monoatomic cation homeostasis | biological process | GO:0030003 | 428 | 4 | 18204 | 49 |
PIK3CB,HIF1A,APOE,SLC4A2 |
2.780e-02 | -3.58 | cell surface receptor protein tyrosine kinase signaling pathway | biological process | GO:0007169 | 428 | 4 | 18204 | 49 |
RGS14,PIK3CB,SYK,CSF1R |
2.781e-02 | -3.58 | MYO9B (myosin IXB) | protein interactions | 4650 | 101 | 2 | 19454 | 50 |
SKAP1,HIF1A |
2.781e-02 | -3.58 | FBXO28 (F-box protein 28) | protein interactions | 23219 | 101 | 2 | 19454 | 50 |
HIF1A,GIT2 |
2.781e-02 | -3.58 | BMAL1 (basic helix-loop-helix ARNT like 1) | protein interactions | 406 | 101 | 2 | 19454 | 50 |
GIT2,HIF1A |
2.781e-02 | -3.58 | CLEC4A (C-type lectin domain family 4 member A) | protein interactions | 50856 | 101 | 2 | 19454 | 50 |
RHBDF2,PTPN6 |
2.788e-02 | -3.58 | negative regulation of apoptotic signaling pathway | biological process | GO:2001234 | 244 | 3 | 18204 | 49 |
HIF1A,CD74,PIK3CB |
2.792e-02 | -3.58 | ADGRG2 (adhesion G protein-coupled receptor G2) | protein interactions | 10149 | 11 | 1 | 19454 | 50 |
GMIP |
2.792e-02 | -3.58 | LAT2 (linker for activation of T cells family member 2) | protein interactions | 7462 | 11 | 1 | 19454 | 50 |
PLCG2 |
2.792e-02 | -3.58 | RPS10-NUDT3 (RPS10-NUDT3 readthrough) | protein interactions | 100529239 | 11 | 1 | 19454 | 50 |
RIN3 |
2.792e-02 | -3.58 | KLHL32 (kelch like family member 32) | protein interactions | 114792 | 11 | 1 | 19454 | 50 |
PARVG |
2.792e-02 | -3.58 | CYP1A2 (cytochrome P450 family 1 subfamily A member 2) | protein interactions | 1544 | 11 | 1 | 19454 | 50 |
HIF1A |
2.792e-02 | -3.58 | SPATA12 (spermatogenesis associated 12) | protein interactions | 353324 | 11 | 1 | 19454 | 50 |
RIN3 |
2.792e-02 | -3.58 | LAX1 (lymphocyte transmembrane adaptor 1) | protein interactions | 54900 | 11 | 1 | 19454 | 50 |
SYK |
2.792e-02 | -3.58 | FERRY3 (FERRY endosomal RAB5 effector complex subunit 3) | protein interactions | 57102 | 11 | 1 | 19454 | 50 |
IL6R |
2.792e-02 | -3.58 | GHSR (growth hormone secretagogue receptor) | protein interactions | 2693 | 11 | 1 | 19454 | 50 |
P2RY6 |
2.810e-02 | -3.57 | leukocyte homeostasis | biological process | GO:0001776 | 97 | 2 | 18204 | 49 |
DOCK10,HIF1A |
2.813e-02 | -3.57 | thyroid-carcinoma-anaplastic_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-anaplastic_carcinoma | 856 | 6 | 16828 | 46 |
DOCK8,PIK3CB,SKAP1,DOCK2,HIF1A,DOCK1 |
2.813e-02 | -3.57 | anaplastic_carcinoma | COSMIC cancer mutations | anaplastic_carcinoma | 856 | 6 | 16828 | 46 |
PIK3CB,SKAP1,DOCK2,DOCK8,HIF1A,DOCK1 |
2.814e-02 | -3.57 | Central carbon metabolism in cancer | KEGG pathways | hsa05230 | 65 | 2 | 7161 | 29 |
PIK3CB,HIF1A |
2.814e-02 | -3.57 | Central carbon metabolism in cancer | KEGG pathways | ko05230 | 65 | 2 | 7161 | 29 |
HIF1A,PIK3CB |
2.823e-02 | -3.57 | Apoptosis-related network due to altered Notch3 in ovarian cancer | WikiPathways | WP2864 | 54 | 2 | 5310 | 26 |
VAV3,APOE |
2.832e-02 | -3.56 | human chr14q23.2 | chromosome location | human chr14q23.2 | 15 | 1 | 26134 | 50 |
HIF1A |
2.832e-02 | -3.56 | human chr12q21.2 | chromosome location | human chr12q21.2 | 15 | 1 | 26134 | 50 |
GLIPR1 |
2.832e-02 | -3.56 | human chr9p24.3 | chromosome location | human chr9p24.3 | 15 | 1 | 26134 | 50 |
DOCK8 |
2.847e-02 | -3.56 | regulation of synapse organization | biological process | GO:0050807 | 246 | 3 | 18204 | 49 |
APOE,SEMA4A,ARHGAP33 |
2.847e-02 | -3.56 | response to toxic substance | biological process | GO:0009636 | 246 | 3 | 18204 | 49 |
ARHGAP33,IPCEF1,APOE |
2.853e-02 | -3.56 | bone-femur-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-femur-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 633 | 5 | 16828 | 46 |
P2RY2,AKAP13,PREX1,RHBDF2,DOCK10 |
2.877e-02 | -3.55 | cellular response to biotic stimulus | biological process | GO:0071216 | 247 | 3 | 18204 | 49 |
SYK,PLCG2,SBNO2 |
2.880e-02 | -3.55 | nitric-oxide synthase binding | molecular function | GO:0050998 | 11 | 1 | 18094 | 48 |
CD74 |
2.880e-02 | -3.55 | cardiolipin binding | molecular function | GO:1901612 | 11 | 1 | 18094 | 48 |
GSDME |
2.880e-02 | -3.55 | GTPase activating protein binding | molecular function | GO:0032794 | 11 | 1 | 18094 | 48 |
RGS14 |
2.880e-02 | -3.55 | T cell receptor binding | molecular function | GO:0042608 | 11 | 1 | 18094 | 48 |
DOCK2 |
2.884e-02 | -3.55 | PDP1 (pyruvate dehydrogenase phosphatase catalytic subunit 1) | protein interactions | 54704 | 103 | 2 | 19454 | 50 |
HIF1A,PRKCD |
2.884e-02 | -3.55 | MANSC1 (MANSC domain containing 1) | protein interactions | 54682 | 103 | 2 | 19454 | 50 |
APOE,PIK3CB |
2.884e-02 | -3.55 | GADD45A (growth arrest and DNA damage inducible alpha) | protein interactions | 1647 | 103 | 2 | 19454 | 50 |
PARVG,MICAL1 |
2.885e-02 | -3.55 | regulation of protein transport | biological process | GO:0051223 | 433 | 4 | 18204 | 49 |
PRKCD,RHBDF2,APOE,HIF1A |
2.885e-02 | -3.55 | inorganic ion homeostasis | biological process | GO:0098771 | 433 | 4 | 18204 | 49 |
APOE,HIF1A,PIK3CB,TBXAS1 |
2.912e-02 | -3.54 | G alpha (q) signalling events | REACTOME pathways | R-HSA-416476 | 192 | 3 | 10285 | 36 |
P2RY6,P2RY2,PRKCD |
2.917e-02 | -3.53 | RECEPTOR_TYR_KIN_III | prosite domains | PS00240 | 8 | 1 | 12186 | 45 |
CSF1R |
2.917e-02 | -3.53 | TH1 | prosite domains | PS51757 | 8 | 1 | 12186 | 45 |
MYO1F |
2.917e-02 | -3.53 | C2_PI3K | prosite domains | PS51547 | 8 | 1 | 12186 | 45 |
PIK3CB |
2.917e-02 | -3.53 | PH_BEACH | prosite domains | PS51783 | 8 | 1 | 12186 | 45 |
WDFY4 |
2.917e-02 | -3.53 | negative regulation of leukocyte proliferation | biological process | GO:0070664 | 99 | 2 | 18204 | 49 |
SLC4A2,PTPN6 |
2.917e-02 | -3.53 | regulation of signaling receptor activity | biological process | GO:0010469 | 99 | 2 | 18204 | 49 |
HIF1A,PRKCD |
2.917e-02 | -3.53 | activation of GTPase activity | biological process | GO:0090630 | 99 | 2 | 18204 | 49 |
TBC1D8,GMIP |
2.917e-02 | -3.53 | response to stress | biological process | GO:0006950 | 3388 | 15 | 18204 | 49 |
VAV3,WAS,SYK,PTPN6,IRF5,IPCEF1,PLCG2,HIF1A,APOE,RGS14,PIK3CB,CSF1R,IL6R,CD74,PRKCD |
2.922e-02 | -3.53 | regulation of receptor catabolic process | biological process | GO:2000644 | 11 | 1 | 18204 | 49 |
APOE |
2.922e-02 | -3.53 | regulation of dendritic cell antigen processing and presentation | biological process | GO:0002604 | 11 | 1 | 18204 | 49 |
CD74 |
2.922e-02 | -3.53 | positive regulation of chemokine (C-X-C motif) ligand 2 production | biological process | GO:2000343 | 11 | 1 | 18204 | 49 |
CD74 |
2.922e-02 | -3.53 | collagen-activated tyrosine kinase receptor signaling pathway | biological process | GO:0038063 | 11 | 1 | 18204 | 49 |
SYK |
2.922e-02 | -3.53 | pinocytosis | biological process | GO:0006907 | 11 | 1 | 18204 | 49 |
DOCK2 |
2.922e-02 | -3.53 | positive regulation of integrin activation | biological process | GO:0033625 | 11 | 1 | 18204 | 49 |
SKAP1 |
2.922e-02 | -3.53 | regulation of fear response | biological process | GO:1903365 | 11 | 1 | 18204 | 49 |
APOE |
2.922e-02 | -3.53 | regulation of cell-cell adhesion mediated by integrin | biological process | GO:0033632 | 11 | 1 | 18204 | 49 |
SKAP1 |
2.922e-02 | -3.53 | negative regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002924 | 11 | 1 | 18204 | 49 |
PTPN6 |
2.922e-02 | -3.53 | negative regulation of platelet aggregation | biological process | GO:0090331 | 11 | 1 | 18204 | 49 |
PRKCD |
2.922e-02 | -3.53 | CD8-positive, alpha-beta T cell activation | biological process | GO:0036037 | 11 | 1 | 18204 | 49 |
WDFY4 |
2.922e-02 | -3.53 | regulation of gamma-delta T cell activation | biological process | GO:0046643 | 11 | 1 | 18204 | 49 |
SYK |
2.922e-02 | -3.53 | negative regulation of mesenchymal cell apoptotic process | biological process | GO:2001054 | 11 | 1 | 18204 | 49 |
HIF1A |
2.922e-02 | -3.53 | negative regulation of cholesterol metabolic process | biological process | GO:0090206 | 11 | 1 | 18204 | 49 |
APOE |
2.931e-02 | -3.53 | SM22_calponin | interpro domains | IPR003096 | 11 | 1 | 18521 | 50 |
VAV3 |
2.931e-02 | -3.53 | WH1/EVH1_dom | interpro domains | IPR000697 | 11 | 1 | 18521 | 50 |
WAS |
2.936e-02 | -3.53 | CDH5 (cadherin 5) | protein interactions | 1003 | 104 | 2 | 19454 | 50 |
PIK3CB,P2RY2 |
2.937e-02 | -3.53 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 24 | 16828 | 46 |
AKAP13,RIN3,PARVG,SYK,P2RY6,DOCK10,ARHGAP33,SKAP1,WDFY4,ARHGAP27,PREX1,ADCY7,MYO1F,PIK3CB,DOCK2,PIK3R5,DOCK1,RGS14,PRKCD,TBXAS1,VAV3,MICAL1,PLCG2,ELMO1 |
2.947e-02 | -3.52 | Phosphatidylinositol 3-kinase, accessory domain (PIK) | gene3d domains | 1.25.40.70 | 9 | 1 | 14470 | 48 |
PIK3CB |
2.947e-02 | -3.52 | BEACH domain | gene3d domains | 1.10.1540.10 | 9 | 1 | 14470 | 48 |
WDFY4 |
2.947e-02 | -3.52 | Nucleotidyltransferases domain 2 | gene3d domains | 1.20.120.330 | 9 | 1 | 14470 | 48 |
GIT2 |
2.951e-02 | -3.52 | kidney-carcinoma-chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 46 |
CSF1R,SYK,PRKCD,NEK6 |
2.951e-02 | -3.52 | chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 46 |
SYK,PRKCD,NEK6,CSF1R |
2.956e-02 | -3.52 | positive regulation of cellular component organization | biological process | GO:0051130 | 1122 | 7 | 18204 | 49 |
DOCK2,SEMA4A,SYK,PLCG2,HIF1A,APOE,SKAP1 |
2.972e-02 | -3.52 | regulation of T cell mediated immunity | biological process | GO:0002709 | 100 | 2 | 18204 | 49 |
DENND1B,WAS |
2.972e-02 | -3.52 | positive regulation of smooth muscle cell proliferation | biological process | GO:0048661 | 100 | 2 | 18204 | 49 |
P2RY6,IL6R |
2.988e-02 | -3.51 | TMEM52B (transmembrane protein 52B) | protein interactions | 120939 | 105 | 2 | 19454 | 50 |
PIK3CB,RHBDF2 |
3.027e-02 | -3.50 | B cell mediated immunity | biological process | GO:0019724 | 101 | 2 | 18204 | 49 |
PRKCD,CD74 |
3.027e-02 | -3.50 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 3 | 18204 | 49 |
APOE,SEMA4A,ARHGAP33 |
3.033e-02 | -3.50 | RCN2 (reticulocalbin 2) | protein interactions | 5955 | 264 | 3 | 19454 | 50 |
APOE,P2RY6,RIN3 |
3.033e-02 | -3.50 | PCBP2 (poly(rC) binding protein 2) | protein interactions | 5094 | 264 | 3 | 19454 | 50 |
RIN3,P2RY6,HIF1A |
3.035e-02 | -3.49 | positive regulation of developmental process | biological process | GO:0051094 | 1385 | 8 | 18204 | 49 |
IL6R,HIF1A,APOE,RGS14,SLC4A2,SYK,SEMA4A,CD74 |
3.040e-02 | -3.49 | PTN (pleiotrophin) | protein interactions | 5764 | 106 | 2 | 19454 | 50 |
NEK6,GSDME |
3.042e-02 | -3.49 | MATCAP2 (microtubule associated tyrosine carboxypeptidase 2) | protein interactions | 23366 | 12 | 1 | 19454 | 50 |
MICAL1 |
3.042e-02 | -3.49 | TENM4 (teneurin transmembrane protein 4) | protein interactions | 26011 | 12 | 1 | 19454 | 50 |
DOCK2 |
3.042e-02 | -3.49 | ROPN1L (rhophilin associated tail protein 1 like) | protein interactions | 83853 | 12 | 1 | 19454 | 50 |
CD74 |
3.042e-02 | -3.49 | RPL17-C18orf32 (RPL17-C18orf32 readthrough) | protein interactions | 100526842 | 12 | 1 | 19454 | 50 |
RIN3 |
3.042e-02 | -3.49 | SIRPB1 (signal regulatory protein beta 1) | protein interactions | 10326 | 12 | 1 | 19454 | 50 |
SYK |
3.042e-02 | -3.49 | SSTR2 (somatostatin receptor 2) | protein interactions | 6752 | 12 | 1 | 19454 | 50 |
PTPN6 |
3.042e-02 | -3.49 | RTL8B (retrotransposon Gag like 8B) | protein interactions | 441518 | 12 | 1 | 19454 | 50 |
RIN3 |
3.042e-02 | -3.49 | FBXO8 (F-box protein 8) | protein interactions | 26269 | 12 | 1 | 19454 | 50 |
HIF1A |
3.042e-02 | -3.49 | NCF4 (neutrophil cytosolic factor 4) | protein interactions | 4689 | 12 | 1 | 19454 | 50 |
PRKCD |
3.042e-02 | -3.49 | TREM2 (triggering receptor expressed on myeloid cells 2) | protein interactions | 54209 | 12 | 1 | 19454 | 50 |
APOE |
3.042e-02 | -3.49 | PTPN20 (protein tyrosine phosphatase non-receptor type 20) | protein interactions | 26095 | 12 | 1 | 19454 | 50 |
PTPN6 |
3.042e-02 | -3.49 | ADGRB3 (adhesion G protein-coupled receptor B3) | protein interactions | 577 | 12 | 1 | 19454 | 50 |
ELMO1 |
3.049e-02 | -3.49 | WH1 | pfam domains | PF00568 | 11 | 1 | 17795 | 50 |
WAS |
3.059e-02 | -3.49 | INTFRNREGFCT | prints domains | PR00267 | 9 | 1 | 5227 | 18 |
IRF5 |
3.062e-02 | -3.49 | OSBPL8 (oxysterol binding protein like 8) | protein interactions | 114882 | 265 | 3 | 19454 | 50 |
CD74,SYK,P2RY6 |
3.073e-02 | -3.48 | C20 prostanoid biosynthesis | BIOCYC pathways | HUMAN_PWY66-374 | 7 | 1 | 902 | 4 |
TBXAS1 |
3.073e-02 | -3.48 | C20 prostanoid biosynthesis | BIOCYC pathways | META_PWY66-374 | 7 | 1 | 902 | 4 |
TBXAS1 |
3.078e-02 | -3.48 | small_intestine | COSMIC cancer mutations | small_intestine | 250 | 3 | 16828 | 46 |
CSF1R,ARHGAP33,PREX1 |
3.082e-02 | -3.48 | regulation of interleukin-8 production | biological process | GO:0032677 | 102 | 2 | 18204 | 49 |
SYK,CD74 |
3.101e-02 | -3.47 | PI Metabolism | REACTOME pathways | R-HSA-1483255 | 79 | 2 | 10285 | 36 |
PIK3CB,PIK3R5 |
3.108e-02 | -3.47 | PROTEIN_KINASE_DOM | prosite domains | PS50011 | 480 | 5 | 12186 | 45 |
CSF1R,SYK,NEK6,PRKCD,NRK |
3.108e-02 | -3.47 | MAPK1 (ERK2) activation | REACTOME pathways | R-HSA-112411 | 9 | 1 | 10285 | 36 |
IL6R |
3.109e-02 | -3.47 | monooxygenase activity | molecular function | GO:0004497 | 104 | 2 | 18094 | 48 |
MICAL1,TBXAS1 |
3.126e-02 | -3.47 | transferase activity, transferring phosphorus-containing groups | molecular function | GO:0016772 | 903 | 6 | 18094 | 48 |
SYK,NRK,NEK6,PIK3CB,PRKCD,CSF1R |
3.138e-02 | -3.46 | unsaturated fatty acid metabolic process | biological process | GO:0033559 | 103 | 2 | 18204 | 49 |
TBXAS1,CD74 |
3.138e-02 | -3.46 | regulation of biomineral tissue development | biological process | GO:0070167 | 103 | 2 | 18204 | 49 |
HIF1A,SLC4A2 |
3.138e-02 | -3.46 | bicarbonate:monoatomic anion antiporter activity | molecular function | GO:0140829 | 12 | 1 | 18094 | 48 |
SLC4A2 |
3.138e-02 | -3.46 | chloride:bicarbonate antiporter activity | molecular function | GO:0140900 | 12 | 1 | 18094 | 48 |
SLC4A2 |
3.138e-02 | -3.46 | non-membrane spanning protein tyrosine phosphatase activity | molecular function | GO:0004726 | 12 | 1 | 18094 | 48 |
PTPN6 |
3.138e-02 | -3.46 | MAP-kinase scaffold activity | molecular function | GO:0005078 | 12 | 1 | 18094 | 48 |
AKAP13 |
3.143e-02 | -3.46 | RIGI (RNA sensor RIG-I) | protein interactions | 23586 | 1739 | 9 | 19454 | 50 |
PLCG2,PTPN6,SLC4A2,RIN3,SBNO2,MYO1F,RHBDF2,GMIP,GIT2 |
3.145e-02 | -3.46 | negative regulation of catalytic activity | biological process | GO:0043086 | 445 | 4 | 18204 | 49 |
RGS14,APOE,GMIP,PRKCD |
3.147e-02 | -3.46 | SLC39A14 (solute carrier family 39 member 14) | protein interactions | 23516 | 108 | 2 | 19454 | 50 |
P2RY2,P2RY6 |
3.147e-02 | -3.46 | BIN1 (bridging integrator 1) | protein interactions | 274 | 108 | 2 | 19454 | 50 |
EHBP1L1,RIN3 |
3.149e-02 | -3.46 | PFN1 (profilin 1) | protein interactions | 5216 | 466 | 4 | 19454 | 50 |
AKAP13,GIT2,DOCK8,DOCK1 |
3.167e-02 | -3.45 | VPS9 | smart domains | SM00167 | 8 | 1 | 9717 | 39 |
RIN3 |
3.167e-02 | -3.45 | PI3K_C2 | smart domains | SM00142 | 8 | 1 | 9717 | 39 |
PIK3CB |
3.181e-02 | -3.45 | PGRMC2 (progesterone receptor membrane component 2) | protein interactions | 10424 | 269 | 3 | 19454 | 50 |
CD74,RHBDF2,P2RY6 |
3.184e-02 | -3.45 | actin filament depolymerization | biological process | GO:0030042 | 12 | 1 | 18204 | 49 |
MICAL1 |
3.184e-02 | -3.45 | regulation of prostaglandin biosynthetic process | biological process | GO:0031392 | 12 | 1 | 18204 | 49 |
CD74 |
3.184e-02 | -3.45 | response to macrophage colony-stimulating factor | biological process | GO:0036005 | 12 | 1 | 18204 | 49 |
CSF1R |
3.184e-02 | -3.45 | positive regulation of dendritic cell cytokine production | biological process | GO:0002732 | 12 | 1 | 18204 | 49 |
PLCG2 |
3.184e-02 | -3.45 | mesenchymal cell apoptotic process | biological process | GO:0097152 | 12 | 1 | 18204 | 49 |
HIF1A |
3.184e-02 | -3.45 | serotonin transport | biological process | GO:0006837 | 12 | 1 | 18204 | 49 |
SYK |
3.184e-02 | -3.45 | insulin secretion involved in cellular response to glucose stimulus | biological process | GO:0035773 | 12 | 1 | 18204 | 49 |
HIF1A |
3.184e-02 | -3.45 | nuclear membrane disassembly | biological process | GO:0051081 | 12 | 1 | 18204 | 49 |
NEK6 |
3.184e-02 | -3.45 | bone trabecula morphogenesis | biological process | GO:0061430 | 12 | 1 | 18204 | 49 |
SBNO2 |
3.184e-02 | -3.45 | regulation of chemokine-mediated signaling pathway | biological process | GO:0070099 | 12 | 1 | 18204 | 49 |
HIF1A |
3.184e-02 | -3.45 | regulation of glial cell apoptotic process | biological process | GO:0034350 | 12 | 1 | 18204 | 49 |
PRKCD |
3.184e-02 | -3.45 | regulation of inflammatory response to wounding | biological process | GO:0106014 | 12 | 1 | 18204 | 49 |
PTPN6 |
3.184e-02 | -3.45 | neurotransmitter-gated ion channel clustering | biological process | GO:0072578 | 12 | 1 | 18204 | 49 |
APOE |
3.184e-02 | -3.45 | inositol phosphate biosynthetic process | biological process | GO:0032958 | 12 | 1 | 18204 | 49 |
PLCG2 |
3.184e-02 | -3.45 | regulation of glomerular mesangial cell proliferation | biological process | GO:0072124 | 12 | 1 | 18204 | 49 |
IL6R |
3.194e-02 | -3.44 | protein polymerization | biological process | GO:0051258 | 104 | 2 | 18204 | 49 |
WAS,PREX1 |
3.194e-02 | -3.44 | regulation of actomyosin structure organization | biological process | GO:0110020 | 104 | 2 | 18204 | 49 |
AKAP13,WAS |
3.204e-02 | -3.44 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 5 | 16828 | 46 |
ELMO1,WDFY4,SKAP1,PIK3CB,DOCK10 |
3.204e-02 | -3.44 | human chr1q31.3 | chromosome location | human chr1q31.3 | 17 | 1 | 26134 | 50 |
DENND1B |
3.204e-02 | -3.44 | human chr16q23.3 | chromosome location | human chr16q23.3 | 17 | 1 | 26134 | 50 |
PLCG2 |
3.222e-02 | -3.44 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 5 | 16828 | 46 |
DOCK10,WDFY4,SKAP1,PIK3CB,ELMO1 |
3.232e-02 | -3.43 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | 12 | 1 | 16828 | 46 |
CSF1R |
3.235e-02 | -3.43 | regulation of innate immune response | biological process | GO:0045088 | 449 | 4 | 18204 | 49 |
APOE,SYK,PTPN6,PLCG2 |
3.243e-02 | -3.43 | Axon guidance | KEGG pathways | ko04360 | 174 | 3 | 7161 | 29 |
PIK3CB,SEMA4A,PLCG2 |
3.243e-02 | -3.43 | Axon guidance | KEGG pathways | hsa04360 | 174 | 3 | 7161 | 29 |
PIK3CB,SEMA4A,PLCG2 |
3.251e-02 | -3.43 | response to type II interferon | biological process | GO:0034341 | 105 | 2 | 18204 | 49 |
WAS,CD74 |
3.251e-02 | -3.43 | antigen processing and presentation | biological process | GO:0019882 | 105 | 2 | 18204 | 49 |
CD74,WDFY4 |
3.251e-02 | -3.43 | positive regulation of myeloid cell differentiation | biological process | GO:0045639 | 105 | 2 | 18204 | 49 |
HIF1A,CD74 |
3.251e-02 | -3.43 | regulation of postsynapse organization | biological process | GO:0099175 | 105 | 2 | 18204 | 49 |
ARHGAP33,APOE |
3.251e-02 | -3.43 | biomineral tissue development | biological process | GO:0031214 | 105 | 2 | 18204 | 49 |
HIF1A,SBNO2 |
3.251e-02 | -3.43 | cellular response to alcohol | biological process | GO:0097306 | 105 | 2 | 18204 | 49 |
P2RY6,ADCY7 |
3.254e-02 | -3.43 | SLC27A2 (solute carrier family 27 member 2) | protein interactions | 11001 | 110 | 2 | 19454 | 50 |
GSDME,P2RY6 |
3.269e-02 | -3.42 | VPS9 domain | gene3d domains | 1.20.1050.80 | 10 | 1 | 14470 | 48 |
RIN3 |
3.269e-02 | -3.42 | Helical hairpin bin | gene3d domains | 1.10.287.570 | 10 | 1 | 14470 | 48 |
SLC4A2 |
3.269e-02 | -3.42 | Rhomboid-like | gene3d domains | 1.20.1540.10 | 10 | 1 | 14470 | 48 |
RHBDF2 |
3.269e-02 | -3.42 | CRIB domain | gene3d domains | 3.90.810.10 | 10 | 1 | 14470 | 48 |
WAS |
3.273e-02 | -3.42 | Interferon Signaling | REACTOME pathways | R-HSA-913531 | 201 | 3 | 10285 | 36 |
PTPN6,IRF5,PRKCD |
3.276e-02 | -3.42 | IRF_1 | prosite domains | PS00601 | 9 | 1 | 12186 | 45 |
IRF5 |
3.276e-02 | -3.42 | CRISP_2 | prosite domains | PS01010 | 9 | 1 | 12186 | 45 |
GLIPR1 |
3.276e-02 | -3.42 | IRF_2 | prosite domains | PS51507 | 9 | 1 | 12186 | 45 |
IRF5 |
3.276e-02 | -3.42 | BEACH | prosite domains | PS50197 | 9 | 1 | 12186 | 45 |
WDFY4 |
3.291e-02 | -3.41 | GABPB2 (GA binding protein transcription factor subunit beta 2) | protein interactions | 126626 | 13 | 1 | 19454 | 50 |
PLCG2 |
3.291e-02 | -3.41 | NFAM1 (NFAT activating protein with ITAM motif 1) | protein interactions | 150372 | 13 | 1 | 19454 | 50 |
SYK |
3.291e-02 | -3.41 | IL6 (interleukin 6) | protein interactions | 3569 | 13 | 1 | 19454 | 50 |
IL6R |
3.291e-02 | -3.41 | EEIG1 (estrogen-induced osteoclastogenesis regulator 1) | protein interactions | 399665 | 13 | 1 | 19454 | 50 |
SKAP1 |
3.291e-02 | -3.41 | RTL10 (retrotransposon Gag like 10) | protein interactions | 79680 | 13 | 1 | 19454 | 50 |
PLCG2 |
3.291e-02 | -3.41 | SEMA4A (semaphorin 4A) | protein interactions | 64218 | 13 | 1 | 19454 | 50 |
SEMA4A |
3.291e-02 | -3.41 | KCNQ4 (potassium voltage-gated channel subfamily Q member 4) | protein interactions | 9132 | 13 | 1 | 19454 | 50 |
CSF1R |
3.291e-02 | -3.41 | ANKH (ANKH inorganic pyrophosphate transport regulator) | protein interactions | 56172 | 13 | 1 | 19454 | 50 |
APOE |
3.291e-02 | -3.41 | REP15 (RAB15 effector protein) | protein interactions | 387849 | 13 | 1 | 19454 | 50 |
SLC4A2 |
3.312e-02 | -3.41 | Inositol phosphate metabolism | KEGG pathways | hsa00562 | 71 | 2 | 7161 | 29 |
PLCG2,PIK3CB |
3.312e-02 | -3.41 | Bile secretion | KEGG pathways | ko04976 | 71 | 2 | 7161 | 29 |
SLC4A2,ADCY7 |
3.312e-02 | -3.41 | Inositol phosphate metabolism | KEGG pathways | ko00562 | 71 | 2 | 7161 | 29 |
PIK3CB,PLCG2 |
3.312e-02 | -3.41 | Bile secretion | KEGG pathways | hsa04976 | 71 | 2 | 7161 | 29 |
SLC4A2,ADCY7 |
3.321e-02 | -3.40 | dDENN | pfam domains | PF03455 | 12 | 1 | 17795 | 50 |
DENND1B |
3.341e-02 | -3.40 | response to alcohol | biological process | GO:0097305 | 262 | 3 | 18204 | 49 |
TBXAS1,P2RY6,ADCY7 |
3.350e-02 | -3.40 | early phagosome | cellular component | GO:0032009 | 13 | 1 | 19108 | 50 |
SYK |
3.350e-02 | -3.40 | chylomicron | cellular component | GO:0042627 | 13 | 1 | 19108 | 50 |
APOE |
3.363e-02 | -3.39 | UBE2V1 (ubiquitin conjugating enzyme E2 V1) | protein interactions | 7335 | 112 | 2 | 19454 | 50 |
P2RY6,RHBDF2 |
3.363e-02 | -3.39 | ENAH (ENAH actin regulator) | protein interactions | 55740 | 112 | 2 | 19454 | 50 |
FYB1,WAS |
3.373e-02 | -3.39 | regulation of cellular catabolic process | biological process | GO:0031329 | 455 | 4 | 18204 | 49 |
APOE,HIF1A,PIK3CB,PRKCD |
3.394e-02 | -3.38 | HCO3TRNSPORT | prints domains | PR01231 | 10 | 1 | 5227 | 18 |
SLC4A2 |
3.394e-02 | -3.38 | HMOX2 (heme oxygenase 2) | protein interactions | 3163 | 276 | 3 | 19454 | 50 |
CD74,P2RY6,APOE |
3.398e-02 | -3.38 | Adherens junction | KEGG pathways | hsa04520 | 72 | 2 | 7161 | 29 |
WAS,PTPN6 |
3.398e-02 | -3.38 | Adherens junction | KEGG pathways | ko04520 | 72 | 2 | 7161 | 29 |
WAS,PTPN6 |
3.418e-02 | -3.38 | ARHGEF7 (Rho guanine nucleotide exchange factor 7) | protein interactions | 8874 | 113 | 2 | 19454 | 50 |
WAS,GIT2 |
3.432e-02 | -3.37 | Regulation of CDC42 activity | Pathway Interaction DB | cdc42_reg_pathway | 30 | 2 | 2226 | 22 |
VAV3,DOCK10 |
3.439e-02 | -3.37 | regulation of protein secretion | biological process | GO:0050708 | 265 | 3 | 18204 | 49 |
HIF1A,RHBDF2,APOE |
3.443e-02 | -3.37 | positive regulation of cell development | biological process | GO:0010720 | 458 | 4 | 18204 | 49 |
CD74,RGS14,HIF1A,SYK |
3.444e-02 | -3.37 | positive regulation of inositol phosphate biosynthetic process | biological process | GO:0060732 | 13 | 1 | 18204 | 49 |
P2RY6 |
3.444e-02 | -3.37 | positive regulation of membrane invagination | biological process | GO:1905155 | 13 | 1 | 18204 | 49 |
PLCG2 |
3.444e-02 | -3.37 | regulation of sphingolipid biosynthetic process | biological process | GO:0090153 | 13 | 1 | 18204 | 49 |
PRKCD |
3.444e-02 | -3.37 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | biological process | GO:1903377 | 13 | 1 | 18204 | 49 |
HIF1A |
3.444e-02 | -3.37 | modulation of process of another organism | biological process | GO:0035821 | 13 | 1 | 18204 | 49 |
SYK |
3.444e-02 | -3.37 | negative regulation of amyloid fibril formation | biological process | GO:1905907 | 13 | 1 | 18204 | 49 |
APOE |
3.444e-02 | -3.37 | regulation of T-helper 2 cell cytokine production | biological process | GO:2000551 | 13 | 1 | 18204 | 49 |
DENND1B |
3.444e-02 | -3.37 | regulation of thymocyte apoptotic process | biological process | GO:0070243 | 13 | 1 | 18204 | 49 |
HIF1A |
3.444e-02 | -3.37 | phospholipid efflux | biological process | GO:0033700 | 13 | 1 | 18204 | 49 |
APOE |
3.444e-02 | -3.37 | membrane disassembly | biological process | GO:0030397 | 13 | 1 | 18204 | 49 |
NEK6 |
3.444e-02 | -3.37 | positive regulation of phagocytosis, engulfment | biological process | GO:0060100 | 13 | 1 | 18204 | 49 |
PLCG2 |
3.444e-02 | -3.37 | regulation of ceramide biosynthetic process | biological process | GO:2000303 | 13 | 1 | 18204 | 49 |
PRKCD |
3.444e-02 | -3.37 | T-helper 17 cell differentiation | biological process | GO:0072539 | 13 | 1 | 18204 | 49 |
IL6R |
3.444e-02 | -3.37 | regulation of dendritic spine maintenance | biological process | GO:1902950 | 13 | 1 | 18204 | 49 |
APOE |
3.444e-02 | -3.37 | positive regulation of mitophagy | biological process | GO:1901526 | 13 | 1 | 18204 | 49 |
HIF1A |
3.444e-02 | -3.37 | negative regulation of homotypic cell-cell adhesion | biological process | GO:0034111 | 13 | 1 | 18204 | 49 |
PRKCD |
3.444e-02 | -3.37 | regulation of tooth mineralization | biological process | GO:0070170 | 13 | 1 | 18204 | 49 |
SLC4A2 |
3.444e-02 | -3.37 | response to peptidoglycan | biological process | GO:0032494 | 13 | 1 | 18204 | 49 |
IRF5 |
3.444e-02 | -3.37 | positive regulation of nitric-oxide synthase activity | biological process | GO:0051000 | 13 | 1 | 18204 | 49 |
HIF1A |
3.447e-02 | -3.37 | Bicarbonate transporters | REACTOME pathways | R-HSA-425381 | 10 | 1 | 10285 | 36 |
SLC4A2 |
3.447e-02 | -3.37 | Adenylate cyclase activating pathway | REACTOME pathways | R-HSA-170660 | 10 | 1 | 10285 | 36 |
ADCY7 |
3.447e-02 | -3.37 | MAPK3 (ERK1) activation | REACTOME pathways | R-HSA-110056 | 10 | 1 | 10285 | 36 |
IL6R |
3.466e-02 | -3.36 | small molecule biosynthetic process | biological process | GO:0044283 | 459 | 4 | 18204 | 49 |
CD74,SYK,PLCG2,TBXAS1 |
3.481e-02 | -3.36 | postsynapse organization | biological process | GO:0099173 | 109 | 2 | 18204 | 49 |
DOCK10,APOE |
3.481e-02 | -3.36 | positive regulation of tumor necrosis factor production | biological process | GO:0032760 | 109 | 2 | 18204 | 49 |
SYK,PLCG2 |
3.488e-02 | -3.36 | IRS4 (insulin receptor substrate 4) | protein interactions | 8471 | 279 | 3 | 19454 | 50 |
RIN3,PIK3CB,PTPN6 |
3.490e-02 | -3.36 | negative regulation of transport | biological process | GO:0051051 | 460 | 4 | 18204 | 49 |
RIN3,CD74,APOE,RHBDF2 |
3.506e-02 | -3.35 | cellular lipid metabolic process | biological process | GO:0044255 | 914 | 6 | 18204 | 49 |
TBXAS1,PLCG2,PIK3CB,CD74,PIK3R5,APOE |
3.506e-02 | -3.35 | chemical homeostasis | biological process | GO:0048878 | 914 | 6 | 18204 | 49 |
SLC4A2,P2RY2,TBXAS1,APOE,HIF1A,PIK3CB |
3.537e-02 | -3.34 | protein localization to membrane | biological process | GO:0072657 | 462 | 4 | 18204 | 49 |
FYB1,SKAP1,APOE,RHBDF2 |
3.539e-02 | -3.34 | negative regulation of leukocyte differentiation | biological process | GO:1902106 | 110 | 2 | 18204 | 49 |
SLC4A2,CD74 |
3.539e-02 | -3.34 | phospholipase C-activating G protein-coupled receptor signaling pathway | biological process | GO:0007200 | 110 | 2 | 18204 | 49 |
P2RY6,P2RY2 |
3.540e-02 | -3.34 | CSF3 (colony stimulating factor 3) | protein interactions | 1440 | 14 | 1 | 19454 | 50 |
PARVG |
3.540e-02 | -3.34 | RHBDF1 (rhomboid 5 homolog 1) | protein interactions | 64285 | 14 | 1 | 19454 | 50 |
HIF1A |
3.540e-02 | -3.34 | C9 (complement C9) | protein interactions | 735 | 14 | 1 | 19454 | 50 |
APOE |
3.540e-02 | -3.34 | IFNA8 (interferon alpha 8) | protein interactions | 3445 | 14 | 1 | 19454 | 50 |
APOE |
3.540e-02 | -3.34 | CHAT (choline O-acetyltransferase) | protein interactions | 1103 | 14 | 1 | 19454 | 50 |
PRKCD |
3.540e-02 | -3.34 | TPSAB1 (tryptase alpha/beta 1) | protein interactions | 7177 | 14 | 1 | 19454 | 50 |
P2RY6 |
3.540e-02 | -3.34 | AGTR2 (angiotensin II receptor type 2) | protein interactions | 186 | 14 | 1 | 19454 | 50 |
PIK3CB |
3.540e-02 | -3.34 | TAS2R7 (taste 2 receptor member 7) | protein interactions | 50837 | 14 | 1 | 19454 | 50 |
MICAL1 |
3.540e-02 | -3.34 | Iqgap3 (IQ motif containing GTPase activating protein 3) | protein interactions | 404710 | 14 | 1 | 19454 | 50 |
SLC4A2 |
3.540e-02 | -3.34 | Fez2 (fasciculation and elongation protein zeta 2) | protein interactions | 225020 | 14 | 1 | 19454 | 50 |
DENND1B |
3.547e-02 | -3.34 | Opioid Signalling | REACTOME pathways | R-HSA-111885 | 85 | 2 | 10285 | 36 |
ADCY7,PRKCD |
3.549e-02 | -3.34 | ovary-carcinoma-mucinous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-mucinous_carcinoma | 456 | 4 | 16828 | 46 |
PRKCD,SYK,NEK6,CSF1R |
3.556e-02 | -3.34 | Beach | smart domains | SM01026 | 9 | 1 | 9717 | 39 |
WDFY4 |
3.556e-02 | -3.34 | PI3Ka | smart domains | SM00145 | 9 | 1 | 9717 | 39 |
PIK3CB |
3.556e-02 | -3.34 | IRF | smart domains | SM00348 | 9 | 1 | 9717 | 39 |
IRF5 |
3.574e-02 | -3.33 | human chr15q25.3 | chromosome location | human chr15q25.3 | 19 | 1 | 26134 | 50 |
AKAP13 |
3.587e-02 | -3.33 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 12 | 16828 | 46 |
AKAP13,DOCK2,PIK3CB,CSF1R,DOCK1,SLC4A2,DOCK10,WDFY4,SKAP1,VAV3,PREX1,ELMO1 |
3.592e-02 | -3.33 | PRKACA (protein kinase cAMP-activated catalytic subunit alpha) | protein interactions | 5566 | 486 | 4 | 19454 | 50 |
DOCK1,AKAP13,HIF1A,RGS14 |
3.598e-02 | -3.32 | positive regulation of lipid localization | biological process | GO:1905954 | 111 | 2 | 18204 | 49 |
APOE,PRKCD |
3.598e-02 | -3.32 | mucinous_carcinoma | COSMIC cancer mutations | mucinous_carcinoma | 458 | 4 | 16828 | 46 |
NEK6,SYK,PRKCD,CSF1R |
3.615e-02 | -3.32 | PRDX3 (peroxiredoxin 3) | protein interactions | 10935 | 283 | 3 | 19454 | 50 |
DOCK8,APOE,NEK6 |
3.619e-02 | -3.32 | signaling adaptor activity | molecular function | GO:0035591 | 113 | 2 | 18094 | 48 |
AKAP13,RGS14 |
3.630e-02 | -3.32 | positive regulation of metabolic process | biological process | GO:0009893 | 3796 | 16 | 18204 | 49 |
SKAP1,SBNO2,WAS,PIK3R5,P2RY6,PLCG2,IRF5,DENND1B,SYK,IL6R,CSF1R,APOE,HIF1A,PIK3CB,CD74,PRKCD |
3.632e-02 | -3.32 | Calcium Regulation in the Cardiac Cell | WikiPathways | WP536 | 151 | 3 | 5310 | 26 |
ADCY7,RGS14,PRKCD |
3.633e-02 | -3.32 | PIK_HELICAL | prosite domains | PS51545 | 10 | 1 | 12186 | 45 |
PIK3CB |
3.633e-02 | -3.32 | VPS9 | prosite domains | PS51205 | 10 | 1 | 12186 | 45 |
RIN3 |
3.635e-02 | -3.31 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 6 | 19454 | 50 |
RIN3,DENND1B,PRKCD,CD74,AKAP13,P2RY6 |
3.638e-02 | -3.31 | carboxylic acid biosynthetic process | biological process | GO:0046394 | 271 | 3 | 18204 | 49 |
SYK,CD74,TBXAS1 |
3.642e-02 | -3.31 | PTGER3 (prostaglandin E receptor 3) | protein interactions | 5733 | 117 | 2 | 19454 | 50 |
PIK3CB,RHBDF2 |
3.642e-02 | -3.31 | PACSIN3 (protein kinase C and casein kinase substrate in neurons 3) | protein interactions | 29763 | 117 | 2 | 19454 | 50 |
RIN3,WAS |
3.652e-02 | -3.31 | oxygen carrier activity | molecular function | GO:0005344 | 14 | 1 | 18094 | 48 |
IPCEF1 |
3.652e-02 | -3.31 | Toll-like receptor binding | molecular function | GO:0035325 | 14 | 1 | 18094 | 48 |
SYK |
3.657e-02 | -3.31 | mononuclear cell migration | biological process | GO:0071674 | 112 | 2 | 18204 | 49 |
DOCK8,IL6R |
3.662e-02 | -3.31 | Gastric acid secretion | KEGG pathways | hsa04971 | 75 | 2 | 7161 | 29 |
SLC4A2,ADCY7 |
3.662e-02 | -3.31 | Gastric acid secretion | KEGG pathways | ko04971 | 75 | 2 | 7161 | 29 |
SLC4A2,ADCY7 |
3.664e-02 | -3.31 | positive regulation of macromolecule metabolic process | biological process | GO:0010604 | 3485 | 15 | 18204 | 49 |
SYK,PLCG2,IRF5,DENND1B,PIK3R5,SBNO2,SKAP1,WAS,CD74,PRKCD,HIF1A,APOE,PIK3CB,CSF1R,IL6R |
3.670e-02 | -3.31 | phosphatidylinositol binding | molecular function | GO:0035091 | 276 | 3 | 18094 | 48 |
GSDME,DENND1B,ARHGAP33 |
3.677e-02 | -3.30 | transcription coregulator binding | molecular function | GO:0001221 | 114 | 2 | 18094 | 48 |
HIF1A,NEK6 |
3.680e-02 | -3.30 | IPO7 (importin 7) | protein interactions | 10527 | 285 | 3 | 19454 | 50 |
RHBDF2,P2RY6,RIN3 |
3.699e-02 | -3.30 | NCKIPSD (NCK interacting protein with SH3 domain) | protein interactions | 51517 | 118 | 2 | 19454 | 50 |
WAS,GIT2 |
3.703e-02 | -3.30 | angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | angioimmunoblastic_T_cell_lymphoma | 269 | 3 | 16828 | 46 |
SYK,CSF1R,PLCG2 |
3.704e-02 | -3.30 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 49 |
P2RY6 |
3.704e-02 | -3.30 | inflammatory response to wounding | biological process | GO:0090594 | 14 | 1 | 18204 | 49 |
HIF1A |
3.704e-02 | -3.30 | positive regulation of viral entry into host cell | biological process | GO:0046598 | 14 | 1 | 18204 | 49 |
CD74 |
3.704e-02 | -3.30 | negative regulation of long-term synaptic potentiation | biological process | GO:1900272 | 14 | 1 | 18204 | 49 |
APOE |
3.704e-02 | -3.30 | positive regulation of phospholipid transport | biological process | GO:2001140 | 14 | 1 | 18204 | 49 |
APOE |
3.704e-02 | -3.30 | regulation of mesenchymal cell apoptotic process | biological process | GO:2001053 | 14 | 1 | 18204 | 49 |
HIF1A |
3.704e-02 | -3.30 | alpha-beta T cell proliferation | biological process | GO:0046633 | 14 | 1 | 18204 | 49 |
DOCK2 |
3.704e-02 | -3.30 | T-helper cell lineage commitment | biological process | GO:0002295 | 14 | 1 | 18204 | 49 |
IL6R |
3.704e-02 | -3.30 | positive regulation of heterotypic cell-cell adhesion | biological process | GO:0034116 | 14 | 1 | 18204 | 49 |
SKAP1 |
3.704e-02 | -3.30 | interleukin-6-mediated signaling pathway | biological process | GO:0070102 | 14 | 1 | 18204 | 49 |
IL6R |
3.704e-02 | -3.30 | cellular response to ethanol | biological process | GO:0071361 | 14 | 1 | 18204 | 49 |
ADCY7 |
3.704e-02 | -3.30 | regulation of unsaturated fatty acid biosynthetic process | biological process | GO:2001279 | 14 | 1 | 18204 | 49 |
CD74 |
3.704e-02 | -3.30 | positive regulation by symbiont of entry into host | biological process | GO:0075294 | 14 | 1 | 18204 | 49 |
CD74 |
3.704e-02 | -3.30 | T-helper 1 cell differentiation | biological process | GO:0045063 | 14 | 1 | 18204 | 49 |
SEMA4A |
3.704e-02 | -3.30 | positive regulation of phospholipid metabolic process | biological process | GO:1903727 | 14 | 1 | 18204 | 49 |
PRKCD |
3.704e-02 | -3.30 | cellular response to lithium ion | biological process | GO:0071285 | 14 | 1 | 18204 | 49 |
ADCY7 |
3.706e-02 | -3.30 | vascular process in circulatory system | biological process | GO:0003018 | 273 | 3 | 18204 | 49 |
P2RY2,TBXAS1,APOE |
3.712e-02 | -3.29 | PRDX2 (peroxiredoxin 2) | protein interactions | 7001 | 286 | 3 | 19454 | 50 |
RIN3,AKAP13,APOE |
3.715e-02 | -3.29 | Rhomboid-like_sf | interpro domains | IPR035952 | 14 | 1 | 18521 | 50 |
RHBDF2 |
3.717e-02 | -3.29 | regulation of regulated secretory pathway | biological process | GO:1903305 | 113 | 2 | 18204 | 49 |
SYK,MICAL1 |
3.717e-02 | -3.29 | positive regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903557 | 113 | 2 | 18204 | 49 |
SYK,PLCG2 |
3.727e-02 | -3.29 | SM22CALPONIN | prints domains | PR00888 | 11 | 1 | 5227 | 18 |
VAV3 |
3.740e-02 | -3.29 | organic acid biosynthetic process | biological process | GO:0016053 | 274 | 3 | 18204 | 49 |
SYK,CD74,TBXAS1 |
3.745e-02 | -3.28 | PSMD13 (proteasome 26S subunit, non-ATPase 13) | protein interactions | 5719 | 287 | 3 | 19454 | 50 |
P2RY6,PTPN6,PREX1 |
3.747e-02 | -3.28 | ovary-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | ovary-carcinoma-endometrioid_carcinoma | 464 | 4 | 16828 | 46 |
CSF1R,NEK6,PRKCD,SYK |
3.754e-02 | -3.28 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 8 | 16828 | 46 |
P2RY6,DOCK1,TBC1D8,DOCK2,GMIP,EHBP1L1,DOCK10,AKAP13 |
3.754e-02 | -3.28 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 8 | 16828 | 46 |
DOCK1,P2RY6,EHBP1L1,DOCK10,AKAP13,DOCK2,GMIP,TBC1D8 |
3.756e-02 | -3.28 | HLA-DPA1 (major histocompatibility complex, class II, DP alpha 1) | protein interactions | 3113 | 119 | 2 | 19454 | 50 |
APOE,CD74 |
3.768e-02 | -3.28 | ATP binding | molecular function | GO:0005524 | 1467 | 8 | 18094 | 48 |
NRK,CSF1R,NEK6,PRKCD,PIK3CB,MYO1F,SYK,ADCY7 |
3.772e-02 | -3.28 | intracellular transport | biological process | GO:0046907 | 1182 | 7 | 18204 | 49 |
DENND1B,SYK,CD74,WAS,RGS14,APOE,HIF1A |
3.777e-02 | -3.28 | VASP (vasodilator stimulated phosphoprotein) | protein interactions | 7408 | 288 | 3 | 19454 | 50 |
FYB1,HIF1A,WAS |
3.779e-02 | -3.28 | VDAC1 (voltage dependent anion channel 1) | protein interactions | 7416 | 494 | 4 | 19454 | 50 |
P2RY6,APOE,CD74,RIN3 |
3.785e-02 | -3.27 | Interleukin-6 signaling | REACTOME pathways | R-HSA-1059683 | 11 | 1 | 10285 | 36 |
IL6R |
3.788e-02 | -3.27 | Ccn1 (cellular communication network factor 1) | protein interactions | 16007 | 15 | 1 | 19454 | 50 |
SLC4A2 |
3.788e-02 | -3.27 | MEP1B (meprin A subunit beta) | protein interactions | 4225 | 15 | 1 | 19454 | 50 |
PRKCD |
3.788e-02 | -3.27 | NBEAL1 (neurobeachin like 1) | protein interactions | 65065 | 15 | 1 | 19454 | 50 |
HIF1A |
3.788e-02 | -3.27 | GCK (glucokinase) | protein interactions | 2645 | 15 | 1 | 19454 | 50 |
GMIP |
3.788e-02 | -3.27 | IRAK1BP1 (interleukin 1 receptor associated kinase 1 binding protein 1) | protein interactions | 134728 | 15 | 1 | 19454 | 50 |
RIN3 |
3.788e-02 | -3.27 | AANAT (aralkylamine N-acetyltransferase) | protein interactions | 15 | 15 | 1 | 19454 | 50 |
P2RY6 |
3.788e-02 | -3.27 | IRF6 (interferon regulatory factor 6) | protein interactions | 3664 | 15 | 1 | 19454 | 50 |
IRF5 |
3.788e-02 | -3.27 | EBI3 (Epstein-Barr virus induced 3) | protein interactions | 10148 | 15 | 1 | 19454 | 50 |
PRKCD |
3.788e-02 | -3.27 | ADRA2A (adrenoceptor alpha 2A) | protein interactions | 150 | 15 | 1 | 19454 | 50 |
PRKCD |
3.808e-02 | -3.27 | learning or memory | biological process | GO:0007611 | 276 | 3 | 18204 | 49 |
RGS14,APOE,HIF1A |
3.814e-02 | -3.27 | ELP3 (elongator acetyltransferase complex subunit 3) | protein interactions | 55140 | 120 | 2 | 19454 | 50 |
HIF1A,SKAP1 |
3.814e-02 | -3.27 | FNBP1 (formin binding protein 1) | protein interactions | 23048 | 120 | 2 | 19454 | 50 |
RIN3,WAS |
3.814e-02 | -3.27 | CD79B (CD79b molecule) | protein interactions | 974 | 120 | 2 | 19454 | 50 |
PTPN6,SYK |
3.825e-02 | -3.26 | acinar_carcinoma | COSMIC cancer mutations | acinar_carcinoma | 1978 | 10 | 16828 | 46 |
DOCK10,RHBDF2,SKAP1,DOCK2,WDFY4,TBC1D8,MICAL1,PLCG2,RIN3,WAS |
3.825e-02 | -3.26 | pancreas-carcinoma-acinar_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-acinar_carcinoma | 1978 | 10 | 16828 | 46 |
WAS,RIN3,PLCG2,MICAL1,TBC1D8,SKAP1,WDFY4,DOCK2,DOCK10,RHBDF2 |
3.837e-02 | -3.26 | fatty acid biosynthetic process | biological process | GO:0006633 | 115 | 2 | 18204 | 49 |
CD74,TBXAS1 |
3.855e-02 | -3.26 | low-density lipoprotein particle | cellular component | GO:0034362 | 15 | 1 | 19108 | 50 |
APOE |
3.857e-02 | -3.26 | RAB GEFs exchange GTP for GDP on RABs | REACTOME pathways | R-HSA-8876198 | 89 | 2 | 10285 | 36 |
RIN3,DENND1B |
3.864e-02 | -3.25 | WH2 | pfam domains | PF02205 | 14 | 1 | 17795 | 50 |
WAS |
3.864e-02 | -3.25 | PBD | pfam domains | PF00786 | 14 | 1 | 17795 | 50 |
WAS |
3.867e-02 | -3.25 | Osteopontin-mediated events | Pathway Interaction DB | avb3_opn_pathway | 32 | 2 | 2226 | 22 |
VAV3,SYK |
3.867e-02 | -3.25 | Alpha-synuclein signaling | Pathway Interaction DB | alphasynuclein_pathway | 32 | 2 | 2226 | 22 |
SYK,PRKCD |
3.872e-02 | -3.25 | EIF3J (eukaryotic translation initiation factor 3 subunit J) | protein interactions | 8669 | 121 | 2 | 19454 | 50 |
CD74,P2RY6 |
3.872e-02 | -3.25 | POLR3B (RNA polymerase III subunit B) | protein interactions | 55703 | 121 | 2 | 19454 | 50 |
SKAP1,CD74 |
3.872e-02 | -3.25 | MED15 (mediator complex subunit 15) | protein interactions | 51586 | 121 | 2 | 19454 | 50 |
HIF1A,RIN3 |
3.898e-02 | -3.24 | regulation of alpha-beta T cell activation | biological process | GO:0046634 | 116 | 2 | 18204 | 49 |
SLC4A2,SYK |
3.908e-02 | -3.24 | phosphatidylglycerol binding | molecular function | GO:1901611 | 15 | 1 | 18094 | 48 |
GSDME |
3.908e-02 | -3.24 | 1-phosphatidylinositol-3-kinase regulator activity | molecular function | GO:0046935 | 15 | 1 | 18094 | 48 |
PIK3R5 |
3.922e-02 | -3.24 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 31 | 16828 | 46 |
CSF1R,ADCY7,DOCK2,PIK3CB,MYO1F,SLC4A2,PRKCD,DOCK1,PIK3R5,MICAL1,VAV3,WAS,ELMO1,PTPN6,PLCG2,NEK6,AKAP13,RHBDF2,IRF5,P2RY2,SYK,P2RY6,APOE,RIN3,DOCK8,ARHGAP33,DOCK10,WDFY4,SKAP1,PREX1,IPCEF1 |
3.930e-02 | -3.24 | RAB5B (RAB5B, member RAS oncogene family) | protein interactions | 5869 | 122 | 2 | 19454 | 50 |
RIN3,PIK3CB |
3.930e-02 | -3.24 | ELK1 (ETS transcription factor ELK1) | protein interactions | 2002 | 122 | 2 | 19454 | 50 |
HIF1A,PLCG2 |
3.938e-02 | -3.23 | D-myo-inositol-5-phosphate metabolism | BIOCYC pathways | META_PWY-6367 | 9 | 1 | 902 | 4 |
PLCG2 |
3.939e-02 | -3.23 | actin filament | cellular component | GO:0005884 | 120 | 2 | 19108 | 50 |
MICAL1,WAS |
3.943e-02 | -3.23 | human chr10q26.2 | chromosome location | human chr10q26.2 | 21 | 1 | 26134 | 50 |
DOCK1 |
3.959e-02 | -3.23 | negative regulation of hemopoiesis | biological process | GO:1903707 | 117 | 2 | 18204 | 49 |
CD74,SLC4A2 |
3.959e-02 | -3.23 | cellular detoxification | biological process | GO:1990748 | 117 | 2 | 18204 | 49 |
IPCEF1,APOE |
3.964e-02 | -3.23 | negative regulation of B cell mediated immunity | biological process | GO:0002713 | 15 | 1 | 18204 | 49 |
PTPN6 |
3.964e-02 | -3.23 | positive regulation of granulocyte macrophage colony-stimulating factor production | biological process | GO:0032725 | 15 | 1 | 18204 | 49 |
SYK |
3.964e-02 | -3.23 | regulation of membrane invagination | biological process | GO:1905153 | 15 | 1 | 18204 | 49 |
PLCG2 |
3.964e-02 | -3.23 | positive regulation of hormone metabolic process | biological process | GO:0032352 | 15 | 1 | 18204 | 49 |
HIF1A |
3.964e-02 | -3.23 | positive regulation of monocyte chemotactic protein-1 production | biological process | GO:0071639 | 15 | 1 | 18204 | 49 |
SYK |
3.964e-02 | -3.23 | collagen-activated signaling pathway | biological process | GO:0038065 | 15 | 1 | 18204 | 49 |
SYK |
3.964e-02 | -3.23 | columnar/cuboidal epithelial cell maturation | biological process | GO:0002069 | 15 | 1 | 18204 | 49 |
HIF1A |
3.964e-02 | -3.23 | negative regulation of B cell apoptotic process | biological process | GO:0002903 | 15 | 1 | 18204 | 49 |
CD74 |
3.964e-02 | -3.23 | sphingosine-1-phosphate receptor signaling pathway | biological process | GO:0003376 | 15 | 1 | 18204 | 49 |
PIK3CB |
3.964e-02 | -3.23 | regulation of inositol phosphate biosynthetic process | biological process | GO:0010919 | 15 | 1 | 18204 | 49 |
P2RY6 |
3.964e-02 | -3.23 | negative regulation of immunoglobulin mediated immune response | biological process | GO:0002890 | 15 | 1 | 18204 | 49 |
PTPN6 |
3.964e-02 | -3.23 | lipoprotein catabolic process | biological process | GO:0042159 | 15 | 1 | 18204 | 49 |
APOE |
3.964e-02 | -3.23 | oxygen transport | biological process | GO:0015671 | 15 | 1 | 18204 | 49 |
IPCEF1 |
3.964e-02 | -3.23 | neutrophil activation involved in immune response | biological process | GO:0002283 | 15 | 1 | 18204 | 49 |
SYK |
3.964e-02 | -3.23 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | biological process | GO:1902166 | 15 | 1 | 18204 | 49 |
CD74 |
3.964e-02 | -3.23 | negative regulation of DNA damage response, signal transduction by p53 class mediator | biological process | GO:0043518 | 15 | 1 | 18204 | 49 |
CD74 |
3.964e-02 | -3.23 | positive regulation of cholesterol metabolic process | biological process | GO:0090205 | 15 | 1 | 18204 | 49 |
APOE |
3.964e-02 | -3.23 | regulation of phagocytosis, engulfment | biological process | GO:0060099 | 15 | 1 | 18204 | 49 |
PLCG2 |
3.975e-02 | -3.23 | SMAD-like_dom_sf | interpro domains | IPR017855 | 15 | 1 | 18521 | 50 |
IRF5 |
3.975e-02 | -3.23 | PI3/4_kinase_CS | interpro domains | IPR018936 | 15 | 1 | 18521 | 50 |
PIK3CB |
3.975e-02 | -3.23 | PI3/4_kinase_cat_sf | interpro domains | IPR036940 | 15 | 1 | 18521 | 50 |
PIK3CB |
3.975e-02 | -3.23 | PI-PLC_fam | interpro domains | IPR001192 | 15 | 1 | 18521 | 50 |
PLCG2 |
3.975e-02 | -3.23 | CRISP-related | interpro domains | IPR001283 | 15 | 1 | 18521 | 50 |
GLIPR1 |
3.975e-02 | -3.23 | CAP_domain | interpro domains | IPR014044 | 15 | 1 | 18521 | 50 |
GLIPR1 |
3.975e-02 | -3.23 | CAP_sf | interpro domains | IPR035940 | 15 | 1 | 18521 | 50 |
GLIPR1 |
3.975e-02 | -3.23 | PLipase_C_Pinositol-sp_Y | interpro domains | IPR001711 | 15 | 1 | 18521 | 50 |
PLCG2 |
3.975e-02 | -3.23 | CNH_dom | interpro domains | IPR001180 | 15 | 1 | 18521 | 50 |
NRK |
3.977e-02 | -3.22 | KCNE3 (potassium voltage-gated channel subfamily E regulatory subunit 3) | protein interactions | 10008 | 294 | 3 | 19454 | 50 |
PIK3CB,RHBDF2,PRKCD |
3.988e-02 | -3.22 | EIF2B3 (eukaryotic translation initiation factor 2B subunit gamma) | protein interactions | 8891 | 123 | 2 | 19454 | 50 |
P2RY6,CD74 |
3.988e-02 | -3.22 | HHV8GK18_gp81 (ORF73) | protein interactions | 4961527 | 123 | 2 | 19454 | 50 |
HIF1A,RGS14 |
3.988e-02 | -3.22 | Fc epsilon receptor (FCERI) signaling | REACTOME pathways | R-HSA-2454202 | 372 | 4 | 10285 | 36 |
PIK3CB,SYK,VAV3,PLCG2 |
3.989e-02 | -3.22 | WH1 | prosite domains | PS50229 | 11 | 1 | 12186 | 45 |
WAS |
4.020e-02 | -3.21 | biological process involved in interaction with symbiont | biological process | GO:0051702 | 118 | 2 | 18204 | 49 |
CSF1R,APOE |
4.035e-02 | -3.21 | EPO (erythropoietin) | protein interactions | 2056 | 16 | 1 | 19454 | 50 |
HIF1A |
4.035e-02 | -3.21 | KCNA6 (potassium voltage-gated channel subfamily A member 6) | protein interactions | 3742 | 16 | 1 | 19454 | 50 |
SLC4A2 |
4.035e-02 | -3.21 | RASGRP3 (RAS guanyl releasing protein 3) | protein interactions | 25780 | 16 | 1 | 19454 | 50 |
PRKCD |
4.035e-02 | -3.21 | KCNJ4 (potassium inwardly rectifying channel subfamily J member 4) | protein interactions | 3761 | 16 | 1 | 19454 | 50 |
PRKCD |
4.035e-02 | -3.21 | TWIST2 (twist family bHLH transcription factor 2) | protein interactions | 117581 | 16 | 1 | 19454 | 50 |
PLCG2 |
4.035e-02 | -3.21 | SELPLG (selectin P ligand) | protein interactions | 6404 | 16 | 1 | 19454 | 50 |
SYK |
4.035e-02 | -3.21 | PRICKLE4 (prickle planar cell polarity protein 4) | protein interactions | 29964 | 16 | 1 | 19454 | 50 |
NEK6 |
4.035e-02 | -3.21 | TNFRSF25 (TNF receptor superfamily member 25) | protein interactions | 8718 | 16 | 1 | 19454 | 50 |
PTPN6 |
4.035e-02 | -3.21 | TMEM88 (transmembrane protein 88) | protein interactions | 92162 | 16 | 1 | 19454 | 50 |
MICAL1 |
4.047e-02 | -3.21 | TNK2 (tyrosine kinase non receptor 2) | protein interactions | 10188 | 124 | 2 | 19454 | 50 |
WAS,NEK6 |
4.047e-02 | -3.21 | TM9SF3 (transmembrane 9 superfamily member 3) | protein interactions | 56889 | 124 | 2 | 19454 | 50 |
P2RY6,P2RY2 |
4.047e-02 | -3.21 | RNF5 (ring finger protein 5) | protein interactions | 6048 | 124 | 2 | 19454 | 50 |
P2RY2,HIF1A |
4.047e-02 | -3.21 | ERLEC1 (endoplasmic reticulum lectin 1) | protein interactions | 27248 | 124 | 2 | 19454 | 50 |
P2RY6,SEMA4A |
4.055e-02 | -3.21 | parathyroid | COSMIC cancer mutations | parathyroid | 476 | 4 | 16828 | 46 |
PRKCD,TBC1D8,DOCK2,PLCG2 |
4.076e-02 | -3.20 | TyrKc | smart domains | SM00219 | 80 | 2 | 9717 | 39 |
SYK,CSF1R |
4.082e-02 | -3.20 | negative regulation of protein transport | biological process | GO:0051224 | 119 | 2 | 18204 | 49 |
RHBDF2,APOE |
4.083e-02 | -3.20 | Oncostatin M Signaling Pathway | WikiPathways | WP2374 | 66 | 2 | 5310 | 26 |
PRKCD,HIF1A |
4.083e-02 | -3.20 | AGE/RAGE pathway | WikiPathways | WP2324 | 66 | 2 | 5310 | 26 |
PRKCD,HIF1A |
4.093e-02 | -3.20 | EPO signaling pathway | Pathway Interaction DB | epopathway | 33 | 2 | 2226 | 22 |
PLCG2,PTPN6 |
4.113e-02 | -3.19 | ALDH3A2 (aldehyde dehydrogenase 3 family member A2) | protein interactions | 224 | 298 | 3 | 19454 | 50 |
RHBDF2,P2RY6,RIN3 |
4.114e-02 | -3.19 | protein-containing complex binding | molecular function | GO:0044877 | 1772 | 9 | 18094 | 48 |
SBNO2,FYB1,SYK,MICAL1,DOCK2,APOE,MYO1F,CD74,PIK3R5 |
4.123e-02 | -3.19 | Eicosanoids | REACTOME pathways | R-HSA-211979 | 12 | 1 | 10285 | 36 |
TBXAS1 |
4.123e-02 | -3.19 | Regulation of gene expression by Hypoxia-inducible Factor | REACTOME pathways | R-HSA-1234158 | 12 | 1 | 10285 | 36 |
HIF1A |
4.123e-02 | -3.19 | PECAM1 interactions | REACTOME pathways | R-HSA-210990 | 12 | 1 | 10285 | 36 |
PTPN6 |
4.134e-02 | -3.19 | PI-PLC-Y | pfam domains | PF00387 | 15 | 1 | 17795 | 50 |
PLCG2 |
4.134e-02 | -3.19 | CAP | pfam domains | PF00188 | 15 | 1 | 17795 | 50 |
GLIPR1 |
4.134e-02 | -3.19 | CNH | pfam domains | PF00780 | 15 | 1 | 17795 | 50 |
NRK |
4.147e-02 | -3.18 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 24 | 16828 | 46 |
MICAL1,VAV3,CSF1R,MYO1F,PIK3CB,DOCK2,SLC4A2,PRKCD,HIF1A,PIK3R5,DOCK1,DOCK8,SBNO2,DOCK10,SKAP1,WDFY4,GMIP,TBC1D8,NEK6,AKAP13,PARVG,SYK,RIN3,GLIPR1 |
4.163e-02 | -3.18 | adenylate cyclase activity | molecular function | GO:0004016 | 16 | 1 | 18094 | 48 |
ADCY7 |
4.163e-02 | -3.18 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | molecular function | GO:0050664 | 16 | 1 | 18094 | 48 |
MICAL1 |
4.163e-02 | -3.18 | diacylglycerol-dependent serine/threonine kinase activity | molecular function | GO:0004697 | 16 | 1 | 18094 | 48 |
PRKCD |
4.166e-02 | -3.18 | KCTD17 (potassium channel tetramerization domain containing 17) | protein interactions | 79734 | 126 | 2 | 19454 | 50 |
RIN3,PLCG2 |
4.207e-02 | -3.17 | chloride transport | biological process | GO:0006821 | 121 | 2 | 18204 | 49 |
SLC4A2,P2RY6 |
4.207e-02 | -3.17 | positive regulation of T cell differentiation | biological process | GO:0045582 | 121 | 2 | 18204 | 49 |
SYK,CD74 |
4.223e-02 | -3.16 | asymmetric cell division | biological process | GO:0008356 | 16 | 1 | 18204 | 49 |
RGS14 |
4.223e-02 | -3.16 | positive regulation of autophagy of mitochondrion | biological process | GO:1903599 | 16 | 1 | 18204 | 49 |
HIF1A |
4.223e-02 | -3.16 | cellular response to prostaglandin E stimulus | biological process | GO:0071380 | 16 | 1 | 18204 | 49 |
P2RY6 |
4.223e-02 | -3.16 | positive regulation of B cell differentiation | biological process | GO:0045579 | 16 | 1 | 18204 | 49 |
SYK |
4.223e-02 | -3.16 | low-density lipoprotein particle remodeling | biological process | GO:0034374 | 16 | 1 | 18204 | 49 |
APOE |
4.223e-02 | -3.16 | negative regulation of alpha-beta T cell proliferation | biological process | GO:0046642 | 16 | 1 | 18204 | 49 |
SLC4A2 |
4.223e-02 | -3.16 | positive regulation of response to tumor cell | biological process | GO:0002836 | 16 | 1 | 18204 | 49 |
GSDME |
4.223e-02 | -3.16 | regulation of cell proliferation involved in kidney development | biological process | GO:1901722 | 16 | 1 | 18204 | 49 |
IL6R |
4.223e-02 | -3.16 | lactate metabolic process | biological process | GO:0006089 | 16 | 1 | 18204 | 49 |
HIF1A |
4.223e-02 | -3.16 | sphingolipid mediated signaling pathway | biological process | GO:0090520 | 16 | 1 | 18204 | 49 |
PIK3CB |
4.223e-02 | -3.16 | locomotory exploration behavior | biological process | GO:0035641 | 16 | 1 | 18204 | 49 |
APOE |
4.223e-02 | -3.16 | response to lithium ion | biological process | GO:0010226 | 16 | 1 | 18204 | 49 |
ADCY7 |
4.223e-02 | -3.16 | intestinal epithelial cell development | biological process | GO:0060576 | 16 | 1 | 18204 | 49 |
HIF1A |
4.223e-02 | -3.16 | positive regulation of immune response to tumor cell | biological process | GO:0002839 | 16 | 1 | 18204 | 49 |
GSDME |
4.223e-02 | -3.16 | positive regulation of membrane protein ectodomain proteolysis | biological process | GO:0051044 | 16 | 1 | 18204 | 49 |
APOE |
4.229e-02 | -3.16 | - | gene3d domains | 3.30.450.200 | 13 | 1 | 14470 | 48 |
DENND1B |
4.235e-02 | -3.16 | DENN_C | interpro domains | IPR043153 | 16 | 1 | 18521 | 50 |
DENND1B |
4.235e-02 | -3.16 | uDENN_dom | interpro domains | IPR005113 | 16 | 1 | 18521 | 50 |
DENND1B |
4.235e-02 | -3.16 | dDENN_dom | interpro domains | IPR005112 | 16 | 1 | 18521 | 50 |
DENND1B |
4.248e-02 | -3.16 | femur | COSMIC cancer mutations | femur | 1197 | 7 | 16828 | 46 |
RIN3,PREX1,P2RY2,WDFY4,AKAP13,RHBDF2,DOCK10 |
4.251e-02 | -3.16 | TRAF1 (TNF receptor associated factor 1) | protein interactions | 7185 | 302 | 3 | 19454 | 50 |
VAV3,GIT2,TBC1D8 |
4.269e-02 | -3.15 | Insulin Signaling | WikiPathways | WP481 | 161 | 3 | 5310 | 26 |
ARHGAP33,PRKCD,PIK3CB |
4.271e-02 | -3.15 | muscle cell differentiation | biological process | GO:0042692 | 289 | 3 | 18204 | 49 |
AKAP13,DOCK2,DOCK1 |
4.282e-02 | -3.15 | CITED2 (Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2) | protein interactions | 10370 | 17 | 1 | 19454 | 50 |
HIF1A |
4.282e-02 | -3.15 | C16orf92 (chromosome 16 open reading frame 92) | protein interactions | 146378 | 17 | 1 | 19454 | 50 |
APOE |
4.282e-02 | -3.15 | PLB1 (phospholipase B1) | protein interactions | 151056 | 17 | 1 | 19454 | 50 |
RIN3 |
4.282e-02 | -3.15 | SLAMF6 (SLAM family member 6) | protein interactions | 114836 | 17 | 1 | 19454 | 50 |
PTPN6 |
4.282e-02 | -3.15 | FAM131C (family with sequence similarity 131 member C) | protein interactions | 348487 | 17 | 1 | 19454 | 50 |
RHBDF2 |
4.282e-02 | -3.15 | RIMBP3C (RIMS binding protein 3C) | protein interactions | 150221 | 17 | 1 | 19454 | 50 |
NEK6 |
4.282e-02 | -3.15 | SAT2 (spermidine/spermine N1-acetyltransferase family member 2) | protein interactions | 112483 | 17 | 1 | 19454 | 50 |
HIF1A |
4.282e-02 | -3.15 | EPB42 (erythrocyte membrane protein band 4.2) | protein interactions | 2038 | 17 | 1 | 19454 | 50 |
SLC4A2 |
4.282e-02 | -3.15 | Kif2c (kinesin family member 2C) | protein interactions | 73804 | 17 | 1 | 19454 | 50 |
SLC4A2 |
4.286e-02 | -3.15 | TACSTD2 (tumor associated calcium signal transducer 2) | protein interactions | 4070 | 128 | 2 | 19454 | 50 |
GSDME,TBC1D8 |
4.286e-02 | -3.15 | PPIB (peptidylprolyl isomerase B) | protein interactions | 5479 | 303 | 3 | 19454 | 50 |
DOCK8,IRF5,PREX1 |
4.286e-02 | -3.15 | EBNA1BP2 (EBNA1 binding protein 2) | protein interactions | 10969 | 303 | 3 | 19454 | 50 |
PTPN6,SYK,GMIP |
4.287e-02 | -3.15 | normal | COSMIC cancer mutations | normal | 16 | 1 | 16828 | 46 |
CSF1R |
4.295e-02 | -3.15 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma | 485 | 4 | 16828 | 46 |
IPCEF1,WDFY4,DOCK8,ELMO1 |
4.295e-02 | -3.15 | medullomyoblastoma | COSMIC cancer mutations | medullomyoblastoma | 485 | 4 | 16828 | 46 |
IPCEF1,WDFY4,ELMO1,DOCK8 |
4.311e-02 | -3.14 | human chr3q22.3 | chromosome location | human chr3q22.3 | 23 | 1 | 26134 | 50 |
PIK3CB |
4.312e-02 | -3.14 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 8 | 18204 | 49 |
RGS14,HIF1A,PIK3CB,SLC4A2,CD74,PTPN6,SYK,SEMA4A |
4.325e-02 | -3.14 | miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma | WikiPathways | WP3593 | 9 | 1 | 5310 | 26 |
HIF1A |
4.330e-02 | -3.14 | WH2 | smart domains | SM00246 | 11 | 1 | 9717 | 39 |
WAS |
4.330e-02 | -3.14 | WH1 | smart domains | SM00461 | 11 | 1 | 9717 | 39 |
WAS |
4.346e-02 | -3.14 | PLD1 (phospholipase D1) | protein interactions | 5337 | 129 | 2 | 19454 | 50 |
HIF1A,PLCG2 |
4.346e-02 | -3.14 | EIF2B4 (eukaryotic translation initiation factor 2B subunit delta) | protein interactions | 8890 | 129 | 2 | 19454 | 50 |
P2RY6,CD74 |
4.349e-02 | -3.14 | testis-germ_cell_tumour-non_seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-non_seminoma | 487 | 4 | 16828 | 46 |
PRKCD,SYK,NEK6,CSF1R |
4.358e-02 | -3.13 | MHC class II protein complex | cellular component | GO:0042613 | 17 | 1 | 19108 | 50 |
CD74 |
4.364e-02 | -3.13 | centriolar satellite | cellular component | GO:0034451 | 127 | 2 | 19108 | 50 |
NEK6,PIK3R5 |
4.381e-02 | -3.13 | TYRKINASE | prints domains | PR00109 | 98 | 2 | 5227 | 18 |
SYK,NEK6 |
4.381e-02 | -3.13 | glycerophospholipid metabolic process | biological process | GO:0006650 | 292 | 3 | 18204 | 49 |
PIK3CB,PIK3R5,PLCG2 |
4.385e-02 | -3.13 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 26 | 16828 | 46 |
AKAP13,EHBP1L1,CD74,IRF5,RIN3,P2RY2,SYK,P2RY6,DOCK10,WDFY4,SBNO2,DOCK8,PREX1,ARHGAP27,IPCEF1,ADCY7,DOCK2,PIK3CB,MYO1F,CSF1R,PIK3R5,DOCK1,SLC4A2,TBXAS1,MICAL1,ELMO1 |
4.385e-02 | -3.13 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 26 | 16828 | 46 |
DOCK10,WDFY4,DOCK8,SBNO2,ARHGAP27,PREX1,IPCEF1,EHBP1L1,AKAP13,IRF5,CD74,RIN3,P2RY2,SYK,P2RY6,TBXAS1,MICAL1,ELMO1,ADCY7,PIK3CB,MYO1F,DOCK2,CSF1R,PIK3R5,DOCK1,SLC4A2 |
4.404e-02 | -3.12 | uDENN | pfam domains | PF03456 | 16 | 1 | 17795 | 50 |
DENND1B |
4.407e-02 | -3.12 | YIPF5 (Yip1 domain family member 5) | protein interactions | 81555 | 130 | 2 | 19454 | 50 |
P2RY2,P2RY6 |
4.415e-02 | -3.12 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 22 | 16828 | 46 |
TBC1D8,CSF1R,EHBP1L1,AKAP13,PIK3CB,DOCK2,SLC4A2,PARVG,APOE,GLIPR1,DOCK1,RIN3,MICAL1,DOCK8,SBNO2,DOCK10,VAV3,SKAP1,WDFY4,PTPN6,ELMO1,PLCG2 |
4.417e-02 | -3.12 | transmembrane receptor protein tyrosine phosphatase activity | molecular function | GO:0005001 | 17 | 1 | 18094 | 48 |
PTPN6 |
4.417e-02 | -3.12 | GDP-dissociation inhibitor activity | molecular function | GO:0005092 | 17 | 1 | 18094 | 48 |
RGS14 |
4.417e-02 | -3.12 | transmembrane receptor protein phosphatase activity | molecular function | GO:0019198 | 17 | 1 | 18094 | 48 |
PTPN6 |
4.433e-02 | -3.12 | large_intestine-colon-carcinoma | COSMIC cancer mutations | large_intestine-colon-carcinoma | 2612 | 12 | 16828 | 46 |
PLCG2,VAV3,ARHGAP33,RIN3,P2RY6,PRKCD,SYK,P2RY2,MYO1F,DOCK2,ADCY7,AKAP13 |
4.448e-02 | -3.11 | cytoskeleton | cellular component | GO:0005856 | 2412 | 11 | 19108 | 50 |
FYB1,NEK6,PIK3R5,AKAP13,ARHGAP33,PARVG,WAS,RGS14,MYO1F,MICAL1,DOCK2 |
4.459e-02 | -3.11 | FCGR activation | REACTOME pathways | R-HSA-2029481 | 13 | 1 | 10285 | 36 |
SYK |
4.461e-02 | -3.11 | regulation of cell-matrix adhesion | biological process | GO:0001952 | 125 | 2 | 18204 | 49 |
SKAP1,PIK3CB |
4.461e-02 | -3.11 | memory | biological process | GO:0007613 | 125 | 2 | 18204 | 49 |
APOE,RGS14 |
4.461e-02 | -3.11 | phosphatidylinositol biosynthetic process | biological process | GO:0006661 | 125 | 2 | 18204 | 49 |
PIK3CB,PLCG2 |
4.461e-02 | -3.11 | mammary gland development | biological process | GO:0030879 | 125 | 2 | 18204 | 49 |
HIF1A,CSF1R |
4.468e-02 | -3.11 | TBCD (tubulin folding cofactor D) | protein interactions | 6904 | 131 | 2 | 19454 | 50 |
RIN3,HIF1A |
4.468e-02 | -3.11 | membrane protein complex | cellular component | GO:0098796 | 1261 | 7 | 19108 | 50 |
PIK3R5,SYK,CD74,PTPN6,SKAP1,PIK3CB,IL6R |
4.479e-02 | -3.11 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 28 | 16828 | 46 |
PARVG,SYK,P2RY6,RIN3,AKAP13,PREX1,ARHGAP27,ARHGAP33,DOCK10,WDFY4,SKAP1,SLC4A2,RGS14,PRKCD,HIF1A,DOCK1,PIK3R5,CSF1R,ADCY7,GIT2,DOCK2,PIK3CB,MYO1F,ELMO1,PLCG2,MICAL1,TBXAS1,VAV3 |
4.481e-02 | -3.11 | T-helper 17 type immune response | biological process | GO:0072538 | 17 | 1 | 18204 | 49 |
IL6R |
4.481e-02 | -3.11 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 49 |
CD74 |
4.481e-02 | -3.11 | negative regulation of vascular endothelial growth factor signaling pathway | biological process | GO:1900747 | 17 | 1 | 18204 | 49 |
PIK3CB |
4.481e-02 | -3.11 | regulation of amyloid fibril formation | biological process | GO:1905906 | 17 | 1 | 18204 | 49 |
APOE |
4.481e-02 | -3.11 | axonal transport of mitochondrion | biological process | GO:0019896 | 17 | 1 | 18204 | 49 |
HIF1A |
4.481e-02 | -3.11 | fatty acid homeostasis | biological process | GO:0055089 | 17 | 1 | 18204 | 49 |
APOE |
4.481e-02 | -3.11 | monocyte differentiation | biological process | GO:0030224 | 17 | 1 | 18204 | 49 |
CSF1R |
4.481e-02 | -3.11 | negative regulation of triglyceride metabolic process | biological process | GO:0090209 | 17 | 1 | 18204 | 49 |
APOE |
4.481e-02 | -3.11 | negative regulation of humoral immune response | biological process | GO:0002921 | 17 | 1 | 18204 | 49 |
PTPN6 |
4.481e-02 | -3.11 | regulation of integrin activation | biological process | GO:0033623 | 17 | 1 | 18204 | 49 |
SKAP1 |
4.481e-02 | -3.11 | cellular response to ATP | biological process | GO:0071318 | 17 | 1 | 18204 | 49 |
P2RY2 |
4.481e-02 | -3.11 | regulation of excitatory synapse assembly | biological process | GO:1904889 | 17 | 1 | 18204 | 49 |
SEMA4A |
4.481e-02 | -3.11 | regulation of plasma membrane organization | biological process | GO:1903729 | 17 | 1 | 18204 | 49 |
PRKCD |
4.481e-02 | -3.11 | high-density lipoprotein particle remodeling | biological process | GO:0034375 | 17 | 1 | 18204 | 49 |
APOE |
4.481e-02 | -3.11 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | biological process | GO:1902165 | 17 | 1 | 18204 | 49 |
CD74 |
4.481e-02 | -3.11 | negative regulation of receptor internalization | biological process | GO:0002091 | 17 | 1 | 18204 | 49 |
RIN3 |
4.481e-02 | -3.11 | regulation of dendritic cell cytokine production | biological process | GO:0002730 | 17 | 1 | 18204 | 49 |
PLCG2 |
4.481e-02 | -3.11 | mammary gland epithelial cell differentiation | biological process | GO:0060644 | 17 | 1 | 18204 | 49 |
HIF1A |
4.481e-02 | -3.11 | positive regulation of vascular permeability | biological process | GO:0043117 | 17 | 1 | 18204 | 49 |
APOE |
4.481e-02 | -3.11 | reverse cholesterol transport | biological process | GO:0043691 | 17 | 1 | 18204 | 49 |
APOE |
4.481e-02 | -3.11 | CD4-positive, alpha-beta T cell lineage commitment | biological process | GO:0043373 | 17 | 1 | 18204 | 49 |
IL6R |
4.484e-02 | -3.10 | cell-cell junction | cellular component | GO:0005911 | 513 | 4 | 19108 | 50 |
SKAP1,PRKCD,PTPN6,WAS |
4.487e-02 | -3.10 | non_seminoma | COSMIC cancer mutations | non_seminoma | 492 | 4 | 16828 | 46 |
NEK6,PRKCD,SYK,CSF1R |
4.490e-02 | -3.10 | cAMP signaling pathway | KEGG pathways | ko04024 | 198 | 3 | 7161 | 29 |
PIK3CB,ADCY7,VAV3 |
4.490e-02 | -3.10 | cAMP signaling pathway | KEGG pathways | hsa04024 | 198 | 3 | 7161 | 29 |
VAV3,ADCY7,PIK3CB |
4.493e-02 | -3.10 | Thyroglobulin_1_sf | interpro domains | IPR036857 | 17 | 1 | 18521 | 50 |
CD74 |
4.493e-02 | -3.10 | A/G_cyclase_CS | interpro domains | IPR018297 | 17 | 1 | 18521 | 50 |
ADCY7 |
4.493e-02 | -3.10 | PLipase_C_PInositol-sp_X_dom | interpro domains | IPR000909 | 17 | 1 | 18521 | 50 |
PLCG2 |
4.493e-02 | -3.10 | Thyroglobulin_1 | interpro domains | IPR000716 | 17 | 1 | 18521 | 50 |
CD74 |
4.493e-02 | -3.10 | RGS_subdom1/3 | interpro domains | IPR024066 | 17 | 1 | 18521 | 50 |
RGS14 |
4.493e-02 | -3.10 | cDENN_dom | interpro domains | IPR001194 | 17 | 1 | 18521 | 50 |
DENND1B |
4.493e-02 | -3.10 | PAC | interpro domains | IPR001610 | 17 | 1 | 18521 | 50 |
HIF1A |
4.516e-02 | -3.10 | skin-ear-malignant_melanoma | COSMIC cancer mutations | skin-ear-malignant_melanoma | 124 | 2 | 16828 | 46 |
WDFY4,PIK3CB |
4.525e-02 | -3.10 | response to ethanol | biological process | GO:0045471 | 126 | 2 | 18204 | 49 |
TBXAS1,ADCY7 |
4.529e-02 | -3.09 | BEX4 (brain expressed X-linked 4) | protein interactions | 56271 | 18 | 1 | 19454 | 50 |
PRKCD |
4.529e-02 | -3.09 | FAM120AOS (family with sequence similarity 120 member A opposite strand) | protein interactions | 158293 | 18 | 1 | 19454 | 50 |
MICAL1 |
4.529e-02 | -3.09 | CSRP3 (cysteine and glycine rich protein 3) | protein interactions | 8048 | 18 | 1 | 19454 | 50 |
RIN3 |
4.529e-02 | -3.09 | Chmp6 (charged multivesicular body protein 6) | protein interactions | 208092 | 18 | 1 | 19454 | 50 |
PTPN6 |
4.529e-02 | -3.09 | PCDHA11 (protocadherin alpha 11) | protein interactions | 56138 | 18 | 1 | 19454 | 50 |
RIN3 |
4.529e-02 | -3.09 | ZKSCAN7 (zinc finger with KRAB and SCAN domains 7) | protein interactions | 55888 | 18 | 1 | 19454 | 50 |
PLCG2 |
4.529e-02 | -3.09 | TM4SF20 (transmembrane 4 L six family member 20) | protein interactions | 79853 | 18 | 1 | 19454 | 50 |
CD74 |
4.529e-02 | -3.09 | GALM (galactose mutarotase) | protein interactions | 130589 | 18 | 1 | 19454 | 50 |
AKAP13 |
4.529e-02 | -3.09 | Lck (lymphocyte protein tyrosine kinase) | protein interactions | 16818 | 18 | 1 | 19454 | 50 |
APOE |
4.529e-02 | -3.09 | DCAF17 (DDB1 and CUL4 associated factor 17) | protein interactions | 80067 | 18 | 1 | 19454 | 50 |
PREX1 |
4.531e-02 | -3.09 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 3 | 18204 | 49 |
RGS14,HIF1A,SEMA4A |
4.531e-02 | -3.09 | ovary-other-neoplasm | COSMIC cancer mutations | ovary-other-neoplasm | 12717 | 40 | 16828 | 46 |
MICAL1,VAV3,WAS,PTPN6,ELMO1,PLCG2,CSF1R,ADCY7,DOCK2,GIT2,PIK3CB,MYO1F,SLC4A2,PRKCD,RGS14,HIF1A,PIK3R5,DOCK1,SBNO2,DOCK8,ARHGAP33,DOCK10,WDFY4,GMIP,SKAP1,PREX1,ARHGAP27,IPCEF1,TBC1D8,AKAP13,EHBP1L1,RHBDF2,CD74,PARVG,P2RY2,SYK,P2RY6,APOE,GLIPR1,RIN3 |
4.547e-02 | -3.09 | Epstein-Barr virus infection | KEGG pathways | hsa05169 | 199 | 3 | 7161 | 29 |
PIK3CB,PLCG2,SYK |
4.547e-02 | -3.09 | Epstein-Barr virus infection | KEGG pathways | ko05169 | 199 | 3 | 7161 | 29 |
PIK3CB,SYK,PLCG2 |
4.558e-02 | -3.09 | FAS (CD95) signaling pathway | Pathway Interaction DB | faspathway | 35 | 2 | 2226 | 22 |
PIK3CB,SYK |
4.579e-02 | -3.08 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 26 | 16828 | 46 |
PREX1,ARHGAP27,IPCEF1,ELMO1,DOCK10,WDFY4,GMIP,SKAP1,VAV3,SBNO2,DENND1B,HIF1A,APOE,RIN3,PIK3R5,DOCK1,PARVG,SLC4A2,PRKCD,AKAP13,ADCY7,DOCK2,GIT2,MYO1F,PIK3CB,CSF1R |
4.590e-02 | -3.08 | cellular response to toxic substance | biological process | GO:0097237 | 127 | 2 | 18204 | 49 |
APOE,IPCEF1 |
4.591e-02 | -3.08 | CDC25B (cell division cycle 25B) | protein interactions | 994 | 133 | 2 | 19454 | 50 |
PIK3CB,PRKCD |
4.596e-02 | -3.08 | ErbB signaling pathway | KEGG pathways | hsa04012 | 85 | 2 | 7161 | 29 |
PIK3CB,PLCG2 |
4.596e-02 | -3.08 | ErbB signaling pathway | KEGG pathways | ko04012 | 85 | 2 | 7161 | 29 |
PLCG2,PIK3CB |
4.615e-02 | -3.08 | skin-malignant_melanoma | COSMIC cancer mutations | skin-malignant_melanoma | 15741 | 46 | 16828 | 46 |
PARVG,EHBP1L1,IRF5,WDFY4,DOCK8,DENND1B,SLC4A2,RGS14,ADCY7,GIT2,MYO1F,PTPN6,ELMO1,VAV3,APOE,RIN3,GLIPR1,P2RY2,P2RY6,SYK,AKAP13,RHBDF2,IL6R,CD74,TBC1D8,NEK6,PREX1,ARHGAP27,IPCEF1,ARHGAP33,SEMA4A,DOCK10,GMIP,SKAP1,SBNO2,HIF1A,PIK3R5,DOCK1,PRKCD,DOCK2,PIK3CB,CSF1R,PLCG2,WAS,TBXAS1,MICAL1 |
4.621e-02 | -3.07 | adenyl ribonucleotide binding | molecular function | GO:0032559 | 1528 | 8 | 18094 | 48 |
NRK,PRKCD,PIK3CB,NEK6,CSF1R,MYO1F,SYK,ADCY7 |
4.652e-02 | -3.07 | response to inorganic substance | biological process | GO:0010035 | 505 | 4 | 18204 | 49 |
PLCG2,ADCY7,HIF1A,PRKCD |
4.652e-02 | -3.07 | monoatomic cation homeostasis | biological process | GO:0055080 | 505 | 4 | 18204 | 49 |
HIF1A,APOE,PIK3CB,SLC4A2 |
4.655e-02 | -3.07 | regulation of protein binding | biological process | GO:0043393 | 128 | 2 | 18204 | 49 |
PRKCD,APOE |
4.671e-02 | -3.06 | heparan sulfate proteoglycan binding | molecular function | GO:0043395 | 18 | 1 | 18094 | 48 |
APOE |
4.673e-02 | -3.06 | DENN | pfam domains | PF02141 | 17 | 1 | 17795 | 50 |
DENND1B |
4.673e-02 | -3.06 | Thyroglobulin_1 | pfam domains | PF00086 | 17 | 1 | 17795 | 50 |
CD74 |
4.673e-02 | -3.06 | PI-PLC-X | pfam domains | PF00388 | 17 | 1 | 17795 | 50 |
PLCG2 |
4.698e-02 | -3.06 | PI3_4_KINASE_1 | prosite domains | PS00915 | 13 | 1 | 12186 | 45 |
PIK3CB |
4.704e-02 | -3.06 | PROTEIN_KINASE_TYR | prosite domains | PS00109 | 94 | 2 | 12186 | 45 |
CSF1R,SYK |
4.720e-02 | -3.05 | response to organophosphorus | biological process | GO:0046683 | 129 | 2 | 18204 | 49 |
P2RY2,P2RY6 |
4.738e-02 | -3.05 | regulation of clathrin-dependent endocytosis | biological process | GO:2000369 | 18 | 1 | 18204 | 49 |
PIK3CB |
4.738e-02 | -3.05 | regulation of granulocyte macrophage colony-stimulating factor production | biological process | GO:0032645 | 18 | 1 | 18204 | 49 |
SYK |
4.738e-02 | -3.05 | angiogenesis involved in wound healing | biological process | GO:0060055 | 18 | 1 | 18204 | 49 |
PIK3CB |
4.738e-02 | -3.05 | positive regulation of neuroinflammatory response | biological process | GO:0150078 | 18 | 1 | 18204 | 49 |
PLCG2 |
4.738e-02 | -3.05 | antifungal innate immune response | biological process | GO:0061760 | 18 | 1 | 18204 | 49 |
PLCG2 |
4.738e-02 | -3.05 | morphogenesis of an epithelial fold | biological process | GO:0060571 | 18 | 1 | 18204 | 49 |
HIF1A |
4.738e-02 | -3.05 | dendritic spine morphogenesis | biological process | GO:0060997 | 18 | 1 | 18204 | 49 |
DOCK10 |
4.738e-02 | -3.05 | gamma-delta T cell activation | biological process | GO:0046629 | 18 | 1 | 18204 | 49 |
SYK |
4.738e-02 | -3.05 | regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002923 | 18 | 1 | 18204 | 49 |
PTPN6 |
4.738e-02 | -3.05 | cell-cell junction maintenance | biological process | GO:0045217 | 18 | 1 | 18204 | 49 |
CSF1R |
4.738e-02 | -3.05 | positive regulation of vascular endothelial growth factor receptor signaling pathway | biological process | GO:0030949 | 18 | 1 | 18204 | 49 |
HIF1A |
4.752e-02 | -3.05 | Nucleotide_cyclase | interpro domains | IPR029787 | 18 | 1 | 18521 | 50 |
ADCY7 |
4.752e-02 | -3.05 | PI3/4_kinase_cat_dom | interpro domains | IPR000403 | 18 | 1 | 18521 | 50 |
PIK3CB |
4.752e-02 | -3.05 | CRIB_dom | interpro domains | IPR000095 | 18 | 1 | 18521 | 50 |
WAS |
4.752e-02 | -3.05 | WH2_dom | interpro domains | IPR003124 | 18 | 1 | 18521 | 50 |
WAS |
4.752e-02 | -3.05 | A/G_cyclase | interpro domains | IPR001054 | 18 | 1 | 18521 | 50 |
ADCY7 |
4.774e-02 | -3.04 | SLITRK3 (SLIT and NTRK like family member 3) | protein interactions | 22865 | 19 | 1 | 19454 | 50 |
RHBDF2 |
4.774e-02 | -3.04 | PEX2 (peroxisomal biogenesis factor 2) | protein interactions | 5828 | 19 | 1 | 19454 | 50 |
PTPN6 |
4.774e-02 | -3.04 | CSF1 (colony stimulating factor 1) | protein interactions | 1435 | 19 | 1 | 19454 | 50 |
CSF1R |
4.774e-02 | -3.04 | LTC4S (leukotriene C4 synthase) | protein interactions | 4056 | 19 | 1 | 19454 | 50 |
PRKCD |
4.774e-02 | -3.04 | ZNF197 (zinc finger protein 197) | protein interactions | 10168 | 19 | 1 | 19454 | 50 |
HIF1A |
4.774e-02 | -3.04 | RCVRN (recoverin) | protein interactions | 5957 | 19 | 1 | 19454 | 50 |
GIT2 |
4.774e-02 | -3.04 | SIT1 (signaling threshold regulating transmembrane adaptor 1) | protein interactions | 27240 | 19 | 1 | 19454 | 50 |
SYK |
4.774e-02 | -3.04 | PDP2 (pyruvate dehydrogenase phosphatase catalytic subunit 2) | protein interactions | 57546 | 19 | 1 | 19454 | 50 |
PRKCD |
4.774e-02 | -3.04 | PPRC1 (PPARG related coactivator 1) | protein interactions | 23082 | 19 | 1 | 19454 | 50 |
PRKCD |
4.779e-02 | -3.04 | PYGB (glycogen phosphorylase B) | protein interactions | 5834 | 136 | 2 | 19454 | 50 |
PRKCD,FYB1 |
4.779e-02 | -3.04 | SNX9 (sorting nexin 9) | protein interactions | 51429 | 136 | 2 | 19454 | 50 |
WAS,PIK3R5 |
4.779e-02 | -3.04 | NAF1 (nuclear assembly factor 1 ribonucleoprotein) | protein interactions | 92345 | 136 | 2 | 19454 | 50 |
SYK,RIN3 |
4.791e-02 | -3.04 | LDHA (lactate dehydrogenase A) | protein interactions | 3939 | 317 | 3 | 19454 | 50 |
DOCK8,HIF1A,RIN3 |
4.791e-02 | -3.04 | RANBP2 (RAN binding protein 2) | protein interactions | 5903 | 317 | 3 | 19454 | 50 |
AKAP13,RHBDF2,WAS |
4.793e-02 | -3.04 | Regulation of IFNG signaling | REACTOME pathways | R-HSA-877312 | 14 | 1 | 10285 | 36 |
PTPN6 |
4.793e-02 | -3.04 | DCC mediated attractive signaling | REACTOME pathways | R-HSA-418885 | 14 | 1 | 10285 | 36 |
DOCK1 |
4.794e-02 | -3.04 | Composition of Lipid Particles | WikiPathways | WP3601 | 10 | 1 | 5310 | 26 |
APOE |
4.797e-02 | -3.04 | Signaling events mediated by TCPTP | Pathway Interaction DB | tcptp_pathway | 36 | 2 | 2226 | 22 |
CSF1R,PIK3CB |
4.828e-02 | -3.03 | TRIM54 (tripartite motif containing 54) | protein interactions | 57159 | 318 | 3 | 19454 | 50 |
NEK6,ELMO1,PARVG |
4.852e-02 | -3.03 | digestive tract development | biological process | GO:0048565 | 131 | 2 | 18204 | 49 |
HIF1A,SLC4A2 |
4.864e-02 | -3.02 | Phosphatidylinositol 3-/4-kinase, catalytic domain | gene3d domains | 1.10.1070.11 | 15 | 1 | 14470 | 48 |
PIK3CB |
4.864e-02 | -3.02 | CAP | gene3d domains | 3.40.33.10 | 15 | 1 | 14470 | 48 |
GLIPR1 |
4.864e-02 | -3.02 | - | gene3d domains | 2.60.200.10 | 15 | 1 | 14470 | 48 |
IRF5 |
4.865e-02 | -3.02 | GCN1 (GCN1 activator of EIF2AK4) | protein interactions | 10985 | 319 | 3 | 19454 | 50 |
NEK6,HIF1A,P2RY6 |
4.916e-02 | -3.01 | defense response to bacterium | biological process | GO:0042742 | 306 | 3 | 18204 | 49 |
IL6R,SYK,PRKCD |
4.937e-02 | -3.01 | positive regulation of cellular component biogenesis | biological process | GO:0044089 | 515 | 4 | 18204 | 49 |
SKAP1,PLCG2,SEMA4A,SYK |
4.940e-02 | -3.01 | ACTA1 (actin alpha 1, skeletal muscle) | protein interactions | 58 | 321 | 3 | 19454 | 50 |
EHBP1L1,HIF1A,PRKCD |
4.941e-02 | -3.01 | PI3_PI4_kinase | pfam domains | PF00454 | 18 | 1 | 17795 | 50 |
PIK3CB |
4.941e-02 | -3.01 | Guanylate_cyc | pfam domains | PF00211 | 18 | 1 | 17795 | 50 |
ADCY7 |
4.945e-02 | -3.01 | lung-carcinoid-endocrine_tumour-atypical | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour-atypical | 508 | 4 | 16828 | 46 |
CSF1R,SYK,PRKCD,NEK6 |
4.968e-02 | -3.00 | MON2 (MON2 homolog, regulator of endosome-to-Golgi trafficking) | protein interactions | 23041 | 139 | 2 | 19454 | 50 |
P2RY6,HIF1A |
4.968e-02 | -3.00 | HOMEZ (homeobox and leucine zipper encoding) | protein interactions | 57594 | 139 | 2 | 19454 | 50 |
NEK6,PARVG |
4.985e-02 | -3.00 | positive regulation of adaptive immune response | biological process | GO:0002821 | 133 | 2 | 18204 | 49 |
DENND1B,SKAP1 |
4.985e-02 | -3.00 | positive regulation of endothelial cell migration | biological process | GO:0010595 | 133 | 2 | 18204 | 49 |
PIK3CB,HIF1A |
4.992e-02 | -3.00 | Longevity regulating pathway | KEGG pathways | hsa04211 | 89 | 2 | 7161 | 29 |
ADCY7,PIK3CB |
4.995e-02 | -3.00 | alpha-beta T cell lineage commitment | biological process | GO:0002363 | 19 | 1 | 18204 | 49 |
IL6R |
4.995e-02 | -3.00 | adenylate cyclase-activating adrenergic receptor signaling pathway | biological process | GO:0071880 | 19 | 1 | 18204 | 49 |
AKAP13 |
4.995e-02 | -3.00 | leukotriene biosynthetic process | biological process | GO:0019370 | 19 | 1 | 18204 | 49 |
SYK |
4.995e-02 | -3.00 | positive regulation of reactive oxygen species biosynthetic process | biological process | GO:1903428 | 19 | 1 | 18204 | 49 |
PLCG2 |
4.995e-02 | -3.00 | chloride ion homeostasis | biological process | GO:0055064 | 19 | 1 | 18204 | 49 |
TBXAS1 |
4.995e-02 | -3.00 | regulation of amyloid-beta clearance | biological process | GO:1900221 | 19 | 1 | 18204 | 49 |
APOE |
4.995e-02 | -3.00 | positive regulation of macrophage chemotaxis | biological process | GO:0010759 | 19 | 1 | 18204 | 49 |
CSF1R |
4.995e-02 | -3.00 | negative regulation of alcohol biosynthetic process | biological process | GO:1902931 | 19 | 1 | 18204 | 49 |
APOE |
4.995e-02 | -3.00 | regulation of protein neddylation | biological process | GO:2000434 | 19 | 1 | 18204 | 49 |
HIF1A |
4.995e-02 | -3.00 | regulation of B cell apoptotic process | biological process | GO:0002902 | 19 | 1 | 18204 | 49 |
CD74 |
4.995e-02 | -3.00 | positive regulation of bone resorption | biological process | GO:0045780 | 19 | 1 | 18204 | 49 |
SYK |
4.995e-02 | -3.00 | regulation of mast cell activation | biological process | GO:0033003 | 19 | 1 | 18204 | 49 |
PTPN6 |
4.995e-02 | -3.00 | production of molecular mediator involved in inflammatory response | biological process | GO:0002532 | 19 | 1 | 18204 | 49 |
SYK |
4.995e-02 | -3.00 | negative regulation of cellular response to vascular endothelial growth factor stimulus | biological process | GO:1902548 | 19 | 1 | 18204 | 49 |
PIK3CB |
4.995e-02 | -3.00 | response to hydroperoxide | biological process | GO:0033194 | 19 | 1 | 18204 | 49 |
PRKCD |